[go: up one dir, main page]

TW200814928A - Fungicidal active compound combinations - Google Patents

Fungicidal active compound combinations Download PDF

Info

Publication number
TW200814928A
TW200814928A TW96110022A TW96110022A TW200814928A TW 200814928 A TW200814928 A TW 200814928A TW 96110022 A TW96110022 A TW 96110022A TW 96110022 A TW96110022 A TW 96110022A TW 200814928 A TW200814928 A TW 200814928A
Authority
TW
Taiwan
Prior art keywords
methyl
group
phenyl
formula
trifluoromethyl
Prior art date
Application number
TW96110022A
Other languages
Chinese (zh)
Inventor
Ulrike Wachendorff-Neumann
Peter Dahmen
Ralf Dunkel
Heiko Rieck
Joerg Nico Greul
Anne Suty-Heinze
Hans-Ludwig Elbe
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200610013784 external-priority patent/DE102006013784A1/en
Priority claimed from DE200610014723 external-priority patent/DE102006014723A1/en
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Publication of TW200814928A publication Critical patent/TW200814928A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The novel active compound combinations comprising a carboxamide of the general formula (I) (group 1) in which R, R1 and R2 are as defined in the description, And the active compound groups (2) to (26) listed in the description have very good fungicidal properties.

Description

200814928 九、發明說明: 【發明所屬之技術領域】 本發明關於新穎的活性化合物組合物,係包含 知的魏胺及第二類已知的具殺地活性化合物,這樣的 ^穎的活性化合物組合物極適於供控制不想要的植物病原 真菌。 > 【先前技術】 已知,某些的羧醯胺類具有殺真菌的性質:例如,得 10 知自W〇 2005/123689之队(3,,4,-二氟聯笨基_2_基w•甲基 -3-(三氟曱基)-1Η-吡唑羧醯胺以及得知自^ 2005/123690 之 N-(3,,4,-二氯聯苯基_2·基)_3_(二氟曱基η· 曱基-1Η-吡唑-4-羧醯胺,這些化合物之活性很好,然而在 低施用率下有時候不夠令人滿意;此外,已知有無數的嗟 15 唑衍生物、苯胺衍生物、二羧基亞醯胺(dicarboximides)及 _ 其他的雜環類’可被使用供控制真菌(參考:Ep_ a 〇 〇4〇 345,DE-A 22 01 063,DE-A 23 24 010,Pesticide Μ麵al,9th200814928 IX. OBJECTS OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to novel active compound compositions comprising a known sulphamine and a second known class of active compounds having a bactericidal activity, such active compounds. The material is extremely suitable for controlling unwanted plant pathogenic fungi. > [Prior Art] It is known that certain carboguanamines have fungicidal properties: for example, a team of 10 known from W〇2005/123689 (3,4,-difluorolinked stupid base_2_ W+methyl-3-(trifluoromethyl)-1Η-pyrazole carboxamide and N-(3,4,-dichlorobiphenyl-2·yl) from ^2005/123690 _3_(difluorodecyl η· decyl-1 Η-pyrazole-4-carboxyguanamine, these compounds have good activity, but are sometimes not satisfactory at low application rates; in addition, countless bismuths are known. 15 Azoline derivatives, aniline derivatives, dicarboxyboximides and other heterocyclics can be used to control fungi (Reference: Ep_ a 〇〇4〇345, DE-A 22 01 063, DE -A 23 24 010,Pesticide al面al,9th

Edition (1991),249 及 827 頁,EP_A〇 382 375 及 Ep_A〇 515 901),然而,這些化合物的作用在低施用率下同樣地常有不 20 足。 【發明内容】 我們目兩已發現種具有極佳的殺真菌的性質新穎的 活性化合物組合物,且其係包含第i類之具式⑴的羧醯胺 200814928Edition (1991), pages 249 and 827, EP_A 382 382 375 and Ep_A 〇 515 901), however, the effects of these compounds are often similarly low at low application rates. SUMMARY OF THE INVENTION We have found novel active compound compositions having excellent fungicidal properties, and which comprise a carboxamide of formula i (1) 200814928

其中 R 代表氫或氟, R1代表齒素,Ci-C^烷基,CVC6-鹵基烷基,氰基,硝基, CrCy烷氧基,具有1至7個氟,氯及/或溴原子之 CrC3-鹵基-燒氧基或代表_c(R4)=N-OR5, R2代表氫,鹵素,CrCV烷基,Q-CV鹵基烷基,氰基, 石肖基,燒氧基’或代表具有1至7個氟,氣及/ 或漠原子之C1-C3-鹵基烧氧基, R4代表氫或甲基’ R5代表crc5-烷基,CrC5-烯基或CrC5-炔基, 以及至少一種挑選自下述第(2)類至第(26)類的活性化合 物: ^£7}jL 具式(II)之史匕Wherein R represents hydrogen or fluorine, R1 represents dentate, Ci-C^alkyl, CVC6-haloalkyl, cyano, nitro, CrCy alkoxy, having from 1 to 7 fluorine, chlorine and/or bromine atoms CrC3-halo-alkoxy or represent _c(R4)=N-OR5, R2 represents hydrogen, halogen, CrCV alkyl, Q-CV haloalkyl, cyano, schishyl, alkoxy' or a C1-C3-halo alkoxy group having 1 to 7 fluorine, gas and/or a desert atom, R4 representing hydrogen or methyl 'R5 representing a crc5-alkyl group, a CrC5-alkenyl group or a CrC5-alkynyl group, and at least An active compound selected from categories (2) to (26) below: ^£7}jL History of formula (II)

其中 A1 代表下述基之一 200814928Where A1 represents one of the following bases: 200814928

A2 代表NH或0, A3 代表N或CH, 5 L 代表下述基之一 R12 *产*八^0丫" *八〆〆、 N^N CH3 CH3 其中以星號(*)標示的鍵係附接至苯基環上, I0 Ru代表笨基,苯亞曱基,苯氧基或吼啶基,各為選擇地 經一或二個相同或相異的,挑選自包括氣,氰基,曱 基及三氟曱基之取代基取代,或代表1-(4-氣苯基)吼唑 -3-基或代表1,2-丙二嗣-雙(0-曱基肪)-1-基’ R12代表氫或氟; 15 第(3)類 具式(III)之三唑類(Triazoles)A2 represents NH or 0, A3 represents N or CH, and 5 L represents one of the following groups: R12 *Production *8^0丫" *Bagua, N^N CH3 CH3 Among them, the bond marked with an asterisk (*) Attached to the phenyl ring, I0 Ru represents a stupid group, a benzylidene group, a phenoxy group or an acridinyl group, each of which is optionally one or two identical or different, selected from the group consisting of a gas, a cyano group, Substituted by a substituent of a fluorenyl group and a trifluoromethyl group, or represents 1-(4-phenylphenyl)oxazol-3-yl or represents 1,2-propanedi-bis(0-fluorenyl)-1- The base 'R12 stands for hydrogen or fluorine; 15 the third class (III) triazoles of formula (III)

鱼 R14 20 其中 Q 代表氫或SH, m 代表0或1, R13代表氫,氟,氣,苯基或4-氯苯氧基, R14代表氫或氣, 200814928 A代表一種直接鍵…CH2….(CH2)2·或_〇_,代 *-ch2-chr丨'或’其中以*號標示的 接至苯環, 5 其中 R15 及 R17-起代表-CH2-CH2-CH[CH(CH3)2;H ° -CH2-CH2-C(CH3)2·, ’ A5 代表C或Si(矽), A 也代表-N(R17)-及A5也一起與Rb及R!6代表 ON-R18之基,其中一起代表下面之基:Fish R14 20 wherein Q represents hydrogen or SH, m represents 0 or 1, R13 represents hydrogen, fluorine, gas, phenyl or 4-chlorophenoxy, R14 represents hydrogen or gas, and 200814928 A represents a direct bond...CH2.... (CH2)2· or _〇_, behalf of *-ch2-chr丨' or 'where the number marked with * is attached to the benzene ring, 5 where R15 and R17- represent -CH2-CH2-CH[CH(CH3) 2;H ° -CH2-CH2-C(CH3)2·, ' A5 stands for C or Si(矽), A also stands for -N(R17)- and A5 also together with Rb and R!6 stands for ON-R18 Base, which together represent the following base:

Vs 口 ,其中以*號標示的鍵係附接至rI7,Vs port, where the key chain marked with * is attached to rI7,

Rl5代表氫,羥基或氰基,Rl5 represents hydrogen, hydroxy or cyano,

Rl6代表1-環丙基乙基,κ氣環丙基,CrQ•烷基,Ci_c『 赵基烧基’ CrCr烧基幾基,CVC2·齒基烧氧基-CVCV b烷基,三甲基矽烷基_Cl_c2-烷基,單氟苯基或苯基, R 5 及 R16 尚一起代表 _〇-CH2_CH(Ri8)-〇_,_〇 Ch2_ CH(R18)-〇V,-0-CH(0CH2CF3HCH2)2-或-0-CH-(2· 氣苯基)-, A,A5及R15尚一起代表、CH=C>,其中以*號標示的鍵係 附接至笨基環, , ^18代表氫,CrC4-烷基或溴; ——具式(I V)之次續酿胺類(Sulphenamides) 20 (IV) 200814928 fci2c、Rl6 stands for 1-cyclopropylethyl, κ gas cyclopropyl, CrQ•alkyl, Ci_c 『Zhaojiaki' CrCr alkyl group, CVC2·dentate alkoxy-CVCV b alkyl, trimethyl矽alkyl_Cl_c2-alkyl, monofluorophenyl or phenyl, R 5 and R16 together represent _〇-CH2_CH(Ri8)-〇_,_〇Ch2_ CH(R18)-〇V,-0-CH( 0CH2CF3HCH2)2- or -0-CH-(2·gasphenyl)-, A, A5 and R15 are also represented together, CH=C>, wherein the bond marked with an * is attached to the stupid base ring, ^ 18 represents hydrogen, CrC4-alkyl or bromine; - Sulphenamides of formula (IV) 20 (IV) 200814928 fci2c,

ch3 其中R19代表氫或甲基; 挑潠自下诫之纈胺醯胺類(Valinamides): (5-1)異丙菌胺(iprovalicarb) (5、2) 妒-〇(4- {[3-(4-氣苯基)-2-丙炔基]氧}冬甲氧基苯 基)乙基]-7V2-(曱基磺醯基)-D-纈胺醯胺 (5'3)苯σ塞菌胺(benthiavalicarb) &-A式(V)之# 感胺類(Carboxamides) 〇 人 /丫、 (V)Ch3 wherein R19 represents hydrogen or methyl; Valinamides from the lower jaw: (5-1) Iprovalicarb (5, 2) 妒-〇 (4- {[3 -(4-Phenylphenyl)-2-propynyl]oxy}methoxyphenyl)ethyl]-7V2-(indolylsulfonyl)-D-decylamine (5'3)benzene σ 塞 val ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben ben

χ/^Ν 、Z 其中 15 X代表2_氯-3_响啶基,代表2,4-二氯-3-处啶基,代表在 馨 3位置經甲基,一氟甲基或三氣甲基取代且於^位置 經氫或氯取代之1_甲基吡唑_4_基,代表4_乙基_2_乙基 胺基-1,3-噻唑_5_基,代表2_甲基_4_三氟甲基_丨,3_噻^ I基’代表h甲基環己基,代表2,2_二氯小乙基冬 2〇 T基環丙基,代表2_氟_2_丙基,3,4-二氯異嗟唾·5_基, 5_,6二二氫-2-甲基+4-氧硫雜環_3_基,4,4_二氧代_5,6_ 二氫·1,4-氧硫雜環_3_基,4_甲基山2,3•噻二唑_5_基’, 4’5 一曱基_2_二甲基石浅基嘆吩各基’卜曱基吼洛·]· 基’其在4·位置經甲基或曱基取代且於5_位置經 200814928 氫或氯取代,或代表經一至三個相同或相異的挑選自 匕括氣’甲基及二氟甲基之取代基取代之苯基,或代 表甲基吱喃-3-基, Y代表一種直接鍵,選擇地經氯,氰基或氧代基之取代 基取代之CrC6_烷二基(亞烷基),代表仏<6_烯二基(亞 烯基)或硫苯二基, Z 代表鼠’ Ci-Cg-烧基或下面之基:χ/^Ν, Z wherein 15 X represents 2_chloro-3-cyanodinyl, which represents 2,4-dichloro-3-pyridinyl, which represents methyl, monofluoromethyl or tri-gas at the position of Xin 3 a 1-methylpyrazole-4-yl group substituted with a methyl group at the position of hydrogen or chlorine, representing a 4-ethyl-2-ethylamino-1,3-thiazole _5- group, representing 2_ Methyl 4-1,4-trifluoromethyl 丨, 3 thia thiol I represents 'h methylcyclohexyl, which stands for 2,2-dichloroethylidene 2〇T-cyclopropyl, representing 2_fluoro_ 2_propyl, 3,4-dichloroisoindolyl 5-yl, 5_,6 didihydro-2-methyl+4-oxathiohetero-3-yl, 4,4-dioxo 5,6_ Dihydro-1,4-oxothioheterocyclyl-3-yl, 4-methylammonium 2,3•thiadiazole_5_yl', 4'5-mercapto-2_dimethylstone shallow group叹 各 ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' a phenyl group substituted with a substituent of 'methyl and difluoromethyl, or a methyl indol-3-yl group, Y representing a direct bond, optionally substituted with a chloro, cyano or oxo group Substituted CrC6-alkyldiyl (alkylene), Represents 仏<6-enediyl(alkenylene) or thiophenyldiyl, and Z represents a murine 'Ci-Cg-alkyl group or a group below:

A6 代表 CH,CBr 或 N, 2 0 R 代表氫,氣,溴,氰基或crcv烷基,選擇地經一或 二個相同或相異的挑選自包括氯及二(crc3-燒基)胺 基羰基之取代基取代之苯基,或代表可經甲基取代之 環丙基-環丙基, r21代表氫,氯或異丙氧基, R 代表氫,氯,溴,羥基,甲基,三氟曱基,三氟甲氧 基,或二(crc3-烷基)胺基羰基, R20 及 R21 也一起代表 *-CH(CH3)-CH2-C(CH3)2-或 *_CH(CH3)_0-C(CH3)2·,其中以*號標示的鍵係附接至 R20 ; 羞IZ)類 挑選自下述之二硫胺基甲酸酯類: (7-1)鋅猛乃浦(mancozeb) (7-2) I孟乃浦(maneb) -11 - 200814928 (7-3)免得爛(metiram) (7-4) 曱基鋅乃浦(propineb) (7-5)得恩地(thiram) (7-6)鋅乃浦(zineb) (7刀)福美鋅(ziram) 第(8)類 具式(VI)之醯基丙胺酸類(Acylalanines)A6 represents CH, CBr or N, 2 0 R represents hydrogen, gas, bromine, cyano or crcv alkyl, optionally selected from one or two identical or different selected from the group consisting of chlorine and bis(rcc3-alkyl)amine a phenyl group substituted with a substituent of a carbonyl group, or a cyclopropyl-cyclopropyl group which may be substituted by a methyl group, r21 represents hydrogen, chlorine or isopropoxy group, and R represents hydrogen, chlorine, bromine, hydroxy group, methyl group, Trifluorodecyl, trifluoromethoxy, or di(crc3-alkyl)aminocarbonyl, R20 and R21 together represent *-CH(CH3)-CH2-C(CH3)2- or *_CH(CH3) _0-C(CH3)2·, where the bond indicated by the * is attached to R20; the imaginary IZ) class is selected from the following dithiocarbamates: (7-1) Zinc Meng Nai Pu (mancozeb) (7-2) I Mengnai (maneb) -11 - 200814928 (7-3) ruin (metiram) (7-4) 曱基锌奈浦 (propineb) (7-5) thiram (7) -6) Zinb (Zineb) (7 knives) ziram (Acylalanines) (8)

1010

* 代表具R-或S-組態之一種碳原子,較佳地為呈現s 組態者, 23 R 代表笨甲基,呋喃基或曱氧基曱基; 15 弟(幻遞__具式(YJI)之本胺基°密咬類(Aflilinopyrimidiiies)* represents a carbon atom with R- or S-configuration, preferably for the s configurator, 23 R for the stupid methyl, furyl or decyl fluorenyl; 15 dior (YJI) of the amine-based bite class (Aflilinopyrimidiiies)

20 其中 R 代表曱基,環丙基或1-丙炔基; ^^&丄:具式(vim的1并咪唑類 -12- 200814928 t2720 wherein R represents fluorenyl, cyclopropyl or 1-propynyl; ^^&丄: has the formula (vim of 1 imidazoles -12- 200814928 t27

其中 R及R 各代表氫或一起代表_〇_Cf2_〇_, R代表氫,烧基胺基幾基或代表3,5-二甲基異嚼唾 -4-基續g藍基, R 代表氯,甲氧基幾基胺基,氯苯基,吱喃基或嘆唾基; M11M_具式(DO之胺基甲酸酯翻Wherein R and R each represent hydrogen or together represent _〇_Cf2_〇_, R represents hydrogen, alkylamino group or represents 3,5-dimethylisox-4-yl continued g blue, R Represents chlorine, methoxylamino, chlorophenyl, fluorenyl or sinyl; M11M_ has a formula (DO urethane turns)

Η 其中 R29代表正·或異丙基, R 代表—(Ci-C〗-烧基)胺基-C2-C4-烧基或二乙氧基苯基, 15 也包括這些化合物之鹽類; , 差(12)類—挑選自下述之二幾基亞醯胺類(Dicarboximides) ·· (12-1)四氯丹(captafol) (12_2)蓋普丹(eaptan) (12·3)福爾培(f〇ipet) 20 (H4)依普同(ipr〇di〇ne) (12-5)撲滅寧(proCymid〇ne) (12-6)免克寧(vincl〇z〇lin) 蓋illl類挑選自下述之胍類(Guanidines): 多寧(dodine) -13· 200814928 (13-2)克熱淨(guazatine) (13-3)雙胍辛胺三乙酸鹽(iminoctadine triacetate) (13-4)克熱淨(烧苯石黃酸鹽)[iminoctadine tris(albesilate)] (13-5)多寧(dodine (游離驗)) 5 (13-6)克熱淨(immoctadine)(游離驗) 第(14)類 選自下述之口来口坐類(Imidazoles) · (14-1)赛座滅(cyazofamid) | (14-2) (14-3 )三嗤唤(triazoxide) ίο (14-4)稻痕 g旨(pefurazoate) 盖(15)類具式(X)之嗎啉類(或其鹽類、Η wherein R29 represents n- or isopropyl, R represents —(Ci-C)-alkyl)amino-C2-C4-alkyl or diethoxyphenyl, and 15 includes salts of these compounds; Poor (12) - selected from the following Dicarboximides · (12-1) tetramdan (captafol) (12_2) eptan (12. 3)培(f〇ipet) 20 (H4) 依普同 (ipr〇di〇ne) (12-5) 灭宁宁(proCymid〇ne) (12-6) 免克宁(vincl〇z〇lin) 盖ill class Selected from the following Guanidines: dodine -13· 200814928 (13-2) guazatine (13-3) diinoctyl triacetate (im3-4) ) 克热净 (burning benzoate) [iminoctadine tris (albesilate)] (13-5) donin (dodine) 5 (13-6) gram heat (immoctadine) (free test) (14) Classes are selected from the following mouths (Imidazoles) · (14-1) Cytofamid | (14-2) (14-3) Triazoxide ίο (14- 4) pefurazoate cover (15) morpholine (or its salt) of formula (X)

15 其中 R31及R32彼此獨立地代表氫或甲基, R33代表CrC14-烷基(較佳地為C12-C14-烷基),c5_C12-環烧 基(較佳地為ClQ-Cirb烧基)’本基-C1-C4-燒基,其可 在苯基部位經鹵素或CrCV烧基取代或代表丙烯基, 其可經氯苯基及二甲氧基苯基取代; 第(10類 具式(XI)之峨口各類(Pyrroles;、 -14- 20 200814928 -35 τWherein R31 and R32 independently of each other represent hydrogen or methyl, R33 represents CrC14-alkyl (preferably C12-C14-alkyl), c5_C12-cycloalkyl (preferably ClQ-Cirb). a radical -C1-C4-alkyl group which may be substituted at the phenyl moiety with a halogen or CrCV alkyl group or a propylene group which may be substituted with a chlorophenyl group and a dimethoxyphenyl group; XI) of all kinds of mouth (Pyrroles;, -14-20 200814928 -35 τ

其中 5 R34代表氯或氰基, R35代表氣或确基, R36代表氯, | R35及R36尚可一起代表-0-CF2-0·; 第Π7)類 挑選自下述之(硫)膦酸酯類: ίο (17-1)福賽得-鋁(fosetyl·A1) (17-2)膦酸 (17-3)曱基立枯鱗(toldophos-methyl) 第Π8)類 具式(XII)之苯基乙醯胺類Wherein 5 R34 represents chlorine or cyano, R35 represents gas or determinate, R36 represents chlorine, | R35 and R36 together represent -0-CF2-0·; and Π7) are selected from the following (thio)phosphonic acid Ester: ίο (17-1) Forsythia-aluminum (fosetyl·A1) (17-2) phosphonic acid (17-3) sulphate sulphate (toldophos-methyl) Π8) genus (XII) Phenylethylamine

(ΧΠ) 其中 R37代表無取代的或經氟-,氯·,溴-,曱基_或乙基-取代的 20 苯基,2-萘基,1,2,3,4-四氫萘基或茚滿基; 第Π9)類選自下述之殺真菌劑類 (19-1)苯并嘆二嗤酯(acibenzolar-S-methy 1) (19-2)氯塞尼(chlorothalonil) (19-3)克絕(cymoxanil) -15- 200814928 (19-4)護粒松(edifenplios) (19-5)凡殺同(famoxadone) (19-6)伏寄南(fluazinam) (19-7)氯氧化銅(copper oxychloride) 5(ΧΠ) wherein R37 represents unsubstituted or substituted by fluorine-, chloro, bromo-, decyl- or ethyl-substituted 20 phenyl, 2-naphthyl, 1,2,3,4-tetrahydronaphthyl Or 茚满基; Π9) is selected from the following fungicides (19-1) acibenzolar-S-methy 1 (19-2) chlorothalonil (19) -3) cymoxanil -15- 200814928 (19-4) granules (edifenplios) (19-5) where fascinated (famoxadone) (19-6) volts south (fluazinam) (19-7) Copper oxychloride 5

10 1510 15

(19-8) 氫氧化銅 (19-9)歐殺斯(oxadixyl) (19-10)螺環菌胺(spiroxamine) (19-11)二硫 S 昆(dkhianon) (19-12)表苯菌酮(metrafenone) (19-13) 口米哇菌酮(fenamidone) (19-14) 2,3-二丁基-6-氯噻吩并[2,3-d]嘧啶-4(3H)-酮 (19-15)撲殺熱(probenazole) (19-16)稻痕靈(isoprothiolane) (19-17)嘉賜黴素(kasugamycin) (19·18)熱必斯(phthalide) (19-19)富米熱斯(ferimzone) (19-20)三賽嗤(tricyclazole) (19-21) N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-甲氧基 苯甲醯胺 (19-22) 2-(4-氯苯基)-N-{2-[3-f 氧基-4-(丙-2-炔-1-基氧) 苯基]乙基}丙-2-快-1 -基氧)乙酿胺 (19-23)快諾芬(quinoxyfen) 第(20)類挑選自下述之硫(脲)衍生物 (20-1)賓克隆(pencycuron) -16- 20 200814928 (20-2)曱基 _ 多保淨(thiophanate-methyl) (20-3)乙基-多保淨(thiophanate-ethyl) 第(21)類具式(XIII)之醯胺類(19-8) Copper hydroxide (19-9) oxadixyl (19-10) spiroxamine (19-11) disulfide S dkhianon (19-12) benzene Metrafenone (19-13) fenamidone (19-14) 2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)- Ketone (19-15) probenazole (19-16) isofothiolane (19-17) kasugamycin (19.18) phthalide (19-19) Fermizone (19-20) tricyclazole (19-21) N-({4-[(cyclopropylamino)carbonyl)phenyl}sulfonyl)-2-methyl Oxybenzamide (19-22) 2-(4-chlorophenyl)-N-{2-[3-f-oxy-4-(prop-2-yn-1-yloxy)phenyl] Ethyl}propan-2-fast-1 -yloxy)ethinamide (19-23) quinoxyfen (20) selected from the following sulfur (urea) derivative (20-1) clone (pencycuron) -16- 20 200814928 (20-2) 曱 _ thiophanate-methyl (20-3) ethyl-polyphanate-ethyl (21) class (XIII) Amidoxime

CICI

其中among them

10 A7 代表一種直接鍵或-〇-, A8 代表-C(=0)NH·或-NHC(=0)-, R38代表氫或CrC4-烷基, R39代表CrC6-烧基; ΆίΖΖΙΜ 具式(XIV)之三唑# 嘧啶類(Triazolopvrimidines) 1510 A7 represents a direct bond or -〇-, A8 represents -C(=0)NH· or -NHC(=0)-, R38 represents hydrogen or CrC4-alkyl, R39 represents CrC6-alkyl; ΆίΖΖΙΜ XIV) Triazoles (Triazolopvrimidines) 15

其中 r4Q代表CVCV烷基或CVCV烯基, R41代表CrC6-烷基, R4G及R41也一起代表經1或2個的CrC6-烷基取代代基取 代之C4-Cr烷二基(亞烷基), •R42代表溴或氣, R及R 彼此獨立地代表氮,氣’氯或甲基’ R及R 彼此獨立地代表氮或氣, -17- 20 200814928 R 代表氫,氟或甲基, 篇(23)類 具式(XV)之破代色 j^WIodochromones) 〇Wherein r4Q represents CVCV alkyl or CVCV alkenyl, R41 represents CrC6-alkyl, and R4G and R41 together represent C4-Cr alkanediyl (alkylene) substituted with 1 or 2 CrC6-alkyl substituents. , R42 represents bromine or gas, R and R independently represent nitrogen, and gas 'chloro or methyl' R and R independently of each other represent nitrogen or gas, -17-20 200814928 R represents hydrogen, fluorine or methyl, (23) The break of the type (XV) j^WIodochromones) 〇

其中 R 代表CrC6-烧基, R49代表CrC6·烷基,C2-C6-烯基或CVC6-炔基; ΜΙΖ^ύΜ 具式 iXVI)之聯茉某藉德胺類(Biphenylcarboxamides)Wherein R represents CrC6-alkyl, R49 represents CrC6.alkyl, C2-C6-alkenyl or CVC6-alkynyl; ΜΙΖ^ύΜ has the formula iXVI) of Biphenylcarboxamides

其中 15 R 代表氫或氟, _ R51代表氟,氯,溴,甲基,三氟甲基,三氟甲氧基, -CH=N-OMe 或-C(Me)=N-OMe, 52 R 代表氫,氟,氯,溴,甲基或三I曱基,Wherein 15 R represents hydrogen or fluorine, _ R51 represents fluorine, chlorine, bromine, methyl, trifluoromethyl, trifluoromethoxy, -CH=N-OMe or -C(Me)=N-OMe, 52 R Represents hydrogen, fluorine, chlorine, bromine, methyl or tri-anthracene,

Het代表下述Hetl至Het7基之一:Het represents one of the following Hetl to Het7 bases:

53 R 代表碘,甲基,二氟曱基或三氟甲基, -18- 200814928 R54代表氫,氟,氯或曱基, R55代表甲基,二氟甲基或三氟甲基, R56代表氯,溴,碘,甲基,二氟甲基或三氟曱基, R57代表甲基或三氟曱基; 5 其中具式(XVI)的聯笨基羧醯胺與具式⑴的羧醯胺是不同 的; 第(25)類具式(XVII)之烷基羧醯胺類53 R represents iodine, methyl, difluorodecyl or trifluoromethyl, -18- 200814928 R54 represents hydrogen, fluorine, chlorine or sulfhydryl, R55 represents methyl, difluoromethyl or trifluoromethyl, R56 represents Chlorine, bromine, iodine, methyl, difluoromethyl or trifluoromethyl, R57 represents methyl or trifluoromethyl; 5 wherein the biphenyl carbamide of formula (XVI) and the carboxy hydrazine of formula (1) The amines are different; the alkyl carboxamides of formula (25) having the formula (XVII)

1010

其中among them

Het的定義如前, R58代表氫或氟, 15Het is defined as before, R58 stands for hydrogen or fluorine, 15

R59代表氫,鹵素,CrC3-烧基或具有1至7個的氟,氯及 /或溴原子之CrC3-鹵基烷基, 第(26)類具式(XVIII)之烷基羧醯胺類R59 represents hydrogen, halogen, CrC3-alkyl or CrC3-haloalkyl having 1 to 7 fluorine, chlorine and/or bromine atoms, and alkylcarboxamide having the formula (XVIII) of (26)

其中 r6()代表氫或氟, -19- 20 200814928 R代表氫,鹵素,Ci-C3-烷基或具有l至7個的氟,氯及 /或溴原子之cvc3-鹵基烷基。 A’代表下述A’l至A,8基之一Wherein r6() represents hydrogen or fluorine, and -19-20 200814928 R represents hydrogen, halogen, Ci-C3-alkyl or cvc3-haloalkyl having 1 to 7 fluorine, chlorine and/or bromine atoms. A' represents one of the following A'l to A, 8 bases

r62代表crc3-烷基, R 代表氫,鹵素,C1-C3-烷基或具有1至7個的氟,氣及 /或溴原子之crc3-鹵基烷基, r64代表氫,鹵素或CrC3-烷基, 15 R 5代表鹵素,CrCy烷基或具有1至7個的氟,氯及/或 ^ 溴原子之C1-C3-鹵基烧基, R 代表氬,鹵素或CrCy烧基,胺基,單-或二(crC3-烧 基)胺基, R 代表氫,鹵素,Ci_C3-烧基或具有1至7個的氟,氯及 20 /或溴原子之crc3-鹵基烷基, R 8代表鹵素,CrCV烧基或具有1至7個的氟,氯及/或 〉臭原子之C1-C3-鹵基烧基, r69代表鹵素,CrC3_烷基或具有1至7個的氟,氯及/或 漠原子之C1-C3- _基烧基, -20- 200814928 R7〇代表氳,鹵素,CrC3-烷基或具有1至7個的氟,氯及 /或溴原子之crc3-鹵基烷基。 5R62 represents crc3-alkyl, R represents hydrogen, halogen, C1-C3-alkyl or has 1 to 7 fluorine, gas and/or bromine atom crc3-haloalkyl, r64 represents hydrogen, halogen or CrC3- Alkyl, 15 R 5 represents halogen, CrCy alkyl or C1-C3-haloalkyl having 1 to 7 fluorine, chlorine and/or bromine atoms, R represents argon, halogen or CrCy alkyl, amine group , mono- or di(crC3-alkyl)amine, R represents hydrogen, halogen, Ci_C3-alkyl or a 1 to 7 fluoro, chloro and 20/ or bromo atomic crc3-haloalkyl, R 8 Represents halogen, CrCV alkyl or C1-C3-haloalkyl having 1 to 7 fluorine, chlorine and/or odor atoms, r69 representing halogen, CrC3_alkyl or having 1 to 7 fluorine, chlorine And/or C1-C3--based alkyl group of the atom, -20- 200814928 R7〇 represents hydrazine, halogen, CrC3-alkyl or crc3-halo having 1 to 7 fluorine, chlorine and/or bromine atoms alkyl. 5

10 1510 15

令人驚訝地,根據本發明的活性化合物組合物的殺真 菌的作用要比個別的活性化合物的活性之和大得多,於 是,有未被預期到的協乘效果存在,且非僅僅是相加的作 第(1)類的化合物以化學式(I)代表一般的定義。 較佳的式(I)之魏醯胺類為,其中 R 代表氫或氟, R1 代表氟,氯,溴,碘,曱基,乙基,正-丙基,異丙基, 三氟甲基,三氯甲基,氰基,甲氧基,乙氧基,正丙 氧基,異丙氧基,三氟曱氧基,三氯甲氧基或代表 -c(r4)=n-or5, R2 代表氫,氟,氯,溴,碘,曱基,乙基,正-丙基,異 丙基,三氟甲基,三氯曱基,氰基,甲氧基,乙氧基, 正丙氧基,異丙氧基,三氟甲氧基或代表三氯甲氧基, R4 代表氫或甲基, R5 代表CrC5_烷基。 特別佳的式⑴之羧醯胺類為,其中 R 代表氫或氟, R1代表氟,氯,曱基,三氟甲基,氰基,曱氧基,三氟 曱氧基,三氯曱氧基或代表-CH=N-OCH3, R2代表氫,氟,氯,曱基,三氟甲基,氰基,曱氧基, 三氟甲氧基或代表三氯甲氧基, -21 - 20 . 200814928 根據本發明的另一具體實施例中,較佳的具式⑴之後 酿胺類為其中R2基係位於聯苯基的遠端苯基環的2,_位置 者(鄰位於近侧的苯基環)。 式(I)包含特別是下述第(1)類之較佳的羧醯胺類(參 5 考:WO 2005/123689 及 WO 2005/123690): (1-1) N-(3,4 - 一氯聯苯基-2-基)-1-甲基-3-(三氟甲 基)-1Η』比备4-緩醯胺,(ι·2)Ν-(3、氯卓氟聯苯基基; _ 甲基-3-(三氟甲基)-1Η-吡唑羧醯胺,(1-3) N-(2,,4,-二氯聯 笨基-2-基)-1-甲基-3-(三氟甲基)·1Η_吡唑-4_羧醯胺,(1_4) Ν伐4’·二氟聯苯基-2-基)小甲基各(三說甲基)_m』比唑斗 羧醯胺,(1-5) N-(2,,5,-二氯聯苯基1基)小甲基各(三氣甲 基HH4嗤冰羧醯胺,(1_6)邮^二說聯苯基冬基)* 甲基-3-(二氟曱基)·1Η』比唾竣酿胺,(卜乃N_(4,·氯1說 聯笨基4基)-1-甲基|(三氟甲基HH•吼嗤*護醢胺,(卜0 15 队(心氣_2,-甲基聯笨基士基)小甲基冬(三敦曱基)_1H』比 • 唾+㈣胺,(1·9) 基聯苯基_2.基)]-甲基 =(三默甲基)-1Η-㈣-4遵酿胺,(1]〇) N书,备甲基聯 笨基-2-基)小曱基-3-(三氟甲私m•吼嗤*綾酿胺, 队(4’_敦_3’·甲基聯笨基1基)小甲基_3_(三敦甲基咣 唾冰賴胺,(1_12) N-(4,mr-甲基聯苯基冬基)+ 甲基-3-(二氟曱基)-ih』h4·敢酿胺,〇一⑶Νκ二氣 聯笨基-2-基)小甲基各(三氟甲基)m4-魏酿胺, (1-14) N-(2’-氣本甲氧基聯笨基·2_基)小甲基_3 _(三氟甲 基MH-口比冬4-羧醯胺,(1七)队(2,,6,_二氟聯苯基么基)小 -22 - 200814928 甲基各(三氟甲基)-lH-吡唑冬羧醯胺,(1-16)Ν-(3,,5,-二甲 基聯苯基-2-基)小曱基各(三氟甲基)_1H_吡唑-4-羧醯胺, 〇17) N-(4’-氯-3’-硝基聯苯基-2-基)-1-甲基_3-(三氟甲 基)-1Η-吼唑4-羧醯胺,(Μ8)Ν-[3\5,-雙(三氟甲基)聯苯基 5 冬基l·1,甲基各(三氟甲基)-lH-吡唑-4-羧醯胺,(1-19) Ν-(3,4 -一甲基聯苯基-2-基)-1-甲基-3-(三氟甲基坐 -4-羧醯胺,(1-20) 1-甲基硝基-3,-(三氟甲基)聯苯基 | -2-基]各(三氟甲基)-1Η^比唑-4-叛醯胺,(1-21) Ν-(4,-甲氧基 -3’-甲基聯苯基-2-基)_1-甲基-3-(三敗甲基緩醯 ίο 胺,二曱氧基聯苯基-2-基)-1-甲基-3-(三氟曱 基)-1Η-吼唑‘羧醯胺’(1·23)Ν-(3,-氟_4,-甲氧基聯苯基-2-基)小曱基-3 -(三氟甲基)-1ΙΚ唾-4-羧酿胺,.(1-24) Ν-(4,_ 氯-3’-甲氧基聯苯基冬基)小甲基_3-(三氟曱基)·1Η^比唑本 綾酿胺,(1-25) Ν·[4’_氯-3’-(三氟曱基)聯苯基·2_基]小甲基 15 -3_(三氟曱基)-1Η^比峻-4-羧醯胺,(1-26) Ν-(3,,5,-二氯聯苯 _ 基-2-基)-1-甲基-3-(三氟曱基比哇-4-叛酿胺,(1-27) >Η4,-甲氧基-2,_甲基聯苯基-2-基)_1_甲基·3_(三氟甲 基)-1Η-吡唑4-羧醯胺,(1-28)Ν-(3,,4^二氯聯笨基_2_基)小 曱基-3-(二氟曱基坐_4·魏酿胺,(1_29) N-(3,-氣-4,· 20 氟聯苯基冬基)-1•甲基-3-(二氣甲基比哇-4-緩醯胺, (1_30) N-(2f,4’-二氯聯苯基-2-基)小甲基_3_(二氟甲基)·ΐΗ_ 吡唑冰羧醯胺,(1-31) N-(3,,4,-二氟聯苯基士基)小甲基 -M二氟甲基)-1Η-°比唑-4-羧醯胺,(1·32) N-(2,,5,-二氯聯笨 基冬基)小甲基-3-(二氟甲基)-111-%唑_4-羧酿胺,(卜33) -23- 200814928 N-(2f,5’-二氟聯苯基-2-基)-1-甲基-3-(二氟甲基)_1Η-ϋ比唑 羧醯胺,(I-34) Ν·(4,-氯-2,·1聯苯基1基)+甲基各(二氟 甲基ΗΗ·-比唑-4-羧醯胺,(l-35)N-(4,-氣_2,_甲基聯苯基_2_ 基)-l-曱基-3-(二氟甲基)-lH-吡唑-4-綾醯胺,(1_36)N-(4f_ 5 氯-3 -甲基聯苯基-2-基)-1-甲基-3-(二氟甲基坐冰羧 醯胺,(1·37)队(4,-氟_2,-甲基聯苯基j基)小曱基各(二氟 甲基)-1Η^比唑冰羧醯胺,(1-38)义(4,-氟-3,_曱基聯苯基_2_ | 基)-1-甲基冬(二氟甲基)-1Η-ϋ比嗤-4-緩驗胺,(1_39) Ν-(4,_ 氯-3’-氟-2’-甲基聯苯基-2-基)-1-曱基各(二氟甲基)_道_吼唾 ίο -4-羧酿胺 ’(1-40) N-(2’,4’-二氟聯苯基-2-基)-1_ 甲基_3_(二氣^ 甲基)-1Η-吡唑冰羧醯胺,(1-41) N-(2,-氟-4’-甲氧基聯笨基 -2-基)-1-甲基 _3-(二氟甲基羧酿胺,(1-42) Ν-ΡΆ1-一氟聯苯基-2-基)-1-甲基-3-(二 I 甲基坐-4· 羧醯胺,(1-43) N-(3f,5,-二甲基聯苯基-2-基)小曱基-3-(二說 is 甲基)-1Η-吡唑-4-羧醯胺,(1·44) N-(4,-氯-3’·硝基聯苯基-2- _ 基)小甲基各(二氟甲基)-1Η-吡唑-4-羧醯胺,(1-45) N-[3,,5,- 雙(二氟甲基)聯苯基-2-基]-1-曱基-3-(二說甲基唾 -4-羧醯胺,(1-46) Ν-(3’,4’-二甲基聯苯基-2-基)-1-甲基-3-(二 氟甲基)-1Η-吡唑-4-羧醯胺,(1-47) 1-曱基-N-[4,-硝基-3H三 2〇 氟甲基)聯苯基-2-基]-3-(二氟曱基)-1Η^比唑-4-羧醯胺, (1-48) N-(4’-甲氧基-3’-甲基聯苯基-2-基)-1-甲基-3-(二氟甲 基)-1Η-吡唑-4-羧醯胺,(1·49) N-(3’,4’-二甲氧基聯苯基-2-基)-1-甲基-3-(二氟甲基)-1Η·吼唑-4-羧醯胺,(1-50) N-(3’-氟甲氧基聯苯基-2-基)小曱基-3-(二氟甲基ΜΗ-吼唑-4- -24- 200814928 羧醯胺,(1_51) N-(4,-氯-3,·甲氧基聯苯基·2-基)小甲基 各(二氟甲基)-1Η』比唑|羧醯胺,(1-52) N-[4f-氯-3,-(三氟 曱基)聯苯基冬基]小甲基各(二氟甲基)-1Η^比唑-4-羧醯 胺’(1-53) Ν-(3’,5,-二氯聯苯基_2_基)小曱基各(二氟甲 基)-1Η-吡唑-4-羧醯胺,(1-54) Ν-(4,·甲氧基-2,-甲基聯苯基 -2-基)小曱基冬(二氟曱基)_ΐΗ-π比唑_4_羧醯胺,(1-55) 3-(二 氟甲基[⑹-(甲氧基亞胺基)甲基]-u,-聯苯基 -2-基}小甲基-1仏吡唑羧醯胺,(1-56) 3兴三氟甲 基[(五)-(曱氧基亞胺基)曱基]_;[,;[,-聯苯基_2_ 基}-1-甲基-1//-吡唑-4-羧醯胺,[(五)-(甲氧基亞 胺基)甲基]-聯苯基-2-基}小曱基冬(三氟曱基)-1//-吡唑4-羧醯胺,(1_58) >(二氟甲基)善《4,_[⑹彳曱氧基亞胺基)甲 基]聯苯基_2_基}小曱基-1乐。比唑冰羧醯胺,(1-59) [(五Μ正-丁氧基亞胺基)甲基]聯苯基-2-基}-1-甲基 -3-(三氟甲基)比唑-4-羧醯胺,(1-60) Ν-{4,-[(1Ζ)-Ν-乙 氧基乙醯亞胺基]聯苯基冬基}小甲基冬(三氟曱基)-1//-吡 唾4-羧醯胺,(1-61) 1-甲基-尽{4,-[(1Ζ)-Ν-丙氧基乙醯亞胺 基]聯苯基-2-基}3·(三氟甲基比ϋ坐-4-叛酸胺,(1-62) 1{44⑹-(異丙氧基亞胺基)曱基]聯苯基冬基}-]-甲基 -3-(三氟甲基)-1/^比唑_4_羧醯胺,(1_63)#-{4,-(£>(乙氧基 亞胺基)曱基}聯本基-2-基]-1-曱基-3-(三氣曱基)-1//-u比唾 -4-羧酸胺’(1-64) 1-曱基-翠{4,-[(£>(丙氧基亞胺基)曱基] 聯苯基-2-基卜3-(三氟曱基比唑_4_羧醯胺,(1-65) A^{44(1Z)-N-異丙氧基乙醯亞胺基]聯苯基_2_基卜1-甲基 -25- 200814928 冬(三氟甲基)-1及·吡唑-4-羧醯胺,(1-66) 7V-{4,_[(1Z)-N-丁 氧基乙醯亞胺基]聯苯基-2-基卜1-曱基-3-(三氟甲基)-1丹_观 唑-4-羧醯胺,(1-67),{3,-氯-4,-[(五)-(曱氧基-亞胺基)甲基] 聯本基-2-基}-1-甲基-3-(三氣甲基)-1//-°比嗤-4-綾酸胺, 5 (1-68) 曱氧基亞胺基)甲基]聯苯基-2-基}小甲基 冬(三氟甲基)-1私吡唑-4-羧醯胺,(1-69)尽{4,-[(1Ε)-Ν-甲 氧基乙醯亞胺基]聯苯基-2-基}-1-曱基-3-(三氟甲基)-1私吡 | 唑冰羧醯胺,(1-70) 7V-{3L氟-4’-[(£>(甲氧基亞胺基)甲基] 聯苯基-2-基}-1-甲基-3-(三氟甲基)-1丑-吡唑-4-羧醯胺, ίο U-71) Μ二氟甲基氟-4’-[(五)-(甲氧基亞胺基)曱基] 聯苯基-2-基}-1-甲基-1//-吡唑冬羧醯胺,(1-72) 環丙基甲氧基)亞胺基]甲基卜聯苯基_2-基)小 甲基各(三氟曱基)-m-吡唑-4-羧醯胺,(1-73) ?H4,-[(五Η丁 氧基亞胺基)甲基]聯苯基_2-基}-3-(二氟甲基)-1-曱基-1乐 15 啦唑-本羧醯胺,(1-74) 3-(二氟曱基)U4,-[(1E)-N-甲氧基 _ 乙醯亞胺基]聯笨基-2-基}-1_甲基-1//-吡唑_4_羧醯胺,(1-75) ’{3'氟-4’-[(五)-(丙氧基亞胺基)甲基]聯苯基_2-基}小甲基 -3-(三氟甲基)-1/^吡唑冬羧醯胺,(1_76) 3-(二氟甲 基氟-44(£>(丙氧基亞胺基)甲基]聯苯基_2-基}小 20 曱基―1#•吡唑l羧醯胺,(1-77),{2,-氯-4,-[(五)-(甲氧基亞 胺基)甲基]聯苯基-2-基卜1-曱基_3·(三氟甲基)-1开-。比唑-4-羧蕴胺,(1-78) I{3’H[(1E)-N-丙氧基乙醯亞胺基]聯苯 基-2-基}小甲基-3-(三氟甲基)·ιπ。比唑-4-羧醯胺,(1-79) 3-(二氟甲基)善{3,-氟-4,-[(1Ε)-Ν-丙氧基乙醯亞胺基]聯苯 -26 - 200814928 基-2-基}小甲基-1//-吼哇-4-魏醯胺,(1-80) 3-(二氟曱 基)-尽{3’-氟·4’-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2-基}小甲基-1好-°比唑-4-羧醯胺,(1-81) Λ^{3,_1-4,-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2-基}小曱基冬(三氟曱基)-1仄 吡唑-4-羧醯胺,(1-82),{3,-氯-4,-[(^)-:^-甲氧基乙醯亞胺 基]聯苯基-2-基}-3-(二氟甲基)-1·曱基比唾-4-羧:酿胺, (1-83) 氯-44(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2-基}-1_甲基-3-(三I甲基)-1//-°比嗤-4-緩蕴胺,(1-84) 3-(二氟 甲基Μ -甲基-ΑΜ4’-[⑹-(丙氧基亞胺基)曱基]聯苯基-2-基}-1丑-吼唑-4-羧醯胺,(1-85) ΛΓ-{4,-[(五)-(甲氧基亞胺基) 甲基]-31-甲基聯苯基-2-基}-1-甲基冬(三氟甲基)-1好-吼唑 冰羧醯胺,(1-86) 3-(二氟甲基)小甲基U4,-[(lE)-isl·丙氧 基乙醯亞胺基]聯苯基-2-基}-1//_吡唑-4-羧醯胺,(1-87) 3-(二氟曱基)-ΛΓ-{44(1 E)-N-異丙氧基乙醯亞胺基]聯苯基 -2-基}-1-曱基·ΐπ吡唑-4-羧醯胺,(1·88) Ν-(4,-{(Ζ)-[(烯丙 氧基)亞胺基]曱基}聯本基-2-基)-3-(二氟^甲基)-1 -甲基-1 吼唑-4-羧醯胺,(1-89)Ν-(4,-{(ΖΗ(烯丙氧基)亞胺基]甲基} 聯苯基-2-基)-1·甲基-3-(三氟曱基)-1//-吼唑-4-羧醯胺, (1-90) 3-(二氟甲基[(五)-(甲氧基亞胺基)曱基]·3’-甲 基聯本基-2-基}-1-曱基-1//- ϋ比嗤-4-叛酿胺’(1-91) I{4’-{(1Z)-N-(烯丙氧基)乙醯亞胺基}聯苯基-2-基}小甲基 -3-(三氟曱基)_ι//·π比唑_4·羧醯胺,(1-92)ΛΜ4,·[(1Ε)-Ν-(烯 丙氧基)乙醯亞胺基]聯苯基-2-基}-3-(二氟曱基)-1-甲基 -1//-吡唑-4-羧醯胺,(1-93) Λ^{4,-[(1Ε)-Ν-(丁-2-炔_1_基氧) -27- 200814928 乙醯亞胺基]聯苯基-、基卜^甲基_3_(三氟甲基凡吡唑_4_ 羧醯胺,(1-94)1-曱基#(4,-{(1Ε)-Ν-[(1-甲基丙-2-烯小基) 氧]乙醯亞胺基}聯苯基-2-基)-3-(三氟甲基)-1私吡唑_4_羧 醯胺,(1-95) 1-曱基-Λ44’-{(ιε)-Ν·[(2-甲基丙-2-烯-1-基)氧] 5 乙醯亞胺基}聯苯基基)-3-(三氟甲基)-1//-啦唑_4-鲮醯 胺,(1-96) 1-曱基-iV-{4’-[(lE)-N-(丙-2-炔-1-基氧)-乙醯亞胺 基]聯苯基-2-基卜3-(三氟甲基比唾4-叛酿胺,(1-97) | Μ—氟甲基)-1-甲基專{4’-[(lE)-N-(丙H)-基氧]乙酿 亞胺基}聯苯基-2-基}-1/^比α坐_4_缓酸胺,(1-98) #-{2,-氣 10 本[⑹_(甲氧基亞胺基)甲基]聯笨基冬基卜3-(二氟甲基)小 甲基-1乐吡唑-4-羧醯胺,(1-99) 曱氧基亞胺基) 曱基]-2’-甲基聯苯基-2-基}-1-甲基}-3-(三氟甲基)-17^比唑 -4-羧醯胺,(1-100) #_{4,-[(1Ζ)-Ν-丁氧基乙醯亞胺基]聯笨 基-2-基}各(二氟甲基)小甲基比0坐_4_羧醯胺,(i-ioi) 15 3_(二氟曱基[(五Η異丙氧基亞胺基)甲基]聯苯基-2- _ 基}小甲基-1/ί- 0比嗤-4-叛醯胺,(1-102) 3-(二氟甲 基)-尽{4’-[(五)-(甲氧基亞胺基)曱基]-2,-甲基聯苯基-2-基}-1-曱基比唾-4-羧醯胺,(1_1〇3)豕{3,_氯-44(五)-(甲 氧基亞胺基)曱基]聯苯基-2-基}-3-(二氟甲基)-1-甲基-1//-2〇 吡唑-4-羧醯胺,(1-104) 3-(二氟曱基)-ΛΓ-{2,-氟-4,-[(五)-(曱氧 基亞胺基)甲基]聯苯基-2-基}_1_曱基-17/ -σ比tr坐叛酿胺, (1·105) M{2’-氟-4’-[(幻-(甲氧基亞胺基)甲基]聯苯基-2-基}-1 -甲基-3-(三敦曱基魏酿胺。 式(II)的化合物包含下述較佳的第(2)類之混合配對物: -28- 200814928 (2-1)亞托敏(azoxystrobin)(得知自:EP-A 0382 375),具化 學式為: 〇Surprisingly, the fungicidal effect of the active compound compositions according to the invention is much greater than the sum of the activities of the individual active compounds, so that unanticipated synergistic effects exist and are not merely phases The compound added as the class (1) represents the general definition by the formula (I). Preferred derivatives of the formula (I) are those wherein R represents hydrogen or fluorine, and R1 represents fluorine, chlorine, bromine, iodine, decyl, ethyl, n-propyl, isopropyl, trifluoromethyl. , trichloromethyl, cyano, methoxy, ethoxy, n-propoxy, isopropoxy, trifluoromethoxy, trichloromethoxy or -c(r4)=n-or5, R2 represents hydrogen, fluorine, chlorine, bromine, iodine, decyl, ethyl, n-propyl, isopropyl, trifluoromethyl, trichloroindolyl, cyano, methoxy, ethoxy, n-propyl Oxy, isopropoxy, trifluoromethoxy or represents trichloromethoxy, R4 represents hydrogen or methyl, and R5 represents CrC5-alkyl. Particularly preferred carboxyguanamines of the formula (1) are those wherein R represents hydrogen or fluorine, and R1 represents fluorine, chloro, decyl, trifluoromethyl, cyano, decyloxy, trifluoromethoxy, trichlorophosphonium Or represents -CH=N-OCH3, R2 represents hydrogen, fluoro, chloro, decyl, trifluoromethyl, cyano, decyloxy, trifluoromethoxy or trichloromethoxy, -21 - 20 According to another embodiment of the present invention, preferred amines of formula (1) are those in which the R 2 group is located at the 2,_ position of the distal phenyl ring of the biphenyl group (nearly adjacent) Phenyl ring). The formula (I) comprises, in particular, the preferred carboxamides of the following class (1) (Ref. 5: WO 2005/123689 and WO 2005/123690): (1-1) N-(3,4 - Monochlorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1Η" than 4-sulfenylamine, (ι·2)Ν-(3, chlorobenzo fluoride biphenyl Base; _ methyl-3-(trifluoromethyl)-1Η-pyrazole carboxamide, (1-3) N-(2,4,-dichlorobiphenyl-2-yl)-1 -methyl-3-(trifluoromethyl)·1Η_pyrazole-4_carboxamide, (1_4) Ν伐 4'·difluorobiphenyl-2-yl) small methyl each (three said A Base)_m"pyrazole carboxamide, (1-5) N-(2,5,2-dichlorobiphenyl 1 yl) small methyl each (trimethylmethylHH4 嗤 ice carboxamide, ( 1_6) post ^ two said biphenyl winter base) * methyl-3-(difluoroindolyl) · 1Η" than salivary amine, (Bai N_ (4, · chlorine 1 said joint stupid base 4 base) -1-methyl|(trifluoromethyl HH•吼嗤* oxime, (Bu 0 15 team (heart 2,-methyl phenyl), small methyl winter (Santun 曱基)_1H 』••Sal+(tetra)amine, (1·9) phenylbiphenyl-2.yl)]-methyl=(trimethyl)-1Η-(tetra)-4 amide, (1)〇) N book , Methyl phenyl phenyl-2-yl) sulfhydryl-3-(trifluoromethyl)嗤* 绫 胺 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Methylbiphenylmethane)+methyl-3-(difluoroindolyl)-ih』h4·Dangan, 〇(3)Νκ二气联基基-2-yl)小methyl each (trifluoromethyl) Base) m4-Weiamine, (1-14) N-(2'-gas methoxy-linked phenyl 2) benzyl-3-yl _(trifluoromethyl MH-mouth than winter 4- Carboxylamamine, (17) team (2,6,-difluorobiphenylmethylene) small-22 - 200814928 methyl (trifluoromethyl)-lH-pyrazole winter carboxamide, (1 -16) Ν-(3,,5,-dimethylbiphenyl-2-yl) benzhydryl (trifluoromethyl)_1H-pyrazole-4-carboxamide, 〇17) N-( 4'-Chloro-3'-nitrobiphenyl-2-yl)-1-methyl-3-(3-trifluoromethyl)-1Η-indazole 4-carboxamide, (Μ8)Ν-[3 \5,-bis(trifluoromethyl)biphenyl 5 meryl l·1, methyl each (trifluoromethyl)-lH-pyrazole-4-carboxamide, (1-19) Ν-( 3,4-Methylbiphenyl-2-yl)-1-methyl-3-(trifluoromethyl-s-carboxycarboxamide, (1-20) 1-methylnitro-3, -(trifluoromethyl)biphenyl |-2-yl](trifluoromethyl)-1Η^bazole-4-treazone, (1-21) Ν-(4,-Methoxy-3'-methylbiphenyl-2-yl)_1-methyl-3-(tri-f-methyl hydrazide), dimethoxybiphenyl-2- ))-1-methyl-3-(trifluoromethyl)-1 Η-carbazole 'carboxycarboxamide' (1·23) Ν-(3,-fluoro-4,-methoxybiphenyl-2 -yl) benzhydryl-3 -(trifluoromethyl)-1 oxime-4-carboxychiral amine, (1-24) Ν-(4,_chloro-3'-methoxybiphenyl winter base ) small methyl 3-(3-trifluoromethyl)·1Η^biazole benzalamine, (1-25) Ν·[4'_chloro-3'-(trifluoromethyl)biphenyl·2 _ base] small methyl 15 -3_(trifluoromethyl)-1 Η ^ 峻 醯 carboxy carbamide, (1-26) Ν-(3,,5,-dichlorobiphenyl _ -2- -1-methyl-3-(trifluoromethyl babi-4-reamine, (1-27) > Η4,-methoxy-2, _methylbiphenyl-2-yl )_1_Methyl·3_(trifluoromethyl)-1Η-pyrazole 4-carboxamide, (1-28) Ν-(3,4^ dichlorobiphenyl-2-yl) fluorenyl -3-(difluoroindolyl sit _4·Wei-enamine, (1_29) N-(3,-gas-4,·20 fluorobiphenylmethanol)-1•methyl-3-(two gas Kibiw-4-sulfonamide, (1_30) N-(2f,4'-dichlorobiphenyl-2-yl)small methyl_3_(difluoromethyl)·ΐΗ_pyrazole ice carboamide , (1-31) N- (3,4,4-difluorobiphenylyl)methylene-M difluoromethyl)-1Η-°Bizozol-4-carboxyguanamine, (1·32) N-(2,,5 ,-dichlorobiphenyl mercapto) small methyl-3-(difluoromethyl)-111-% azole _4-carboxycarnitine, (Bu 33) -23- 200814928 N-(2f,5'- Difluorobiphenyl-2-yl)-1-methyl-3-(difluoromethyl)_1Η-indopazole carboxamide, (I-34) Ν·(4,-chloro-2,·1 Biphenyl 1 yl) + methyl each (difluoromethyl hydrazine - azole azole carboxy carbamide, (l-35) N-(4, - gas_2, _methylbiphenyl_2_ -l-mercapto-3-(difluoromethyl)-lH-pyrazole-4-decylamine, (1_36) N-(4f_ 5 chloro-3-methylbiphenyl-2-yl) -1-methyl-3-(difluoromethyl-sodium carbofuramide, (1·37) team (4,-fluoro-2,-methylbiphenylj-yl) fluorenyl (difluorocarbamate) Base)-1Η^biazole ice carbofuramide, (1-38) sense (4,-fluoro-3,-mercaptobiphenyl-2-yl)-1-methyl winter (difluoromethyl)- 1Η-ϋ比嗤-4--test amine, (1_39) Ν-(4,_chloro-3'-fluoro-2'-methylbiphenyl-2-yl)-1-indenyl (difluoro Methyl)_道_吼吼ίο -4-carboxyl-amine '(1-40) N-(2',4'-difluorobiphenyl-2-yl)-1_methyl_3_(二气^ Methyl)-1Η-pyrazole ice carboxy Amine, (1-41) N-(2,-fluoro-4'-methoxybiphenyl-2-yl)-1-methyl-3-(difluoromethylcarboxylate, (1-42) ) Ν-ΡΆ1-fluorobiphenyl-2-yl)-1-methyl-3-(di-Imethyl-s--4-carboxycarboxamide, (1-43) N-(3f,5,-two Methylbiphenyl-2-yl) benzhydrin-3-(two isis methyl)-1Η-pyrazole-4-carboxamide, (1·44) N-(4,-chloro-3' · Nitrobiphenyl-2- yl) small methyl each (difluoromethyl)-1 Η-pyrazole-4-carboxamide, (1-45) N-[3,,5,- bis ( Difluoromethyl)biphenyl-2-yl]-1-indolyl-3-(dimethylsulfate-4-carboxamide, (1-46) Ν-(3',4'-dimethyl Base phenyl-2-yl)-1-methyl-3-(difluoromethyl)-1 Η-pyrazole-4-carboxamide, (1-47) 1-mercapto-N-[4, -nitro-3H tris(2)fluoromethyl)biphenyl-2-yl]-3-(difluoroindolyl)-1Η^bazole-4-carboxamide, (1-48) N-(4 '-Methoxy-3'-methylbiphenyl-2-yl)-1-methyl-3-(difluoromethyl)-1Η-pyrazole-4-carboxyguanamine, (1·49) N-(3',4'-Dimethoxybiphenyl-2-yl)-1-methyl-3-(difluoromethyl)-1Η·carbazole-4-carboxamide, (1- 50) N-(3'-fluoromethoxybiphenyl-2-yl) benzhydrin-3-(difluoromethylhydrazine-hydrazine -4- -24- 200814928 Carboxylamidine, (1_51) N-(4,-chloro-3, methoxybiphenyl-2-yl) small methyl (difluoromethyl)-1Η Carbazole|Carboxylamidine, (1-52) N-[4f-chloro-3,-(trifluoromethyl)biphenylmungyl]methylenemethyl(difluoromethyl)-1Η^bazole-4 - Carboxylamamine '(1-53) Ν-(3',5,-Dichlorobiphenyl-2-yl)beryl (difluoromethyl)-1Η-pyrazole-4-carboxyguanamine ,(1-54) Ν-(4,·methoxy-2,-methylbiphenyl-2-yl)beryl mercapto (difluoroindolyl)_ΐΗ-π-pyrazole_4_carboxamide ,(1-55) 3-(Difluoromethyl[(6)-(methoxyimino)methyl]-u,-biphenyl-2-yl}smallmethyl-1pyrazole carboxamide ,(1-56) 3H-trifluoromethyl[(5)-(decyloxyimino)indolyl]-;[,;[,-biphenyl-2-yl}-1-methyl-1 //-pyrazole-4-carboxyguanamine, [(5)-(methoxyimino)methyl]-biphenyl-2-yl} beryllyl winter (trifluoromethyl)-1/ /-pyrazole 4-carboxyguanamine, (1_58) > (difluoromethyl) good "4, _[(6) oximeimido) methyl] biphenyl-2-yl} fluorenyl -1 music. Butyrazole carbamazepine, (1-59) [(quinone-n-butoxyimino)methyl]biphenyl-2-yl}-1-methyl-3-(trifluoromethyl) Biazole-4-carboxydecylamine, (1-60) Ν-{4,-[(1Ζ)-Ν-ethoxyethyl quinone imino]biphenyl meryl} small methyl winter (trifluoromethane -1//-pyridin 4-carboxydecylamine, (1-61) 1-methyl-exhaustion of {4,-[(1Ζ)-fluorenyl-propoxyacetamido]biphenyl- 2-yl}3·(trifluoromethyl ϋ -4--4--4-oxo-amine, (1-62) 1{44(6)-(isopropoxyimino)indolyl]biphenyl-glycolyl}-] -methyl-3-(trifluoromethyl)-1/^biazole_4_carboxamide, (1_63)#-{4,-(£>(ethoxyimino)indolyl} Benyl-2-yl]-1-mercapto-3-(trimethylsulfonyl)-1//-u than sal-4-carboxylic acid amine '(1-64) 1-mercapto-cui {4, -[(£>(propoxyimino)indolyl]biphenyl-2-ylbu-3-(trifluoromethylpyrazole-4-4carboxamide, (1-65) A^{44 (1Z)-N-isopropoxyacetammine]biphenyl-2-yl-2-methyl-25- 200814928 Winter (trifluoromethyl)-1 and pyrazole-4-carboxyindole Amine, (1-66) 7V-{4,_[(1Z)-N-butoxyacetamido]biphenyl-2-ylbu 1-indolyl-3-(trifluoromethyl) -1 Dan _ oxazol-4-carboxyguanamine, (1-67 ),{3,-chloro-4,-[(5)-(decyloxy-imino)methyl] hydrazino-2-yl}-1-methyl-3-(trimethylmethyl) -1//-° than 嗤-4-decanoate, 5 (1-68) decyloxyimido)methyl]biphenyl-2-yl}small methyl winter (trifluoromethyl)- 1 private pyrazole-4-carboxyguanamine, (1-69) to the end of {4,-[(1Ε)-Ν-methoxyethylidene imino]biphenyl-2-yl}-1-fluorenyl -3-(trifluoromethyl)-1 pirin | azole ice carboxamide, (1-70) 7V-{3L fluoro-4'-[(£>(methoxyimino)methyl] Biphenyl-2-yl}-1-methyl-3-(trifluoromethyl)-1 ugly-pyrazole-4-carboxamide, ίο U-71) Μdifluoromethylfluoro-4'- [(5)-(Methoxyimino)indenyl]biphenyl-2-yl}-1-methyl-1//-pyrazole winter carboxamide, (1-72) cyclopropyl Oxy)imido]methylidene-2-yl)methylmethyl(trifluoromethyl)-m-pyrazole-4-carboxamide, (1-73) ?H4,-[ (5Η Butoxyimino)methyl]biphenyl-2-yl}-3-(difluoromethyl)-1-indolyl-1-le-15-oxazole-carbocarboxamide, (1- 74) 3-(Difluoroindenyl) U4,-[(1E)-N-methoxy-ethylideneimido]biphenyl-2-yl}-1_methyl-1//-pyrazole _4_Carboxyamine, (1-75) '{3' Fluor-4'-[(five )-(propoxyimino)methyl]biphenyl-2-yl}small methyl-3-(trifluoromethyl)-1/^pyrazolecarboxamide, (1_76) 3-( Difluoromethylfluoro-44 (£>(propoxyimino)methyl]biphenyl-2-yl}small 20 fluorenyl-1#•pyrazole 1 carboxamide, (1-77) ,{2,-chloro-4,-[(5)-(methoxyimino)methyl]biphenyl-2-ylbu-1-indolyl_3·(trifluoromethyl)-1 -. Biazole-4-carboxycyanamine, (1-78) I{3'H[(1E)-N-propoxyethylideneimido]biphenyl-2-yl}small methyl-3-( Trifluoromethyl)·ιπ. Biazole-4-carboxyguanamine, (1-79) 3-(difluoromethyl)-good {3,-fluoro-4,-[(1Ε)-fluorenyl-propoxyacetamido]biphenyl -26 - 200814928 benzyl-2-yl}small methyl-1//-吼w-4--4-carbylamine, (1-80) 3-(difluoroindolyl)-exhaustive {3'-fluoro·4' -[(1Ε)-Ν-methoxyethinium imino]biphenyl-2-yl}small methyl-1--pyrazole-4-carboxamide, (1-81) Λ^{ 3, _1-4,-[(1Ε)-Ν-methoxyethyl quinone imino]biphenyl-2-yl} hydrazinoyl (trifluoromethyl)-1 pyrazole-4-carboxylate Indoleamine, (1-82), {3,-chloro-4,-[(^)-:^-methoxyacetamido]biphenyl-2-yl}-3-(difluoromethyl) Base)-1 - mercaptopyrene-4-carboxyl: tyrosine, (1-83) chloro-44(1Ε)-Ν-methoxyethoxylated imino]biphenyl-2-yl}-1 _Methyl-3-(tri-Imethyl)-1//-° than 嗤-4-sodium amide, (1-84) 3-(difluoromethyl hydrazine-methyl-ΑΜ4'-[(6)- (propoxyimino)indenyl]biphenyl-2-yl}-1 ugly-oxazole-4-carboxyguanamine, (1-85) ΛΓ-{4,-[(5)-(A Oxyimido)methyl]-31-methylbiphenyl-2-yl}-1-methyl winter (trifluoromethyl)-1-carbazole carbamide, (1-86) 3-(Difluoromethyl)small methyl U4,-[(lE)-isl·propoxyacetamidine Imino]biphenyl-2-yl}-1//-pyrazole-4-carboxamide, (1-87) 3-(difluoroindolyl)-indole-{44(1 E)-N -isopropoxyacetammine]biphenyl-2-yl}-1-indolyl ΐπpyrazole-4-carboxyguanamine, (1·88) Ν-(4,-{(Ζ) -[(allyloxy)imino]indenyl}bibenyl-2-yl)-3-(difluoro(methyl)-1 -methyl-1 oxazole-4-carboxamide, ( 1-89) Ν-(4,-{(ΖΗ(allyloxy)imino]methyl}biphenyl-2-yl)-1·methyl-3-(trifluoromethyl)-1 //-carbazole-4-carboxamide, (1-90) 3-(difluoromethyl[(penta)-(methoxyimino)indolyl]·3'-methylbenzidine- 2-yl}-1-indolyl-1//- ϋ比嗤-4-Rebel amine '(1-91) I{4'-{(1Z)-N-(allyloxy)ethene Amino}biphenyl-2-yl}small methyl-3-(trifluoromethyl)_ι//·π-pyrazole_4·carboxamide, (1-92)ΛΜ4,·[(1Ε)- Ν-(allyloxy)acetammine]biphenyl-2-yl}-3-(difluoroindolyl)-1-methyl-1//-pyrazole-4-carboxamide (1-93) Λ^{4,-[(1Ε)-Ν-(but-2-yne_1_yloxy) -27- 200814928 Ethylene imine]biphenyl-, phenyl-methyl _3_(trifluoromethyl-isopyrazole_4_carboxamide, (1-94)1-mercapto #(4,-{(1Ε)-Ν-[( 1-methylprop-2-enyl small group) oxy] acetamido]}biphenyl-2-yl)-3-(trifluoromethyl)-1 private pyrazole _4_carboxamide, ( 1-95) 1-decyl-Λ44'-{(ιε)-Ν·[(2-methylprop-2-en-1-yl)oxy] 5 acetamido]}biphenyl)- 3-(trifluoromethyl)-1//-lazolyl 4-mercaptoamine, (1-96) 1-indenyl-iV-{4'-[(lE)-N-(prop-2- Alkyn-1-yloxy)-acetamidomino]biphenyl-2-ylbu 3-(trifluoromethyl-pyr-4-rebel, (1-97) | fluorenyl-fluoromethyl)- 1-methyl-specific {4'-[(lE)-N-(propyl H)-yloxy]ethinyl}}biphenyl-2-yl}-1/^ ratio α sitting_4_slow acid Amine, (1-98) #-{2,-gas 10 this [(6)_(methoxyimino)methyl] phenylidene carbazyl 3-(difluoromethyl)small methyl-1 Oxazole-4-carboxyguanamine, (1-99) nonyloxyimido) fluorenyl]-2'-methylbiphenyl-2-yl}-1-methyl}-3-(trifluoromethyl) ) -17 -17 -17 -4- 醯 醯 醯 醯, (1-100) #_{4,-[(1Ζ)-Ν-butoxyacetamido]] phenyl-2-yl} (Difluoromethyl) small methyl group is 0 _4_carboxamide, (i-ioi) 15 3_(difluoroindolyl [(penta-isopropoxyimino)methyl]biphenyl- 2- _ yl} small methyl-1/ί- 0 than 嗤-4-treazone, (1-1 02) 3-(Difluoromethyl)-exhaustive {4'-[(5)-(methoxyimino)indolyl]-2,-methylbiphenyl-2-yl}-1-indole Kibi sal-4-carboxamide, (1_1〇3)豕{3,_chloro-44(penta)-(methoxyimino)indolyl]biphenyl-2-yl}-3-( Difluoromethyl)-1-methyl-1//-2-pyrazole-4-carboxamide, (1-104) 3-(difluoroindolyl)-indole-{2,-fluoro-4, -[(5)-(decyloxyimino)methyl]biphenyl-2-yl}_1_mercapto-17/-σ ratio tr aruin, (1·105) M{2' -Fluoro-4'-[(phantom-(methoxyimino)methyl]biphenyl-2-yl}-1 -methyl-3-(tripdenyl thioglycolamine). The compound of formula (II) comprises the following preferred blend of pair (2): -28- 200814928 (2-1) azoxystrobin (obtained from: EP-A 0382 375), with The chemical formula is: 〇

M CNM CN

YVYV

(2-2)氟口密菌醋(fluoxastrobin)(得知自:DE_A 196 02 095),具化學式為:(2-2) Fluoxastrobin (known from: DE_A 196 02 095), with the chemical formula:

(2-3) (2幻-2-(2- {[6-(3-氯-2-曱基苯氧基)-5-氟-4-嘧啶基] 15(2-3) (2 Magic-2-(2-{[6-(3-Chloro-2-indolylphenoxy)-5-fluoro-4-pyrimidinyl] 15

氧}苯基)-2-(甲氧基亞胺基)-Λ/"甲基乙酸胺(得知 自:DE_A 196 46 407,ΕΡ-Β 0 712 396),具化學式 為:Oxygen}phenyl)-2-(methoxyimino)-oxime/"methylacetic acid amine (obtained from: DE_A 196 46 407, ΕΡ-Β 0 712 396), with the chemical formula:

(2-4)三氟敏(trifloxystrobin)(得知自:EP-A 0 460 575),具 化學式為· 20 200814928 〇(2-4) Trifloxystrobin (available from: EP-A 0 460 575) with a chemical formula of 20 200814928 〇

(2-5) (2 五)-2-(曱氧基亞胺基甲基-2-(2-{[({(l 五)·Η3- 5 (三氟甲基)苯基]乙二基}-胺基)氧]甲基}苯基)乙醯 胺(得知自:ΕΡ-Α0 569 384),具化學式為:(2-5) (2 5)-2-(oximeoxyiminomethyl-2-(2-{[({(l 5)·Η3- 5 (trifluoromethyl)phenyl]) }}-amino)oxy]methyl}phenyl)acetamide (known from: ΕΡ-Α0 569 384), with the chemical formula:

10 〇10 〇

(2-6) (2£>2-(曱氧基亞胺基甲基-2- {2-[(五)-({1-[3-(三 氟甲基)苯基]乙氧基}亞胺基)-甲基]苯基}乙醯胺(得 知自:ΕΡ-Α0 596 254),具化學式為: 15(2-6) (2£>2-(decyloxyiminomethyl-2-{2-[(5)-({1-[3-(trifluoromethyl)phenyl]ethoxy) (imino)-methyl]phenyl}acetamide (known from: ΕΡ-Α0 596 254), with the chemical formula: 15

(2-7)肪鱗菌胺(orysastrobinX得知自:DE-A 195 39 324), 具化學式為: 〇(2-7) Adiscalin (orsastrobin X is known from: DE-A 195 39 324), with the chemical formula: 〇

(2-8) 5-甲氧基-2·曱基-4-(2-{[({(1幻小[3_(三氟甲基)苯基] -30- 20 200814928 乙二基}胺基)氧]-甲基}苯基)_2,4-二氫-3F-1,2,4-三 唑-3-酮(得知自:WO 98/23155),具化學式為:(2-8) 5-Methoxy-2·indolyl-4-(2-{[({(1) singular [3_(trifluoromethyl)phenyl) -30- 20 200814928 ethylenediyl)amine Oxy]-methyl}phenyl)_2,4-dihydro-3F-1,2,4-triazol-3-one (obtained from: WO 98/23155), having the chemical formula:

(2-9)克收辛-甲基(kresoxim-methyl)(得知自·· EP-A 0 253 213),具化學式為:(2-9) Kresoxim-methyl (know from EP-A 0 253 213) with the chemical formula:

1515

(2-10)大滅唾丙(dimoxystrobin)(得知自:ΕΡ-Α0 398 692), 具化學式為:(2-10) dimoxystrobin (known from: ΕΡ-Α0 398 692), with the chemical formula:

(2-11)咬氧菌酯(picoxystrobin)(得知自:ΕΡ-Α0 278 595), 具化學式為: -31- .200814928 ο(2-11) picoxystrobin (known from: ΕΡ-Α0 278 595), with the chemical formula: -31- .200814928 ο

(2-12)嗤菌胺酯(pyraclostrobin)(得知自:DE_A44 23 612), 具化學式為:(2-12) Pyraclostrobin (known from: DE_A44 23 612), with the chemical formula:

10 〇10 〇

(2-13)苯氧菌胺(metominostrobin)(得知自:EP-A 0 398 692),具化學式為: 15(2-13) Metominostrobin (available from: EP-A 0 398 692) with the chemical formula: 15

(2-14)英司多丙(enestrobin)(得知自·· EP-A 0 936 213),具 化學式為:(2-14) enestrobin (known as EP-A 0 936 213) with the chemical formula:

式(III)的化合物包含下述較佳的第(3)類之混合配對 物 -32- 200814928 (3-1)氮雜康峻(azaconazole)(得知自:DE_A 25 51 560), 具化學式為:The compound of formula (III) comprises the following preferred mixture of the class (3) - 32- 200814928 (3-1) azaconazole (known from: DE_A 25 51 560), having the chemical formula for:

5 (3-2)伊他康唑(etaconazole)(得知自:DE-A25 51 560),具 化學式為:5 (3-2) Itaconazole (known from: DE-A25 51 560), with the chemical formula:

1010

(3-3)普比康嗤(propiconazole)(得知自:DE-A 25 51 560), 具化學式為:(3-3) propiconazole (known from: DE-A 25 51 560), with the chemical formula:

15 (3-4)待芬康嗤(difenoconazole)(得知自:EP-A 0 112 284),具化學式為:15 (3-4) Waiting for difanoconazole (available from: EP-A 0 112 284), with the chemical formula:

(3-5) 溴克利(bromuconazoleX得知自:EP-A 0 258 161), -33- 20 200814928(3-5) Bromoclazole (bromuconazoleX is known from: EP-A 0 258 161), -33- 20 200814928

CH—(CH2)2CH3 CH0 具化學式為:CH—(CH2)2CH3 CH0 has the chemical formula:

(3-6)西普康唾(cyproconazole)(得知自:DE-A 34 06 993), 具化學式為:(3-6) cyproconazole (known from: DE-A 34 06 993), with the chemical formula:

(3-7)菲克斯(hexaconazole)(得知自:DE-A30 42 303),具 化學式為: •(ch2)3ch3 ch2 (3-8)平康唑(penconazole)(得知自:DE-A 27 35 872),具 化學式為: C! (3-9)邁克別尼(myclobutanil)(得知自:ΕΡ-Α 0 145 294), -34- 200814928 具化學式為:(3-7) hexaconazole (known from: DE-A30 42 303), with the chemical formula: • (ch2) 3ch3 ch2 (3-8) penconazole (recognized from: DE -A 27 35 872), with the chemical formula: C! (3-9) myclobutanil (known from: ΕΡ-Α 0 145 294), -34- 200814928 with the chemical formula:

ClCl

(ch2)3ch3(ch2)3ch3

1010

1515

(3-10)四康嗤(tetraconazole)(得知自:EP-AO 234 242),具 化學式為:(3-10) tetraconazole (available from: EP-AO 234 242) with the chemical formula:

CICI

CH—CHr〇~CF2CF2H (3-11)福採扶(fhitriafblX得知自:EP-A0 015 756),具化學 式為:CH-CHr〇~CF2CF2H (3-11) Fucaifu (fhitriafblX is known from: EP-A0 015 756), with the chemical formula:

FF

(3-12)依普座(epoxiconazole)(得知自:ΕΡ-Α0 196 038),具 化學式為:(3-12) epoxiconazole (known from: ΕΡ-Α0 196 038), with the chemical formula:

(3-13)護發嗤(flusilazole)(得知自:EP-A 0 068 813),具化 -35- 20 200814928 學式為:(3-13) Flusilazole (obtained from: EP-A 0 068 813), with the formula -35- 20 200814928

(3-14)辛康唾(simeconazole)(得知自:EP-A 0 537 957),具 化學式為: ΟΗ F—y--CH—Si(CH3)3 CH2 (3-15)普硫康唾(prothioconazole)(得知自:WO 96/16048) 具化學式為: 15(3-14) simeconazole (available from: EP-A 0 537 957) with the chemical formula: ΟΗ F—y--CH—Si(CH3)3 CH2 (3-15) Prothioconazole (available from: WO 96/16048) with the chemical formula: 15

(3_16)芬布康。坐(fenbuconazole)(得知自·· DE-A37 21 786) 具化學式為: -36- 20 200814928(3_16) Fenbu Kang. Sitting (fenbuconazole) (learned from DE-A37 21 786) with the chemical formula: -36- 20 200814928

5 (3-17)得克力(tebuconazole)(得知自:EP-AO 040 345),具 化學式為:5 (3-17) tebuconazole (available from: EP-AO 040 345) with the chemical formula:

10 (3-18)10 (3-18)

艾普那唑(ipconazole)(得知自:ΕΡ-Α0 329 397),具 化學式為:Ipconazole (known from: ΕΡ-Α0 329 397) with the chemical formula:

1515

(3-19)滅康唑(metconazole)(得知自:EP-A 0 329 397),具 化學式為:(3-19) metconazole (available from: EP-A 0 329 397) having the chemical formula:

(3-20)三替康唑(triticonazole)(得知自:EP-A 0 378 953), 具化學式為: -37- 20 200814928(3-20) Triticonazole (available from: EP-A 0 378 953) with the chemical formula: -37- 20 200814928

(3-21)比多農(bitertanol)(得知自:DE-A 23 24 010),具化 學式為:(3-21) Bitertanol (known from: DE-A 23 24 010), with a chemical formula:

OH Ο - 〒H—CH—C(CH3)3 10 (3-22)三泰隆(triadimenol)(得知自:DE-A23 24 010),具化 學式為:OH Ο - 〒H-CH-C(CH3)3 10 (3-22) triadimenol (known from: DE-A23 24 010), with chemical formula:

(3-23)三泰芬(triadimefon)(得知自:DE-A22 01 063),具化 學式為.(3-23) Triadimefon (learned from: DE-A22 01 063), with a chemical formula.

(3-24)氟啥康嗤(fluquinconazoleX得知自:EP-A 0 183 458),具化學式為: -38- 20 200814928(3-24) Fluconconazole X (fluquinconazoleX is known from: EP-A 0 183 458), with the chemical formula: -38- 20 200814928

(3-25)嘻康唾(quinconazole)(得知自:EP-AO 183 458),具 化學式為:(3-25) quinconazole (known from: EP-AO 183 458), with the chemical formula:

ίο (3-26)二氯布康唾(diclobutrazole)(得知自:DE-A 27 37 489),具化學式為:Ίο (3-26) Diclobutrazole (known from: DE-A 27 37 489), having the chemical formula:

15 (3-27)得尼康唑(diniconazoleX得知自:DE-A30 10 560), 具化學式為:15 (3-27) Deconazole (diniconazoleX is known from: DE-A30 10 560), with the chemical formula:

(3-28)得尼康嗤-M(diniconazole-M),具化學式為: -39- 200814928(3-28) Nikon 嗤-M (diniconazole-M) with the chemical formula: -39- 200814928

5 (3-29)扶康嗤(furconazole)(得知自:EP-AO 230 844),具化 學式為:5 (3-29) Furconazole (available from: EP-AO 230 844), with a chemical formula:

1010

(3-30)優尼康唑(imiconazole)(得知自:0£-八 30 10 560), 具化學式為:(3-30) Uniconazole (known from: ££-eight 30 10 560), with the chemical formula:

1515

(3-31)優尼康嗤P(uniconazoleP),具化學式為:(3-31) Uniconazole P, with the chemical formula:

式(IV)的化合物包含下述較佳的第(4)類之混合配對 物: (4-1)二氯氟尼(dichlofluanidX得知自:DE-A 11 93 498), -40- 20 200814928 具化學式為:The compound of formula (IV) comprises the following preferred complex of class (4): (4-1) dichloroflunisi (dichlofluanid X is known from: DE-A 11 93 498), -40- 20 200814928 With the chemical formula:

(4-2) 曱基益發靈(tolylfhianid)(得知自 具化學式為: DE-A 11 93 498),(4-2) Tolylfhianid (known as: DE-A 11 93 498),

1010

DE_A 40 26 966), 第(5)類之較佳的混合配對物為: (5-1) 異丙菌胺(iprovalicarb)(得知自: 15 具化學式為:DE_A 40 26 966), the preferred mixed counterpart of class (5) is: (5-1) Iprovalicarb (known from: 15 chemical formula:

2〇 (5-3)苯嗟菌胺(ben1;hiavalicarb)(得知自 具化學式為: :WO 96/04252), -41 - 2008149282〇 (5-3) Benzoguanamine (ben1; hiavalicarb) (known to have the chemical formula: :WO 96/04252), -41 - 200814928

式(V)的化合物包含下述較佳的第(6)類之混合配對物: 5 (6-1) 2-氣-N-(l,1,3-二甲基印滿-4-基)於驗酸胺(得知自: ΕΡ-Α0 256 503),具化學式為:The compound of formula (V) comprises the following preferred complex of class (6): 5 (6-1) 2-Gas-N-(l,1,3-dimethylin-4-yl) In the acid test amine (known from: ΕΡ-Α0 256 503), the chemical formula is:

1010

(6-2)白克力(boscalid)(得知自:DE-A 195 31 813),具化 學式為:(6-2) Boscalid (known from: DE-A 195 31 813), with a chemical formula:

(6-3)福滅比(furametpyr)(得知自:EP-A 0315 502),具化 學式為:(6-3) Furametpyr (available from: EP-A 0315 502), with a chemical formula:

(6-4) Ν·(3-對-甲苯基噻吩-2-基)-1·曱基-3-三氟曱基-1H- 吡唑-4-羧醯胺(得知自:ΕΡ-Α0 737 682),具化學式 -42- 200814928 為(6-4) Ν·(3-p-Tolylthiophen-2-yl)-1·indolyl-3-trifluorodecyl-1H-pyrazole-4-carboxamide (available from: ΕΡ- Α0 737 682), with the chemical formula -42- 200814928

C (6-5)噻唑菌胺(ethaboxam)(得知自:EP-A 0 639 574),具 化學式為:C (6-5) ethaboxam (obtained from: EP-A 0 639 574) with the chemical formula:

〇 CN〇 CN

(6-6)環醯菌胺(fenhexamid)(得知自:EP-A0 339 418),具 化學式為:(6-6) fenhexamid (known from: EP-A0 339 418), having the chemical formula:

(6-7)卡普米(carpropamid)(得知自:ΕΡ·Α 0 341 475),具 化學式為: 20(6-7) carpropamid (from ΕΡ·Α 0 341 475), with the chemical formula: 20

(6-8) 2 -氣-4-(2-氣-2-曱基丙酿基胺基)-Ν,Ν-二曱基苯甲酿 >43- 200814928 胺(得知自:EP-A0 600 629),具化學式為: 5(6-8) 2-Gas-4-(2-Ga-2-mercaptopropylamino)-indole, fluorene-dimercaptobenzoic brewing>43- 200814928 Amine (Know from: EP- A0 600 629), with the chemical formula: 5

10 (6-9)氟啶醯菌胺(fluopicolide)(得知自:WO 99/42447), 具化學式為:10 (6-9) fluopicolide (known from: WO 99/42447), with the chemical formula:

(6-10)唾查醯胺(zoxamide)(得知自:EP-A 0 604 019),具化 學式為:(6-10) Salicin (zoxamide) (obtained from: EP-A 0 604 019), with a chemical formula:

(6-11) 3,4-二氯-N-(2-氰基苯基)異噻唑-5-羧醯胺(得知自: WO 99/24413),具化學式為:(6-11) 3,4-Dichloro-N-(2-cyanophenyl)isothiazol-5-carboxamide (available from: WO 99/24413), having the chemical formula:

(6-1¾卡保信(carb〇xin)(得知自:US 3,249,499),具化學式 -44· 200814928 為··(6-13⁄4 carb〇xin (obtained from: US 3,249,499), with the chemical formula -44· 200814928 as...

5 (6-13)噻醯菌胺(tiadinil)(得知自:US 6,616,054),具化學 式為:5 (6-13) tiadinil (obtained from: US 6,616,054) with the chemical formula:

1010

1515

(6-14 嗟菌胺(penthiopyrad)(得知自:EP-A 0 737 682),具 化學式為:(6-14 penthiopyrad (known from: EP-A 0 737 682), with the chemical formula:

(6-15)矽噻菌胺(silthiofam)(得知自:WO 96/18631),具化 學式為:(6-15) silthiofam (obtained from: WO 96/18631), with a chemical formula:

CH, (6-16) N-[2-(l,3-二甲基丁基)苯基]-1-甲基-4-(三氟曱基)- -45- 20 200814928 1H-吡咯-3-羧醯胺(得知自:WO 02/38542),具化學 式為:CH, (6-16) N-[2-(l,3-dimethylbutyl)phenyl]-1-methyl-4-(trifluoromethyl)- -45- 20 200814928 1H-pyrrole- 3-carboxyguanamine (known from: WO 02/38542) with the chemical formula:

(心1?)福多寧(flutolanilX得知自:DE-A 27 31 522),具化 學式為:(Heart 1?) Fortune (flutolanil X learned from: DE-A 27 31 522), with a chemical formula:

(6_18)芬富南(fenfuram)(得知自:0£-八20 06471),具化學 式為二(6_18) Fenfuram (known from: 0£-eight 20 06471), with a chemical formula of two

(649)嘉保信(oxycarboxin)(得知自:US 3,399,214),具化 學式為:(649) oxycarboxin (available from: US 3,399,214) with a chemical formula of:

(6-20)塞氟醯胺(thifluzamide)(得知自:EP-A 0 371 950), 具化學式為: -46- 200814928(6-20) thifluzamide (known from: EP-A 0 371 950), with the chemical formula: -46- 200814928

(6-21) N-{2-[3-氯-5-(三氟甲基)吼啶-2-基]乙基卜2-(三氟 5 甲基)苯甲醯胺,具化學式為:(6-21) N-{2-[3-Chloro-5-(trifluoromethyl)acridin-2-yl]ethyl-2-(trifluoro-5methyl)benzamide, chemical formula :

10 (6-22) N-(2-雙環丙基-2-基苯基)-1-甲基-3-三氟甲基-1H-吡唑-4-羧醯胺(得知自:WO 2006/015865),具化學 式為.10 (6-22) N-(2-Dicyclopropyl-2-ylphenyl)-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide (available from: WO 2006/015865), with chemical formula.

(6-23) N-(2-雙環丙基-2-基苯基)-1-甲基-3-二氟甲基-1H- 吡唑-4-羧醯胺(得知自:WO 2006/015865),具化學 式為:(6-23) N-(2-Dicyclopropyl-2-ylphenyl)-1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxamide (available from: WO 2006 /015865), with the chemical formula:

(6-24) N-[2-(l’-甲基雙環丙基-2-基)苯基]-1-甲基-3-三氟甲 基-1H-吡唑-4-羧醯胺(得知自:WO 2006/015865), -47- 200814928 具化學式為:(6-24) N-[2-(l'-Methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxyguanamine (Knowed from: WO 2006/015865), -47- 200814928 has the chemical formula:

55

10 (6-25) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-二氟甲 基-1Η-吡唑羧醯胺(得知自:WO 2006/015865), 具化學式為:10 (6-25) Ν-[2-(Γ-Methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-difluoromethyl-1Η-pyrazole carboxamide (known From: WO 2006/015865), with the chemical formula:

1515

(6-26) Ν·[1 -(5- >臭-3-氯°比唆-2-基)乙基]-2,4-二氣終驗酿 胺,具化學式為:(6-26) Ν·[1 -(5- >odor-3-chloropyrene-pyridyl-2-yl)ethyl]-2,4-dialdehyde final amine amine, with the chemical formula:

(6-27) 比喘>2-基)甲基-2,4-二氯於驗酸胺,具 化學式為:(6-27) Bichuan>2-yl)methyl-2,4-dichloro acid in acid test, having the chemical formula:

第(7)類之較佳的混合配對物為: -48- 20 200814928 (7-1) (7-2) 5 (7-3) ίο (7-4) 15 (7-5) 鋅錳乃浦(mancozeb)(得知自:DE-A 12 34 704),具 有IUPAC名稱為:錳亞乙基雙(二硫胺基甲酸酯)(聚 合性)與鋅鹽之錯合物 錳乃浦(maneb)(得知自:US 2,504,404),具化學式為:The preferred blending partner of class (7) is: -48- 20 200814928 (7-1) (7-2) 5 (7-3) ίο (7-4) 15 (7-5) Zinc Manganese Mancozeb (known from: DE-A 12 34 704), having the IUPAC name: manganese ethylene bis(dithiocarbamate) (polymerizable) and zinc salt complex manganese (maneb) (from (US 2,504,404), with the chemical formula:

免得爛(metiram)(得知自:DE-A 1076434),具有 IUPAC名稱為:鋅氨化物亞乙基雙(二硫胺基甲酸 酯)-聚(亞乙基秋蘭姆二硫化物) 甲基鋅乃浦(propineb)(得知自:GB 935 981),具化 學式為:Free of metiram (known from: DE-A 1076434), having the IUPAC name: zinc amide ethylene bis(dithiocarbamate)-poly(ethylene thiuram disulfide) Methyl zinc is a propineb (known from: GB 935 981), with the chemical formula:

得恩地(thiram)(得知自:US 1,972,961),具化學式為:Thiram (available from: US 1,972,961) with the chemical formula:

(7-6) 鋅乃浦(zineb)(得知自·· DE-A 10 81 446),具化學式 •49- 20 .200814928(7-6) Zinna (Zineb) (known as DE-A 10 81 446), with chemical formula • 49-20.200814928

(7-7) 福美鋅(ziram)(得知自:US 2,588,428),具化學式為:(7-7) Zirma (known from: US 2,588,428) with the chemical formula:

1010

ch3 ch3 式(VI)的化合物包含下述較佳的第(8)類之混合配對 物·· (8-1)本達樂(benalaxylX得知自:DE_A 29 03 612),具化 學式為:Ch3 ch3 The compound of the formula (VI) comprises the following preferred mixed complex of the (8) class (8-1) Bendal (benalaxyl X is known from: DE_A 29 03 612), and has a chemical formula:

1515

(8-2)福達樂(furalaxyl)(得知自:DE-A 25 13 732),具化學 式為:(8-2) Furalaxyl (known from: DE-A 25 13 732), with the chemical formula:

(8-3)滅達樂(metalaxyl)(得知自:DE-A 25 15 091),具化 學式為: -50 - 20 200814928(8-3) Metalaxyl (available from: DE-A 25 15 091), with a chemical formula: -50 - 20 200814928

5 (8-4)滅達樂-Μ (得知自:WO 96/01559),具化學式為:5 (8-4) 灭达乐-Μ (known from: WO 96/01559), with the chemical formula:

ίο (8-5)本達樂-M,具化學式為:Ίο (8-5) Bunda-M, with the chemical formula:

式(VII)的化合物包含下述較佳的第(9)類之混合配對 物: (9-1)西普地尼(cyprodinil)(得知自:EP-A 0 310 550),具 化學式為.The compound of formula (VII) comprises the following preferred mixed partner of class (9): (9-1) cyprodinil (known from: EP-A 0 310 550) having the chemical formula .

ch3 (9-2)滅盤尼比(mepanipyrim)(得知自:ΕΡ·Α 0 270 111), 具化學式為: -51 - 200814928Ch3 (9-2) mepanipyrim (known from: ΕΡ·Α 0 270 111), with the chemical formula: -51 - 200814928

5 (9-3)必滅寧(pyrimethanil)(得知自:DD 151 404),具化學 式為、5 (9-3) pyrimethanil (from DD 151 404), with chemical formula,

式(VIII)的化合物包含下述較佳的第(10)類之混合配對 物:The compound of formula (VIII) comprises the following preferred blend of class (10):

(10-1) 6-氣- 5-[(3,5 -二曱基異嗯ϋ坐-4-基)石黃酸基]-2,2-二氣^ is -5H-[1,3]二噁茂并[4,5-f>苯并咪唑(得知自:WO _ 97/06171),具化學式為:(10-1) 6-Gas- 5-[(3,5-Dimercaptopurine-4-yl)-retinyl]-2,2-digas^ is -5H-[1,3 Dioxin and [4,5-f> benzimidazole (obtained from: WO _ 97/06171), with the chemical formula:

(10-2)免賴得(benomyl)(得知自:US 3,631,176),具化學式 -52 - 200814928(10-2) benomyl (available from: US 3,631, 176), with the chemical formula -52 - 200814928

(10-3)貝芬替(carbendazim)(得知自:US 3,010,968),具化 學式為:(10-3) carbendazim (available from: US 3,010,968) with a chemical formula:

(10-4)氯芬那峻(chlorfenazole),具化學式為:(10-4) Chlorfenazole, which has the chemical formula:

(10-5)麥穗寧(fuberidazoleX得知自:DE-A 12 09 799),具 化學式為:(10-5) Mai Sui Ning (fuberidazoleX is known from: DE-A 12 09 799), with the chemical formula:

(10-6)腐絕(thiabendazole)(得知自:US 3,206,468),具化學 式為:(10-6) thiabendazole (obtained from: US 3,206,468) with the chemical formula:

式(IX)的化合物包含下述較佳的第(11)類之混合配對 -53- 20 200814928 物: (1M)二硫芬克(didhofencarbX得知自:EP-A 0 078 663) 具化學式為:The compound of formula (IX) comprises the following preferred blend of pair (11) - 53-20 200814928: (1M) dithiofenac (didhofencarb X is known from: EP-A 0 078 663) :

EtO CH,EtO CH,

(11-2)普拔克(propam〇carb)(得知自:US 3,513,241),具化 學式為: .CH. 、Ν Η ! CH. (11-3)鹽酸普拔克(pr0pam〇carl>liydrochloride)(得知自:US 3,513,241),具化學式為: 15 Η CH,(11-2) propam〇carb (obtained from: US 3,513,241), with the chemical formula: .CH., Ν Η ! CH. (11-3) Propyl hydrochloride (pr0pam〇carl>liydrochloride ) (Know from: US 3,513,241), with the chemical formula: 15 Η CH,

HCI (11-4)普拔克-福賽得(fosetyi),具化學式為 20 η^Λ h^ch3 f| VN - P -〇 CH,HCI (11-4), fosetyi, with a chemical formula of 20 η^Λ h^ch3 f| VN - P -〇 CH,

H 較佳的第(12)類之混合配對物為: (12-1)四氯丹(captaf〇i)(得知自:us 3,178,447) ’ 具化學式 為: -54- 200814928H Preferred mixed partner of class (12) is: (12-1) tetramdanium (captaf〇i) (known from: us 3,178,447) ' has the chemical formula: -54- 200814928

(12-2)蓋普丹(captan)(得知自:US 2,553,770),具化學式為:(12-2) Captan (available from: US 2,553,770) with the chemical formula:

5 (12-3)福爾培(folpet)(得知自:US2,553,770),具化學式為:5 (12-3) Folpet (known from: US2, 553, 770) with the chemical formula:

10 (12-4)依普同(iprodione)(得知自:DE-A 21 49 923),具化 學式為: 1510 (12-4) Iprodione (available from: DE-A 21 49 923), with a chemical formula: 15

(12-5)撲滅寧(procymidone)(得知自:DE-A 20 12 656),具 化學式為:(12-5) Procymidone (known from: DE-A 20 12 656), with the chemical formula:

CICI

CI (12-6)免克寧(vinclozolin)(得知自:DE-A 22 07 576),具化 學式為: -55- 20 200814928CI (12-6) vinclozolin (known from: DE-A 22 07 576), with a chemical formula: -55- 20 200814928

5 較佳的第(13)類之混合配對物為: (13-1)多寧(dodine)(得知自:GB 11 03 989),具化學式為:5 The preferred mixed counterpart of class (13) is: (13-1) dodine (known from: GB 11 03 989), with the chemical formula:

(13-2)克熱淨(Suazatine)(得知自:GB 11 14 155) (13-3)雙胍辛胺二乙酸鹽 Gminoctadine triacetate)(得知 自:EP-A 0 155 509),具化學式為:(13-2) Suazatine (available from: GB 11 14 155) (13-3) Gminoctadine triacetate (known from: EP-A 0 155 509), with chemical formula for:

Hr nh2 15 )克熱淨(烧苯石黃酸鹽)[iminoctadine tris(albesilate)](得 ( 知自:ΕΡ-Α0 155 509),具化學式為:Hr nh2 15 ) gram heat (burning benzoate) [iminoctadine tris (albesilate)] (derived from: ΕΡ-Α0 155 509), with the chemical formula:

S〇3H 2〇 5)多寧(dodine (游離驗)) (1 η 〜 ml (13-6) 克熱淨(imm〇ctadine)(游離驗),具化學式為: -56- 200814928S〇3H 2〇 5) Doning (dodine) (1 η ~ ml (13-6) gram heat (imm〇ctadine) (free test), with the chemical formula: -56- 200814928

較佳的第(14)類之混合配對物為: (14-1)賽座滅(cyazofamid)(得知自:EP-A 0 298 196),具 化學式為:Preferred mixed partners of class (14) are: (14-1) cyazofamid (available from: EP-A 0 298 196) having the chemical formula:

1010

CN CI^^/N、s〇2MMe2 Φ ch3 (14-2)撲克拉(prochloraz)(得知自:DE-A 24 29 523),具化 學式為: 15CN CI^^/N, s〇2MMe2 Φ ch3 (14-2) Prochloraz (learned from: DE-A 24 29 523), with a chemical formula: 15

CICI

(14-3)三嗤嗪(triazoxide)(得知自:DE_A 28 02 488),具化 20 學式為:(14-3) Triazoxide (known from: DE_A 28 02 488), with 20 formulas:

(14-4)稻痕酯(pefurazoate)(得知自:ΕΡ·Α 0 248 086),具化 -57- 200814928 學式為:(14-4) Pefurazoate (known from: ΕΡ·Α 0 248 086), with -57- 200814928

10 1510 15

式(X)的化合物包含下述較佳的第(15)類之混合配對 物: (15-1)阿得摩福(&1出111〇卬11)(得知自:00 140 041),具化學 式為:The compound of formula (X) comprises the following preferred mixed partner of class (15): (15-1) Adelmo (&1 out 111〇卬11) (from 00 140 041) , with the chemical formula:

CH CH, (15-2)三得芬(tridemorph)(得知自:GB 988 630),具化學式 為:CH CH, (15-2) tridemorph (known from: GB 988 630), with the chemical formula:

ch3 (15-3)敵草隆(dodemorph)(得知自:DE-A 25 432 79),具化 學式為: -58 - 200814928Ch3 (15-3) dodemorph (known from: DE-A 25 432 79), with a chemical formula: -58 - 200814928

或乙酸敵草隆 5 (15-4)芬普比福(fenpropimorph)(得知自:DE-A 26 56 747),具化學式為:Or diclofenac 5 (15-4) fenpropimorph (known from: DE-A 26 56 747), with the chemical formula:

(15-5)大滅芬(dimethomorphX 得知自:EP-A 0219 756),具 化學式為:(15-5) Dafenfen (dimethomorphX is known from: EP-A 0219 756), with the chemical formula:

式(XI)的化合物包含下述較佳的第(16)類之混合配對 20 物: (16-1)芬畢克尼(fbnpiclonilK得知自:EP-A 0236 272),具 化學式為: -59- 200814928The compound of formula (XI) comprises the following preferred mixed pair 20 of class (16): (16-1) fenbikini (fbnpiclonil K is known from: EP-A 0236 272), having the chemical formula: - 59- 200814928

NCNC

NHNH

Cl Cl EP-A 0 206 999),具 :JP 65-25876),具化 (16-2)伏地噁尼(fludioxonil)(得知自 化學式為: ΗCl Cl EP-A 0 206 999), with :JP 65-25876), with (16-2) fludioxonil (known from the chemical formula: Η

(16-3) σ比略尼精(pyrrolnitrin)(得知自 學式為:(16-3) σ pyrrolnitrin (known as self-learning:

CICI

CI NO. 較佳的第(17)類之混合配對物為: 15 (17-1)福賽得-鋁(fosetyl-Al)(得知自:DE-A 24 56 627),具 化學式為: Π A1H, ΌΗ 20 (17-2)膦酸(已知的化學品),具化學式為 f?CI NO. The preferred hybrid partner of class (17) is: 15 (17-1) fosetyl-Al (known from: DE-A 24 56 627), having the chemical formula: Π A1H, ΌΗ 20 (17-2) phosphonic acid (known chemical) with chemical formula f?

HoiHoi

OH (17-3)曱基立枯磷(tolclophos-methyl)(得知自:DE-A25 01 •60- 200814928 040),具化學式為: h3cOH (17-3) tolclophos-methyl (known from: DE-A25 01 • 60- 200814928 040) with the chemical formula: h3c

ClCl

s 0令0、 Cl 〜CH, CH. 式(XII)的化合物包含下述之較佳的第(18)類之混合配 對物,其為得知自WO 96/23793且各可呈E或Z異構物存 在者,因此,式(XII)的化合物可為·由不同比例的異構物形 成之混合物,或是單種的異構物型式存在,較佳的式(XII) 的化合物為其E異構物: (18-1)化合物 2-(2,3-二氫-1H-茚-5-基)-N-[2-(3,4_二曱氧基 苯基)乙基]-2-(甲氧基亞胺基)乙醯胺,具化學式為: 15s 0 令 0, Cl 〜CH, CH. The compound of formula (XII) comprises the preferred mixed partner of class (18) below, which is known from WO 96/23793 and each may be E or Z The isomer is present, therefore, the compound of formula (XII) may be a mixture of different ratios of isomers, or a single isomer form, preferably a compound of formula (XII) E isomer: (18-1) compound 2-(2,3-dihydro-1H-indol-5-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl] -2-(methoxyimino)acetamide with the chemical formula: 15

(18-2)化合物N-[2-(3,4-二曱氧基苯基)乙基]-2-(甲氧基亞 胺基)-2-(5,6,7,8-四氮-蔡-2-基)乙酿胺’具化學式為:(18-2) Compound N-[2-(3,4-Dimethoxyphenyl)ethyl]-2-(methoxyimino)-2-(5,6,7,8-tetra Nitrogen-Cai-2-yl)Ethylamine has the chemical formula:

(18·3)化合物2-(4-氯苯基)-N-[2-(3,4-二曱氧基苯基)乙 基]甲氧基亞胺基)-乙酿胺’具化學式為·· -61 - 20 200814928(18·3) Compound 2-(4-chlorophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]methoxyimino)-ethonamide For ·· -61 - 20 200814928

5 (18-4)化合物2-(4-溴苯基)-N-[2-(3,4-二甲氧基苯基)乙 基]-2-(甲氧基亞胺基)-乙醯胺,具化學式為:5 (18-4) Compound 2-(4-Bromophenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(methoxyimino)-B Indoleamine, with the chemical formula:

1010

(18-5)化合物2-(4-甲基苯基)-N-[2-(3,4-二曱氧基苯基)乙 基]-2-(曱氧基亞胺基)-乙醯胺,具化學式為:(18-5) Compound 2-(4-methylphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(decyloxyimino)-B Indoleamine, with the chemical formula:

1515

(18-6)化合物2-(4-乙基苯基)-N-[2-(3,4-二甲氧基苯基)乙 基]-2-(曱氧基亞胺基)_乙醯胺,具化學式為:(18-6) Compound 2-(4-ethylphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(decyloxyimino)-B Indoleamine, with the chemical formula:

較佳的第(19)類之混合配對物為: -62- 200814928 (19-1)苯并嗟二唾S旨(acibenzolar-S_methyl)(得知自:ΕΡ-Α0 313 512),具化學式為:A preferred mixed partner of the (19) class is: -62- 200814928 (19-1) acibenzolar-S_methyl (known from: ΕΡ-Α0 313 512), having the chemical formula :

10 (19-2)氯塞尼(chlorothalonil)(得知自:US3,290,353),具化 學式為:10 (19-2) chlorothalonil (available from: US3, 290, 353) with a chemical formula:

CNCN

(19-3)克絕(cymoxanil)(得知自:DE-A 23 12 956),具化學 式為: 15(19-3) cymoxanil (available from: DE-A 23 12 956) with the chemical formula: 15

(19-4)護粒松(edifenphos)(得知自·· DE-A 14 93 736),具化 學式為:(19-4) edifenphos (known as DE-A 14 93 736), with a chemical formula:

(19_5)凡殺同(famoxadone)(得知自:EP-A 0 393 911),具 -63- 20 200814928 化學式為:(19_5) Where is the famoxadone (available from: EP-A 0 393 911), with -63- 20 200814928 The chemical formula is:

10 (19-6)伏寄南(fluazinam)(得知自:EP-A 0 031 257),具化 學式為:10 (19-6) volts to the south (fluazinam) (obtained from: EP-A 0 031 257), with a chemical formula:

1515

(19-7)氯氧化銅(copper oxychloride) (19-9)歐殺斯(oxadixyl)(得知自:0£-八30 30 026),具化學 式為:(19-7) Copper oxychloride (19-9) oxadixyl (obtained from: 0£-eight 30 30 026), with the chemical formula:

(19-10)螺環菌胺(spiroxamine)(得知自:DE-A 37 35 555), 具化學式為:(19-10) Spiroxamine (known from: DE-A 37 35 555), having the chemical formula:

h3c (19-11)二硫醌(dithianon)(得知自:JP-A 44-29464),具化學 -64- 20 200814928 式為: 〇H3c (19-11) dithianon (available from: JP-A 44-29464), with chemistry -64-20 201414928: 〇

ο (19_12)表苯菌酮(metrafenone)(得知自:ΕΡ-Α 0 897 904), 具化學式為:ο (19_12) metrafenone (known from: ΕΡ-Α 0 897 904), with the chemical formula:

(19-13)口米唾菌酮(fenamid〇ne)(得知自:ΕΡ-Α 0 629 616),具 化學式為:(19-13) fenamidone (known from: ΕΡ-Α 0 629 616), with the chemical formula:

(19-14)2,3-二丁基-6-氣噻吩并[2,3-d]嘧啶-4(3H>酮(得知 自:WO 99/14202),具化學式為:(19-14) 2,3-Dibutyl-6-oxothieno[2,3-d]pyrimidin-4 (3H> ketone (obtained from: WO 99/14202) having the chemical formula:

(19-15)撲殺熱(probenazole)(得知自:US 3,629,428),具化 學式為: -65- 200814928(19-15) Probenazole (available from: US 3,629,428) with a chemical formula: -65- 200814928

10 >〇 、 (19-16)稻瘂靈(isoprothiolane)(得知自:US 3,856,814),具化 學式為:10 > 〇 , (19-16) Isoprothiolane (obtained from: US 3,856,814), with a chemical formula:

(19-17)嘉賜黴素(1<^1^3111>^11)(得知自:〇3 1 094 567),具 化學式為:(19-17) Carbachol (1<^1^3111>^11) (from 〇3 1 094 567), with the chemical formula:

1515

(19-18)熱必斯(phthalide)(得知自:JP-A 57-55844),具化學 式為:(19-18) phthalide (known from: JP-A 57-55844), with the chemical formula:

CI (19-19)富米熱斯(ferimzone)(得知自:EP-A 0 019 450),具 化學式為: -66- 200814928CI (19-19) Ferimzone (available from: EP-A 0 019 450) with the chemical formula: -66- 200814928

(19-20)三賽唑(tricyclazole)(得知自·· DE-A 22 50 077),具 化學式為:(19-20) Tricyclazole (known as DE-A 22 50 077) with the chemical formula:

10 (19-21)N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-甲氧基苯 甲醯胺,具化學式為··10 (19-21) N-({4-[(cyclopropylamino)carbonyl]phenyl}sulfonyl)-2-methoxybenzenecarbamamine, with the chemical formula...

1515

(19-22)2-(4-氯苯基)-N-{2-[3-甲氧基-4-(丙-2-炔-1 -基氧)苯 基]乙基丙-2-快-1-基氧)乙釀胺(得知自:WO 01/87822),具化學式為:(19-22) 2-(4-Chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethylpropan-2- Fast-1-yloxy)ethylamine (known from: WO 01/87822), with the chemical formula:

(19_23)快諾芬(quinoxyfen)(得知自:EP-A 0326 330),具化 學式為: -67- 20 200814928 C!(19_23) quinoxyfen (known from: EP-A 0326 330), with a chemical formula: -67- 20 200814928 C!

F 較佳的第(20)類之混合配對物為: (20-1)賓克隆(pencycuron)(得知自·· DE-A 27 32 257),具化 學式為:F. Preferred mixed partner of class (20) is: (20-1) pencycuron (known as DE-A 27 32 257) with a chemical formula of:

(20-2)甲基-多保淨(thiophanate-methyl)(得知自:DE-A 18 06 123),具化學式為:(20-2) thiophanate-methyl (obtained from: DE-A 18 06 123), with the chemical formula:

Η Η (20-3)乙基-多保淨(thiophanate-ethyl)(得知自:DE-A 18 06 123),具化學式為:Η Η (20-3) ethyl-polyphanate-ethyl (known from: DE-A 18 06 123), with the chemical formula:

Η Η 較佳的第(21)類之混合配對物為: -68- 200814928 (21-1) 氰菌胺(fenoxanil)(得知自:EP-A 0 262 393),具化學 式為:Η 较佳 Preferred mixed partner of class (21) is: -68- 200814928 (21-1) fenoxanil (known from: EP-A 0 262 393), having the chemical formula:

5 (21-2)雙氯氰菌胺(diclocymet)(得知自:JP-A 7-206608), 具化學式為: 較佳的第(22)類之混合配對物為: (22-1) 5-氯-N-[(lS)-2,2,2-三氟-1-甲基乙基]-6-(2,4,6·三氟 苯基)[1,2,4]三唑并[l,5-a]嘧啶-7-胺(得知自:US is 5,986,135),具化學式為:5 (21-2) Diclocymet (known from: JP-A 7-206608), with the chemical formula: The preferred blend of the (22) class is: (22-1) 5-Chloro-N-[(lS)-2,2,2-trifluoro-1-methylethyl]-6-(2,4,6-trifluorophenyl)[1,2,4] Zoledolo[l,5-a]pyrimidin-7-amine (obtained from: US is 5,986,135) with the chemical formula:

2〇 (22-2) 5-氣-N-[(1R)-1,2-二曱基丙基]-6-(2,4,6-三氣苯 基)[1,2,4]三唑并[l,5-a]嘧啶-7-胺(得知自:WO 02/38565),具化學式為: -69- 2008149282〇(22-2) 5-Gas-N-[(1R)-1,2-Dimercaptopropyl]-6-(2,4,6-trisylphenyl)[1,2,4] Triazolo[l,5-a]pyrimidin-7-amine (known from: WO 02/38565) with the chemical formula: -69- 200814928

(22-3) 5 -氯-6-(2-氣-6-氣苯基)-7-(4-曱基六氮ϋ比唆-1-基) 5 [1,2,4]三唑并[l,5-a]-嘧啶(得知自:US 5,593,996), 具化學式為:(22-3) 5-Chloro-6-(2-aero-6-phenylphenyl)-7-(4-mercaptohexanitropyridinium-1-yl) 5 [1,2,4]triazole And [l,5-a]-pyrimidine (known from: US 5,593,996), with the chemical formula:

1010

(22-4) 5-氯-6·(2,4,6-三氟苯基)-7-(4-曱基六氫吼啶-1-基) [1,2,4]三唑并[l,5-a]嘧啶(得知自:DE-A 101 24 208),具化學式為: 15(22-4) 5-Chloro-6·(2,4,6-trifluorophenyl)-7-(4-mercaptohexahydroacridin-1-yl)[1,2,4]triazole [l,5-a]pyrimidine (known from: DE-A 101 24 208) with the chemical formula: 15

較佳的第(23)類之混合配對物為: (23_ 1) 2- 丁氧基-6-破-3-丙基苯弁σ比喃-4-嗣(得知自· WO 03/014103),具化學式為: -70- 20 200814928 ΟA preferred mixed partner of the (23) class is: (23_ 1) 2-butoxy-6-bromo-3-propylbenzoquinone σ-pyran-4-嗣 (known from WO 03/014103 ), with the chemical formula: -70- 20 200814928 Ο

(23-2) 2-乙氧基-6-碘-3-丙基苯并吡喃-4-酮(得知自:WO 03/014103),具化學式為:(23-2) 2-Ethoxy-6-iodo-3-propylbenzopyran-4-one (obtained from: WO 03/014103), having the chemical formula:

^ ^ ch3 ch3^ ^ ch3 ch3

10 (23-3) 6-碘-2-丙氧基-3-丙基苯并吡喃-4-酮(得知自:WO 03/014103),具化學式為:10 (23-3) 6-iodo-2-propoxy-3-propylbenzopyran-4-one (obtained from: WO 03/014103), having the chemical formula:

(23-4) 2-丁-2-快基氧-6-破-3-丙基苯弁ϋ比喃-4-嗣(得知自: WO 03/014103),具化學式為: 15(23-4) 2-but-2-Quinyloxy-6-bromo-3-propylphenylpyrenepyran-4-pyrene (obtained from: WO 03/014103), with the chemical formula: 15

(23-5) 6-蛾-2-(1-曱基丁乳基)-3-丙基苯弁1^比喃-4-嗣(得知 自:WO 03/014103),具化學式為:(23-5) 6-Moth-2-(1-decylbutyryl)-3-propylbenzoquinone 1^pyran-4-嗣 (obtained from: WO 03/014103), with the chemical formula:

(23-6) 2-丁-3-烯基氧-6-碘苯并吡喃-4-酮(得知自:WO 03/014103),具化學式為: -71 ~ 20 200814928(23-6) 2-but-3-enyloxy-6-iodobenzopyran-4-one (obtained from: WO 03/014103) with the chemical formula: -71 ~ 20 200814928

(23-7) 3-丁基-6-碘-2-異丙氧基苯并吡喃-4-酮(得知自:WO 03/014103),具化學式為:(23-7) 3-butyl-6-iodo-2-isopropoxybenzopyran-4-one (obtained from: WO 03/014103) having the chemical formula:

10 〇10 〇

較佳的第(24)類之混合配對物為: (24-1) N-(3’,4’-二氯-5-氟聯苯基-2-基)-3-(二氟甲基)-1 -甲基-1H-吡唑-4-羧醯胺(得知自:WO 03/070705), 具化學式為: 15Preferred mixed partners of class (24) are: (24-1) N-(3',4'-dichloro-5-fluorobiphenyl-2-yl)-3-(difluoromethyl) )-1 -Methyl-1H-pyrazole-4-carboxyguanamine (known from: WO 03/070705), with the chemical formula: 15

(24-2) 4-(二氟甲基)-2-甲基-N-[4f•(三氟曱基聯苯基 -2-基]-1,3-噻唑-5-羧醯胺(得知自:WO 03/066610), 具化學式為: -72- 20 200814928(24-2) 4-(Difluoromethyl)-2-methyl-N-[4f•(trifluoromethylbiphenyl-2-yl)-1,3-thiazole-5-carboxamide ( Learned from: WO 03/066610), with the chemical formula: -72- 20 200814928

5 (24-3) N-(3’-氣-4’-氯聯苯基-2-基)-4·(二氣曱基)-2-甲 基-1,3-噻唑-5-羧醯胺(得知自:WO 03/066610),具 化學式為:5 (24-3) N-(3'-Gas-4'-chlorobiphenyl-2-yl)-4·(dioxamethyl)-2-methyl-1,3-thiazole-5-carboxylate Guanamine (available from: WO 03/066610) with the chemical formula:

(24-4) N-(3’,4’-二氯-1,Γ-聯苯基-2-基 >5-氟-1,3-二甲基 -1H-吡唑-4-羧醯胺(得知自:WO 00/14701),具化學 式為.(24-4) N-(3',4'-Dichloro-1, fluorene-biphenyl-2-yl> 5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxylate Indoleamine (known from: WO 00/14701), with chemical formula.

2〇 (24-5) N-(4’-氣-3’-亂-l,r_聯苯基-2-基)-2-曱基-4-(三氣甲 基)-1,3-噻唑-5-羧醯胺(得知自:W0 03/066609),具 化學式為: -73- 2008149282〇(24-5) N-(4'-gas-3'-random-l,r_biphenyl-2-yl)-2-mercapto-4-(trimethylmethyl)-1,3 -thiazole-5-carboxamide (available from: W0 03/066609) with the chemical formula: -73- 200814928

5 (24-6) N-(4’-氯聯苯基-2-基)-4-(二氟甲基)-2-曱基-1,3- 噻唑-5-羧醯胺(得知自:WO 03/066610),具化學式5 (24-6) N-(4'-chlorobiphenyl-2-yl)-4-(difluoromethyl)-2-mercapto-1,3-thiazole-5-carboxyguanamine (known From: WO 03/066610), with chemical formula

(24-7) ΛΚ4’·溴-1,Γ-聯苯基-2-基)-4-(二氟曱基)-2-曱基 胃1,3-噻唑-5-羧醯胺(得知自:WO 03/066610),具化 15 學式為..(24-7) ΛΚ4'·bromo-1,Γ-biphenyl-2-yl)-4-(difluoroindolyl)-2-indolyl gastric 1,3-thiazole-5-carboxyguanamine Known from: WO 03/066610), with 15 learning styles:

較佳的第(25)類之混合配對物為: (25-1) Λ42-(1,3-二曱基丁基)苯基]-1,3-二甲基-lif-口 比唑-4-羧醯胺,具化學式為: -74- 20 200814928Preferred mixed partners of class (25) are: (25-1) Λ42-(1,3-dimercaptobutyl)phenyl]-1,3-dimethyl-lif-mouthbazole- 4-carboxyguanamine with the chemical formula: -74- 20 200814928

(25-2)落{2-(l,3-二甲基丁基)苯基氟-1,3-二甲基 5 吡唑-4-羧醯胺(得知自:WO 03/010149),具化學式(25-2) Falling {2-(l,3-dimethylbutyl)phenylfluoro-1,3-dimethyl-5 pyrazole-4-carboxamide (available from: WO 03/010149) With chemical formula

(25-3) Λ42-(1,3-二甲基丁基)苯基]_5-氯-1,3-二甲基-1凡吡 唑-4-羧醯胺(得知自:JP-A 10-251240),具化學式為:(25-3) Λ42-(1,3-dimethylbutyl)phenyl]_5-chloro-1,3-dimethyl-1phenazineazole-4-carboxamide (available from: JP- A 10-251240), with the chemical formula:

15 (25-4) 3-(二氟甲基)-7\^[2-(1,3-二甲基丁基)苯基]_ι·甲基 -1//-吡唑-4-羧醯胺,具化學式為:15 (25-4) 3-(Difluoromethyl)-7\^[2-(1,3-dimethylbutyl)phenyl]_ι·methyl-1//-pyrazole-4-carboxylate Indoleamine, with the chemical formula:

(25-5) 3-(三氟甲基)善[2-(1,3-二甲基丁基)苯基]冬氟小甲 基-177-吡唑-4_羧醯胺(得知自:DE-A 103 03 589), -75« 200814928 具化學式為:(25-5) 3-(Trifluoromethyl)-[2-(1,3-dimethylbutyl)phenyl]oxofluoromethyl-177-pyrazole-4-carboxamide (known From: DE-A 103 03 589), -75« 200814928 The chemical formula is:

(25-6) 3-(三氟甲基)_#_[2_(1,3_二甲基丁基)苯基]_5_氣甲 基比唾_4_叛醯胺(得知自:jp_A 仙), • 具化學式為:(25-6) 3-(Trifluoromethyl)_#_[2_(1,3-dimethylbutyl)phenyl]_5_qimethyl than salivation-4_tetamine (known from: jp_A 仙), • has the chemical formula:

(25-7) 1,3-二甲基#[2心,3,3-三甲基)苯基^比唾冰緩 酸胺(得知自·· JP-A 10-251240),具化學式為:(25-7) 1,3-Dimethyl#[2,3,3-trimethyl)phenyl^ is more than a salicylamine (known as JP-A 10-251240), with a chemical formula for:

(25-8) 5-氟-1,,3_二甲基善[2(1,3,3·三甲基丁基)笨基]•心比 n敌酿胺(得知自:WO 03/010149),具化學式為·(25-8) 5-Fluoro-1,3-dimethylso[2(1,3,3·trimethylbutyl) stupid base]• Heart ratio n entrained amine (known from: WO 03 /010149), with chemical formula

(25-9) 3-(二敗甲基)小甲基善[2_(1,3,3_三曱基丁基)笨 -76- 200814928 基]4仏吡唑-4-羧醯胺,具化學式為:(25-9) 3-(disodium methyl) small methyl good [2_(1,3,3_tridecylbutyl) stupid-76- 200814928 base]4 pyrazole-4-carboxyguanamine, With the chemical formula:

(25-10)3-(三氟曱基)-1-甲基三甲基丁基)笨 基]-1//-吡唑-4-羧醯胺,具化學式為··(25-10) 3-(Trifluoromethyl)-1-methyltrimethylbutyl)phenyl]-1//-pyrazole-4-carboxyguanamine, having the chemical formula··

(25-11)3-(二氣甲基)-5遠_1_曱基养三曱基丁基) 苯基Η凡吼唾冰羧醯胺(得知自:dE-A 103 〇3 589),具化學式為:(25-11) 3-(dimethylmethyl)-5 far-1_indolyl tridecylbutyl) phenyl hydrazine hydrazine carbaryl amide (known from: dE-A 103 〇 3 589 ), with the chemical formula:

(25_12)t(三氟甲基)·5-氯-1-甲基善[2-(1,3,3-三甲基丁基) 苯基]-1丹·^比唾-4-羧醯胺(得知自:jp A 1〇_25124〇), 具化學式為: 200814928(25_12)t(trifluoromethyl)·5-chloro-1-methyl good [2-(1,3,3-trimethylbutyl)phenyl]-1 dan·^ than sal-4-carboxyl Guanamine (known from: jp A 1〇_25124〇), with the chemical formula: 200814928

5 (25-13)#-[2-(1,3-(二甲基丁基)苯基)-2-碘苯甲醯胺(得知 自:DE-A 102 29 595),具化學式為:5(25-13)#-[2-(1,3-(dimethylbutyl)phenyl)-2-iodobenridamide (known from: DE-A 102 29 595), with chemical formula :

(25-14)2-碘,3,3-三甲基丁基)苯基]苯甲醯胺(得知 自:DE-A 102 29 595),具化學式為:(25-14) 2-iodo, 3,3-trimethylbutyl)phenyl]benzamide (found from: DE-A 102 29 595), having the chemical formula:

(25-15)豕[2-(1,3-二甲基丁基)苯基]-2-(三氟曱基)苯甲醯胺 (得知自:DE-A 102 29 595),具化學式為:(25-15) 豕[2-(1,3-Dimethylbutyl)phenyl]-2-(trifluoromethyl)benzamide (available from: DE-A 102 29 595), with The chemical formula is:

(25-16)2-(三氟甲基)-7V-[2-(l,3,3-三曱基丁基)苯基]苯甲醯 -78- 20 200814928 胺(得知自:DE-A 102 29 595),具化學式為:(25-16) 2-(Trifluoromethyl)-7V-[2-(l,3,3-tridecylbutyl)phenyl]benzamide-78- 20 200814928 Amine (Know from: DE -A 102 29 595), with the chemical formula:

5 式(XVIII)的化合物包含下述較佳的第(26)類之混合配 | 對物: (26-1) 5-氟-1,3-二曱基-N-[2-(3-曱基丁基)苯基;HH-吼唑 ίο -4-羧醯胺,具化學式為:5 The compound of the formula (XVIII) comprises the following preferred compound of the above (26) class | Pair: (26-1) 5-fluoro-1,3-didecyl-N-[2-(3-曱 butyl phenyl) phenyl; HH-carbazole ίο -4-carboxamide, with the chemical formula:

1515

(26-2) 3-(二氟曱基)-N-[2-(3,3-二曱基丁基)-4-氟苯基]-1-曱 基-1//*吡唑4-羧醯胺,具化學式為:(26-2) 3-(Difluoroindolyl)-N-[2-(3,3-dimercaptobutyl)-4-fluorophenyl]-1-indenyl-1//*pyrazole 4 - Carboxylamamine, with the chemical formula:

(26-3) 3-(二氟甲基)-Ν-[2-(3,3·二曱基丁基)苯基]-1-甲基 -1Η-吡唑-4-羧醯胺,具化學式為: -79- 200814928(26-3) 3-(Difluoromethyl)-indole-[2-(3,3·didecylbutyl)phenyl]-1-methyl-1Η-pyrazole-4-carboxamide, With the chemical formula: -79- 200814928

(26-4) N-[2-(3,3-二甲基丁基)苯基]-2-(三氟曱基)苯甲酿 胺,具化學式為:(26-4) N-[2-(3,3-dimethylbutyl)phenyl]-2-(trifluoromethyl)benzamide, having the chemical formula:

(26-5) N-[2-(3,3-二甲基丁基)-4-氟苯基]-2-甲基冰(三氟甲 ίο 基)-1,3-噻唑-5-羧醯胺,具化學式為:(26-5) N-[2-(3,3-dimethylbutyl)-4-fluorophenyl]-2-methyl ice (trifluoromethyl)-1,3-thiazole-5- Carboxyamine, with the chemical formula:

1515

(26-6) N-[2-(3,3-二甲基丁基)-3-甲基噻吩-2-羧醯胺,具化 學式為:(26-6) N-[2-(3,3-Dimethylbutyl)-3-methylthiophene-2-carboxamide, with chemical formula:

(全部均為得知自WO 2005/042494)。 化合物(6-7),加普安(caipropamid),具有三個不對稱 的經取代的碳原子,因此,化合物(6-7)可以是由不同的異 構物形成之混合物或單獨的組分之型式,特別佳的化合物 20 200814928 為··(^3i〇-2,2-二氯氣苯基)乙基]-1-乙基-3- 甲基環丙烷羧醯胺,具化學式為:(All are known from WO 2005/042494). The compound (6-7), caipropamid, has three asymmetric substituted carbon atoms, and therefore, the compound (6-7) may be a mixture formed of different isomers or a separate component. The type, particularly excellent compound 20 200814928 is (^3i〇-2,2-dichlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamide, which has the chemical formula:

以及 (/iU*S>2,2-二氣Κ(1〇小(4-氯苯基)乙基]小乙基_3_甲基 環丙烷羧醯胺,具化學式為:And (/iU*S>2,2-dioxane (1 〇 small (4-chlorophenyl)ethyl) small ethyl _3_methylcyclopropanecarboxamide, having the chemical formula:

15 特別佳的第(2)至(26)類的活性化合物為下述之活性化 ϋ 合物: (2-1)亞托敏(azoxyStr〇bin),(2-2)氟嘧菌酯(fluoxastrobin),(2_3) (2£>2-(2- {[6-(3-氯-2-甲基苯氧基)_5_氟-4-嘧啶基]氧y苯 基)-2-(甲氧基亞胺基)-ΛΓ-甲基乙醯胺,(2_4)三氟敏 2〇 (trifloxystrobin),(2-5) (2£>2-(甲氧基亞胺基)# 甲基 2-(2_{[({(1万)-1-[3_(二氟甲基)苯基]乙二基卜胺基)氧]甲基} 苯基)乙醯胺’(2·6) (2幻士(甲氧基亞胺基)·|甲^ -2-{2-[(五)-({1-[3-(三氟甲基)苯基]乙氧基丨亞胺基甲基]苯 基}乙醯胺,(2-8) 5-甲氧基_2-甲基冰(2-{[({(1幻小[3_(三氣 -81 - 200814928 甲基)苯基]乙二基}胺基)氧]-甲基}苯基)-2,4-二氫 -3F-1,2,4-三唑-3-酮 ’ (2-9) 克收辛-甲基 (kresoxim-methyl),(2-10)大滅哇丙(dimoxystrobin),(2-11) 咬氧菌酯(picoxystrobin),(2-12)唾菌胺酯(pyraclostrobin),(2 -13 ) 5 苯氧菌胺(metominostrobin),(2-14)英司多丙(enestrobin), (3-3)普比康嗤(propiconazole),(3-4)待芬康唾 (difenoconazole),(3-6)西普康唾(cyproconazole),(3-7)菲 | 克斯(hexaconazole),(3-8)平康嗤(penconazole),(3-9)邁 克別尼(myclobutanil),(3·10)四康嗤(tetraconazole),(3-12) 10 依普座(epoxiconazole),(3-13)護石夕唾(flusilazole),(3-15) 普硫康哇(prothioconazole) ,(3-16) 芬布康嗤 (fenbuconazole),(3-17)得克力(tebuconazole),(3-19)滅康 唑(metconazole),(3-21)比多農(bitertanol),(3-22)三泰隆 (triadimenol),〇23)三泰芬(triadimefon),(3-24)氟喹康 15 唑(fluquinconazole),(3-26)二氯布康唑(diclobutrazole), _ (3-27)得尼康唑(diniconazole),(4-1)二氯氟尼 (dichlofluanid) ’(4-2)曱基益發靈(tolylfhianid),(5-1)異丙 菌胺(iprovalicarb),(5-3)苯噻菌胺(benAiavalicarb),(6_2) 白克力(boscalid),(6-5)噻唑菌胺(ethaboxam),(6-6)環醯 20 菌胺(fenhexamid),(6-7)卡普米(carpropamid),(6-8) 2-氣 -4-(2-氟-2-甲基丙酿基胺基)_况#-二甲基苯甲酿胺,(6-9)殺 菌劑(picobenzamid),(6_10)唑查醯胺(zoxamide),(6-11) 3,4_二氯-N-(2-氰基苯基)異°塞唾-5-叛醢胺,(6-14) σ塞菌胺 (penthiopyrad),(6-16) Λ42-(1,3-二曱基丁基)苯基]-1-甲基 -82- 200814928 冰(三氟甲基)_1丑_吼咯-3-羧醯胺,(6-17)福多寧 (flutolanil),(6·21) N-{2-〇氯·5-(三氟甲基)π比啶冬基]乙 基}-2-(三氟甲基)苯甲醯胺,(6-22) Ν-(2-雙環丙基-2-基笨 基)_卜曱基-3-二氟甲基-lji-u比唾_4_叛酿胺,(6-23) Ν-(2-雙 5 壞丙基-2-基苯基)-1-甲基-3-二敗甲基-111-°比唾-4-叛酿胺, (6-24) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-三氟甲 基-1Η-吡唑-4-羧醯胺,(6-25) Ν-[2-(Γ-曱基雙環丙基-2-基) , 苯基]-1-甲基-3-二氟曱基-1Η· σ比峻-4-緩酿胺,(6-26) N-[l-(5-溴-3-氣0比咬-2-基)乙基]-2,4-二氯於驗酿胺,(6,27) ίο Ν·(5-溴-3-氯吡啶-2-基)甲基-2,4-二氣菸鹼醯胺,(7-1)鋅猛 乃浦(mancozeb),(7-2)猛乃浦(maneb),(7-4)甲基鋅乃浦 (propineb),(7-5)得恩地(thiram),(7-6)鋅乃浦(zineb),(8-l) 本達樂(benalaxyl),(8-2)福達樂(furalaxyl),(8-3)滅達樂 (metalaxyl),(8,4)滅達樂-M(metalaxyl-M),(8:5)本達樂 is -M(benalaxyl-M),(9,1)西普地尼(cyprodinil),(9-2)滅盤 尼比(mepanipyrim),(9-3)必滅寧(pyrimethanil),(10-1) 6-15 Particularly preferred active compounds of the above categories (2) to (26) are the following activated compounds: (2-1) azoxy Str〇bin, (2-2) fluoxastrobin ( Fluoxastrobin),(2_3) (2£>2-(2- {[6-(3-chloro-2-methylphenoxy)_5_fluoro-4-pyrimidinyl]oxy yphenyl)-2- (methoxyanilide)-oxime-methylacetamide, (2_4) trifloxystrobin, (2-5) (2£>2-(methoxyimino)# Methyl 2-(2_{[({(1))-1-[3_(difluoromethyl)phenyl]ethanediylamino)oxy]methyl}phenyl)acetamidamine' (2· 6) (2 phantom (methoxyimino)·|^^ -2-{2-[(5)-({1-[3-(trifluoromethyl)phenyl]ethoxy oxime) Aminomethyl]phenyl}acetamidamine, (2-8) 5-methoxy-2-methyl ice (2-{[({(1) is a small [3_(three gas-81 - 200814928 methyl) Phenyl]ethylenediyl}amino)oxy]-methyl}phenyl)-2,4-dihydro-3F-1,2,4-triazol-3-one' (2-9) Kresoxim-methyl, (2-10) dimoxystrobin, (2-11) picoxystrobin, (2-12) pyracostrobin, 2 -13 ) 5 phenoxystrobin (metominostrobin), (2-14) Enestrobin, (3-3) propiconazole, (3-4) difenoconazole, (3-6) cyproconazole, (3-7) ) hexaconazole, (3-8) penconazole, (3-9) myclobutanil, (3·10) tetraconazole, (3-12) 10 epoxiconazole, (3-13) flusilazole, (3-15) prothioconazole, (3-16) fenbuconazole, (3- 17) tebuconazole, (3-19) metconazole, (3-21) than bitertanol, (3-22) triadimenol, 〇23) tritopine (triadimefon), (3-24) fluquinconazole, (3-26) diclobutrazole, _ (3-27) diniconazole, (4-1) Dichlofluanid '(4-2) 曱基益发灵 (tolylfhianid), (5-1) isopropyl carbamide (iprovalicarb), (5-3) benzothiazol (benAiavalicarb), (6_2) Boscalid, (6-5) ethaboxam, (6-6) guanidine 20 fenhexamid ), (6-7) carpropamid, (6-8) 2-gas-4-(2-fluoro-2-methylpropanylamino)_condition #-dimethylbenzamide , (6-9) bactericide (picobenzamid), (6_10) zoxamide, (6-11) 3,4-dichloro-N-(2-cyanophenyl) iso-salt- 5-treazone, (6-14) σs-subtilamine (penthiopyrad), (6-16) Λ42-(1,3-didecylbutyl)phenyl]-1-methyl-82- 200814928 ice (trifluoromethyl)_1 ugly 吼 吼 -3--3-carboxamide, (6-17) flutolanil, (6·21) N-{2-〇chloro·5-(trifluoromethyl Π-pyridinyl]ethyl}-2-(trifluoromethyl)benzamide, (6-22) Ν-(2-bicyclopropyl-2-ylphenyl)-diphenyl-3- Fluoromethyl-lji-u is more than salivary _4_ apoein, (6-23) Ν-(2-bis 5 propyl propyl-2-ylphenyl)-1-methyl-3- dioxin methyl -111-° than saliva-4-rebel, (6-24) Ν-[2-(Γ-methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-trifluoromethyl Base-1-pyrazole-4-carboxyguanamine, (6-25) Ν-[2-(indolyl-bicyclopropyl-2-yl), phenyl]-1-methyl-3-difluoro曱基-1Η· σ比峻-4- slowly brewing amine, (6-26) N-[l-(5-bromo-3-gas 0-bit-2-yl)ethyl]-2,4-di chlorine In the test of amine, (6,27) ίο Ν·(5-bromo-3-chloropyridin-2-yl)methyl-2,4-di-nicotinamide, (7-1) zinc snail (mancozeb), (7-2) Manna, (7-4) methyl zinc (propineb), (7-5) thiram, (7-6) zinc napu ( Zineb), (8-l) Benalaxyl, (8-2) furalaxyl, (8-3) metalaxyl, (8, 4) vandal-M ( metalaxyl-M), (8:5) Bendais is -M (benalaxyl-M), (9,1) cyprodinil, (9-2) mepanipyrim, (9 -3) Pyrimen (pyrimethanil), (10-1) 6-

W 氯-5-[(3,5-二甲基異噁唑-4-基)磺醯基]-2,2-二氟-5H-[1,3]二 σ惡茂并[4,5-f]-苯并味嗤,(10-3)貝芬替(carbendazim),(11-1) 二硫芬克(diethofencarb),(11-2)普拔克(propamocarb), 2〇 (11-3)鹽酸普拔克(propamocarb_hydrochloride),(11-4)普 拔克-福賽得(fosetyl),(12-2)蓋普丹(^?丨&11),(12-3)福爾 培(folpet),(12-4)依普同(iprodione),(12-5)撲滅寧 (procymidone),(13-1)多寧(dodine),(13-2)克熱淨 (guazatine),(13-3)雙胍辛胺三乙酸鹽(iminoctadine •83- 200814928 triacetate) ’(14-1)赛座滅(Cyazofainid),(14-2)撲克拉 (prochloraz),(14-3)三唑嗪(triazoxide),(15-4)芬普比福 (fenpropimorph),(15-5)大滅芬(dimethomorph),(16-2)伏 地噁尼(fludioxonil),(17-1)福赛得-鋁(fbsetyl-Al),(17-2) 5 膦酸 ’(17·3)曱基立枯磷(toldophos-methyl),(19-1)笨并 噻二唑酯(acibenzolar-S-methyl) ,(19-2)氣塞尼 (chlorothalonil),(19-3)克絕(cymoxanil),(19-5)凡殺同 瞻 (famoxadone),(19-6)伏寄南(fluazinam),(19-7)氣氧化銅 (copper oxychloride),(19_9)歐殺斯(oxadixyl),(19-10)螺 ίο 環菌胺(spiroxamine),(19-13)咪唑菌酮(fenamidone), (19-22) 2-(4-氯苯基)-N-{2-[3-曱氧基-4-(丙-2-炔小基氧)苯 基]乙基}-2-(丙-2-炔-1-基氧)乙醯胺,(19-23)快諾芬 (quinoxyfen),(20-1)賓克隆(pencycuron),(2〇-2)曱基_多 保淨(thiophanate-methyl),(22-1) 5-氯-Λ4(/5>2,2,2_三氟-l is 甲基乙基]各(2,4,6-三氟笨基)[1,2,4]三。坐并[l,5-a], 口定 胺,(22-2) 5-氯二曱基丙基]-6-(2,4,6-三氟苯 _ 基)[1,2,4]三唑并[l,5_a]嘧啶-7-胺,(22-4) 5-氯各(2,4,6-三氣 苯基)-7-(4-曱基六氫吼啶-1-基)[1,2,4]三唑并[l,5-a]嘧咬, (23-1) 2-丁氧基-6-破-3-丙基苯并吡喃-4·酮,(23-2) 2-乙氧 2〇 基-6-碘-3-丙基苯并吡喃·‘酮,(23-3) 6-碘-2-丙氧基-3·丙基 苯并啦喃-4·酮,(24-1)沁(3,,4,-二氯-5-氟·1,1’_聯苯基_2_ 基)-3·(二 It 甲基)-1-甲基比嗤-4-羧酿胺,(24-7) Λ^(4,_ 溴-1,Γ-聯苯基-2-基)-4-(二氟曱基)-2-甲基-1,3H5-竣醯 胺,(25-1) 1[2-(1,3-二曱基丁基)苯基]-ΐ,3·二甲基-1//•吡唾 -84- 200814928 领醯胺,(25_2) ^{2_(1,3_二甲基丁基)苯基卜5_氣妙二 Y 基-1心比唾-續_,(25_8) 甲基善[2(1,3,3_ 二甲基丁基)苯基Η//』比唾_4_叛_,(25·13^_[2 (ι,3 (二 甲基丁基)苯基)-2-碘苯曱醯胺,(25_15)尽{2_〇,3-二甲基丁 5 基)苯基卜三氟甲基)苯甲酸胺。 極佳的第(2)至(26)類的活性化合物為下述之活性化合 物: | (2-2)氟。治_ 酯(fluoxastrobin),(2-3)(2五)-2-(2-{[6-(3-氯-2- 甲基苯氧基)_5_氟喷啶基]氧}苯基)冬(曱氧基亞胺基)善 10 曱基乙酿胺,(2·4)、三氟敏(trifloxystrobin),(3-15)普硫康 唑(prothioconazole),(3,17)得克力(tebuconazole),(3-21) 比多農(bitertanol),(3-22)三泰隆(triadimenol),(3-24)氟 喹康唑(fluquinconazole),(4-1)二氯氟尼(dichlofluanid), (4-2)甲基益發靈(tolylfluanid),(5-1)異丙菌胺 15 (iprovalicarb),(6-6)環酸菌胺(fenhexamid),(6-7)卡普米 除 (caipropamid),(6-9)殺菌劑(picobenzamid),(6-14)嗔菌胺 (penthiopyrad),(6-17)福多寧(fhitolanil),(6-21) Ν-{2-[3-氯-5-(三氟曱基)吡啶-2-基]乙基卜2-(三氟甲基)苯甲醯胺, (6-22) N-(2-雙環丙基-2-基苯基)-1-曱基-3-三氟甲基-1H-口比 20 唑-4-羧醯胺,(6-23) Ν-(2-雙環丙基-2-基苯基)-1-曱基-3-二 氟甲基-1H-吡唑-4-羧醯胺,(6-24) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-三氟甲基-lH-u比唑·4·羧醯胺,(6-25) Ν-〇(Γ-甲基雙環丙基-2-基)苯基]·1-曱基-3-二氟甲基-1Η-吡唑-4-羧醯胺,(6-26)Ν-[1-(5-溴-3-氣吡啶-2-基)乙基]-2,4- -85- 200814928 二氯菸鹼醯胺,(6-27) 1^-(5_溴-3_氯吡啶-2-基)曱基-2,4-二氯 於驗醯胺’(7_4)曱基鋅乃浦(pr〇pineb),(8_4)滅達樂 -M(metalaxyl-M),(8-5)本達樂_M(benalaxyl-M),(9麵3)必 滅寧(pyrimethanil),(10-3)貝芬替(carbendazim),(11-4)普 5 拔克-福賽付(f〇setyl) ’(12-4)依普同(iprocji〇ne),(14-2)撲 克拉(prochloraz),(14-3)三唾唤(triazoxide),(16-2)伏地 噁尼(fludioxonil),(17-3)甲基立枯磷(toidophos-methyl), 除 (19-10)螺環菌胺(spiroxamine),(19-22) 2-(4-氣苯 基)-N-{2-[3-甲氧基-4-(丙-2-炔-1-基氧)苯基]乙基}-2-(丙-2-ίο 炔小基氧)乙酿胺,(19-23)快諾芬(quinoxyfen),(22-4) 5- 氯-6-(2,4,6-三I苯基)-7-(4-甲基六氫吼。定-1-基)[1,2,4]三嗤 并[l,5-a]嘧啶,(24-1) A^(3f,4,-二氯-5-氟·1,Γ-聯苯基-2-基)-3-(二氟甲基)小甲基-lif-吡唑-4-羧醯胺,(25-2) Λ^2-(1,3-二曱基丁基)苯基}·5-氟-1,3-二甲基-1好-吡唑-4-15 羧醯胺,(25-13) ΛΓ-[2-(1,3-(二甲基丁基)苯基)冬碘苯甲醯 ,胺。 較佳的活性化合物組合物包含兩類的活性化合物且在 各情形為:至少一種具式(I)之羧醯胺化合物(第(1)類)’以 及至少一種如下述之第(2)類至第(26)類之化合物,這些組 2〇 合物為Α至W之活性化合物組合物。 較佳之活性化合物組合物,其中第(1)類之式(I)的綾醯 胺化合物係挑選自下面表A中所列之化合物·· -86 - 200814928 表A : 編號 羧醯胺的化學名稱 (1-1) N-(3V^二氯聯苯基-2-基)小甲基-3-(三氟甲基)-1Η ^比唑-4-羧醯胺 (1-2) N_(3’-氯-4’-氟聯苯基-2-基)小甲基-3-(三氟甲基比唑-4-羧醯 胺 (1-3) N-(2f,4L二氯聯苯基-2-基)小甲基各(三氟甲基)-1Η』比唑-4-羧醯胺 (1-4) N-(3f,4’-二氟聯苯基-2-基)小甲基各(三氟甲基)-1Η-吡唑-4-羧醯胺 (1-5) N-(2’,5f-二氯聯苯基冬基)小甲基各(三氟甲基)-1Η-吡唑斗羧醯胺 (1-6) Ν-(2*,5*-二氣聯苯基-2-基)-1-甲基-3-(二敦甲基魏驢胺 (1-7) N-(4’-氣-2’-氟聯苯基冬基)小甲基各(三氟甲基)-1ΗΜ比唑冰羧醯 胺 (1-8) N-(4T-氣-2’-甲基聯苯基-2-基)-1-甲基-3-(二氣甲基竣 醯胺 (1-9) N-(4’-氯-3’-甲基聯苯基-2-基)小甲基各(三氟甲基)-1Η-吼唑冬羧 ϋ胺 (1-10) N-(4L鼠-2’-甲基聯苯基-2-基)-1-甲基-3-(二鼠甲基)-1Η-σΛσ坐-4-竣 醯胺 (1-11) Ν-(4’-氣-3^·•甲基聯苯基-2-基)-1-甲基-3-(二氣甲基比嗤-4-竣 醯胺 (1-12) N-(4f-氣-3’-氣甲基聯苯基-2-基)-1-甲基-3-(二氣甲基)-1Η·α比嗤 -4-羧醯胺 (1-13) Ν-(2’,4’-二氟聯苯基-2-基)小甲基各(三氟甲基)-1Η』比唑斗羧醯胺 (1-14) NW-氟U氧基聯苯基-2-基)小甲基-3 -(三氟曱基)_ 1H』比唑斗 羧醯胺 (1-15) 二氣聯苯基-2-基)-1-甲基-3-(二氣甲基)-1Η-ϋΐ^坐-4-魏酿胺 -87- 200814928 編號 羧醯胺的化學名稱 (1-16) N-(3’,5f-二甲基聯苯基-2-基)小甲基-3-(三氟甲基)-1Η ^比唑冰羧醯 胺 (1-17) N-(4’-氯U肖基聯苯基-2-基)小甲基-3-(三氟甲基)-1Η ^比唑-4-羧 醯胺 (1-18) N-[3\5f-雙(二氣甲基)聯苯基-2-基]-1-甲基-3-(二氣曱基 冬羧醯胺 (1-19) N-(3’,4’-二甲基聯苯基-2-基)小甲基-3-(三氟甲基)·1Η·吼唑-4-羧醯 胺 (1-20) 1-甲基-N-[4W肖基-3’-(三氟甲基)聯苯基-2-基]各(三氟甲基)-1Η-α比 唑-4-羧醯胺 (1-21) N-(4f-甲氧基-3^甲基聯苯基-2-基)小甲基各(三氟甲基)-1Η-吼唑 -4-羧醯胺 (1-22) N-(3*,4’-二甲氧基聯苯基-2-基)-1-甲基-3-(二氣甲基)-1Η-ϋΛσ坐-4-竣 醯胺 (1-23) N-(3’-氣-4’-甲乳基聯苯基-2-基)-1-甲基-3 -(二氣甲基 羧醯胺 (1-24) N-(4’-氯-3’-甲氧基聯苯基-2-基)小甲基各(三氟甲基)-1Η-吼唑-4- 羧醯胺 (1-25) N-[4’-氯-3H三氟甲基)聯苯基-2-基]小甲基-3-(三氟甲基)-1Η^比唑 -4-羧醯胺 (1-26) N-(3\5L二氣聯苯基-2*•基)-1-甲基-3-(二氣甲基)-111-啦唾-4-竣酿胺 (1-27) N-(4’-甲氧基-2’-甲基聯苯基-2-基)-1-甲基-3-(三氟甲基)-1Η·吼唑 -4-羧醯胺 (1-28) N-(3f,4L二氯聯苯基-2-基)-1-甲基各(二氟甲基)-1Η-吼唑-4-羧醯胺 (1-29) Ν-(3、氯氟聯苯基-2-基)小甲基-3-(二氟甲基)-1Η-吼唑-4-羧醯 胺 (1-30) N-(2’,4f-二氯聯苯基-2-基)-1 -甲基各(二氟曱基)-1H-吡唑-4-羧醯胺 (1-31) N-(3’,仁二氟聯苯基-2-基)小甲基-3-(二氟甲基)-1Η-吼唑-4-羧醯胺 -88- 200814928 編號 羧醯胺的化學名稱 (1-32) ST-(2*,5*-二氣聯苯基-2-基)-1-甲基-3-(二氣甲基^^。比峻-斗-魏酿胺 (1-33) Ν-(2’,5^二氟聯苯基-2-基)小甲基-3-(二氟甲基比唑斗羧醯胺 (1-34) N-(4’-氯-2匕氟聯苯基-2-基)小甲基各(二氟甲基)-1Η-吼唑斗羧醯 胺 (1-35) N-(4*-氣-2匕甲基聯本基·2-基)-1-甲基-3-(二氣甲基)-1Η-σ比坐-4-竣 龜胺 (1-36) Ν-(4’-氯-3’画甲基聯苯基-2-基)-1鑛甲基-3-(二氟甲基)嫌111-0比口坐-4-竣 酸胺 (1-37) N-(4L氣-2f-甲基聯苯基-2-基)-1-甲基-3-(二鼠甲基敌 醯胺 (1-38) N-(4f-鼠-3’-甲基聯苯基-2-基)·1-甲基-3-(二鼠甲基)-111-°比°坐-4-竣 醯胺 (1-39) N-(4’-氯-3f-氟-2’-甲基聯苯基-2-基)小甲基各(二氟甲基)-111-¾匕唑 -4-羧醯胺 (140) N-(2’,4’-二氟聯苯基-2-基)小甲基各(二氟曱基)-1Η-咻唑-4-羧醯胺 (1-41) Ν-(2。氣-4’-甲氧基聯苯基-2-基)-1-甲基-3-(二氣甲基 羧醯胺 (1-42) N-(2f,6f-二亂聯苯基-2-基)-1-甲基-3-(二氣曱基)-1Η-ϋ比17坐-4-竣酿胺 (1-43) Ν-(3’,5’-二甲基聯苯基-2-基)-1-甲基-3-(二氣甲基)-1Η-σ比嗤-4-竣隨 胺 (1-44) N-(4f-鼠-3*-石肖基聯苯基-2-基)-1-甲基-3-(二亂曱基竣 醯胺 (1-45) N-[3’,5f-雙(三氟甲基)聯苯基-2-基]-1-甲基-3-(二氟甲基)-1Η ^比唑 斗羧醯胺 (1-46) N-(3’,4’-二甲基聯苯基-2-基)小曱基各(二氟甲基)-1Η-吼唑-4·羧醯 胺 (1-47) I-甲基"N-[4’-石肖基-3f-(二氣甲基)聯苯基-2-基]-3-(二氣甲基)-1Η-σΛ 唑-4-羧醯胺 -89- 200814928 編號 羧醯胺的化學名稱 (1-48) Ν·(4’-甲氧基-3’-曱基聯苯基-2-基)小甲基各(二氟甲基)_1H-吼唑 -4-羧醯胺 (1-49) N-(3’,4’-二甲氧基聯苯基冬基)小甲基各(二氟甲基)-1Η·吼唑斗羧 酿胺 (1-50) Ν-(3,-氣-4,-甲氧基聯苯基-2-基)-1·甲基-3-(二說甲基)-1Η-口比口坐-4- 羧醯胺 (1-51) N-(4f-氯-3f-甲氧基聯苯基-2-基)·1-甲基-3-(二氣甲基)-1Η-σ比嗤-4_ 羧醯胺 (1-52) Ν-[4’-氯-3’-(三氟甲基)聯苯基-2·基]-1-甲基各(二氟甲基)-1Η·-比唑 -4-羧醯胺 (1-53) N-dS’-二鼠聯苯基基)-1-甲基-3-(二鼠甲基)-1Η-ϋΛσ:^-4-竣酸胺 (1-54) Ν-(4’-甲氧基-2’-甲基聯苯基-2-基)-1-甲基-3-(二氣甲基)-lH-atb嗤 -4-羧醯胺 (1-55) 3-(二氟甲基)#{3’-氟-44(⑹-(甲氧基亞胺基)甲基Η,Γ-聯苯基-2-基甲基吡唑4-羧醯胺 (1-56) 3-(三氟甲基)-ΛΜ31-氟-44(£>(甲氧基亞胺基)甲基]-1,Γ-聯苯基-2-基卜1 -甲基比唑-4-魏醯胺 (1-57) Ν_{4’·[⑹-(甲氧基亞胺基)甲基]-聯苯基-2-基}小甲基各(三氟曱 基)-1//-吡唑-4-羧醯胺 (1-58) 3-(二氟甲基)[⑹-(甲氧基亞胺基)甲基]聯苯基冬基}小甲基 比峻-4-魏醯胺 (1-59) (正-丁氧基亞胺基)甲基]聯苯基-2-基}-1-甲基-3-(二氣甲 基)-1//-吡唑4-羧醯胺 (1-60) N-{44(1Z)-N-乙氧基乙醯亞胺基]聯苯基-2-基}小甲基-3-(三氟甲 基)-1//·吼唑4-羧醯胺 (1-61) 1_曱基-AL{44(1Z)-N-丙氧基乙醯亞胺基]聯苯基-2-基}3-(三氟甲 基)-1//-吼唑-4-魏醯胺 (1-62) 尽{4’-[⑹-(異丙氧基亞胺基)甲基]聯苯基-2-基卜]-曱基-3-(三氟甲 基)-1从°比嗤-4-叛ϋ胺 (1-63) ΛΜ4’-⑻·(乙氧基亞胺基)甲基}聯苯基-2-基}小甲基各(三氟甲 基)-1//-°比唑-4·羧醯胺 -90- 200814928 編號 羧醯胺的化學名稱 (1-64) 1 -甲基-^H4L[C£K丙氧基亞胺基)甲基]聯苯基-2-基} -3 -(三氤甲 基)-1//-吡唑-4-羧醯胺 (1-65) iV-{4’-[(lZ)-N-異丙氧基乙醯亞胺基]聯苯基_2-基}小甲基各(三氟 甲基比σ坐-4-幾酿胺 (1-66) ΛΓ-{44(1Ζ)-Ν-丁氧基乙醯亞胺基]聯苯基-2-基卜μ甲基_3·(三氟甲 基比唾-4-缓ϋ胺 (1-67) iV~{3L氯44(£>(曱氧基-亞胺基)甲基]聯苯基_2_基卜甲基各(三 氟甲基)-1从吡唑-4-羧醯胺 (1-68) #-{34(幻·(甲氧基亞胺基)甲基]聯苯基-2-基}-1-甲基各(三氟甲 基)-1//-吡唑-4-羧醯胺 (1-69) 7V»{44(1E)-N-甲氧基乙醯亞胺基]聯苯基冬基}小甲基各(三氟甲 基)-li/j比峻-4-叛醯胺 (1-70) 私{3’-說_44⑹·(甲氧基亞胺基)甲基]聯笨基-2-基}小甲基各(三氟 甲基)-1乐吡唑-4-羧醯胺 (1-71) 3-(二氟甲基)-尽{3’-氟44(£>(曱氧基亞胺基)甲基]聯苯基-2-基}小甲基-1乐吡唑-4-羧醯胺 (1-72) {(ZH(環丙基甲氧基)亞胺基]甲基卜聯苯基_2_基)小甲基 -3-(三氟甲基)-li^比唑冰羧醯胺 (1-73) AM44(£>( 丁氧基亞胺基)甲基]聯苯基_2·基卜3-(二氟甲基)小甲基 -1//-°比峻-4-魏Si胺 (1-74) 3-(二氟甲基)# {44( 1 E)-N-甲氧基乙醯亞胺基]聯苯基_2-基}小甲 基-1/ί-吡唑-4-羧醯胺 (1-75) iV_{3f-氟-4’-[(£)-(丙氧基亞胺基)甲基]聯苯基_2-基}-1-甲基_3-(三氟 甲基)-li/·吡唑-4-羧醯胺 (1-76) 3-(二氟甲基)善{3’H[(£>(丙氧基亞胺基)甲基]聯苯基冬 基H-甲基-1好』比唑-4-羧醯胺 (1-77) {Γ-氯卓P>(甲氧基亞胺基)甲基]聯苯基_2-基}-1 -甲基-3-(三氟 曱基咄唑-4-羧醯胺 (1-78) ΛΜ3’-氟-44(1E)-N-丙氧基乙醯亞胺基]聯苯基冬基}]-甲基;(三 1甲基)-1私°比唾-4~叛醯胺 (1-79) 3-(二氟甲基)#{,氟44(ie)-n-丙氧基乙醯亞胺基]聯苯基Z 基}小甲基-1从吡唑冰羧醯胺 -91 - 200814928 編號 羧醯胺的化學名稱 (1-80) 3-(二氟甲基氟-4’-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2- 基}小甲基比嗤-4-羧醯胺 (1-81) (1-82) M{3’-氟-^[(ΙΕ^Ν·甲氧基乙醯亞胺基]聯苯基-2-基}小甲基-3-(三 氟甲基)-1//-°比。坐-4-魏隨胺 氯-4’-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基丨基}各(二氟甲 基)_1_甲基-1私口比口坐-4-緩酸胺 (1-83) 氯-4’-[(1Ε)-Ν-甲氧基乙醯亞胺基]聯苯基-2-基}小甲基-3-(三 氟甲基)4杯吡唑-4-羧醯胺 (1-84) 3-(二氟甲基)小甲基#{44⑹-(丙氧基亞胺基)甲基]聯苯基-2-基}-1//^比嗤-4-魏醯胺 (1-85) iH44(£>(曱氧基亞胺基)甲基]甲基聯苯基-2-基}小甲基各(三 1甲基)-1//-°比哇-4-魏ϋ胺 (1 -86) Η二氟甲基Η-甲基#{4,-[(1Ε)-Ν-丙氧基乙醯亞胺基]聯苯基-2-基卜l/ί-吡唑-4-羧醯胺 (1-87) Η二氟甲基ΗΗ44(ιε)善異丙氧基乙醯亞胺基]聯苯基-2-基卜1· 甲基-1//^比嗤-4-羧酿胺 (1-88) N-(4I-{(ZH(烯丙氧基)亞胺基]甲基}聯苯基_2_基)冬(二氟甲基)小 甲基-1乐吡唑冰羧醯胺 (1-89) Ν·(4Η(Ζ)-[(烯丙氧基)亞胺基]甲基}聯苯基-2-基)小甲基各(三氟 甲基比哇-4-魏驢胺 (1-90) 3-(二氟甲基HV-{44(£>(甲氧基亞胺基)甲基]-3,-曱基聯苯基-2-基}-1-甲基-1//-°比嗤-4-叛醯胺 (1-91) iV-{4t-{(lZ)-N-(烯丙氧基)乙醯亞胺基}聯苯基基卜^曱基;(三 氟甲基)·17ϊ^比唑-4-羧醯胺 (1-92) Μ{44( 1 Ε)-Ν-(烯丙氧基)乙醯亞胺基;|聯苯基_2_基卜3·(二氟甲 基)小甲基-1//-°比嗤-4-籍醯胺 (1-93) 尽{4’-[(1Ε)-Ν-(丁 ·2·炔-1-基氧)乙醯亞胺基]聯苯基_2_基}小甲基 -3-(三氟甲基比哇-4-緩醯胺 (1-94) 1-甲基#(4’-{(1Ε)-Ν-[(1-甲基丙!烯小基)氧]乙醯亞胺基丨聯苯基 -2-基)_3-(三氟甲基)-1乐〇比嗤冰羧醯胺 (1-95) 1-甲基#(4f-{(lE)-N-[(2_甲基丙冬烯小基)氧]乙醯亞胺基}聯苯基 基)各(三氟甲基)-1//-咖坐-4-魏醯胺 •92- 200814928 編號 羧醯胺的化學名稱 (1-96) 1 -甲基1 EHSl·(丙-2-炔小基氧)-乙醯亞胺基]聯苯基-2-基}-3-(—'氣甲基比碎_4-幾^8^胺 (1-97) 3-f氟-甲基甲基#{44(1Ε)·Ν_(丙冬炔基氧]乙醯亞胺基} 聯苯基-2-基}-1//^比n叛醯胺 (1-98) 尽心氯卓[⑹·(甲氧基亞胺基)甲基]聯苯基冬基}各(二氟甲 基)-1 ·甲基-1丑^比唾《4_錄S蓀胺 (1-99) 曱氧基亞胺基)甲基]_2L甲基聯苯基丨基甲 基}各(三II甲基Viz/Lir比嗤_4_羧驢胺 (1-100) TV»{4L[(1Z)善丁氧基乙醯亞胺基]聯苯基·2·基卜3-(二氟甲基)小曱 基-1//-°比嗤冬繞酿胺 (1-101) 3-(二氟曱基HV^{44(£>(異丙氡基亞胺基)甲基]聯苯基基卜^甲 基-1/ί-吼嗤-4-緩醯胺 (1-102) Η二氟甲基)#{44(£>(甲氧基亞胺基)甲基]-2,-甲基聯苯基冬 基Η -甲基-1杯咣唑-4-羧醯胺 (1-103) M{3L氯4’-[(五Η甲氧基亞胺基)甲基]聯苯基-2-基卜3-(二氟甲 基)小甲基-li/』比嗤冰緩酸胺 (1-104) 3-(二氟甲基>^-{2^氟-4f-[(£)-(甲氧基亞胺基)甲基]聯苯基_2_ 基}小甲基-Li/-σ比吐-4-魏醯胺 〇105) 尽{Π44⑹-(甲氧基亞胺基)甲基]聯苯基冬基}小甲基;(三氟 曱基Hif-吡唑-4·羧醯胺。 除了具式(I)的第⑴類幾酸胺外,活性化合物組合物A 也包含第(2)類的式(II)之史托比系(strobilurin)W chloro-5-[(3,5-dimethylisoxazol-4-yl)sulfonyl]-2,2-difluoro-5H-[1,3]di-sigma oxo[4,5 -f]-benzopyrene, (10-3) carbendazim, (11-1) diefhofencarb, (11-2) propamocarb, 2〇 (11 -3) propamocarb_hydrochloride, (11-4), fosetyl, (12-2), Gapdan (^?丨 & 11), (12-3) Folpet, (12-4) iprodione, (12-5) procymidone, (13-1) dodine, (13-2) gram heat (guazatine) ), (13-3) bis-octylamine triacetate (iminoctadine • 83- 200814928 triacetate) '(14-1) Cyazofainid, (14-2) prochloraz, (14-3) Triazoxide, (15-4) fenpropimorph, (15-5) dimethomorph, (16-2) fludioxonil, (17-1)赛得-aluminium (fbsetyl-Al), (17-2) 5 phosphonic acid '(17·3) sulphate (toldophos-methyl), (19-1) benzothiazolidine (acibenzolar-S) -methyl) , (19-2) chlorothalonil, (19-3) Cymoxanil, (19-5) famoxadone, (19-6) fluazinam, (19-7) copper oxychloride, (19_9) octopus (oxadixyl), (19-10) snail ί spiroxamine, (19-13) fenamidone, (19-22) 2-(4-chlorophenyl)-N-{2- [3-methoxy-4-(prop-2-ynyloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamidamine, (19-23) Quinoxyfen, (20-1) pencycuron, (2〇-2) thiophenate- thiophenate-methyl, (22-1) 5-chloro-Λ4 (/5>2, 2,2_Trifluoro-l is methylethyl] each (2,4,6-trifluorophenyl)[1,2,4]tri. Sit and [l,5-a], dentate amine, (22-2) 5-chlorodimercaptopropyl]-6-(2,4,6-trifluorobenzene-yl)[1,2,4 Triazolo[l,5_a]pyrimidin-7-amine, (22-4) 5-chloro(2,4,6-triphenyl)-7-(4-mercaptohexahydroacridine-1 -yl)[1,2,4]triazolo[l,5-a]pyrimidine, (23-1) 2-butoxy-6-bromo-3-propylbenzopyran-4·one ,(23-2) 2-ethoxy-2-mercapto-6-iodo-3-propylbenzopyran-', (23-3) 6-iodo-2-propoxy-3-propylbenzene And ketone-4·one, (24-1) 沁(3,,4,-dichloro-5-fluoro·1,1'-biphenyl-2-yl)-3·(di-It methyl)- 1-methyl-p-indene-4-carboxylamine, (24-7) Λ^(4,_bromo-1, fluoren-biphenyl-2-yl)-4-(difluoroindolyl)-2- Methyl-1,3H5-decylamine, (25-1) 1[2-(1,3-didecylbutyl)phenyl]-indole, 3·dimethyl-1//•pyrrole- 84- 200814928 领醯amine, (25_2) ^{2_(1,3_dimethylbutyl)phenyl b-5_气妙二Y base-1 heart than saliva-continued _, (25_8) methyl good [ 2(1,3,3-dimethylbutyl)phenylhydrazine//" than saliva_4_rebellion_, (25·13^_[2 (ι,3 (dimethyl)phenyl))- 2-iodobenzoguanamine, (25_15) as far as {2_〇,3-dimethylbutanyl)phenyltrifluoro Methyl) benzoic acid amine. The excellent active compounds of the above categories (2) to (26) are the following active compounds: | (2-2) Fluorine. _ _ flu (fluoxastrobin), (2-3) (2 5)-2-(2-{[6-(3-chloro-2-methylphenoxy)_5-fluoropyridinyl]oxy}phenyl ) winter (nonoxyimino) good 10 mercaptoamine, (2.4), trifloxystrobin, (3-15) prothioconazole, (3,17) Tebuconazole, (3-21) bitertanol, (3-22) triadimenol, (3-24) fluquinconazole, (4-1) dichlorofluoride (dichlofluanid), (4-2) methyl phenylephrine (tolylfluanid), (5-1) isopropyl amide 15 (iprovalicarb), (6-6) fenhexamid, (6-7) Caipropamid, (6-9) picobenzamid, (6-14) penthiopyrad, (6-17) fhitolanil, (6-21) Ν-{ 2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl 2-(trifluoromethyl)benzamide, (6-22) N-(2-bicyclopropyl -2-ylphenyl)-1-indolyl-3-trifluoromethyl-1H-port ratio 20 azole-4-carboxyguanamine, (6-23) Ν-(2-bicyclopropyl-2-yl Phenyl)-1-mercapto-3-difluoromethyl-1H-pyrazole-4-carboxamide, (6-24) Ν-[2-(Γ-methylbicyclopropyl-2-yl) benzene 1-methyl-3-trifluoromethyl-lH-u-pyrazole·4·carboxamide, (6-25) Ν-〇(Γ-methylbicyclopropyl-2-yl)phenyl ··1-Mercapto-3-difluoromethyl-1Η-pyrazole-4-carboxamide, (6-26)Ν-[1-(5-bromo-3-pyridin-2-yl)B Base]-2,4- -85- 200814928 Dichloronicotinium amide, (6-27) 1^-(5-bromo-3-chloropyridin-2-yl)indolyl-2,4-dichloro醯 醯 ''(7_4) 曱 锌 乃 ( (pr〇pineb), (8_4) 达达乐-M (metalaxyl-M), (8-5) 达达乐_M (benalaxyl-M), (9 No. 3) Pyrimethanil, (10-3) Befendazim, (11-4) Pu 5 Buck-Fusie Fu (f〇setyl) '(12-4) Yi Putong Iprocji〇ne), (14-2) prochloraz, (14-3) triazoxide, (16-2) fludioxonil, (17-3) methyl chlorpyrifos (toidophos-methyl), except (19-10) spiroxamine, (19-22) 2-(4-phenylphenyl)-N-{2-[3-methoxy-4-( Prop-2-yne-1-yloxy)phenyl]ethyl}-2-(propyl-2-ίο alkynyloxy)ethinamide, (19-23) quinoxyfen, (22-4 ) 5-Chloro-6-(2,4,6-triIphenyl)-7-(4-methylhexahydroindole. Ding-1-yl)[1,2,4]triazino[l,5-a]pyrimidine, (24-1) A^(3f,4,-dichloro-5-fluoro·1, Γ-linked Phenyl-2-yl)-3-(difluoromethyl)succinymethyl-lif-pyrazole-4-carboxamide, (25-2) Λ^2-(1,3-dimercaptobutyl Phenyl}·5-fluoro-1,3-dimethyl-1-pyrazole-4-15 carboxamide, (25-13) ΛΓ-[2-(1,3-(dimethyl) Base) phenyl) winter iodobenzamide, amine. Preferred active compound compositions comprise two classes of active compounds and in each case: at least one carboxamide compound of formula (I) (category (1)) and at least one class (2) as described below To the compound of the class (26), these Group 2 conjugates are active compound compositions of hydrazine to W. A preferred active compound composition wherein the indoleamine compound of the formula (I) of the formula (I) is selected from the compounds listed in Table A below. - 86 - 200814928 Table A: Chemical Name of the Number Carboxamide (1-1) N-(3V^Dichlorobiphenyl-2-yl)小methyl-3-(trifluoromethyl)-1Η^Bizozol-4-carboxyguanamine (1-2) N_( 3'-Chloro-4'-fluorobiphenyl-2-yl) small methyl-3-(trifluoromethylpyrazole-4-carboxyguanamine (1-3) N-(2f, 4L dichlorinated Phenyl-2-yl)small methyl(trifluoromethyl)-1Η"pyrazole-4-carboxamide (1-4) N-(3f,4'-difluorobiphenyl-2-yl Small methyl each (trifluoromethyl)-1 Η-pyrazole-4-carboxamide (1-5) N-(2',5f-dichlorobiphenylmethylene) small methyl each (trifluoro Methyl)-1Η-pyrazol carboxamide (1-6) Ν-(2*,5*-di-biphenyl-2-yl)-1-methyl-3-(di Dunmethylmethyl) Indoleamine (1-7) N-(4'-gas-2'-fluorobiphenylmethanol) small methyl (trifluoromethyl)-1pyridazole ice carboguanamine (1-8) N- (4T-Gas-2'-Methylbiphenyl-2-yl)-1-methyl-3-(dimethylmethylguanamine (1-9) N-(4'-chloro-3'- Methyl biphenyl-2-yl) small methyl each (trifluoromethyl)-1 Η-carbazole winter carboxamide (1-10) N-(4L mouse - 2'-Methylbiphenyl-2-yl)-1-methyl-3-(dimethylmethyl)-1Η-σΛσ sit-4-decylamine (1-11) Ν-(4'-qi -3^·•Methylbiphenyl-2-yl)-1-methyl-3-(dimethyl-methyl-pyridin-4-indoleamine (1-12) N-(4f-gas-3' -gas methylbiphenyl-2-yl)-1-methyl-3-(dimethylmethyl)-1Η·α than 嗤-4-carboxyguanamine (1-13) Ν-(2',4 '-Difluorobiphenyl-2-yl) small methyl each (trifluoromethyl)-1 Η 比 azole carbamide (1-14) NW-fluoro U oxybiphenyl-2-yl) Small methyl-3-(trifluoromethyl)-1H"pyrazole carboxamide (1-15) di-biphenyl-2-yl)-1-methyl-3-(dimethyl) -1Η-ϋΐ^Sit-4-Weiamine-87- 200814928 No. Chemical name of carboxamide (1-16) N-(3',5f-dimethylbiphenyl-2-yl)methyl -3-(Trifluoromethyl)-1Η ^Bymazole Ice Carboxamide (1-17) N-(4'-Chloro U-Schothylbiphenyl-2-yl) Small Methyl-3-(Trifluoro Methyl)-1Η^Bizozol-4-carboxamide (1-18) N-[3\5f-bis(dimethylmethyl)biphenyl-2-yl]-1-methyl-3-( Dimethyl carbaryl carbamide (1-19) N-(3',4'-dimethylbiphenyl-2-yl) small methyl-3-(trifluoromethyl)·1Η·carbazole -4-carboxyguanamine (1-20) 1-methyl-N-[4W -3'-(trifluoromethyl)biphenyl-2-yl](trifluoromethyl)-1Η-α-pyrazole-4-carboxamide (1-21) N-(4f-methoxy -3^methylbiphenyl-2-yl)methylmethyl(trifluoromethyl)-1Η-indazole-4-carboxamide (1-22) N-(3*,4'-di Methoxybiphenyl-2-yl)-1-methyl-3-(dimethylmethyl)-1Η-ϋΛσ sit-4-decylamine (1-23) N-(3'-gas-4 '-Methyllacylbiphenyl-2-yl)-1-methyl-3-(dimethylcarbamoylamine (1-24) N-(4'-chloro-3'-methoxybiphenyl Benzyl-2-yl)methylmethyl(trifluoromethyl)-1Η-indazole-4-carboxamide (1-25) N-[4'-chloro-3H-trifluoromethyl)biphenyl- 2-yl]small methyl-3-(trifluoromethyl)-1Η^bazole-4-carboxamide (1-26) N-(3\5L di-biphenyl-2*•yl)- 1-methyl-3-(dimethylmethyl)-111-lasyl-4-indole amine (1-27) N-(4'-methoxy-2'-methylbiphenyl-2- 1-methyl-3-(trifluoromethyl)-1Η·carbazole-4-carboxamide (1-28) N-(3f,4L dichlorobiphenyl-2-yl)-1 -methyl each (difluoromethyl)-1 Η-carbazole-4-carboxamide (1-29) Ν-(3, chlorofluorobiphenyl-2-yl) small methyl-3-(difluoro Methyl)-1Η-indazole-4-carboxamide (1-30) N-(2',4f-dichlorobiphenyl-2-yl)-1 Di(difluorodecyl)-1H-pyrazole-4-carboxamide (1-31) N-(3', lenodifluorobiphenyl-2-yl) small methyl-3-(difluoro Methyl)-1Η-oxazole-4-carboxyguanamine-88- 200814928 No. Chemical name of carboxamide (1-32) ST-(2*,5*-di-biphenyl-2-yl)- 1-methyl-3-(dimethylmethyl^^.峻 - 斗 - weiwei amine (1-33) Ν-(2',5^difluorobiphenyl-2-yl) small methyl-3-(difluoromethylbiazole carbamoylamine (1 -34) N-(4'-Chloro-2匕fluorobiphenyl-2-yl)methylmethyl(difluoromethyl)-1Η-indazole carbamide (1-35) N-(4 *-Gas-2匕Methyl-benzino-2-yl)-1-methyl-3-(dimethylmethyl)-1Η-σ ratio -4-meramide (1-36) Ν-( 4'-Chloro-3' draw methylbiphenyl-2-yl)-1 ore methyl-3-(difluoromethyl) 111-0 than oral -4-nonanoic acid amine (1-37) N-(4L-gas-2f-methylbiphenyl-2-yl)-1-methyl-3-(di-methylmethylpropionamide (1-38) N-(4f-rat-3'-A Benzyl-2-yl)-1-methyl-3-(di-methyl)-111-° ratio 坐-4-decylamine (1-39) N-(4'-chloro-3f -Fluoro-2'-methylbiphenyl-2-yl)methanol (difluoromethyl)-111-3⁄4 oxazole-4-carboxamide (140) N-(2',4'- Difluorobiphenyl-2-yl) small methyl each (difluoroindolyl)-1Η-carbazole-4-carboxamide (1-41) Ν-(2. gas-4'-methoxy linkage Phenyl-2-yl)-1-methyl-3-(dioxamethylcarboxamide (1-42) N-(2f,6f-disorder biphenyl-2-yl)-1-methyl -3-(dimethyl fluorenyl)-1 Η-ϋ ratio 17 sitting -4- 竣 胺 (1-43) Ν-(3',5'-dimethyl Benzyl-2-yl)-1-methyl-3-(dimethylmethyl)-1Η-σ 嗤-4-竣 with amine (1-44) N-(4f-rat-3*-肖 肖 基 biphenyl-2-yl)-1-methyl-3-(disorder decyl decylamine (1-45) N-[3',5f-bis(trifluoromethyl)biphenyl-2 -yl]-1-methyl-3-(difluoromethyl)-1Η^biazole carbamide (1-46) N-(3',4'-dimethylbiphenyl-2-yl ) bismuthyl (difluoromethyl)-1 Η-carbazole-4·carboxycarboxamide (1-47) I-methyl "N-[4'-Shishouji-3f-(di-gas methyl) Phenyl-2-yl]-3-(dimethylmethyl)-1Η-σΛ azole-4-carboxyguanamine-89- 200814928 No. Chemical Name of Carboxylamamine (1-48) Ν·(4'-A Oxy-3'-mercaptobiphenyl-2-yl)methanol (difluoromethyl)_1H-indazole-4-carboxamide (1-49) N-(3',4'- Dimethoxybiphenylbiyl)small methyl(difluoromethyl)-1Η·carbazole carboxylamine (1-50) Ν-(3,-gas-4,-methoxybiphenyl Benzyl-2-yl)-1·methyl-3-(di-methyl)-1Η-oral ratio -4-carboxamide (1-51) N-(4f-chloro-3f-methoxy Biphenyl-2-yl)·1-methyl-3-(dimethylmethyl)-1Η-σ 嗤-4_ Carboxamide (1-52) Ν-[4'-chloro-3'-( Trifluoromethyl)biphenyl-2·yl]-1- Methyl (difluoromethyl)-1 Η·-Bizozol-4-carboxamide (1-53) N-dS'-di-r-phenylphenyl)-1-methyl-3-(two mouse Base)-1Η-ϋΛσ:^-4-decanoic acid amine (1-54) Ν-(4'-methoxy-2'-methylbiphenyl-2-yl)-1-methyl-3- (dimethyl)-lH-atb嗤-4-carboxamide (1-55) 3-(difluoromethyl)#{3'-fluoro-44((6)-(methoxyimino) A Base, Γ-biphenyl-2-ylmethylpyrazole 4-carboxydecylamine (1-56) 3-(trifluoromethyl)-indole 31-fluoro-44 (£>(methoxyiamine) Methyl]-1, fluorenyl-biphenyl-2-yl b-methylpyrazole-4-propanolamine (1-57) Ν_{4'·[(6)-(methoxyimino group )methyl]-biphenyl-2-yl}small methyl (trifluoromethyl)-1//-pyrazole-4-carboxamide (1-58) 3-(difluoromethyl)[ (6)-(Methoxyimino)methyl]biphenylmungyl}small methyl ratio -4--4-weisamine (1-59) (n-butoxyimino)methyl]biphenyl Benzyl-2-yl}-1-methyl-3-(dimethylmethyl)-1//-pyrazole 4-carboxamide (1-60) N-{44(1Z)-N-ethoxy Ethylene imido]biphenyl-2-yl}small methyl-3-(trifluoromethyl)-1//·carbazole 4-carboxamide (1-61) 1_mercapto-AL{ 44(1Z)-N-propoxyacetammine]biphenyl-2-yl}3-(three Methyl)-1//-carbazole-4-propanolamine (1-62) by {4'-[(6)-(isopropoxyimino)methyl]biphenyl-2-yl] - mercapto-3-(trifluoromethyl)-1 from ° 嗤-4-treazone (1-63) ΛΜ4'-(8)·(ethoxyimino)methyl}biphenyl-2 -yl}small methyl each (trifluoromethyl)-1//-°bazole-4·carboxamide-90- 200814928 No. Chemical name of carboxamide (1-64) 1 -methyl-^H4L [C£K propoxyimino)methyl]biphenyl-2-yl}-3-(3-mercaptomethyl)-1//-pyrazole-4-carboxamide (1-65) iV -{4'-[(lZ)-N-isopropoxyacetammine]biphenyl-2-yl}small methyl each (trifluoromethyl ratio σ sit-4-cartoamine (1 -66) ΛΓ-{44(1Ζ)-Ν-butoxyacetammine]biphenyl-2-ylbu-methyl-3-3(trifluoromethyl-pyria-4-hydrazide ( 1-67) iV~{3L Chlorine 44 (£>(decyloxy-imino)methyl]biphenyl-2-diylmethyl(trifluoromethyl)-1 from pyrazole-4-carboxyl Indoleamine (1-68) #-{34(幻·(methoxyimino)methyl]biphenyl-2-yl}-1-methyl each (trifluoromethyl)-1//- Pyrazole-4-carboxyguanamine (1-69) 7V»{44(1E)-N-methoxyethyl quinone imino]biphenylmethylene}methylmethyl(trifluoromethyl)-li /j ratio -4-Rebelamine (1-70) Private {3'-say _44(6)·(methoxyimino)methyl] phenylidene-2-yl}small methyl each (trifluoromethyl)- 1 Lepyrazol-4-carboxyguanamine (1-71) 3-(Difluoromethyl)-exhaustive {3'-fluoro 44 (£>(decyloxyimino)methyl]biphenyl- 2-yl}small methyl-1-leprazole-4-carboxamide (1-72) {(ZH(cyclopropylmethoxy)imido)methyl bphenyl-2-yl) small Methyl-3-(trifluoromethyl)-li^biazole carbamide (1-73) AM44 (£>(butoxyimino)methyl]biphenyl-2·kib 3 -(difluoromethyl)small methyl-1//-° ratio -4--4- Wei Si amine (1-74) 3-(difluoromethyl)# {44( 1 E)-N-methoxy Ethylene imido]biphenyl-2-yl}sodiummethyl-1/ί-pyrazole-4-carboxamide (1-75) iV_{3f-fluoro-4'-[(£)-( Propoxyimido)methyl]biphenyl-2-yl}-1-methyl-3-(3-trifluoromethyl)-li/·pyrazole-4-carboxyguanamine (1-76) 3 -(difluoromethyl)good {3'H[(£>(propoxyimino)methyl]biphenylyl-H-methyl-1-"pyrazole-4-carboxamide" 1-77) {Γ-Chloropi P>(methoxyimino)methyl]biphenyl-2-yl}-1 -methyl-3-(trifluoromethylcarbazole-4-carboxyindole Amine (1-78) ΛΜ3'-fluoro-44(1E)-N- Ethoxyacetimido]biphenylmungyl}]-methyl; (tri-1methyl)-1 private ratio salivary-4~tretachlor (1-79) 3-(difluoromethyl) #{,Fluorine 44(ie)-n-propoxyacetammine]biphenyl Z-based}small methyl-1 from pyrazole-carbocarboxamide-91 - 200814928 No. Chemical name of carboxamide 1-80) 3-(Difluoromethylfluoro-4'-[(1Ε)-fluorenyl-methoxyethylidene imino]biphenyl-2-yl}methylmethylpyrene-4-carboxyindole Amine (1-81) (1-82) M{3'-Fluoro-^[(ΙΕ^Ν·methoxyethyl quinone imino)biphenyl-2-yl}small methyl-3-(three Fluoromethyl)-1//-° ratio. -4-Si with amine chloro-4'-[(1Ε)-Ν-methoxyethyl hydrazide]biphenyl fluorenyl} each (difluoromethyl)_1_methyl-1 private ratio Oral -4-oxoamine (1-83) chloro-4'-[(1Ε)-Ν-methoxyethinylidene]biphenyl-2-yl}small methyl-3-(three Fluoromethyl) 4 cups pyrazole-4-carboxamide (1-84) 3-(difluoromethyl) small methyl #{44(6)-(propoxyimino)methyl]biphenyl-2 -yl}-1//^ is more than 嗤-4-weisamine (1-85) iH44 (£>(decyl imino)methyl]methylbiphenyl-2-yl} small methyl Each (tri-1methyl)-1//-° than wow-4-propanolamine (1 -86) Η difluoromethyl hydrazine-methyl #{4,-[(1Ε)-Ν-propoxy Ethyl imino]biphenyl-2-yl b l/ί-pyrazole-4-carboxamide (1-87) Η difluoromethyl ΗΗ 44 (ιε) good isopropoxyacetammine Biphenyl-2-yl b 1·methyl-1//^ than 嗤-4-carboxychiral amine (1-88) N-(4I-{(ZH(allyloxy)imido)] }}biphenyl-2-yl) winter (difluoromethyl) small methyl-1-leprazole carbaryl amide (1-89) Ν·(4Η(Ζ)-[(allyloxy) Amino]methyl}biphenyl-2-yl)small methyl each (trifluoromethyl-wow-4-weizamine (1-90) 3-(difluoromethyl HV-{44(£&gt) (methoxy imino group Methyl]-3,-fluorenylbiphenyl-2-yl}-1-methyl-1//-° than 嗤-4-treazone (1-91) iV-{4t-{(lZ) -N-(allyloxy)ethylidene imino}biphenylyl bromide; (trifluoromethyl)·17ϊ^bazole-4-carboxyguanamine (1-92) Μ{44( 1 Ε)-Ν-(allyloxy)ethylideneimine;|biphenyl-2_ylbu3·(difluoromethyl)small methyl-1//-° than 嗤-4- Indoleamine (1-93) is as far as {4'-[(1Ε)-Ν-(丁·2·alkyn-1-yloxy)ethylidene imino]biphenyl-2-yl}small methyl-3 -(Trifluoromethylbiwow-4-carboamine (1-94) 1-methyl#(4'-{(1Ε)-Ν-[(1-methylpropion!-enyl)oxy]B醯iminophosphonium biphenyl-2-yl)-3-(trifluoromethyl)-1loindole 嗤 ice carboxamide (1-95) 1-methyl#(4f-{(lE)-N -[(2_methylpropionene small)oxy]ethinylidene}biphenylyl)(trifluoromethyl)-1//-cafe-4-weizamide•92- 200814928 The chemical name of the number of carboxamide (1-96) 1 -methyl 1 EHSl · (prop-2-yne small oxygen) - acetamido] biphenyl-2-yl}-3- (-' Gas methyl ratio _4- succinimide (1-97) 3-f fluoro-methylmethyl #{44(1Ε)·Ν_(propionyloxy) etiminoimine} biphenyl Ke-2-yl}-1//^ ratio n rebel amine (1-98) Dedicated to the chlorine [[6)·(methoxyimino)methyl]biphenyl-mungyl} each (difluoromethyl)-1 ·methyl-1 ugly than the saliva "4_ recorded S-amine (1 -99) 曱oxyimino)methyl]_2L methylbiphenyl fluorenylmethyl} each (tri-II methyl Viz/Lir than 嗤_4_carboxamide (1-100) TV»{4L [(1Z) succinyloxyethylidene imino]biphenyl·2·kib 3-(difluoromethyl) fluorenyl-1//-° than 嗤 winter winding amine (1-101) 3-(Difluoroindolyl HV^{44(£>(isopropylideneimino)methyl]biphenylyl)methyl-1/ί-吼嗤-4-sulfanylamine (1 -102) ΗDifluoromethyl)#{44(£>(methoxyimino)methyl]-2,-methylbiphenyl mercaptopurine-methyl-1 carbazole-4- Carboxylamidine (1-103) M{3L chloro 4'-[(pentamethoxyanilide)methyl]biphenyl-2-ylbu 3-(difluoromethyl)smallmethyl-li /" 嗤 嗤 嗤 缓 ( 1-10 (1-104) 3-(Difluoromethyl> gt-{2^Fluoro-4f-[(£)-(methoxyimino)methyl]biphenyl _2_基}小methyl-Li/-σ ratio 吐-4-魏醯amine 〇105) Π{Π44(6)-(methoxyimino)methyl]biphenylmethylene}methyl; Fluorinyl Hif-pyrazole-4·carboxamide. In addition to the acid amine of the formula (1) of the formula (I), the active compound composition A also comprises the strobilurin of the formula (II) of the class (2).

其中A1,L及R11的定義如前。 較佳的活性化合物組合物A,其中第(2)類之式(η)之史 -93- 200814928 托比系(Strobilurin)係挑選自下列化合物: 〇1)亞托敏(azoxystrobin),(2-2)氟嘴菌酯(fluoxastrobin),(2-3) (2£>2-(2- {[6-(3-氯-2-曱基苯氧基)-5-氟-4-嘧啶基]氧}苯 基)-2-(甲氧基亞胺基曱基乙醯胺,(2-4)三氟敏 5 (trifloxystrobin),(2-5) (2五)-2-(甲氧基亞胺基甲基 -2-(2-{[({(1£>1-[3-(三氟曱基)苯基]乙二基}胺基)氧]甲基} 苯基)乙醯胺,(2-6) (2£>2-(甲氧基亞胺基甲基 , _2-{2-[(五)-({1-[3-(三氟甲基)苯基]乙氧基}亞胺基> 甲基]苯 基}乙1藍胺,(2-7)將醚菌胺(orysastrobin),(2-8) 5-甲氧基_2_ 10 甲基冰(2-{[({(1五)小[3-(三氟曱基)苯基]乙二基}胺基)氧]_ 曱基}苯基)-2,4-二氮-37^-l,2,4-三σ坐-3-嗣,(2-9)克收辛··甲 基(kresoxim-methyl),(2-10)大滅唾丙(dimoxystrobin), (2-11)咬氧菌酯(picoxystrobin),(2-12)唑菌胺酯 (pyraclostrobin) ’(2-13)苯氧菌胺(metominostrobin),(2-14) 15 英司多丙(enestrobin)。 _ 特別佳的活性化合物組合物A,其中第(2)類之式(Π) 之史托比系(Strobilurin)係挑選自下列化合物: (2-1)亞托敏(azoxystrobin),穴2-2)氟嘧菌酯饵⑽幼拊成!!),^。) (2£>2-(2-{[6_(3-氯-2-甲基苯氧基)·5-氟-4-,咬基]氧}苯 20 基)_2_(甲氧基亞胺基)-尽甲基乙醯胺,(2-4)三氟敏 (trifloxystrobin)’(2-9)克收辛-甲基(kres〇xim-methyl),(2-10) 大滅唾丙(dimoxystrobin),(2-11)啶氧菌酯(picoXyStrobin),(2-12) 嗤囷胺醋(pyraclostrobin) ’(2-13)苯氧菌胺(met〇niinostrobin)。Among them, A1, L and R11 are as defined above. Preferred active compound composition A, wherein the history of formula (2) (η)-93-200814928 Strobilurin is selected from the following compounds: 〇1) azoxystrobin, (2) -2) Fluoxastrobin, (2-3) (2£>2-(2-{[6-(3-chloro-2-indolylphenoxy)-5-fluoro-4- Pyrimidinyl]oxy}phenyl)-2-(methoxyiminomercaptoacetamide, (2-4) trifloxystrobin, (2-5) (2-5)-2-( Methoxyiminomethyl-2-(2-{[({(1£>1-[3-(trifluoromethyl)phenyl]ethanediyl}amino)oxy)methyl}benzene Ethylamine, (2-6) (2£>2-(methoxyiminomethyl, _2-{2-[(5)-({1-[3-(trifluoromethyl)) Phenyl]ethoxy}imine>methyl]phenyl}ethyl 1 leucine, (2-7) willsostazone, (2-8) 5-methoxy_2_10 Methyl ice (2-{[({(1)5)[[((((((((()))]]]]]] -37^-l,2,4-three sigma sitting -3-嗣, (2-9) 克 辛 辛 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克 克2-11) picoxystrobin, (2-12) pyraclostrobin (pyr Aclostrobin) '(2-13) methotrexate (metominostrobin), (2-14) 15 enestrobin. _ Particularly good active compound composition A, of which type (2) (Π) The Strobilurin line was selected from the following compounds: (2-1) Azoxystrobin, Acupoint 2-2) Fluorobacteria bait (10) Cubs!!), ^.) (2£ >2-(2-{[6_(3-Chloro-2-methylphenoxy)·5-fluoro-4-, octyl]oxy}benzene 20-yl)_2-(methoxyimino)- As far as methyl acetamide, (2-4) trifloxystrobin' (2-9) kexin-methyl (kres〇xim-methyl), (2-10) dimoxystrobin (2-11) picoXyStrobin, (2-12) pyracostrobin '(2-13) phenoxynibine (met〇niinostrobin).

特別要被強調的活性化合物組合物A,包含挑選自表A -94- 200814928 中之第⑴類的式(I)之綾醯胺,以及㈣亞托敏(az〇xys加㈣^ 特別要被強調的活性化合物組合物A,包含挑選自表A 二之第⑴類的式⑴之羧醯胺,以及(2_2)氟嘧菌萨 (fluoxastrobin)。 曰The active compound composition A to be particularly emphasized, comprising the guanamine of the formula (I) selected from the group (1) in Table A-94-200814928, and (iv) the azotoxin (az xy s plus (4) ^ The active compound composition A is emphasized, comprising a carboguanamine of the formula (1) selected from the group (1) of Table A, and (2_2) fluoxastrobin.

10 1510 15

特別要被強調的活性化合物組合物A,包含挑選自参 中之第(1)類的式(I)之羧醯胺,以及(2-3) (2£>2-(2-{[6、(3 氯甲基苯氧基)_5_氟-4-嘧啶基]氧}苯基)_2_(甲 於 基甲基乙醯胺。 "^ 特別要被強調的活性化合物組合物A,包含挑選自參A 中之第⑴類的式(I)之羧醯胺,以及(2-4)三^敏 (trifloxystrobin)。 斗寸別要被強調的活性化合物組合物A ’包含挑選自| a 中之第(1)類的式(I)之羧醯胺,以及(2-9)克收辛-甲茂 (kresoxim-methyl) 〇 特別要被強調的活性化合物組合物A,包含挑選自表a 中之第⑴類的式(I)之羧醯胺,以及(2-10)大滅嗤内 (dimoxystrobin) 〇 特別要被強調的活性化合物組合物八,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(2-11)啶氧菌龍 (picoxystrobin) 〇 特別要被強調的活性化合物組合物A,包含挑選自表A 中之第⑴類的式⑴之羧醯胺,以及(2_〗2)唑菌胺酉旨 (pyraclostrobin)。The active compound composition A to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the reference class (1), and (2-3) (2£>2-(2-{[ 6. (3 chloromethylphenoxy)_5_fluoro-4-pyrimidinyl]oxy}phenyl)_2_(methylidylmethylacetamide. "^ In particular, the active compound composition A to be emphasized, Included is a carboguanamine of the formula (I) selected from the group (1) of the reference A, and (2-4) a trifloxystrobin. The active compound composition A' to be emphasized is selected from | The carboxamide of the formula (I) of the class (1), and the active compound composition A of (2-9) kresoxim-methyl oxime, which is particularly emphasized, The carboxamide of the formula (I) of the class (1) in Table a, and the active compound composition of the (2-10) dimoxystrobin, especially emphasized, are included in Table A. Carboxylamidines of the formula (I), and (2-11) picoxystrobin 活性 The active compound composition A to be particularly emphasized, comprising the formula (1) selected from the class (1) in Table A Carboxyamine, and (2_2)azole Pyramidin (pyraclostrobin).

特別要被強調的活性化合物組合物A,包含挑選自表A -95- 20 200814928 中之第⑴類的式⑴之羧醯胺,以及(2-13)苯氧菌胺 (metominostrobin) 〇 除了具式⑴的羧醯胺(第(1)類化合物)外,活性化合物組 合物B也包含式(III)之三唑化合物(第(3)類化合物)The active compound composition A to be particularly emphasized, comprising the carboxamide of the formula (1) selected from the group (1) in Table A-95-20 200814928, and (2-13) metominostrobin in addition to In addition to the carboguanamine of the formula (1) (the compound of the formula (1)), the active compound composition B also contains the triazole compound of the formula (III) (the compound of the (3) class)

1010

⑽ 其中 Q,m,R14,R15,A4,A5,R16 及 R17 的定義如前。 較佳的活性化合物組合物B,其中第(3)類之式(III)之三 唾(triazole)係挑選自下面所列之化合物: 15 (3-1)氮雜康嗤(azaconazole),(3-2)伊他康唑(etaconazole),(3-3) 普比康嗤(propiconazole),〇4)待芬康峻(difenoconazole),(3-5) 溴克利(bromuconazole),(3-6)西普康嗤(cyproconazole), (3-7)菲克斯(hexaconazole),(3-8)平康峻(penconazole), (3-9)邁克別尼(myclobutanil) ,(3-10)四康嗤 (tetraconazole),(3-11)福採扶(flutriafol),(3-12)依普座 (epoxiconazole),(3-13)護矽嗤(fhisilazole),(3-14)辛康唑 (simeconazole),(3-15)普硫康唑(prothioconazole),(3-16) 芬布康唑(fenbuconazole),(3-17)得克力(tebuconazole), (3-18)艾普那唾(ipconazole) ,(3-19)滅康嗤 (metconazole),(3-20)三替康唾(triticonazole),(3-21)比多 農(bitertanol),(3-22)三泰隆(triadimenol),(3-23)三泰芬 -96- 20 200814928 (triadimefon),(3-24)氣喧康嗤(fluquinconazole),(3-25)哇 康峻(quinconazole),(3-26)二氯布康嗤(diclobutrazole), (3-27)得尼康嗤(diniconazole),(3-28)得尼康嗤-Μ (diniconazole-M),(3,29)扶康嗤(furconazole),(3_30)優尼 5 康唾(uniconazole),(3-31)優尼康唆 P (uniconazole P)。 特別佳的活性化合物組合物B,其中第(3)類之式(III) 之三唑係挑選自下面所列的化合物: | (3·3)普比康唾(propiconazole),(3-4)待芬康嗤 (difenoconazole),(3-6)西普康口坐(cyproconazole),(3-7)菲 ίο 克斯(hexaconazole),(3-15)普硫康嗤(prothioconazole), (3-17)得克力(tebuconazole) , (3-19)滅康唾 (metconazole),(3-21)比多農(bitertanol),(3-22)三泰隆 (triadimenol),(3-24)氣喧康嗤(fluquinconazole),(3-27)得 尼康哇(diniconazole)。(10) where Q, m, R14, R15, A4, A5, R16 and R17 are as defined above. Preferred active compound composition B, wherein the triazole of the formula (III) of the class (3) is selected from the compounds listed below: 15 (3-1) azaconazole, ( 3-2) Itaconazole, (3-3) propiconazole, 〇4) difanoconazole, (3-5) bromuconazole, (3- 6) cyproconazole, (3-7) hexaconazole, (3-8) penconazole, (3-9) myclobutanil, (3-10) ) tetraconazole, (3-11) flutriafol, (3-12) epoxiconazole, (3-13) fhisilazole, (3-14) xin Simeconazole, (3-15) prothioconazole, (3-16) fenbuconazole, (3-17) tebuconazole, (3-18) Ai Ipconazole, (3-19) metconazole, (3-20) triticonazole, (3-21) than bitertanol, (3-22) Triadimenol, (3-23) three tedin-96- 20 200814928 (triadimefon), (3-24) fluquinconazole ), (3-25) quinconazole, (3-26) diclobutrazole, (3-27) diniconazole, (3-28) Nikon 嗤-Μ (diniconazole-M), (3,29) furconazole, (3_30) uniconazole (uniconazole), (3-31) uniconazole P (uniconazole P). Particularly preferred active compound composition B, wherein the triazole of formula (III) of formula (3) is selected from the compounds listed below: | (3·3) propiconazole, (3-4) ) to dofonconazole, (3-6) cyproconazole, (3-7) hexaconazole, (3-15) prothioconazole, ( 3-17) tebuconazole, (3-19) metconazole, (3-21) than bitertanol, (3-22) triadimenol, (3-24) ) fluquinconazole, (3-27) diniconazole.

15 特別要被強調的活性化合物組合物B,包含挑選自表A • 中之第(1)類的式(I)之羧醯胺,以及(3-3)普比康唑 (propiconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(3-4)待芬康唑 2〇 (difenoconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(3-6)西普康唑 (cyproconazole)。15 The active compound composition B to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (3-3) propiconazole 〇 The active compound composition B to be emphasized, including the carboguanamine of the formula (I) selected from the class (1) in Table A, and (3-4) the difenoconazole oxime (difenoconazole) are particularly emphasized Active Compound Composition B, comprising carboxamide attached to formula (I) of Table (1), and (3-6) cyproconazole.

特別要被強調的活性化合物組合物B,包含挑選自表A -97- 200814928 中之第(1)類的式⑴之羧醯胺,以及(3-7)菲克斯 (hexaconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(3-15)普硫康唑 5 (prothioconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(3-17)得克力 , (tebuconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 10 中之第(1)類的式(I)之羧醢胺,以及(3-19)滅康唑 (metconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(3-21)比多農 (bitertanol) °The active compound composition B to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the class (1) in Table A-97-200814928, and (3-7) hexaconazole 〇 The active compound composition B, which is emphasized, comprises the carboxamide which is selected from the class (1) of the class (1) in Table A, and the activity of (3-15) prothioconazole 5 which is particularly emphasized. Compound composition B, comprising a carboguanamine of formula (I) selected from the group (1) in Table A, and (3-17) an active compound composition particularly emphasized by tebuconazole B, comprising the carboxamide of the formula (I) selected from the group (1) in Table A10, and (3-19) the active compound composition B of the conconazole, especially emphasized, comprising Carboxylidene of formula (I) of class (1) selected from Table A, and (3-21) than bitertanol °

15 特別要被強調的活性化合物組合物B,包含挑選自表A | 中之第(1)類的式(1)之羧醯胺,以及(3-22)三泰隆 (triadimenol) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式⑴之羧醯胺,以及(3-24)氟喹康唑 2〇 (fhiquinconazole) 〇 特別要被強調的活性化合物組合物B,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(3-27)得尼康唑 (diniconazole) 〇 除了具式⑴的羧醯胺(第(1)類化合物)外,活性化合物組 -98-15 The active compound composition B to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the group (1) in Table A |, and (3-22) triadimenol, especially to be The active compound composition B is emphasized, comprising the carboxamide which is selected from the formula (1) of the class (1) in Table A, and the activity of (3-24) fluoroquinconazole 2 (fhiquinconazole) which is particularly emphasized. Compound Composition B, comprising carboxamide attached to formula (I) of Table (1), and (3-27) diniconazole, in addition to carboxamide having formula (1) (1) Compounds), active compound group-98-

I 200814928 合物C也包含式(iv)之次磺醯胺(Sulphenamide)(第(4)類化 合物)I 200814928 Compound C also contains Sulphenamide of the formula (iv) (Group (4) compound)

其中R19的定義如前。 | 較佳的活性化合物組合物C,其中第(4)類之式(IV)之次 磺酸胺係挑選自列於下面之化合物: ίο (4-1)二氯氟尼(dichlofluanid),(4-2)甲基益發靈(tolylfluanid)。 特別要被強調的活性化合物組合物C,包含挑選自表a 中之第(1)類的式(I)之羧醯胺,以及(4-1)二氯氟尼 (dichlofluanid) 〇 特別要被強調的活性化合物組合物C,包含挑選自表a 15 中之第⑴類的式(I)之羧醯胺,以及(4-2)曱基益發靈 , (tolylfluanid)。 除了具式(I)的羧醯胺(第⑴類化合物)外,活性化合物組 合物D也包含挑選自包含下述(第(5)類)之顯胺酿胺 (valinamide): 2〇 (5-1)異丙菌胺(iprovalicarb),(5-2) 氯笨 基)-2-丙炔基]氧}-3-甲氧基苯基)乙基]-7V2-(甲基磺醯基)-;^ 纖胺酿胺,(5-3)苯嗟菌胺(benthiavalicarb)。 較佳的活性化合物組合物D,其中第(5)類之纈胺醯胺 係挑選自列於下面之化合物·· -99- 200814928 (5-1)異丙菌胺(iprovalicarb),(5-3)笨噻菌胺(benthiavw^^Wherein R19 is as defined above. A preferred active compound composition C wherein the sulfenic acid amine of the formula (IV) of the formula (4) is selected from the group consisting of: ίο (4-1) dichlofluanid, ( 4-2) Tolylfluanid. The active compound composition C to be particularly emphasized, comprising a carboguanamine of the formula (I) selected from the group (1) in Table a, and (4-1) dichlofluanid 〇 are particularly The active compound composition C is emphasized, comprising a carboxamide selected from the group (I) of the class (1) in Table a 15 and (4-2) tolylfluanid. In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound composition D also comprises a valinamide selected from the following (category (5)): 2〇(5) -1) Iprovalicarb, (5-2) chlorophenyl)-2-propynyl]oxy}-3-methoxyphenyl)ethyl]-7V2-(methylsulfonyl) )-;^ Fibrin amine, (5-3) benthiavalicarb. Preferred active compound composition D, wherein the amidoxime amine of the group (5) is selected from the following compounds: -99-200814928 (5-1) iprovalicarb, (5- 3) Streptomycin (benthiavw^^

特別要被強調的活性化合物組合物D,包含挑選自表A 中之第⑴類的式⑴之缓醯胺,以及(5])異丙菌胺 (iprovalicarb) 〇 5 特別要被強調的活性化合物組合物D,包含挑選自表a 中之第(1)類的式(I)之叛驢胺,以及(5-3)苯噻菌胺 (benthiavalicarb)。 ⑩ 除了具式⑴的羧醯胺(第⑴類化合物)外,活性化合物組 合物E也包含挑選自包含下述(第(6)類)之式(v)之羧醯胺 10The active compound composition D to be particularly emphasized, comprising the slow-acting amine of the formula (1) selected from the group (1) in Table A, and (5) the active compound particularly emphasized by iprovalicarb 〇5 Composition D, comprising a rebel amine of formula (I) selected from class (1) of Table a, and (5-3) benthiavalicarb. 10 In addition to the carboxamide (formula (1) compound) of the formula (1), the active compound composition E also contains a carboxamide selected from the following formula (v) (v).

其中,X,Y及Z的定義如前面所定義者。 較佳的活性化合物組合物Ε,其中第(6)類之式之羧 15 醯胺係挑選自列於下面之化合物: _(6-1)2-氣-]^-(1,1,3-二甲基印滿-4-基)於驗_胺,(6_2)白克 力(boscalid) ’ (6-3)福滅比(furametpyr),(6-4) Ν-(3-對-甲苯 基售吩_2·基)小甲基-3·三氟甲基·ιη·吼吐—4-叛酸胺,(6-5) 噻唑菌胺(ethaboxam),(6-6)環醯菌胺(fenhexamid),(6胃7) 20 卡普米(carpropamid),(6-8) 2-氯4-(2-氟-2-曱基丙醯基胺 基、-N,N-一甲基本甲酿胺,(6-9)殺菌劑(picobenzamid), (6-10)唑查醯胺(zoxamide),(6-11) 3,4-二氣-N-(2-氰基苯基) 異α塞嗤-5-叛醯胺,(6-12)卡保信(carboxin),(6-13) σ塞醯菌 胺(tiadinil) ’(6_14)嗟菌胺(penthiopyrad),(6_15)石夕嗔菌胺 -100 - 200814928 (silthiofam),(6-16) ΛΚ2-(1,3-二曱基 丁基)苯基]小甲基 -4-(三氟甲基比咯-3-羧醯胺,(6-17)福多寧 (flutolanil),(6-18)芬富南(fenfuram),(6]9)嘉保信 (oxycarboxin),(6-20)塞氟醯胺(thifluzamide),(6-21) 5 N-{2_[3_氯,5_(三氟甲基户比咬-2_基]乙基}-2_(二氣甲基)苯甲 醯胺,(6-22) N-(2-雙環丙基-2-基苯基)小甲基各三氟甲基 -1H-吼唑-4-羧醯胺,(6-23) Ν-(2-雙環丙基-2-基苯基)-1-甲 ,基-3-二氟甲基-1H-吡唑-4-羧醯胺,(6-24) Ν-|>(Γ-曱基雙環 丙基-2-基)笨基]小甲基-3-三氟甲基-1Η-11比唾-4-叛酿胺, 10 (6-25) Ν-[2-(Γ-曱基雙環丙基-2-基)苯基]-1-甲基二氟f 基-1H-吡唑·4-羧醯胺,(6-26) N-[l-(5-溴-3-氯吡啶-2-基)乙 基]-2,4-一氯私驗酸胺’(6-27) N-(5-溴-3-氯°比咬-2-基)甲基 -2,4-二氣菸鹼醯胺。 特別佳的活性化合物組合物E,其中第(6)類之式(v)之 15 羧醯胺係挑選自列於下面之化合物: • (6-2)白克力(boscalid),(6-5) 口塞哇菌胺(ethab〇xam),(6_6) 環醯菌胺(fenhexamid),(6-7)卡普米(carpr〇pamid),(6_8) 2_ 氯-4-(2-氟-2-甲基丙醯基胺基)落二甲基苯甲醯胺,(6_9) 殺菌劑(picobenzamid),(6-10)唑查醯胺(z〇xamide),(6 u) 20 3,扣二氣^氰基苯基)異噻唑-5-羧醯胺,(6-14)噻菌胺 (penthiopyrad),(6-16)尽〇(1,3-二甲基丁基)苯基]甲基 -4-(三氟甲基)-1//-吼咯-3·羧醯胺,(心17)福多寧 (flutolanil) ’(6-21) N-{2-[3'氣士(三氟曱基)吼啶_2_基]乙 基卜2-(三氟曱基)苯曱醯胺,(6Q2) N-(2-雙環丙基-2-基笨 -101 - 200814928 基)-1-甲基-3-三氟曱基_lHl·吡唑-4-羧醯胺,(6-23) N-(2-雙 環丙基-2-基苯基)-1-甲基-3-二氟曱基-1H-吡唑-4-羧醯胺, (6-24) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-三氟甲 基-ΙΚΜ比唑-4-羧醯胺,(6-25) Ν-[2-(Γ-甲基雙環丙基-2-基) 5 苯基]小甲基冬二氟曱基-1Η-吡唑-4-羧醯胺,(6-26) 1^-[1-(5->臭-3-氣吼唆-2-基)乙基]-2,4-二氯於驗酿胺’(6-27) Ν-(5-溴-3-氯吡啶-2-基)曱基-2,4-二氯菸鹼醯胺。 ,極佳的活性化合物組合物Ε,其中第(6)類之式(V)之羧 醯胺係挑選自列於下面之化合物: ίο (6-2)白克力(boscalid),(6-6)環醯菌胺(£€111^\311^〇1),(6-7) 卡普米(carpropamid),(6-9)殺菌劑(picobenzamid),(6-14) 嗟菌胺(pentiiiopyrad),(6-17)福多寧(flutolanil),(6-21) N-{2-[3-氯-5-(三氟曱基)吼啶-2-基]乙基}-2-(三氟甲基)苯甲 醯胺,(6-22) N-(2-雙環丙基-2-基苯基)-1-甲基-3-三氟甲基 is -1H-吡唑-4-羧醯胺,(6-23) Ν-(2-雙環丙基-2-基苯基)-1-甲 _ 基-3-二氟甲基-1H-吡唑-4-羧醯胺,(6-24) Ν-[2-(Γ-甲基雙環 丙基-2-基)苯基]-1-甲基-3-三氟甲基-1Η-吡唑-4_羧醯胺, (6-25) Ν-[2-(Γ_甲基雙環丙基-2-基)苯基]-1-曱基-3-二氟甲 基-1Η-吡唑-4-羧醯胺,(6-26) N-[l-(5-溴-3-氯吡啶-2-基)乙 2〇 基]-2,4-二氯菸鹼醯胺,(6-27) Ν-(5-溴-3-氯吼啶-2-基)甲基 -2,4-二氯菸鹼醯胺。 特別要被強調的活性化合物組合物Ε,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(6-2)白克力(boscalid)。Among them, the definitions of X, Y and Z are as defined above. A preferred active compound composition, wherein the carboxy 15 guanamine of the formula (6) is selected from the group consisting of: _(6-1) 2-gas-]^-(1,1,3 - dimethylindol-4-yl) in the test amide, (6_2) benzoic (boscalid) ' (6-3) blessing ratio (furametpyr), (6-4) Ν-(3-p-tolyl吩 · · · 小 小 小 小 · · — — — — — — — — — 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- 4- (fenhexamid), (6 stomach 7) 20 carpropamid, (6-8) 2-chloro 4-(2-fluoro-2-mercaptopropylaminol, -N,N-methylmethyl Amine, (6-9) bactericide (picobenzamid), (6-10) zoxamide, (6-11) 3,4-digas-N-(2-cyanophenyl) α stopper-5-treazone, (6-12) carboxin, (6-13) σ xidinium '(6_14) cuminamide (penthiopyrad), (6_15) Shi Xi Triamcinol-100 - 200814928 (silthiofam), (6-16) ΛΚ2-(1,3-dimercaptobutyl)phenyl]p-methyl-4-(trifluoromethylpyrrol-3-carboxyindole Amine, (6-17) flutolanil, (6-18) fenfuram, (6] 9) jiacarin (oxycarbox) In), (6-20) thifluzamide, (6-21) 5 N-{2_[3_Chlorine, 5_(trifluoromethyl-to-bit-2-yl)ethyl}-2_ (di-gas methyl) benzepidine, (6-22) N-(2-bicyclopropyl-2-ylphenyl) small methyl each trifluoromethyl-1H-indazole-4-carboxamide ,(6-23) Ν-(2-biscyclopropyl-2-ylphenyl)-1-methyl,yl-3-difluoromethyl-1H-pyrazole-4-carboxyguanamine, (6-24 ) Ν-|>(Γ-fluorenylbicyclopropyl-2-yl) stupyl] small methyl-3-trifluoromethyl-1Η-11 is more than salivary-4, 7 (6-25) Ν-[2-(Γ-Mercaptobiscyclopropyl-2-yl)phenyl]-1-methyldifluorof-yl-1H-pyrazole·4-carboxamide, (6-26) N- [l-(5-Bromo-3-chloropyridin-2-yl)ethyl]-2,4-chloro-purine acid amine '(6-27) N-(5-bromo-3-chloro-° ratio bite -2-yl)methyl-2,4-dione nicotinamide. Particularly preferred active compound composition E, wherein the carboxamide of the formula (v) of formula (v) is selected from the following Compounds: • (6-2) boscalid, (6-5) ethab〇xam, (6_6) fenhexamid, (6-7) carp 〇pamid),(6_8) 2_ chloro-4-(2-fluoro-2-methylpropanylamino) Benzobenzamide, (6_9) fungicide (picobenzamid), (6-10) oxazolamide (z〇xamide), (6 u) 20 3, dehydrogenated 2 cyanophenyl)isothiazole-5 - Carboxylamamine, (6-14) penthiopyrad, (6-16) 〇 (1,3-dimethylbutyl)phenyl]methyl-4-(trifluoromethyl)- 1//-吼咯-3·Carboxyguanidamine, (heart 17) Futonin (flutolanil) '(6-21) N-{2-[3' gas (trifluoromethyl) acridine_2 Ethyl 2-(trifluoromethyl)benzamide, (6Q2) N-(2-bicyclopropyl-2-yl-101-200814928)-1-methyl-3-trifluoroanthracene _lHl·pyrazole-4-carboxamide, (6-23) N-(2-bicyclopropyl-2-ylphenyl)-1-methyl-3-difluoroindolyl-1H-pyrazole -4-carboxyguanamine, (6-24) Ν-[2-(Γ-methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-trifluoromethyl-indoleazole- 4-carboxyguanamine, (6-25) Ν-[2-(Γ-methylbicyclopropyl-2-yl) 5 phenyl] small methyl dimethyl difluoroindolyl-1 Η-pyrazole-4-carboxylate Indoleamine, (6-26) 1^-[1-(5->Smelly-3-athracepin-2-yl)ethyl]-2,4-dichloro in the amine ('-27 Ν-(5-Bromo-3-chloropyridin-2-yl)indolyl-2,4-dichloronicotinium amide. An excellent active compound composition, wherein the carboxamide of the formula (V) of the formula (V) is selected from the following compounds: ίο (6-2) boscalid, (6-6) Cyclosporin (£€111^\311^〇1), (6-7) carpropamid, (6-9) bactericide (picobenzamid), (6-14) guanidinamide (pentiiiopyrad), (6-17) Flutolanil, (6-21) N-{2-[3-chloro-5-(trifluoromethyl)acridin-2-yl]ethyl}-2-(three Fluoromethyl)benzamide,(6-22) N-(2-bicyclopropyl-2-ylphenyl)-1-methyl-3-trifluoromethyl is-1H-pyrazole-4- Carboxylamidine, (6-23) Ν-(2-bicyclopropyl-2-ylphenyl)-1-methyl-3-yl-3-difluoromethyl-1H-pyrazole-4-carboxamide, ( 6-24) Ν-[2-(Γ-Methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-trifluoromethyl-1Η-pyrazole-4_carboxamide, ( 6-25) Ν-[2-(Γ_Methylbicyclopropyl-2-yl)phenyl]-1-mercapto-3-difluoromethyl-1Η-pyrazole-4-carboxyguanamine, ( 6-26) N-[l-(5-Bromo-3-chloropyridin-2-yl)ethyl 2indolyl]-2,4-dichloronicotinium amide, (6-27) Ν-(5- Bromo-3-chloroacridin-2-yl)methyl-2,4-dichloronicotinium amide. The active compound composition, particularly emphasized, comprises carboxamide selected from the group (I) of Table (1), and (6-2) boscalid.

特別要被強調的活性化合物組合物E,包含挑選自表A -102 - 200814928 中之第(1)類的式⑴之羧醯胺,以及(6-6)環醯菌胺 (fenhexamid) 〇 特別要被強調的活性化合物組合物E,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(6-7)卡普米 5 (carpropamid) 〇 特別要被強調的活性化合物組合物E,包含挑選自表A 中之第(1)類的式(1)之羧醯胺,以及(6-9)殺菌劑 _ (picobenzamid) 〇 特別要被強調的活性化合物組合物E,包含挑選自表A ίο 中之第(1)類的式(I)之羧醯胺,以及(6-14)噻菌胺 (penthiopyrad) 〇 特別要被強調的活性化合物組合物E,包含挑選自表A 中之第(1)類的式(1)之羧醯胺,以及(6-17)福多寧 (flutolanil)。The active compound composition E to be particularly emphasized, comprising the carboxamide of the formula (1) selected from the group (1) in Table A-102 - 200814928, and (6-6) fenhexamid 〇 The active compound composition E to be emphasized, including the carboguanamine of the formula (I) selected from the class (1) in Table A, and (6-7) carpropamid 〇 are particularly emphasized. The active compound composition E, comprising the carboxamide which is selected from the formula (1) of the class (1) in Table A, and (6-9) the active compound composition which is particularly emphasized by the picobenzamid E, comprising a carboxamide which is selected from the group (I) of the class (1) in Table A ίο, and (6-14) penthiopyrad 活性 an active compound composition E which is particularly emphasized, including The carboxamides of the formula (1) of the class (1) in Table A, and (6-17) flutolanil were selected.

is 特別要被強調的活性化合物組合物E,包含挑選自表A _ 中之第(1)類的式(I)之羧醯胺,以及(6-21) N-{2-[3-氯-5-(三 氟甲基)吡啶-2-基]乙基}-2-(三氟甲基)苯甲醯胺。 特別要被強調的活性化合物組合物E,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(6_22)N-(2-雙環丙基-2-2〇 基本基)-1-曱基-3-^氣甲基-1Η-σ比°坐-4-竣酿胺。 特別要被強調的活性化合物組合物Ε,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(6-23)N-(2-雙環丙基-2-基苯基)-1-甲基-3-二氟曱基-1H-吡唑-4-羧醯胺。The active compound composition E to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (6-21) N-{2-[3-chloro 5-5-(Trifluoromethyl)pyridin-2-yl]ethyl}-2-(trifluoromethyl)benzamide. The active compound composition E to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (6_22) N-(2-bicyclopropyl-2-2? The basic group)-1-mercapto-3-^ gas methyl-1Η-σ ratio ° sit-4-anthracene amine. The active compound composition 特别 particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (6-23) N-(2-bicyclopropyl-2- Phenyl)-1-methyl-3-difluoroindolyl-1H-pyrazole-4-carboxamide.

特別要被強調的活性化合物組合物E,包含挑選自表A -103- 200814928 牿 氣甲基-1H-吡唑冰羧醯胺。The active compound composition E, which is particularly emphasized, comprises the selected from the group A-103-200814928, helium methyl-1H-pyrazole ice carboguanamine.

中之活性化合物組合物E,包含挑選自表A 本基]基·3·二鼠甲基·1Η“Κ4-細胺。 ^別要被強調的活性化合物組合物ε 中之第(1)類的式(I)之羧醯胺,以及 乂The active compound composition E, which is selected from the group A (group), the base, the dimethyl group, the methyl group, the quinone 4-minamine, and the class (1) of the active compound composition ε to be emphasized. Carboxamide of formula (I), and hydrazine

10 15 衫基)乙基]从二氯祕^及(6,仰备3叙 中之ΖΪΓλ觸活性化合物組合物Ε,包含挑選自表A 基)甲基-2,4-二氯菸鹼醯胺。 疋 人物=1=1)的㈣胺(第⑴類化合物)外,活性化合物級 (=1 Γ自包含下述(第(7)類)之二硫胺基甲酸酿: (-1)鋅錳乃浦(mancozeb),(7_2)錳乃浦—eb),㈤ 得爛(meti_,(7_4)甲基鋅乃浦(pr〇pineb) (75)得恩地 _ram) ’(7_6)鋅乃浦(zineb),(7 7)福美鋅⑵叫。 車父佳的活性化合物組合物F,其中第⑺類之二硫胺基 甲酸酯係挑選自列於下面之化合物: (7-1)鋅錳乃浦(mancozeb),(7-2)錳乃浦(maneb),(7_4)甲 基鋅乃浦(propineb),(7-5)得恩地(也如1!1),(7_6)鋅乃浦 (zineb) 〇 特別佳的活性化合物組合物F,其中第(7)類之二硫胺 基甲酸酯係挑選自列於下面之化合物: 〇1)鋅錳乃浦(mancozeb),(7-4)甲基鋅乃浦(pr〇pineb)。 -104· 20 200814928 特別要被強調的活性化合物組合物F,包含挑選自表a 中之第⑴類的式(I)之羧醯胺,以及(7-1)鋅錳乃浦 (mancozeb) 〇 特別要被強調的活性化合物組合物F,包含挑選自表a 中之第(1)類的式(I)之羧醯胺,以及(74)甲基鋅乃浦 (propineb) 〇 除了具式⑴的羧醯胺(第⑴類化合物)外,活性化合物組 合物G也包含挑選自包含下述(第(8)類)之式(VI)的醯基丙 胺酸10 15 基基)ethyl] from dichloromethane and (6, 备 3 3 3 3 ΖΪΓ ΖΪΓ ΖΪΓ 触 触 Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε Ε 甲基 甲基 甲基 甲基 甲基 甲基 甲基amine. ( person=1 = 1) of the (tetra)amine (the compound of the (1) type), the active compound grade (=1 Γ from the dithiocarbamate containing the following (class (7)): (-1) zinc manganese Naipo (mancozeb), (7_2) Manganese-eb), (5) Bad (meti_, (7_4) methyl zinc napo (pr〇pineb) (75) Dean _ram) '(7_6) Zinc Napo (zineb), (7 7) Fumei Zinc (2) called. The active compound composition F of the parent company, wherein the dithiocarbamate of the (7) class is selected from the following compounds: (7-1) Manganese (mancozeb), (7-2) manganese Naipu (maneb), (7_4) methyl zinc is the propineb, (7-5) Dean (also as 1!1), (7_6) zinc napu (zineb) 〇 particularly good active compound composition F, wherein the dithiocarbamate of the (7) class is selected from the following compounds: 〇 1) Zn Mn 浦 (mancozeb), (7-4) methyl Zn pu pu (pr〇pineb ). -104· 20 200814928 The active compound composition F to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table a, and (7-1) the zinc manganese (mancozeb) 〇 The active compound composition F to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the class (1) in Table a, and (74) the propineb of the formula (1) in addition to the formula (1) In addition to the carboxamide (the compound of the formula (1)), the active compound composition G also contains the mercaptoalanine selected from the formula (VI) which is described below (category (8)).

其中,*及R23的定義如前面之定義。 15 較佳的活性化合物組合物G,其中第(8)類之式(VI)之醯 _ 基丙胺酸係挑選自列於下面之化合物: (8-1)本達樂(benalaxyl),(8-2)福達樂(fUralaxyl),(8-3)滅 達樂(metalaxyl) ’(8-4)滅達樂-M (metalaxyl-M),(8-5)本 達樂-M (benalaxyl-M) ° 20 特別佳的活性化合物組合物G,其中第(8)類之式(VI) 之醯基丙胺酸係挑選自列於下面之化合物: (8-3)滅達樂(metalaxyl),(8-4)滅達樂-M(metalaxyl-M), (8-5)本達樂-M(benalaxyl-M)。Among them, the definitions of * and R23 are as defined above. A preferred active compound composition G, wherein the hydrazine-based propylamine of the formula (8) is selected from the group consisting of: (8-1) benalaxyl, (8) -2) fUralaxyl, (8-3) metalaxyl '(8-4) tadal-M (metalaxyl-M), (8-5) borda-M (benalaxyl -M) ° 20 Particularly preferred active compound composition G, wherein the mercaptoalanine of the formula (8) is selected from the following compounds: (8-3) metalaxyl (8-4) Metalaxyl-M, (8-5) Benalaxyl-M.

特別要被強調的活性化合物組合物G,包含挑選自表A -105- 200814928 中之第⑴類的式(i)之羧醯胺,以及(8-3)滅達樂 (metalaxyl) 〇 特別要被強調的活性化合物組合物G,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(8-4)滅達樂 5 -M(metalaxyl-M)。 特別要被強調的活性化合物組合物G,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(8-5)本達樂 . -M(benalaxyl-M) 〇 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 ίο 合物Η也包含挑選自下述(第(9)類)之苯胺基嘧啶: (9-1)西普地尼(cyprodinil),(9-2)滅盤尼比(|1160&1^}^1111),(9-3) 必滅寧(pyrimethanil)。 特別要被強調的活性化合物組合物H,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(9-1)西普地尼 15 (cyprodinil)。The active compound composition G to be particularly emphasized, comprising the carboguanamine of the formula (i) selected from the group (1) in Table A-105-200814928, and (8-3) metalaxyl oxime The emphasized active compound composition G comprises carboxamide which is selected from the group (I) of the class (1) in Table A, and (8-4) metalaxyl-M. The active compound composition G to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the class (1) in Table A, and (8-5) Benalaxyl-M (benalaxyl-M) In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound group Η Η Η also contains an anilinopyrimidine selected from the following (category (9)): (9-1 ) cyprodinil, (9-2) annihilation (|1160&1^}^1111), (9-3) pyrimethanil. The active compound composition H to be particularly emphasized includes carboxyguanamine of the formula (I) selected from the group (1) in Table A, and (9-1) cyprodinil.

| 特別要被強調的活性化合物組合物Η,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(9-2)滅盤尼比 (mepanipyrim) 〇 特別要被強調的活性化合物組合物H,包含挑選自表A 20 中之第⑴類的式⑴之羧醯胺,以及(9-3)必滅寧 (pyrimethanil)。 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 合物I也包含挑選自下述(第(1〇)類)之式(VIII)的苯并咪唑 -106- >27200814928 (vm) 其中,r25 ’ r26 ’ r27及R28的定義如前面之定義。 5 較佳的活性化合物組合物〗,其中第(10)類之式(Vii 之苯并咪唑係挑選自列於下面之化合物:The active compound composition 特别 particularly emphasized, comprising carboxamides of formula (I) selected from class (1) in Table A, and (9-2) mepanipyrim 〇 The emphasized active compound composition H comprises carboxamide which is selected from the formula (1) of the class (1) in Table A 20, and (9-3) pyrimethanil. In addition to the carboxamide (Formula (1) compound) of formula (I), active compound composition I also comprises benzimidazole-106 selected from formula (VIII) below (category (1)) - >27200814928 (vm) where r25 ' r26 ' r27 and R28 are as defined above. 5 Preferred active compound compositions, wherein the formula (10) (the benzimidazoles of Vii are selected from the following compounds:

10 (HM) 6-氯-5-[(3,5-二甲基異噁唑基)磺醯基]_2,厶二氟 -5H-[1,3]二噁茂并|»f]-苯并咪唑,(ι〇_2)免賴得 (benomyl) ’(10-3)貝务替(carbencJazim),(10-4)氯芬那嗅 (chlorfenazole),(10-5)麥穗寧(fuberidazole),(10-6)腐矣刀 (thiabendazole) 〇 特別佳的活性化合物組合物I,其中第(1〇)類之式(Vl 之苯并咪唑為: (10-3)貝芬替(carbendazim)。 1510 (HM) 6-Chloro-5-[(3,5-dimethylisoxazolyl)sulfonyl]_2, indole difluoro-5H-[1,3]dioxole||f]- Benzimidazole, (ι〇_2)-free (benomyl) '(10-3) baccen (carbencJazim), (10-4) chlorfenazole, (10-5) Mai Suining (fuberidazole), (10-6) thiabendazole 〇 Particularly preferred active compound composition I, wherein the formula (1〇) is (benzazole of V1 is: (10-3) befenfen (carbendazim). 15

R RR R

特別要被強調的活性化合物組合物I,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(10-3)貝芬替 (carbendazim) 〇 除了具式(I)的羧醯胺(第⑴類化合物)外,活性化合物% 合物J也包含挑選自下述(第(11)類)之式(IX)的胺基曱酸酷The active compound composition I to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the class (1) in Table A, and (10-3) the carbendazim in addition to the formula ( In addition to the carboxamide (class (1) compound) of I), the active compound % J also contains the amine bismuth acid of formula (IX) selected from the following (category (11)).

其中,R29及R30的定義如前面之定義。 較佳的活性化合物組合物J,其中第(11)類之胺基曱酸 -107- 20 200814928 酯係挑選自列於下面之化合物: (11-1)二硫芬克(diethofencarb),(11-2)普拔克(propamocarb), (11-3)鹽酸普拔克(propamocarb-hydrochloride) ’(11-4)普拔 克-福赛得(fosetyl)。Among them, the definition of R29 and R30 is as defined above. Preferred active compound composition J, wherein the amine group of the (11) class of decanoic acid-107-20 200814928 is selected from the following compounds: (11-1) diefhofencarb (11) -2) propamocarb, (11-3) propamocarb-hydrochloride '(11-4), fosetyl.

5 特別要被強調的活性化合物組合物J,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(11-1)二硫芬克 (diethofencarb) 〇5 The active compound composition J to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (11-1) diethofencarb (diethofencarb)

& 特別要被強調的活性化合物組合物J,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及普拔克 ίο (propamocarb) 〇 特別要被強調的活性化合物組合物J,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(11-3)鹽酸普拔克 (propamocarb-hydrochloride) 〇 特別要被強調的活性化合物組合物J ’包含挑選自表A 15 中之第(1)類的式(I)之羧醯胺,以及(Π-4)普拔克-福賽得 (fosetyl)。 除了具式(I)的羧酿胺(第(1)類化合物)外,活性化合物組 合物K也包含挑選自下述(第(12)類)之二羧基亞醯胺 (dicarboximide): 2〇 (12-1)四氯丹(captafol),(12-2)蓋普丹(captan),(12-3)福 爾培(folpet),(12-4)依普同(iprodione),(12-5)撲滅寧 (procymidone),(12-6)免克寧(vinclozolin)。 較佳的活性化合物組合物κ’其中第(12)類之二羧基亞 醯胺係挑選自列於下面之化合物: -108 - 200814928 (12_2)蓋普丹(captan),(12_3)福爾培(f〇ipet),(12_4)依普 同(iprodione)。& In particular, the active compound composition J, which contains the carboxamide of the formula (I) selected from the class (1) in Table A, and the activity to be particularly emphasized by Propacarb (propamocarb) Compound composition J, comprising a carboguanamine of formula (I) selected from the group (1) in Table A, and (11-3) an active compound to be particularly emphasized by propamocarb-hydrochloride Composition J' comprises carboxamide which is selected from the group (I) of the class (1) in Table A 15 and (Π-4), fosetyl. In addition to the carboxychiral amine of the formula (I) (the compound of the formula (1)), the active compound composition K also contains dicarboxyboximide selected from the following (category (12)): 2〇 (12-1) tetramdan (captafol), (12-2) captan (captan), (12-3) folfet, (12-4) iprodione, (12 -5) Procymidone, (12-6) vinclozolin. A preferred active compound composition κ' wherein the dicarboxy carbamide of the group (12) is selected from the group consisting of: -108 - 200814928 (12_2) captan, (12_3) fore (f〇ipet), (12_4) Iprodione.

特別要被強調的活性化合物組合物K,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(12-2)蓋普丹(captan)。The active compound composition K to be particularly emphasized includes carboxyguanamine of the formula (I) selected from the group (1) in Table A, and (12-2) captan.

5 特別要被強調的活性化合物組合物K,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(12-3)福爾培(folpet)。5 The active compound composition K to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (12-3) folpet.

特別要被強調的活性化合物組合物K,包含挑選自表A | 中之第⑴類的式(I)之羧醯胺,以及(12-4)依普同 (iprodi〇ne) 〇 10 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 合物L也包含挑選自下述(第(13)類)之胍(guanidine): (13-1)多寧(d〇dine),(13-2)克熱淨(guazatine),(13-3)雙 胍辛胺三乙酸鹽(iminoctadine triacetate),(13-4)克熱淨(烧 本石頁酸鹽)[iminoctadine tris(albesilate)],(13-5)多寧(dodine 15 (游離驗))’(13-6)克熱淨(immoctadine)(游離驗)。 p 較佳的活性化合物組合物L,其中第(13)類之胍係挑選 自列於下面之化合物: (13-1)多寧(dodine),(13-2)克熱淨(guazatine)。 特別要被強調的活性化合物組合物L,包含挑選自表A 20 中之第⑴類的式(I)之羧醯胺,以及(13-1)多寧(dodine)。 特別要被強調的活性化合物組合物L,包含挑選自表A 中之第⑴類的式⑴之叛醯胺,以及(13-2)克熱淨 (guazatine) 〇 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 -109- 200814928 合物Μ也包含挑選自下述(第(14)類)之咪唾(imidazole): (14-1)賽座滅(cyazofamid),(14-2)撲克拉(prochloraz),(14-3) 二口坐嘻(triazoxide) ’(14_4)稻盘醋化^\^2€^6)0 5The active compound composition K to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A | and (12-4) iprodi〇ne 〇10 In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound composition L also contains guanidine selected from the following (category (13)): (13-1) tannin ( D〇dine), (13-2) guazatine, (13-3) iminoctadine triacetate, (13-4) gram heat (burning shale) [ Iminoctadine tris (albesilate)], (13-5) donin (dodine 15 (free test)) '(13-6) gram hot (immoctadine) (free test). p Preferred active compound composition L, wherein the lanthanide of class (13) is selected from the group consisting of: (13-1) dodine, (13-2) guazatine. The active compound composition L to be particularly emphasized includes carboxyguanamine of the formula (I) selected from the group (1) in Table A 20, and (13-1) dodine. The active compound composition L to be particularly emphasized, comprising the rebel amine of formula (1) selected from the class (1) in Table A, and (13-2) guazatine 〇 in addition to the carboxy group of formula (I) In addition to the indoleamine (the compound of the (1) class), the active compound group -109-200814928 compound also contains the imidazole selected from the following (category (14)): (14-1) (cyazofamid), (14-2) poker pull (prochloraz), (14-3) two sitting 嘻 (triazoxide) '(14_4) rice dish vinegar ^ \ ^ 2 € ^ 6) 0 5

10 較佳的活性化合物組合物M,其中第(14)類之咪唑係挑 選自列於下面之化合物: (14-2)撲克拉(prochloraz),(14-3)三唑嗪(triazoxide)。 特別要被強調的活性化合物組合物Μ,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(14-2)撲克拉 (prochloraz) 〇 特別要被強調的活性化合物組合物M,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(14_3)三唑嗪 (triazoxide) 〇 除了具式(I)的羧醯胺(第⑴類化合物)外,活性化合物組 合物N也包含挑選自下述(第(15)類)之式(X)之嗎啉 15A preferred active compound composition M, wherein the imidazole of the (14) class is selected from the group consisting of: (14-2) prochloraz, (14-3) triazoxide. In particular, the active compound composition Μ, including the carboxamides of formula (I) selected from class (1) in Table A, and (14-2) prochloraz 〇 are particularly emphasized The active compound composition M comprises a carboguanamine of the formula (I) selected from the group (1) in Table A, and (14_3) triazoxide, in addition to the carboguanamine having the formula (I) ( In addition to the compound of the above formula (1), the active compound composition N also contains morpholine 15 of the formula (X) selected from the following (category (15))

(morpholine)(morpholine)

(X) 其中,R31,R32及R33的定義如前。 較佳的活性化合物組合物N,其中具式(X)之第(15)類 之嗎啉係挑選自列於下面之化合物: (15-1)阿得摩福(aldimorph),(15-2)三得芬(tridemorph), (15-3)敵草隆(dodemorph),(15-4)芬普比福(fenpropimorph), (15-5)大滅芬(dimethomorph) 〇 -110- 20 200814928 特別佳的活性化合物組合物N,其中具式(X)之第(15) 類的嗎啉係挑選自列於下面之化合物: (15-4)芬普比福(fenpropimorph),(15-5)大滅芬 (dimethomorph) 〇(X) wherein R31, R32 and R33 are as defined above. Preferred active compound composition N, wherein the morpholine group of the formula (15) is selected from the following compounds: (15-1) aldimorph, (15-2) ) tridemorph, (15-3) dodemorph, (15-4) fenpropimorph, (15-5) dimethomorph 〇-110-20 2014 Particularly preferred active compound composition N, wherein the morpholine of the formula (15) of the formula (X) is selected from the following compounds: (15-4) fenpropimorph, (15-5) ) dimethomorph 〇

5 特別要被強調的活性化合物組合物N,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(15-4)芬普比福 (fenpropimorph) 〇5 The active compound composition N to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (15-4) fenpropimorph 〇

| 特別要被強調的活性化合物組合物N,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(15-5)大滅芬 ίο (dimethomorph) ° 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 合物Ο也包含挑選自下述(第(16)類)之式(XI)之吡咯 (pyrrole)The active compound composition N to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the class (1) in Table A, and (15-5) dimethomorph ° In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound composition Ο also contains pyrrole of the formula (XI) selected from the following (class (16)).

其中,R34,R35及R36的定義如前。 較佳的活性化合物組合物〇’其中具式(XI)之第(16)類 之吡咯係挑選自列於下面之化合物: 2〇 (16-1)芬畢克尼(fenpiclonil),(16-2)伏地 σ惡尼 (fludioxonil),(16,3) °比洛尼精(pyrrolnitrin)。 特別佳的活性化合物組合物〇,其中具式以1)之第(16) 類之吡咯係挑選自列於下面之化合物: (16-2)伏地σ惡尼(fludioxonil)。 -111- 200814928Among them, R34, R35 and R36 are as defined above. Preferred active compound compositions 吡' wherein the pyrrole of the group (16) of the formula (XI) is selected from the following compounds: 2〇(16-1)fenpiclonil, (16- 2) Fludioxonil, (16,3) ° pyrrolnitrin. A particularly preferred active compound composition, wherein the pyrrole of the formula (16) of the formula 1) is selected from the group consisting of: (16-2) fludioxonil. -111- 200814928

特別要被強調的活性化合物組合物〇,包含挑選自表A 中之第⑴類的式⑴之羧醯胺,以及(16_2)伏地噁尼 (fludioxonil) 〇 除了具式(I)的叛醯胺(第(丨)類化合物)外,活性化合物組 $ 合物P也包含挑選自下述(第〇乃類)之膦酸酯: (Π-1)福赛得-鋁(f0Setyi_A1),(17_2)膦酸,(17·3)曱基立 枯鱗(tolclophos-methyl)。In particular, the active compound composition 〇 contains carboxyguanamines of the formula (1) selected from the group (1) in Table A, and (16_2) fludioxonil 〇 in addition to the ruthenium amine of the formula (I) In addition to the (第) compound, the active compound group P also contains a phosphonate selected from the following (diterone): (Π-1) Forsythia-aluminum (f0Setyi_A1), (17_2 Phosphonic acid, (17·3) tolclophos-methyl.

隱 特別要被強調的活性化合物組合物P,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(17_丨)福賽得_鋁 ίο (fosetyl-Al) 〇In particular, the active compound composition P to be emphasized, comprising the carboxamide of the formula (I) selected from the class (1) in Table A, and (17_丨) Forsyth_aluminum ίο (fosetyl-Al) 〇

特別要被強調的活性化合物組合物p,包含挑選自表A 中之第(1)類的式⑴之羧醯胺,以及(17-3)曱基立枯磷 (tolclophos-methyl) 〇 除了具式⑴的羧酿胺(第〇)類化合物)外,活性化合物組 15 合物Q也包含挑選自下述(第(19)類)之殺真菌劑: (19-1)本并嘆一唾醋(acibenzolar-S-methyl),(19-2)氣塞尼 (chlorothalonil),(19-3)克絕(eymoxanil),(19·4)護粒松 (edifenphos),(19-5)凡殺同(fam〇xadone),(19-6)伏寄南 (fluazinam),(19-7)氣氧化銅(copper OXyChl〇ride),(19-8) 2〇 氫氧化銅(copper hydroxide),(19-9)歐殺斯(oxadixyl), (19-10)螺環菌胺(spiroxamine),(19-11)二硫酉昆 (dithianon),(19-12)表苯菌酮(metrafenone),(19-13)咪嗤 菌酮(fenamidone),(19-14)2,3-二丁基-6-氣嗟吩并[2,3-(1]、密 ^_4(3H)_酮,(19-15)撲殺熱(probenazole),(19-16)稻瘦 112 200814928 靈(isoprothiolane) ’(19-17)嘉賜黴素(kasugamycin),(19-18) 熱必斯(phthalide),(19-19)富米熱斯(ferimzone),(19-20) 三赛唑(tricyclazole),(19-21) Ν·({4-[(環丙基胺基)幾基]苯 基}磺醯基)-2-曱氧基苯曱醯胺,(19-22) 2-(4-氯苯 5 基;曱氧基冰(丙-2-炔小基氧)苯基]乙基}-2-(丙_2_ 块-1-基氧)乙醯胺,(19-23)快諾芬(quinoxyfen)。 較佳的活性化合物組合物Q,其中第(19)類之殺真菌劑 | 係挑選自列於下面之化合物: (19-1)苯并噻二唑酯(acibenzolar-S-methyl),(19-2)氯塞尼 ίο (chlorothalonil),(19-3)克絕(cymoxanil),(19-5)凡殺同 (famoxadone),(19-6)伏寄南(fluazinam),(19-7)氯氧化銅 (copper oxychloride),(19_9)歐殺斯(oxadixyl),(19-10)螺 環菌胺(spiroxamine),(19-13)咪唾菌酮(fenamidone), (19-21) N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-甲氧基 15 苯甲醯胺,(19-22)2-(4-氯苯基)-:^{2-[3-甲氧基-4-(丙-2-炔 p . -1·基氧)苯基]乙基丙-2-炔-1-基氧)乙隨胺,(19-23)快 諾芬(quinoxyfen) 〇 特別佳的活性化合物組合物Q,其中第(19)類之殺真菌 劑係挑選自列於下面之化合物: 2〇 (19-2)氯塞尼(chlorothalonil),(19-7)氯氧化銅(COpper oxychloride),(19-10)螺環菌胺(spiroxamine),(19_21) N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-曱氧基苯甲醯 胺,(19-22)2-(4-氯苯基甲氧基-4-(丙-2-炔小基氧) 苯基]乙基}-2-(丙-2-炔-1-基氧)乙醯胺,(19-23)快諾芬 -113- 200814928 (quinoxyfen) 〇The active compound composition p to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the class (1) in Table A, and (17-3) tolclophos-methyl oxime In addition to the carboxychiral (terpenoid) compound of formula (1), the active compound group 15 compound Q also contains a fungicide selected from the following (category (19)): (19-1) Acibenzolar-S-methyl, (19-2) chlorothalonil, (19-3) yemoxanil, (19·4) edifenphos, (19-5)杀 同 (fam〇xadone), (19-6) volt nan (fluazinam), (19-7) copper OXyChl〇ride, (19-8) 2 〇 copper hydroxide (copper hydroxide), (19-9) oxadixyl, (19-10) spiroxamine, (19-11) dithianon, (19-12) meperfenone , (19-13) fenamidone, (19-14) 2,3-dibutyl-6-azepine [2,3-(1], 密^_4(3H)-one (19-15) probenazole, (19-16) rice thin 112 200814928 spirit (isoprothiolane) '(19-17) kasugamycin (kasugamycin), (19- 18) phthalide, (19-19) ferimzone, (19-20) tricyclazole, (19-21) Ν·({4-[(cyclopropyl) Amino)diyl]phenyl}sulfonyl)-2-decyloxybenzamine, (19-22) 2-(4-chlorophenyl-5-yl; decyloxy ice (propan-2-yne small) Phenoxy)phenyl]ethyl}-2-(propan-2-yl-1-yloxy)acetamide, (19-23) quinoxyfen. Preferred active compound composition Q, wherein 19) fungicides | are selected from the following compounds: (19-1) benzothiazolidine (acibenzolar-S-methyl), (19-2) chlorhexidine ίο (chlorothalonil), ( 19-3) cymoxanil, (19-5) famoxadone, (19-6) fluazinam, (19-7) copper oxychloride, (19_9) Oxadixyl, (19-10) spiroxamine, (19-13) fenamidone, (19-21) N-({4-[(cyclopropylamine) (carbonyl)phenyl]sulfonyl)-2-methoxyl benzoguanamine, (19-22) 2-(4-chlorophenyl)-:^{2-[3-methoxy- 4-(prop-2-yne p. -1·yloxy)phenyl]ethylprop-2-yn-1-yloxy)diethylamine (19-23) quinoxyfen 〇 a particularly preferred active compound composition Q, wherein the fungicide of class (19) is selected from the following compounds: 2〇(19-2) chlorseni (chlorothalonil), (19-7) COpper oxychloride, (19-10) spiroxamine, (19_21) N-({4-[(cyclopropylamino)carbonyl)benzene (sulfonyl)-2-decyloxybenzamide, (19-22) 2-(4-chlorophenylmethoxy-4-(prop-2-yne small oxy) phenyl] }}-2-(prop-2-yn-1-yloxy)acetamide, (19-23) vebufen-113- 200814928 (quinoxyfen) 〇

特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(19-2)氣塞尼 (chlorothalonil)。The active compound composition Q to be particularly emphasized includes carboxamide which is selected from the group (I) of the class (1) in Table A, and (19-2) chlorothalonil.

5 特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(19-7)氯氧化銅(copper oxychloride)- .5 The active compound composition Q to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (19-7) copper oxychloride.

• 特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第(1)類的式⑴之羧醯胺,以及(19-10)螺環菌胺 10 (spiroxamine) 〇 特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(19-21) N-({4-[(環丙基 胺基)羰基]苯基}磺醯基)_2_曱氧基苯甲醯胺。 特別要被強調的活性化合物組合物Q,包含挑選自表A 15 中之第⑴類的式(I)之羧醯胺,以及(19-22) 2-(4-氯笨 φ 基)-N-{2-[3-甲氧基斗(丙-2-炔小基氧)苯基]乙基卜2-(丙七 炔-基氧)乙醯胺。 特別要被強調的活性化合物組合物Q,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(19_23)快諾芬 2〇 (quinoxyfen) 〇 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 合物R也包含挑選自下述(第(20)類)之(硫)脲衍生物: (20-1)賓克隆(pencycuron) ,(20-2)甲基-多保淨 (thiophanate-methyl),(20-3)乙基-多保淨(thiophanate_ethyl)。 -114- 200814928 較佳的活性化合物組合物R,其中第(2〇)類之(硫)脲衍 生物係挑選自列於下面之化合物: (20-1)賓克隆(pencycur〇n),(2〇 2)曱基多保淨 (thiophanate-methyl) 〇• The active compound composition Q to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the class (1) in Table A, and (19-10) spiroxamine 10, especially The active compound composition Q is emphasized, comprising the carboxamide of formula (I) selected from the class (1) in Table A, and (19-21) N-({4-[(cyclopropylamino)) Carbonyl]phenyl}sulfonyl)_2_decyloxybenzamide. The active compound composition Q to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the class (1) in Table A 15 and (19-22) 2-(4-chlorophenyl)-N -{2-[3-Methoxy phenyl (prop-2-ynyloxy)phenyl]ethyl 2-(propyn-7-yloxy)acetamide. The active compound composition Q to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the class (1) in Table A, and (19_23) quinoxyfen in addition to the formula (I) In addition to the carboxamide (the compound of the class (1)), the active compound composition R also comprises a (thio)urea derivative selected from the following (category (20)): (20-1) penmone (pencycuron) ), (20-2) thiophanate-methyl, (20-3) ethyl-polyphanate_ethyl. -114- 200814928 A preferred active compound composition R wherein the (thio)urea derivative of the (2) class is selected from the group consisting of: (20-1) penmone (pencycur〇n), ( 2〇2) thiophanate-methyl 〇

5 特別要被強調的活性化合物紐合物R,包含挑選自表A 中之第⑴類的式⑴之羧醯胺,以及(20-1)賓克隆 (pencycuron) 〇 _ 除了具式(1)的羧醯胺(第(1)類化合物)外,活性化合物組 合物S也包含挑選自下述(第(22)類)之式(XIV)之三唑并嘧 10 口定 R415 In particular, the active compound R, which is to be emphasized, comprises carboxamide which is selected from the formula (1) of the class (1) in Table A, and (20-1) pencycuron 〇_ except for the formula (1) In addition to the carboxamide (the compound of the formula (1)), the active compound composition S also contains the triazole pyrimidine 10 of the formula (XIV) selected from the following (category (22)).

15 其中,R40,R41,R42,R43,R44,R45,R46 及 R47 的定義如 前。 較佳的活性化合物組合物S,其中第(22)類之式(XIV) 的三嗤并嘧啶係挑選自下面之化合物: (22-1) 5m仰-2,2,2-三氟小甲基乙基]-6·(2,4,6-三氟苯 2〇 基)Π,2,4]三唑并[1,5-a]嘧啶-7·胺,(22-2) 5-氯-尽[(77^1,2一 二曱基丙基]-6-(2,4,6-三氟苯基)[1,2,4]三嗤并[l,5-a>密。定-7-胺’(22-3) 5-氯-6-(2-氯氟苯基)-7-(4-曱基六氫°比唆《4_ 基)[1,2,4]三唑并[i,5-a]-嘧啶,(22-4) 5-氯各(2,4,6-三氟笨 基)-7-(4-甲基六氫π比啶基)[yj]三唑并[l,5_a]嘧啶。 -115- 200814928 特別佳的活性化合物組合物S,其中第(22)類之式(XIV) 的三哇并嘧啶係挑選自下面之化合物: (22-1) 5•氯三氟曱基乙基]_6_(2,4,6_三氟苯 基)[1,2,4]三唑并[15_a]嘧啶_7_胺,(22 2) 5 一甲基丙基P6_(2,4,6-三氟苯基)[1,2,4]三唑并[l,5-a]嘧啶-7- 胺,(22-4) 5-氯-6-(2,4,6-三氟苯基)_7_(4_甲基六氫0比啶 基)Π,2,4]三唑并p,^],啶。 響特別要被強調的活性化合物組合物s,包含挑選自表A 中之第(1)類的式(1)之綾醯胺,以及(22_1) 5-氯 1〇 Ψ &]^6»(2Λ6-^ ^ ^^)[1?2,4] 二唾并[l,5-a],唆-7-胺。 特別要被強調的活性化合物組合物s,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(22-2)5-氯_7^^/7^_1,2一 —曱基丙基]_6-(2,4,6-三氟苯基)pj,4]三唑并[L^a]嘧啶_7_ 15 胺。15 where R40, R41, R42, R43, R44, R45, R46 and R47 are as defined above. A preferred active compound composition S, wherein the triamed pyrimidine of the formula (XIV) is selected from the group consisting of: (22-1) 5m -2,2,2-trifluoropyrimidine Ethylethyl]-6·(2,4,6-trifluorobenzene-2-indenyl)indole, 2,4]triazolo[1,5-a]pyrimidin-7-amine, (22-2) 5- Chlorine-exhaustion [(77^1,2-dihydroxypropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triterpene [l,5-a> dense Ding-7-amine '(22-3) 5-chloro-6-(2-chlorofluorophenyl)-7-(4-mercaptohexahydrogen 唆 "4_ base" [1,2,4] Triazolo[i,5-a]-pyrimidine, (22-4) 5-chloro(2,4,6-trifluorophenyl)-7-(4-methylhexahydropyridinyl)[ Yj]Triazolo[l,5_a]pyrimidine. -115- 200814928 A particularly preferred active compound composition S, wherein the trihalopyrimidine of the formula (22) is selected from the following compounds: (22 -1) 5•Chlorotrifluoromethylethyl]_6_(2,4,6-trifluorophenyl)[1,2,4]triazolo[15_a]pyrimidine-7-amine, (22 2) 5 Monomethylpropyl P6_(2,4,6-trifluorophenyl)[1,2,4]triazolo[l,5-a]pyrimidin-7-amine, (22-4) 5-chloro- 6-(2,4,6-trifluorophenyl)_7_(4-methylhexahydro 0-pyridyl)indole, 2,4]triazolo p,^], pyridine. The active compound composition s, comprising the guanamine of formula (1) selected from the group (1) in Table A, and (22_1) 5-chloro 〇Ψ &]^6»(2Λ6-^ ^ ^^)[1?2,4] Disporin [l,5-a], indole-7-amine. The active compound composition s, which is particularly emphasized, contains the first (1) selected from Table A. Carboxylamidines of the formula (I), and (22-2) 5-chloro-7(^^^7^_1,2-monodecylpropyl]_6-(2,4,6-trifluorophenyl ) pj, 4] triazolo[L^a]pyrimidine_7_15 amine.

_ 将別要被強調的活性化合物組合物S,包含挑選自表A :之第⑴類的式⑴之賴胺,以及(22_4) 5'氣·6_(2,4,6、三氟 苯基>7_(4-甲基六氫錢-1·基)[U,4]三峻并[1»密啶。 除了具式(I)的羧醯胺(第(1)類化合物)外,活性化合物組 2〇 合物T也包含挑選自下述(第(23)類)之式(XV)之碘代色酮_ The active compound composition S to be emphasized, including the lysine of the formula (1) selected from the class (1) of Table A, and (22_4) 5' gas·6_(2,4,6, trifluorophenyl) >7_(4-Methylhexahydro-l-yl)[U,4]Sanjun[1»-pyridine. In addition to the carboxamide (Formula (1)) of formula (I), The active compound group 2 chelate T also contains an iodochromone of the formula (XV) selected from the following (category (23))

其中,R48及R49的定義如前。 •116- 200814928 車父佳的活性化合物組合物T,其中第(23)類之式(χν) 的蛾代色酮係挑選自下面之化合物: (23-1) 2-丁氧基冬蛾冬丙基苯并^比喃冰酮,(23—2) 2-乙氧 基冬碘-3-丙基苯并吡喃-4-酮,(23-3) 6-碘-2-丙氧基_3-丙基 苯并吡喃+酮,(23_4)2_丁冬炔基氧冬碘冬丙基苯并吡喃 冰酮,(23-5) 6-碘-2-(1-甲基丁氧基丙基苯并吡喃冬酮, (23-6) 2-丁-3-烯基氧-6-破苯并°比喃_4-酮,(23-7) 3-丁基-6- 峨-2-異丙氧基苯并ϋ比喃·ζμ酮。 特別佳的活性化合物組合物Τ,其中第(23)類之式(XV) 的碘代色酮係挑選自下面之化合物: (23-1) 2-丁氧基-6-埃冬丙基苯并η比喃冰酮,(23-2) 2-乙氧 基-6-硬-3-丙基苯并吡喃-4-酮。 特別要被強調的活性化合物組合物Τ,包含挑選自表A 中之第⑴類的式⑴之羧醯胺,以及(23-1) 2-丁氧基-6-碘-3-丙基苯并u比喃-4-酮。 特別要被強調的活性化合物組合物τ,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(23_2)2_乙氧基_6-碘_3_ 丙基苯并吡喃-4-酮。 除了具式⑴的缓酿胺(第(1)類化合物)外,活性化合物組 合物U也包含挑選自下述(第(24)類)之式(XVI)之聯苯基羧 醢胺 、117、 200814928Among them, R48 and R49 are as defined above. • 116- 200814928 Che’s active compound composition T, wherein the moth ketone of the formula (23) (χν) was selected from the following compounds: (23-1) 2-butoxy moth winter Propyl benzopyrene, (23-2) 2-ethoxybutyrozin-3-propylbenzopyran-4-one, (23-3) 6-iodo-2-propoxy _3-propyl benzopyran + ketone, (23_4) 2 - butyrynyloxytoluene iodo-propyl benzopyrane, (23-5) 6-iodo-2-(1-methylbutyl Oxypropyl benzopyranone, (23-6) 2-but-3-enyloxy-6-branched benzopyrano-4-one, (23-7) 3-butyl-6 - Indole-2-isopropoxybenzopyrenepyrene, a particularly preferred active compound composition, wherein the iodochromone of the formula (23) is selected from the following compounds: (23-1) 2-butoxy-6-angyl benzopyrano-pyranone, (23-2) 2-ethoxy-6-bromo-3-propylbenzopyran-4 - ketone. The active compound composition 特别 particularly emphasized, comprising carboxyguanamine of formula (1) selected from the group (1) in Table A, and (23-1) 2-butoxy-6-iodo-3- Propyl benzo-pyran-4-one. Active compound composition to be particularly emphasized τ, which comprises the carboxamide of formula (I) selected from the class (1) in Table A, and (23_2)2-ethoxy-3-6-iodo-3-propylbenzopyran-4-one. In addition to the slow-acting amine of the formula (1) (the compound of the formula (1)), the active compound composition U also contains a biphenylcarbendazim of the formula (XVI) selected from the following (category (24)), 117 , 200814928

10 15 較佳的活性化合物組合物U,其中第(24)類之式(χνι) 的聯苯基羧臨胺係挑選自下面之化合物: (24-1) Λ4Ί·二氯-5备1,Γ-聯苯基一2-基)|(二氟甲基)小 甲基-1凡吡唑斗羧醯胺,(24_2) 4_(二氟甲基)·2_甲基 善[4 _(二氟甲基聯苯基·2_基]塞唾_5-羧驢胺, (24-4),(3’,4’-二氯-1,1、聯苯基 1基)士氣山3·二甲基_. 吡唑-4-羧醯胺,(24-5) ΛΚ4,-氯-3,·氟-U,-聯苯基-2-基)-2-甲基-4-(三氟曱基)-1,3-噻吐-5-叛醯胺,(24-6)1(4,-氯-1,Γ-聯苯基-2-基)-4-(二氟甲基)-2-曱基-1,3-噻唑-5-羧醯胺, (24-7) ΛΚ4’-漠-1,Γ-聯苯基-2-基)-4-(二氟甲基)-2-甲基-1,3- 噻唑-5-羧醯胺。 特別佳的活性化合物組合物U,其中第(24)類之式(XVI) 的聯苯基羧醯胺係挑選自下面之化合物: (24-1) ΛΚ3’,4’-二氯-5-氟-1,Γ-聯苯基-2-基)各(二氟甲基)小 甲基-1//-吡唑-4-羧醯胺,(24-3) 3-(三氟曱基:氟 44(五)_(甲氧基亞胺基)甲基]-U’-聯苯基_2-基}-1-甲基 • l/fj比嗤-4-叛酿胺,(24-7)豕(4’->臭-1,1/-聯苯基-2-基)-4-(二 氟曱基)-2-甲基-1,3-噻唑-5-羧醯胺。 -118- 20 200814928 t別要被強調的活性化合物組合物U,包含挑選自表A 发第(1)類的式(I)之叛酸胺,以及(24-1) AK3’,4’-二氣-5- 氟I1 ·聯笨基基)、3_(二氟甲基)-1_甲基-l/fj比唑-4-羧醯 胺。10 15 Preferred active compound composition U, wherein the biphenylcarboxylamine of the formula (24) is selected from the following compounds: (24-1) Λ4Ί·dichloro-5. Γ-biphenyl-2-yl)|(difluoromethyl)small methyl-1-propionazole carboxamide, (24_2) 4_(difluoromethyl)·2_methyl good [4 _( Difluoromethylbiphenyl·2_yl]pyrene-5-carboxyguanamine, (24-4), (3',4'-dichloro-1,1,biphenyl-1-yl) Shiqishan 3 · dimethyl _. pyrazole-4-carboxamide, (24-5) ΛΚ4,-chloro-3, fluoro-U,-biphenyl-2-yl)-2-methyl-4-( Trifluoromethyl)-1,3-thiox-5-treazone, (24-6)1(4,-chloro-1, fluorene-biphenyl-2-yl)-4-(difluoromethyl) ))-2-mercapto-1,3-thiazole-5-carboxyguanamine, (24-7) ΛΚ4'-di-1, Γ-biphenyl-2-yl)-4-(difluoromethyl )-2-methyl-1,3-thiazole-5-carboxamide. A particularly preferred active compound composition U wherein the biphenylcarbendazim of the formula (24) is selected from the group consisting of: (24-1) ΛΚ3',4'-dichloro-5- Fluorin-1, fluorene-biphenyl-2-yl) each (difluoromethyl) small methyl-1//-pyrazole-4-carboxamide, (24-3) 3-(trifluoromethyl) :Fluorum 44 (5)-(methoxyimino)methyl]-U'-biphenyl-2-yl}-1-methyl•l/fj than 嗤-4-Rebel, (24 -7) 豕(4'->Smelly-1,1/-biphenyl-2-yl)-4-(difluoroindolyl)-2-methyl-1,3-thiazole-5-carboxyindole -118- 20 200814928 t The active compound composition U to be emphasized, including the tickamines of formula (I) selected from Table A (1), and (24-1) AK3', 4 '-Digas-5-fluoro I1 · phenyl group), 3_(difluoromethyl)-1_methyl-l/fj-pyrazole-4-carboxamide.

5 特別要被強調的活性化合物組合物U,包含挑選自表A 中之第⑴類的式(I)之羧醯胺,以及(24-7)7\K4U,r-聯苯 基1基)冰(二氟甲基>2-曱基-1,3-噻唑-5-羧醯胺。 | 除了具式(I)的緩醯胺(第⑴類化合物)外,活性化合物組 合物V也包含挑選自下述(第(25)類)之式(XVII)之烧基叛醯 ίο 胺5 The active compound composition U to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (24-7)7\K4U,r-biphenylyl group) Ice (difluoromethyl)> 2-mercapto-1,3-thiazole-5-carboxamide. | In addition to the slow-acting amine of the formula (I) (the compound of the formula (1)), the active compound composition V is also Contains a burnt-rebel ο ο ο amine selected from the following (Class (25))

15 其中,Het,R50及R58的定義如前。 | 較佳的活性化合物組合物V,其中第(25)類之式(XVII) 的烷基羧醯胺係挑選自下面之化合物: (25-1) ,3·一 曱基 丁基)笨基]_ 1,3-二曱基-1 片 j比哇-4- 羧醯胺,(25-2) ΛΜ2-(1,3-二甲基丁基)苯基}-5-氟-1,3-二甲 2〇 基-1丑-咐唑-4-羧醯胺,(25-3) Aq2-(1,3-二甲基丁基)苯 基]-5-氯—^甲基-1//-0比17坐-4-竣酿胺,(25-4) 3-(二氣甲 基)-尽[2-(1,3-二曱基丁基)苯基H·甲基-1//^比唑-4-羧醯 胺,(25-5) 3-(三氟甲基)-Λ42-(1,3-二曱基丁基)苯基]-5_氟 -1-甲基-1//-0比°坐-4-竣酿胺 ’(25-6) 3·(三氣甲基)"Ί·[2-(1,3- -119- 200814928 二甲基丁基)苯基]·5-氯-1-曱基比嗤-4-綾酿胺,(25-7) 1,3-二甲基-’[2-(1,3,3-三甲基)苯基]-177-〇比嗤冰緩gf胺, (25-8) 5-氟-1,3-二甲基善[2(1,3,3-三曱基丁基)苯基比 唑-4-羧醯胺,(25-9) 3-(二氟甲基)-1-甲基三甲 5 基丁基)苯基]-1凡吡唑-4-羧醯胺,(25-10) 3-(三氟甲基)-1_ 曱基-7Η2-(1,3,3-三曱基丁基)苯基比唑竣醯胺, (25-11) 3-(二氟甲基)-5-氣-1-曱基-|[2-(1,3,3-三曱基 丁基) _ 苯基吡唑-4·羧醯胺,(25-12) 3-(三氟曱基)_5-氯小甲基 -ΛΓ-[2·(1,3,3-二曱基丁基)苯基]比0坐4-綾酸胺,(25-13) ίο 尽[2-(1,3-(—曱基丁基)苯基)-2-破苯曱酿胺,(25·14) 2-碘 -A^[2-(l,3,3-二甲基丁基)本基]苯甲酿胺,(25]5)jV-[2-(l,3- 二曱基丁基)苯基]-2-(三氟甲基)笨曱醯胺,(25_16) 2_(三氟 曱基)善[2-(1,3,3·三甲基丁基)苯基]苯甲醯胺。 特別佳的活性化合物組合物V,其中第(25)類之式 15 (xvii)的烧基叛酿胺係挑選自下面之化合物: • (25-1) WK1,3-二甲基丁基)笨基H,3-二甲基-1//-吡唑4一 羧醯胺,(25-2) 7V-{2-(l,3-二甲基丁基)苯基卜孓氟^^一二 基-1A吡唑-4-羧醯胺,(25-8) 5-氟],3_二甲基卩(1,3,3_ 二甲基丁基)苯基]-lii-吡唑-4-羧醯胺,(25_13) (二 20 曱基丁基)苯基)-2_碘苯曱醯胺,(25-15)Λ42-(1,3-二曱基丁 基)本基]-2-(三氟甲基)苯甲醯胺。 知別要被強調的活性化合物組合物 中之第⑴類的式(1)之細,以及㈣ 丁基)苯基]-1,3-二甲基-l/ί-吡唑_4_羧醯胺。 120- 200814928 特別要被強調的活性化合物組合物V,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(25-2)Ι{2-(1,3-二甲基 丁基)笨基氟-1,3_二甲基-l/ί-吡唑-4-羧醯胺。 特別要被強調的活性化合物組合物V,包含挑選自表A 5 中之第(1)類的式(I)之羧醯胺,以及(25-8) 5-氟-1,3-二甲基15 Among them, Het, R50 and R58 are as defined above. A preferred active compound composition V, wherein the alkylcarboxyguanamine of the formula (25) is selected from the group consisting of: (25-1), 1,3-mercaptobutyl) ] _ 1,3-dimercapto-1 tablet j-wow-4-carboxamide, (25-2) ΛΜ2-(1,3-dimethylbutyl)phenyl}-5-fluoro-1, 3-dimethyl 2-mercapto-1 ugly-oxazole-4-carboxamide, (25-3) Aq2-(1,3-dimethylbutyl)phenyl]-5-chloro-^methyl- 1//-0 to 17 -4- an amine, (25-4) 3-(dimethyl)-[2-(1,3-didecylbutyl)phenyl H.methyl -1//^Bizozol-4-carboxamide, (25-5) 3-(trifluoromethyl)-indole 42-(1,3-didecylbutyl)phenyl]-5-fluoro-1 -Methyl-1//-0 ratio ° 竣-4- 竣 胺 ' '(25-6) 3 · (three gas methyl) " Ί · [2-(1,3- -119- 200814928 dimethyl Benzyl)phenyl]·5-chloro-1-indenylpyrimidine-4-indoleamine, (25-7) 1,3-dimethyl-'[2-(1,3,3-tri Methyl)phenyl]-177-indole 嗤 嗤 缓 gf amine, (25-8) 5-fluoro-1,3-dimethyl good [2 (1,3,3-tridecylbutyl)benzene Kebizozol-4-carboxyguanamine, (25-9) 3-(difluoromethyl)-1-methyltrimethylpentyl)phenyl]-1-pyrazol-4-carboxamide 25-10) 3-(Trifluoromethyl)-1_indolyl-7Η2-(1,3,3-tridecylbutyl)phenylpyrazinium, (25-11) 3-(difluoro Methyl)-5-ani-1-indolyl-|[2-(1,3,3-tridecylbutyl) _phenylpyrazole-4.carboxamide, (25-12) 3-( Trifluoroindolyl)_5-chlorosuccinyl-indenyl-[2·(1,3,3-dimercaptobutyl)phenyl] is more than 0-position of 4-decanoic acid amine, (25-13) ίο 2-(1,3-(-decylbutyl)phenyl)-2-benzophenentamine, (25·14) 2-iodo-A^[2-(l,3,3-dimethyl Butyl)benzyl]benzamide, (25]5)jV-[2-(l,3-dimercaptobutyl)phenyl]-2-(trifluoromethyl) cumamine, 25_16) 2_(Trifluoromethyl)-[2-(1,3,3·trimethylbutyl)phenyl]benzamide. Particularly preferred active compound composition V, wherein the alkylidene amine of formula (25) of formula 15 (xvii) is selected from the following compounds: • (25-1) WK1,3-dimethylbutyl) Stupid H,3-dimethyl-1//-pyrazole 4-carboguanamine, (25-2) 7V-{2-(l,3-dimethylbutyl)phenyl bromide ^^ Di-diyl-1A pyrazole-4-carboxamide, (25-8) 5-fluoro], 3-dimethylindole (1,3,3-dimethylbenzyl)phenyl]-lii-pyrazole -4-carboxamide, (25_13) (di-20 decylbutyl) phenyl)-2_iodobenzamide, (25-15) Λ42-(1,3-didecylbutyl) group ]-2-(Trifluoromethyl)benzamide. Knowing the fineness of the formula (1) of the (1) class and the (tetra)butyl)phenyl]-1,3-dimethyl-l/ί-pyrazole_4_carboxylate in the active compound composition to be emphasized Guanamine. 120- 200814928 The active compound composition V to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the class (1) in Table A, and (25-2) Ι {2-(1,3) - dimethylbutyl) phenyl fluoride-1,3-dimethyl-l/ί-pyrazole-4-carboxamide. The active compound composition V to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A5, and (25-8) 5-fluoro-1,3-dimethyl base

善[2(1,3,3-三甲基丁基)苯基]·吡唑4羧醯胺Q 特別要被強調的活性化合物組合物V,包含挑選自表A | 中之第(1)類的式(I)之羧醯胺,以及(25-13)翠[2_(1,3_(二甲 基丁基)苯基)-2-硬笨甲醯胺。Good [2(1,3,3-trimethylbutyl)phenyl]pyrazole 4 Carboxamide Q The active compound composition V, which is particularly emphasized, contains the first (1) selected from Table A | Carboxylamidines of the formula (I), and (25-13) chloro[2-(1,3-(dimethylbenzyl)phenyl)-2-bromoformamide.

10 特別要被強調的活性化合物組合物V,包含挑選自表A 中之第(1)類的式(I)之羧醯胺,以及(25·15)Λ42-(1,3-二甲基 丁基)笨基]-2-(三氟甲基)笨甲酿胺。 除了具式(I)的羧醯胺(第⑴類化合物)外,活性化合物組 合物w也包含挑選自下述(第(26)類)之式(xvm)之烷基羧 15 醯胺10 The active compound composition V to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (25·15) Λ42-(1,3-dimethyl Butyl) phenyl]-2-(trifluoromethyl) benzoate. In addition to the carboguanamine of the formula (I) (the compound of the formula (1)), the active compound composition w also contains an alkylcarboxyl decylamine of the formula (xvm) selected from the following (class (26))

其中,A,,R60及R70的定義如前。 較佳的活性化合物組合物W,其中第(26)類之式(XVIII) 的烷基羧醯胺係挑選自下面之化合物: (26-1) 5-氟-1,3-二甲基-Λ42-(3·甲基丁基)苯基吼唑-4- -121- 200814928 羧醯胺,(26-2)3-(二氟甲基)-#-[2-(3,3-二曱基丁基)-4-氟苯 基]-1-甲基-1//- π比ΰ坐-4-竣酿胺’(26-3) 3-(二氣甲 基)-Ί-[2·(3,3 -二曱基丁基)苯基]-1 -甲基-1//- ^比σ坐-4-竣酿 胺,(26-4),[2-(3,3-二曱基丁基)苯基]-2-(三氟曱基)苯甲醯 5 胺,(26-5)iV-[2-(3,3-二甲基丁基)-4-氟苯基]-2-曱基-4-(三氟 曱基)-1>噻唑-5-羧醯胺,(26-6) Λ42-(3,3-二甲基丁基)-3-甲基噻吩-2-羧醯胺。 | 特別要被強調的活性化合物組合物W,包含挑選自表 A中之第(1)類的式(I)之羧醯胺,以及(26-1) 5-氟-1,3-二甲基 ίο -iV-[2-(3-甲基丁基)苯基]-177-°比0坐-4-竣酿胺。 特別要被強調的活性化合物組合物W,包含挑選自表 A中之第(1)類的式(I)之羧醯胺,以及(26-2) 3-(二氟曱 基)-ΛΓ-[2-(3,3-二甲基丁基)-4-氟苯基]-1-曱基-1//-吼唑-4-羧 醯胺。 15 特別要被強調的活性化合物組合物W,包含挑選自表 _ A中之第(1)類的式(I)之羧醯胺,以及(26-3) 3-(二氟甲 基)-7\^[2-(3,3-二甲基丁基)苯基]-1-曱基唾-4-叛酸胺。 特別要被強調的活性化合物組合物W,包含挑選自表 A中之第(1)類的式(1)之羧醯胺,以及(26-4)7\42-(3,3-二甲 20 基丁基)苯基]-2-(三氟曱基)苯甲醯胺。 特別要被強調的活性化合物組合物W,包含挑選自表 A中之第(1)類的式(I)之羧醯胺,以及(26-5) Λ42-(3,3-二甲 基丁基)-4-氣苯基]-2-曱基-4-(三氟^曱基)-1,3-嗟σ坐-5-叛酿 胺0 -122- 200814928 特別要被強調的活性化合物組合物W,包含挑選自表 之第(1)類的式(I)之羧酸胺,以及(26_6) 二甲 土丁基V3-甲基嗟吩_2_羧醯胺。 人除了式(I)的一種活性化合物外,根據本發明的活性化 &物組合物包含至少—種挑選自第(2)至(26)類的化合物, 此外,匕們可能也包含另外的殺真菌地活性添加物。Among them, A, R60 and R70 are as defined above. A preferred active compound composition W, wherein the alkylcarboxamide of the formula (26) is selected from the group consisting of: (26-1) 5-fluoro-1,3-dimethyl- Λ42-(3·methylbutyl)phenylcarbazole-4-121-200814928 Carboxylamidine, (26-2)3-(difluoromethyl)-#-[2-(3,3-di Mercaptobutyl)-4-fluorophenyl]-1-methyl-1//- π ΰ 竣-4-竣 胺 ''(26-3) 3-(dimethyl)-Ί-[ 2·(3,3-dimercaptobutyl)phenyl]-1 -methyl-1//- ^ ratio σ sit-4-anthracene, (26-4), [2-(3,3 -dimercaptobutyl)phenyl]-2-(trifluoromethyl)benzamide 5 amine, (26-5)iV-[2-(3,3-dimethylbutyl)-4-fluoro Phenyl]-2-mercapto-4-(trifluoromethyl)-1>thiazole-5-carboxamide, (26-6) Λ42-(3,3-dimethylbutyl)-3-methyl Thiophene-2-carboxamide. The active compound composition W to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (26-1) 5-fluoro-1,3-dimethyl The base ίο -iV-[2-(3-methylbutyl)phenyl]-177-° is -4-anthracene than 0. The active compound composition W to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (26-2) 3-(difluoroindolyl)-fluorene- [2-(3,3-Dimethylbutyl)-4-fluorophenyl]-1-indolyl-1//-carbazole-4-carboxamide. 15 The active compound composition W to be particularly emphasized, comprising the carboxamide of the formula (I) selected from the group (1) in Table A, and (26-3) 3-(difluoromethyl)- 7\^[2-(3,3-Dimethylbutyl)phenyl]-1-mercaptosin-4-tetamine. The active compound composition W to be particularly emphasized, comprising the carboguanamine of the formula (1) selected from the class (1) in Table A, and (26-4)7\42-(3,3-dimethyl 20 butyl phenyl)-2-(trifluoromethyl)benzamide. The active compound composition W to be particularly emphasized, comprising the carboguanamine of the formula (I) selected from the group (1) in Table A, and (26-5) Λ42-(3,3-dimethylbutyl) 4-)Phenyl]-2-mercapto-4-(trifluoromethyl)-1,3-indole sitting--5-rebel amine 0-122- 200814928 Active compound to be emphasized Composition W, comprising a carboxylic acid amine of formula (I) selected from the group (1), and (26_6) dimethyl butyl V3-methyl porphin-2-carboguanamine. In addition to an active compound of formula (I), the activating & composition according to the invention comprises at least one compound selected from classes (2) to (26), and furthermore, we may also comprise additional A fungicidal active additive.

10 1510 15

以某種重I比例存在下,協乘的效果特別地明顯,然而, 在/舌性化合物組合物中之活性化合物之重量比例可在相對 地廣的範圍間變化,通常,根據本發明的活性化合物組合 物所包含之式⑴的化合物以及來自第(2)至(26)類之混合配 對物,其混合比例被例示於下面的表B中。 如果根據本發明的活性化合物組合物中之活性化合物 混合比例係以重量比為依據,即,式⑴的活性化合物: 外匕合的配對物之重量比例。 :混合的比例 混合配對物 較佳的混合比例 特別佳的混合比例 第(2)类員:史托比系(Strobilurins) 50 : 1 至 1 ·· 50 10 : 1 至 1 : 20 : (3-15)以外的三唑類 50 : 1 至 1 : 50 20 : 1 至 1 : 20 普硫康ϋ坐(prothioconazole) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(4)類:次磺醯胺類(sulphenamides) 1 : 1 至 1 : 150 1 : 1 至 1 : 100 -123- 200814928 混合配對物 較佳的混合比例 特別佳的混合比例 第(5)類:纈胺醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 ·· 20 第⑹類:羧醯胺類 50 : 1 至 1 : 50 20 : 1 至 1 : 20 第(7)類:二硫胺基甲酸酯類 1 : 1 至 1 : 150 1 : 1 至 1 : 100 第⑻類:醯基丙胺酸類 10 : 1 至 1 : 150 5 : 1 至 1 : 100 第(9)類:苯胺基嘧啶類 5 : 1 至 1 : 50 1 : 1 至 1 : 20 第(10)類:苯并咪唑類 10 : 1 至 1 : 50 5 : 1 至 1 : 20 第(11)類:(1H)以外的胺基甲酸醋類 1 : 1 至 1 : 150 1 : 1 至 1 : 100 (11-1):二硫芬克(diethofencarb) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(12)類:(12-1)/(12-2)/(12-3) 1 : 1 至 1 : 150 1 : 5 至 1 : 100 第(12)類:(12-4)/(12-5)/(12-6) 5 : 1 至 1 : 50 1 : 1 至 1 : 20 第(13)類:胍 100 : 1 至 1 : 150 20 : 1 至 1 : 100 第(14)類··咪唑 50 ·· 1 至 1 ·· 50 10 : 1 至 1 : 20 第(15)類:嗎啉 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(16)類··吡咯 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(17)類:(17-3)以外的(硫)膦酸酯類 10 : 1 至 1 ·· 150 1 : 1 至 1 : 100 (17-3)甲基立枯麟(tolclophos-methyl) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(18)類:苯基乙醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 -124- 200814928The effect of synergy is particularly pronounced in the presence of a certain weight I ratio, however, the weight ratio of active compound in the/tongue compound composition can vary over a relatively wide range, typically, the activity according to the invention The compound of the formula (1) and the mixed partner from the group (2) to (26) contained in the compound composition are mixed in the following Table B. If the active compound mixing ratio in the active compound composition according to the invention is based on the weight ratio, i.e. the active compound of the formula (1): the weight ratio of the externally conjugated counterpart. : Mixed proportions of mixed counterparts. Preferred mixing ratios are particularly good. Mixing ratios (2): Strobilurins 50 : 1 to 1 · · 50 10 : 1 to 1: 20 : (3- 15) Other triazoles 50 : 1 to 1: 50 20 : 1 to 1: 20 Prothioconazole 50 : 1 to 1: 50 10 : 1 to 1: 20 Category (4): Sulfenamides 1 : 1 to 1: 150 1 : 1 to 1: 100 -123- 200814928 Mixing ratios preferred mixing ratios particularly preferred mixing ratios Category (5): amidoxime 50 : 1 to 1: 50 10 : 1 to 1 ·· 20 Category (6): Carboxylamamines 50 : 1 to 1: 50 20 : 1 to 1: 20 Category (7): Dithiocarbamate 1 : 1 to 1: 150 1 : 1 to 1: 100 Class (8): Mercapto Alanine 10 : 1 to 1: 150 5 : 1 to 1: 100 Category (9): Anilinopyrimidines 5 : 1 to 1 : 50 1 : 1 to 1: 20 Category (10): Benzimidazoles 10 : 1 to 1: 50 5 : 1 to 1: 20 Category (11): Amino formates other than (1H) 1 : 1 to 1: 150 1 : 1 to 1: 100 (11-1): diethofencarb 50 : 1 to 1: 50 10 : 1 to 1: 20 Class (12): (12-1) / (12-2) / (12-3) 1 : 1 to 1: 150 1 : 5 to 1: 100 Class (12): (12 -4)/(12-5)/(12-6) 5 : 1 to 1: 50 1 : 1 to 1: 20 Class (13): 胍100 : 1 to 1: 150 20 : 1 to 1: 100 Class (14) · · Imidazole 50 ·· 1 to 1 ·· 50 10 : 1 to 1: 20 Class (15): Morpholine 50 : 1 to 1: 50 10 : 1 to 1: 20 (16) Class··pyrrole 50 : 1 to 1: 50 10 : 1 to 1: 20 Class (17): (Sulfur) phosphonates other than (17-3) 10 : 1 to 1 ·· 150 1 : 1 to 1 : 100 (17-3) tolclophos-methyl 50 : 1 to 1: 50 10 : 1 to 1: 20 Category (18): phenylacetamide 50 : 1 to 1: 50 10 : 1 to 1: 20 -124- 200814928

混合配對物 較佳的混合比例 特別佳的混合比例 (19-1):苯并噻二唑酯 (acibenzolar-S-methyl) 50 : 1 至 1 : 50 20 : 1 至 1 : 20 (19-2):氣塞尼(chlorothalonil) 1 : 1 至 1 : 150 1 : 1 至 1 : 100 (19-3) ··克絕(cymoxanil) 10 : 1 至 1 : 50 5 : 1 至 1 : 20 (19-4):護粒松(edifenphos) 10 : 1 至 1 : 50 5 : 1 至 1 : 20 (19-5):凡殺同(famoxadone) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-6):伏寄南(fluazinam) 50 ·· 1 至 1 : 50 10 : 1 至 1 : 20 (19-7):氧氯化銅(copper oxychloride) 1 : 1 至 1 : 150 1 : 5 至 1 : 100 (19-8):氫氧化銅(copper hydroxide) 1 : 1 至 1 : 150 1 : 5 至 1 : 100 (19-9) ··歐殺斯(oxadixyl) 10 : 1 至 1 ·· 150 5 ·· 1 至 1 : 100 (19-10):螺環菌胺(spiroxamine) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-11) ··二石荒酉昆(dithianon) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-12):表苯菌酮(metrafenone) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-13):味 σ坐菌酮(fenamidone) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-14) ·· 2,3-丁基-6-氯噻吩并[2,3-d]嘧 啶-4(3H)酮 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-15) ··撲殺熱(probenazole) 10 : 1 至 1 : 150 5 ·· 1 至 1 ·· 100 (19-16):稻瘦靈(isoprotiliolane) 10 : 1 至 1 : 150 5 : 1 至 1 : 100 -125- 200814928 混合配對物 較佳的混合比例 特別佳的混合比例 (19-17) ··嘉賜黴素(kasugamycin) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-18) ··熱必斯(phthalide) 10 : 1 至 1 : 150 5 ·· 1 至 1 ·· 100 (19-19):富米熱斯(ferimzone) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-20):三賽^(tricyclazole) 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-21) : N-({4-[(環丙基胺基)-羰基]苯 基}磺醯基)-2-甲氧基苯甲醯 胺 10 : 1 至 1 : 150 5 : 1 至 1 : 100 (19-22) : 2-(4-氯苯基甲氧基 斗(丙-2-炔4-基氧)苯基]乙 基}-2-(丙-2-快-1-基氧)乙酿胺 50 : 1 至 1 : 50 10 : 1 至 1 : 20 (19-23):快諾芬(quinoxyfen) 10 : 1 至 1 : 150 5 : 1 至 1 : 100 第(20)類:(硫)脲衍生物 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(21)類:醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(22)類:三唑并嘧啶類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(23)類:碘代色酮類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(24)類:聯苯基羧醯胺 50 : 1 至 1 : 50 10 ·· 1 至 1 : 20 第(25)類:烷基羧醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 : 20 第(26)類:烷基羧醯胺類 50 : 1 至 1 : 50 10 : 1 至 1 : 20A preferred mixing ratio of the mixed counterpart is particularly good (19-1): acibenzolar-S-methyl 50 : 1 to 1: 50 20 : 1 to 1: 20 (19-2 ): chlorothalonil 1 : 1 to 1: 150 1 : 1 to 1: 100 (19-3) · · cymoxanil 10 : 1 to 1: 50 5 : 1 to 1: 20 (19 -4): edifenphos 10 : 1 to 1: 50 5 : 1 to 1: 20 (19-5): famoxadone 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-6): fluazinam 50 ·· 1 to 1: 50 10 : 1 to 1: 20 (19-7): copper oxychloride 1 : 1 to 1: 150 1 : 5 to 1: 100 (19-8): Copper hydroxide 1 : 1 to 1: 150 1 : 5 to 1: 100 (19-9) · Oxdixyl 10 : 1 to 1 ·· 150 5 ·· 1 to 1: 100 (19-10): spiroxamine 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-11) ··二石荒酉昆 (dithianon 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-12): metrafenone 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-13): taste σ Fenamidone 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-14) ·· 2,3-Butyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)one 50 : 1 to 1: 50 10 : 1 to 1: 20 (19- 15) ················································ 100 -125- 200814928 Mixing ratios are preferred. Mixing ratios are particularly good (19-17) ··Kasugamycin 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-18 ························· : 20 (19-20): Tricyclazole 50 : 1 to 1: 50 10 : 1 to 1: 20 (19-21) : N-({4-[(cyclopropylamino)-carbonyl) Phenyl}sulfonyl)-2-methoxybenzamide 10 : 1 to 1: 150 5 : 1 to 1: 100 (19-22) : 2-(4-chlorophenylmethoxy bucket (prop-2-ynyl-4-yloxy)phenyl]ethyl}-2-(propan-2-free-1-yloxy)ethinamide 50 : 1 to 1: 50 10 : 1 to 1: 20 ( 19-23): quinoxyfen 10 : 1 to 1: 150 5 : 1 to 1: 100 Category (20): (thio)urea derivative 50 : 1 to 1 : 50 10 : 1 to 1: 20 Category (21): decylamines 50 : 1 to 1: 50 10 : 1 to 1: 20 Category (22): Triazolopyrimidines 50 : 1 to 1: 50 10 : 1 to 1: 20 Class (23): Iodochromones 50 : 1 to 1: 50 10 : 1 to 1: 20 Category (24): Biphenylcarboxylamine 50 : 1 to 1 : 50 10 ·· 1 to 1: 20 Class (25): Alkylcarboxamides 50 : 1 to 1: 50 10 : 1 to 1: 20 Class (26): Alkylcarboxamides 50 : 1 to 1: 50 10 : 1 to 1: 20

各情形下,混合的比例係選用可達到協乘的混合者, -126 - 200814928 式(I)化合物與式(2)至(26)之一的化合物間之比例可視個別 的化合物而變動。 根據本發明的活性化合物組成物具有強力的殺微生物 的作用且可被使用於作物保護及材料保護方面,供控制不 5 想要的微生物,例如,真菌及細菌。 於作物保護方面,作為殺真菌劑類時,可被使用於供 控制根腫菌(Plasmodiophoromycetes)、卵菌(Oomycetes)、壺 | 菌(Chytridiomycetes)、接合菌(Zygomycetes)、子囊菌 (Ascomycetes)、擔子菌(Basidiomycetes)及不完全菌類 ίο (Deuteromycetes)之真菌。 於作物保護方面,作為殺細菌劑類時,可被使用於供 控制假單胞菌科(Pseudomonadaceae)、根瘤菌科 (Rhizobiaceae)、腸道桿菌科(Enterobacteriaceae)、棒狀桿菌 科(Corynebacteriaceae)及鏈球菌科(Streptomycetaceae)之細 15 菌0 p 列於上面的屬名下之造成真菌與細菌性疾病之一些病 原菌,可予舉例說明者如下,但不僅限於這些: 造成白粉病(powdery mildew)之病原菌,例如, 布氏白粉菌屬(Blumeria species),例如,大麥粉狀黴菌病原 2〇 後[Blumeria graminis) ·, 單囊殼屬(Podosphaera species),例如蘋果白粉病菌 {Podosphaera leucotricha) \ 單絲殼屬(Sphaerotheca species),例如,紅豆白粉病菌 (Sphaerotheca fuliginea); -127- 200814928 鉤絲殼屬(Uncinula species),例如,葡萄鉤絲殼 necator) \ 造成銹病(rust)之病原菌,例如, 鐵銹菌屬(Gymnosporangium species),例如,杜松梨鐵銹菌 5 (Gymnosporangium sabinae) ·, 咖啡銹病屬(Hemileia species),例如,駝孢銹病菌(开 vastatrix) \ , 銹菌屬(Phakopsora species),例如,大豆銹病菌(外以吵似⑺ pachyrhizi A Phakopsora meibomiae) \ i〇 銹菌屬(Puccinia secies),例如,小麥赤銹病菌 recondita) \ 單抱錄菌屬(Uromyces species),例如,疲頂單胞錄菌 {Uromyces appendiculatus); 造成疾病之卵菌綱(Oomycetes)病原菌,例如, 15 盤梗霉屬(Bremia species),例如,萵苣盤梗霉⑺ ^ lactucae) \ 霜霉屬(Peronospora species),例如,豌豆霜霉 />加)或蕓薹霜霉(戶; 疫病屬(Phytophthora species),例如,致病疫 _ (ρ知 2〇 infestans) \ 露菌屬(Plasmopara species),例如,葡萄露菌 viticola); 假霜霉菌屬(Pseudoperonospora species),例如,葎草假霜霉 (Pseudopewnospora humUliHMtMPseud〇per_sp〇ra -128- 200814928 cubensis); 腐霉菌屬(Pythium species),例如,終極腐霉菌(,如麵 ultimum); 造成葉斑點病與葉枯萎之病原菌,例如, 鏈格孢菌屬(Alternaria species),例如,早疫病鏈格抱菌 {Alternaria solani);In each case, the mixing ratio is selected from a mixture which can achieve synergy, and the ratio between the compound of the formula (I) and the compound of one of the formulas (2) to (26) may vary depending on the individual compound. The active compound compositions according to the invention have a strong microbicidal action and can be used for crop protection and material protection for controlling undesirable microorganisms such as fungi and bacteria. For crop protection, when used as a fungicide, it can be used for controlling Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and incomplete fungi ίο (Deuteromycetes) fungi. In the case of crop protection, when used as a bactericide, it can be used for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae, and Streptomycetaceae, 15 genus 0 p Listed under the generic name above, some of the pathogens causing fungal and bacterial diseases can be exemplified as follows, but not limited to these: causing powdery mildew (powdery mildew) Pathogens, for example, Blumeria species, for example, Blumeria graminis of the barley powdery fungus pathogen, Podosphaera species, such as powdery mildew (Podosphaera leucotricha) \ monofilament Sphaerotheca species, for example, Sphaerotheca fuliginea; -127- 200814928 Uncinula species, for example, necator, causing rust pathogens, for example, rust Gymnosporangium species, for example, Gymnosporangium sabinae, coffee Hemileia species, for example, Phyllostachys pubescens (Kvastatrix) \ , Phakopsora species, for example, soybean rust (external (7) pachyrhizi A Phakopsora meibomiae) \ i rust fungus ( Puccinia secies), for example, wheat rust pathreta), Uromyces species, for example, Uromyces appendiculatus; Oomycetes pathogen causing disease, for example, 15 Bremia species, for example, Phytophrenia (7) ^ lactucae), Peronospora species, for example, pea downy mildew/> plus or downy mildew (household; Phytophthora) Species), for example, Phytophthora infestation, Plasmopara species, for example, Grape bacterium viticola; Pseudoperonospora species, for example, Pseudomonas sinensis ( Pseudopewnospora humUliHMtMPseud〇per_sp〇ra -128- 200814928 cubensis); Pythium species, for example, Pythium ultimum (such as ultimum); causing leaf spot disease and leaf blight a pathogen of wilting, for example, an Alternaria species, for example, Alternaria solani;

10 1510 15

褐斑病菌屬(Cercospora species),例如,甜菜褐斑病菌 {Cercospora beticola); 星病菌屬(Cladiosporum species),例如,黃瓜黑星病菌 {Cladiosporium cucumerinum) ·, 抱腔菌屬(Cochliobolus species),例如禾旋孢腔菌 (分生孢子型:Drechslera,syn :長蠕 孢); 炭疽菌屬(Colletotrichum species),例如,炭疽菌 {Colletotrichum lindemuthaniuni) \Cercospora species, for example, Cercospora beticola; Cladiosporum species, for example, Cladiosporium cucumerinum, Cochliobolus species, for example Helminthosporium (conidial type: Drechslera, syn: Helminthosporium); Colletotrichum species, for example, Anthrax (Colletotrichum lindemuthaniuni)

Cycloconium species,例如,孔雀斑菌(Cje/oco/iiwm oleaginum) \ 蒂腐病菌屬(Diaporthe species),例如,柑桔黑點病菌 (Diaporthe citri) l 柑桔瘡痕病菌屬(Elsinoe species),例如,树桔瘡痴病菌 (Elsinoe fawcettii) \ 炭疽菌屬(Gloeosporium species),例如,桃炭疽菌 (Gloeosporium laeticolor) \ 炭疽菌屬(Glomerella species),例如,葡萄晚腐菌(G/omere//a -129- 20 200814928 cingulata); 黑腐菌屬(Guignardia sPecies),例如,葡萄專腐菌 (Guignardia bidwelli) ·, 5Cycloconium species, for example, Cje/oco/iiwm oleaginum \Diaporthe species, for example, Diaporthe citri l Elsinoe species, for example , Elsinoe fawcettii \ Gloeosporium species, for example, Gloeosporium laeticolor \ Glomerella species, for example, grape late rot fungi (G/omere//a -129- 20 200814928 cingulata); Guignardia sPecies, for example, Guignardia bidwelli ·, 5

10 1510 15

球腔菌屬(Leptosphaeriaspecies),例如,十字花科小球腔菌 {Leptosphaeria maculans) \ 稻瘟病菌屬(Magnaporthe species),例如,稻瘦黴菌 (Magnaporthe grisea) \ 蔓枯病菌屬(Mycosphaerella species),例如, graminicola ·, 葉枯病菌屬(Phaeosphaeria species),例如,小麥颖枯菌 {Phaeosphaeria nodorum) \ 核腔菌屬(Pyrenophora species),例如,圓核腔菌病菌 (Pyrenophora teres) \ 葉斑病菌屬(Ranmlaria species) ’例如,如麵仏命 collo-cygni ·, 喙孢屬(Rhyndiosporium species),例如,小麥雲紋病菌 {Rhynchosporium secalis) \ 殼針抱屬(Septoriaspecies),例如’斑栝菌叩ζ·〇 ; 淡紅核瑚菌屬(Typhula species),例如,小麥雪腐菌(办户“以 incarnata) ·, 黑星菌屬(Venturia species),例如,蘋果黑星病菌作价 inaequalis) \ 造成根與莖的疾病之病原菌,例如, 伏革菌屬(Corticium species),例如,c〇rtidum客圆纟臟围; -130- 20 200814928 鐮刀菌屬(Fusarium species),例如,蘿S黃葉病菌(FMsar/wm oxysporum) \ 禾頂囊殼菌屬(Gaeumannomyces species),例如,小麥全钱 病菌; 5Leptosphaeria species, for example, Leptosphaeria maculans \ Magnaporthe species, for example, Magnaporthe grisea \ Mycosphaerella species, For example, graminicola ·, Phaeosphaeria species, for example, Phaeosphaeria nodorum, Pyrenophora species, for example, Pyrenophora teres \ Leaf spot genus (Ranmlaria species) 'For example, collo-cygni, Rhyndosporium species, for example, Rhynchosporium secalis, Septoriaspecies, such as 'Saccharomyces cerevisiae · 〇; Typhula species, for example, wheat rot fungus (housekeeper "in incarnata"), genus Ventura species (for example, apple black spot disease as inaequalis) \ causing roots a pathogen of a disease of the stem, for example, a Corticium species, for example, c〇rtidum, a round body; -130- 20 200814928 Fusarium species, for example, FMsar/wm oxysporum \ Gaeumannomyces species, for example, wheat whole pathogen; 5

10 1510 15

根腐病菌屬(Rhizoctonia species),例如,立枯絲核菌 (Rhizoctonia solani) ·,Rhizoctonia species, for example, Rhizoctonia solani,

Tapesia species,例如,Tapesia acuformis ; 黑腐菌屬(Thielaviopsis species),例如,煙草根黑腐菌 {Thielaviopsis basicola); 造成穗與花序(包括玉米穗軸)的疾病(ear and panicle diseases)之病原菌,例如, 鏈格抱菌屬(Alternaria species),例如,鏈格抱菌(Alternaria spp.); 麴黴屬(Aspergillus species),例如,黃麴菌 flavus); 星病菌屬(Cladiosporium species),例如,星病菌屬 (Cladiosporium spp·) ·, 麥角菌屬(Claviceps species),例如,麥角病菌 purpurea); 錄孢菌屬(Fusarium species),例如大刀鐮抱 culmorum); 赤徽菌屬(Gibberella species),例如,玉蜀黍赤黴 zeae) \ 雪黴菌屬(Monographella species),例如,小麥雪腐病菌 -131 - 20 200814928 (Monographella nivalis) \ 造成黑穗病(smuts)之真菌,例如, 軸黑粉菌屬(Sphacelotheca species),例如,絲轴專粉菌 (Sphacelotheca reiliana) \ 腥黑粉菌屬(Tilletia species),例如小麥網腥黑粉菌(乃心如 caries) \ 黑麥桿黑穗病菌 條黑粉菌屬(Urocystis species),例如Tapesia species, for example, Tapesia acuformis; Thielaviopsis species, for example, Thielaviopsis basicola; pathogens causing ear and panicle diseases, including corn and cob, For example, Alternaria species, for example, Alternaria spp.; Aspergillus species, for example, Flavobacterium flavus; Cladiosporium species, for example, Cladicporium spp. ·, Claviceps species, for example, ergot fungus purpurea; Fusarium species, such as culmorum; Gibberella species ), for example, Zeaeus zeae) \Monographella species, for example, wheat snow rot - 131 - 20 200814928 (Monographella nivalis) \ A fungus that causes smuts, for example, A. sphaeroides Sphacelotheca species, for example, Sphacelotheca reiliana \ Tilletia species, such as wheat net Black powder fungus (heart is like caries) \ rye stem smut (Urocystis species), for example

10 1510 15

{Urocystis occulta); 黑穗菌屬(Ustilago species) ’例如’散黑穗病菌(仍价叹〇 nuda) \ 造成水果腐壞(fruit rot)之病原菌,例如, 麴徽屬(Aspergillus species) ’例如,黃麴 flavus); 灰黴菌屬(Botiytis species),例如,灰葡萄孢⑺输少怡 cinerea); ’擴展青黴菌 油采囷核病菌 ’黃萎輪枝徽 青黴菌屬(Penicillium species),例如 {Penicillium expansum) \ 菌核菌屬(Sclerotinia species),例如, (Sclerotinia sclerotiorum); 黃萎菌屬(Verticilium species),例如 {Verticilium alboatrum) \ 種子-與土壤-攜帶的造成腐爛與枯萎病,以及造成幼苗 疾病之病原菌,例如, 鐮孢菌屬(Fusarium species),例如,大刀鐮孢 20 200814928 culmorum) \ 疫病屬(Phytophthora species),例如,疫黴菌(Ρ/叫叩; cactorum); 腐霉菌屬(Pythium species),例如,終極腐霉菌(巧如画 ultimum); 根腐病菌屬(Rhizoctonia species),例如,立枯絲核菌 (Rhizoctonia solani);{Urocystis occulta); Ustilago species 'eg 'S. serrata nuda' \ A pathogen causing fruit rot, for example, Aspergillus species 'eg , Astragalus flavous; Botititis species, for example, Botrytis cinerea (7) to lose cinerea); 'Expanding Penicillium oil 囷 病 ' 'Penicilium species, for example, Penicillium species, for example {Penicillium expansum) \Sclerotinia species, for example, (Sclerotinia sclerotiorum); Verticilium species, such as {Verticilium alboatrum) \ Seed-and soil-borne causing decay and blight, and Pathogens causing seedling diseases, for example, Fusarium species, for example, Fusarium oxysporum 20 200814928 culmorum) Phytophthora species, for example, Phytophthora (Ρ/Ρ 叩; cactorum); Pythium (Pythium species), for example, Pythium ultimum (ultimate); Rhizoctonia species, for example, Rhizoctonia solani (Rhi) Zoctonia solani);

10 15 白絹病菌屬(Sclerotium species),例如,白絹病菌(&/"〇(〜所 rolfsii); 造成癌種,蟲癌(galls)及簇葉(witches’broom)的疾病之 病原囷,例如, 腐爛菌屬(Nectria species),例如,梨樹潰瘍菌(TVecir/a galligena); 造成枯萎病之病原菌,例如, 褐腐菌屬(Monilinia species),例如,鏈核盤菌 laxa) \ 造成葉、花與果實的變形之病原菌,例如, 外囊囷屬(Taphrina species),例如,崎形外囊菌(rop/zWwfl deformans); 造成木質植物的退化性疾病之病原菌,例如,10 15 Sclerotium species, for example, chalk pathogens (&/"〇(~所rolfsii); pathogens causing cancer, galls and witches'broom For example, Nectria species, for example, TVecir/a galligena; a pathogen causing blight, for example, Monilinia species, for example, Trichophyton laxa) Pathogenic bacteria causing deformation of leaves, flowers and fruits, for example, Taphrina species, for example, rop/zWwfl deformans; pathogens causing degenerative diseases of woody plants, for example,

Esca species,例如,Phaemoniella ; 造成花及種子的疾病之病原菌,例如, 灰黴菌屬(Botrytis species),例如,灰葡萄孢(万沿 cinerea); >133- 20 200814928 造成植物球莖的疾病之病原菌,例如, 根腐病菌屬(Rhizoctonia species),例如,&上 ^ 立枯絲核菌 (Rhizoctonia solani); 造成疾病之細菌病原菌,例如, 野菜黃單胞桿 黃單胞桿菌屬(Xanthomonas species),例如, ϋ (Xanthomonas campestris pv. oryzae); 瓜類細菌性褐斑 假單胞菌屬(Pseudomonas species),例如,Esca species, for example, Phaemoniella; pathogens causing diseases of flowers and seeds, for example, Botrytis species, for example, Botrytis cinerea; >133-20 200814928 Pathogen causing disease of plant bulbs For example, Rhizoctonia species, for example, & Rhizoctonia solani; bacterial pathogen causing disease, for example, Xanthomonas species For example, Xanthomonas campestris pv. oryzae; Pseudomonas species, for example,

10 1510 15

8 {Pseudomonas syringae pv. Lachrymans); 軟腐病菌屬(Erwinia species),例如,蘋果熱萎调菌(^^仏 amylovora) \ 較佳者係用於供控制下述的大豆疾病類: 造成葉子、莖、豆莢及種子的真菌疾病之病原菌,例如, 鏈格菌葉斑病(alternaria leaf spot) 印此· temiissima),炭疽病(anthracnose) {Colletotrichum gloeosporoides dematium var. truncatum)^ M (brown spot) (大丑殼針抱,*’葉斑與枯萎病(cercospora leaf spot and blight)(大丑紫斑病菌,灸汝wcAzz), 濕、腐(ehomephora)葉始萎病(Choanephora infundibuiifera trispora (syn·)) ,dactuliophora 葉 iii 病(Dactuliophora gfyches) ’ 霜黴病(downy mildew)(毛豆露病菌,尸 mfl似/iwrfcfl),drechslera 枯萎病,灰斑病 (frogeye leaf spot)(大豆灰斑病菌,so力·ηα),小 光殼屬(leptosphaerulina)葉班病(胡麻斑病菌, 的/〇///),phyllostica 葉斑病(大豆葉斑病 -134- 20 200814928 58 {Pseudomonas syringae pv. Lachrymans); Erwinia species, for example, apple heat-treating bacteria (^^仏amylovora) \ Preferred for use in controlling the following soybean diseases: causing leaves, stems Pathogens of fungal diseases such as pods and seeds, for example, alternaria leaf spot, temiissima, anthracnose {Colletotrichum gloeosporoides dematium var. truncatum)^ M (brown spot) Ugly shell needle, *' cercospora leaf spot and blight (large ugly pathogen, moxibustion wcAzz), wet and rot (ehomephora) leaf wilting (Choanephora infundibuiifera trispora (syn)), Dactuliophora leaf iii disease (Dactuliophora gfyches) 'downy mildew (d. edema, corpse mfl / iwrfcfl), drechslera blight, frogeye leaf spot (soybean gray spot, soli · ηα ), Leptosphaerulina (Isolation), phyllostica leaf spot (Soybean leaf spot) -134-20 200814928 5

10 15 菌,白粉病(powdery mildew)(厚朴 白粉病菌,¢/¾^^),剛毛殼孢(pyrenochaeta) 葉斑病CPy⑼oc/m以fl g/jc/«es),絲核菌屬的結球,鎮葉, 與網狀枯萎(rhizoctonia aerial,foliage,and web blight)(立 枯絲核菌,Rhizoctonia solani),錢病{Phakopsora pachyrhizi),結蘇病(scab,Sphaceloma glycines),黑、腐病 (stemphylium leaf blight) ,高粱葉 斑病(target spot)(黃瓜斑病菌,; 造成根及莖基部的真菌疾病之病原菌,例如,黑根腐 病(black root rot)(麗赤殼菌,,炭 腐病(charcoal rot)(菜豆殼球抱,Macrophomina /?/ζαχβ〇/ζ>2β),萎〉周病或疫病(fusarium blight or wilt),根腐 病,以及豆莢與根頸腐病[大豆根腐病菌謂 oxyworwm),直琢鐮刀菌(F⑽ar/wm oribcer似),半裸鐮刀 菌(Fusarium semitectum),表賊钃:刀菌(Fusarium equiseti)], mycoleptodiscus 根腐病(鳳眼蓮孢黴, terrestris),新赤殼菌(neocosmospora) (Neocosmopspora voszTz/ecifl),豆莢與莖萎凋病(p〇d and stem blight)(大豆黑點 病菌,Diaporthe phaseolorum),i 腐病(stem canker)(大 l 良、廣瘍病嵐 ’ Diaporthe phaseolorum var· caulivora),疫霉r 瘸病立疫霉菌,Phytophthora megasperma),褐 1 腐病 (brown stem rot)(大豆莖褐腐病菌,gregfl/iz), 藤% 截屬病(Pythium aphanidermatum,Pythium irregulare, Pythium debaryanum ,Pythium myriotylum ,Pythium -135- 20 200814928 w/Umi/m),rhizoctonia根腐病,莖腐朽病,以及猝倒病 (damping-off)(立枯絲核菌,穴Zn’zoc⑹z/fl仰/⑽/),莖菌核病 (sclerotinia stem decay)(油菜菌核病菌,Sc/eroOWa sc/eroi/orwm),白絹病(sclerotinia southern blight)(白絹病 菌,Sc/er加/ma ro//hz·),thielaviopsis 根腐病(根串珠黴, Thielaviopsis basicola)。 根據本發明的活性化合物組合物在需用於供控制植物 疾病的濃度下,可被植物忍受得很好的事實下,允許以其 處理整株的植物(植物在地表上部分及根系),繁殖用的材料 以及種子,及用於處理土壤,根據本發明的活性化合物組 合物可被使用於葉面之施用或是作為種子敷料。 ★根據本發明的活性化合物在需用於供控制植物疾病的 /辰度下,可被植物忍受得很好的事實下,允許以其處理種 =因此,根據本發明的活性化合物可被使用作為種子敫 棣旦十病原A真菌造成對作物植物之大部分的傷害,可能 3 =子儲存期間及種子被引人土壤中、植物萌發時及 20 内即受到攻擊,此期間特別地為關鍵點, ==的植物的根及幼苗為特職敏感,且甚至是 成物以_^= Λ 亡,藉由㈣適當的組 趣。υ子及明發中的植物因此特別地令人感到興 處理土壤及地表上的植物部位,由於考慮到作 ~ 136 - 200814928 劑對環境以及對人類及動物健康之 有待,力叫少活性化合物被施用的量。的鱗’仍 藉由處理植物的種子以防治病原直 好長-段時間4不斷的被改進之目標_ 已被知道 理常遭遇到一遠志|、、木址人 …、而’種子的處 有必要發展供保護種子及萌發中的植於疋 在播,植物萌發後立即再施用作物保護以= ^外的此外也有必要最適化所應用二二2 =’ Μ提供對種子及萌芽中的植物之最適#的保== ^到病原真ϋ之攻擊,但又不會讓所 ==;特別的,供處理種子的方法也應= 才物的内殺真菌的性質列人考慮,使種子與萌芽中 植物可以使用最低量的作物保護劑以達到最適當的保護作 用。 又 15 20 本發明因此特別也關於一種用於保護種子與萌芽中的 植物’使其免於受到病原錢攻擊的方法,係藉由以根據 本發明的組合物處理種子。. 本^明同樣也關於使用根據本發明的組合物用於處理 種子以保護種子及萌芽中的植物,使其免於受到病原真菌 侵害的用途。 ’ 此外,本發明也關於已經過根據本發明的組合物處 理,受到保護可提供免於病原真菌傷害之種子。 本發明的優點之一為,根據本發明的組成物之特別的 全身性性質,以這些組成物處理種子,不僅能保護種子本 -137- 200814928 身,也使得萌芽後的植物得 以此種方式,y 即進行的處理。 〜伹初得到保護,免於病原真菌之攻擊, 可省去在作物播種時以及之後短時間内需立 此外要被視為優點者係根據本發明的混合物也可被 應用於,特別是轉殖基因植物的種子。 室林業或園藝中之任何所述的植物 使用在祓物的種子(例如,小麥、大麥 根據本發明的組合物適於供保護被應用在農業、溫10 15 bacteria, powdery mildew (powdery mildew) (Anopheles sinensis, ¢/3⁄4^^), Pyrreochaeta leaf spot disease CPy (9) oc / m to fl g / jc / « es), Rhizoctonia Ball, leaf, and rhizoctonia aerial (foliage, and web blight) (Rhizoctonia solani), money disease {Phakopsora pachyrhizi), saab (Sabceloma glycines), black, rot Disease (stemphylium leaf blight), sorghum leaf spot (P. oleracea); a pathogen causing fungal diseases at the base of roots and stems, for example, black root rot (L. erythraea, Charcoal rot (Macrophomina /?/ζαχβ〇/ζ> 2β), Fusarium blight or wilt, root rot, and pod and root rot [ Soybean root rot is called oxyworwm), Fusarium oxysporum (F(10)ar/wm oribcer-like), Fusarium semitectum, Fusarium equiseti, mycoleptodiscus root rot , terrestris), Neocapmospora (Neocosmopspora) voszTz/ecifl), pod and stem blight (Diaporthe phaseolorum), i stem disease (stem canker) (Dalporthe phaseolorum var· caulivora) ), Phytophthora megasperma, brown stem rot (gum stem rot, gregfl/iz), Pythium aphanidermatum, Pythium irregulare, Pythium debaryanum , Pythium myriotylum, Pythium -135- 20 200814928 w/Umi/m), rhizoctonia root rot, stem rot, and damping-off (Rhizobacter serrata, Zn'zoc(6)z/fl/ (10)/), sclerotinia stem decay (Sclerotium sclerotiorum, Sc/eroOWa sc/eroi/orwm), sclerotinia southern blight (Cretaceous, Sc/er plus /ma ro/ /hz·), thielaviopsis root rot (Telecaopsis, Thielaviopsis basicola). The active compound composition according to the present invention allows plants which are treated with the whole plant (plants on the surface part and roots) to be propagated under the fact that they can be tolerated by plants at a concentration required for controlling plant diseases. The active compound compositions according to the invention can be used for foliar application or as seed dressings for the materials and seeds used, as well as for the treatment of soil. The active compound according to the invention is allowed to be treated by the plant under the fact that it can be used to control the disease of the plant, and the active compound according to the invention can be used as Seeds of the pathogenic A fungi cause most of the damage to crop plants, possibly 3 during sub-storage and when the seeds are introduced into the soil, when the plants are germinated and within 20, which is particularly critical. The roots and seedlings of plants with == are sensitive to special duties, and even the objects are _^= ,, with (4) appropriate group interest. The plants in the scorpion and the hair are therefore particularly pleasing to the soil and on the surface of the plant. Due to the consideration of the environment and the health of humans and animals, the active compounds are called The amount administered. The scales are still treated by treating the seeds of the plants to prevent the pathogens from being long-lasting. The goal of continuous improvement is _ _ has been known to encounter a distant ambition |,, wooden site people ... and 'the seed's Necessary development for the protection of seeds and germination of plants in the planting, plant protection immediately after plant germination to = = outside the external is also necessary to optimize the application of 2 2 = ' Μ provide seed and germinated plants The best #的保== ^ to the pathogen Zhenzhen attack, but will not let the ==; special, the method for processing the seed should also = the nature of the fungus inside the funeral, consider the seed and the sprout Medium plants can use the lowest amount of crop protection agent to achieve the most appropriate protection. Still 15 20 The invention thus relates in particular to a method for protecting seed and germinated plants from attack by pathogens by treating the seed with the composition according to the invention. The invention also relates to the use of a composition according to the invention for treating seeds to protect plants from germinating plants from pathogenic fungi. Furthermore, the invention also relates to seeds which have been treated according to the invention and which are protected from pathogenic fungi. One of the advantages of the present invention is that, according to the particular systemic nature of the compositions of the present invention, the treatment of seeds with these compositions not only protects the seed body, but also allows the post-emergence plant to behave this way. y is the processing performed. ~ The initial protection is protected from the attack of pathogenic fungi, and it is possible to dispense with the need to be considered as an advantage when crops are planted and shortly thereafter. The mixture according to the invention can also be applied, in particular, the transgenic gene. Plant seeds. Any of the plants described in the field of forestry or horticulture (see, wheat, barley) The composition according to the invention is suitable for protection in agriculture, warm

:從用匕分離自植物並已除去穗軸、殼、莖椁、外套(莢)、 j毛或果肉者,於是,例如,有可能處理已被收穫、清理 過及水分已被乾燥至15%重量以下的種子,或者,有可能 處理乾燥後,經水處理並再乾燥之種子。 μ 當處理種子時,需非常地小心地選用施加至種子的根 據本發明之組成物的量及/或其他添加物的量以避免種子的 萌發受到傷害,例如,特別要牢記在心的是,在某種施用 200814928 率下可能造成植物毒害效果之活性化合物。 根據本發明的組成物可被直接地施用,即是說,不需 要包含另外的組分或無需稀釋下被使用;習慣上,宜以適 當的配製劑型式施用組成物至種子;用於處理種子之適當 的配製劑及方法,為行家所知,且被彼露於,例如,下述: from the use of cockroaches to separate plants from the cob, shell, stem, coat (pod), j hair or pulp, so, for example, it is possible that the treatment has been harvested, cleaned and the moisture has been dried to 15% Seeds below the weight, or, possibly, treated with water, dried and then dried. μ When handling seeds, the amount of the composition according to the invention applied to the seed and/or the amount of other additives must be chosen with great care to avoid damage to the germination of the seed, for example, in particular, An active compound that may cause a plant toxic effect at a rate of 200814928. The composition according to the invention can be applied directly, that is to say without the need to contain additional components or used without dilution; it is customary to apply the composition to the seed in a suitable formulation form; for treating the seed Suitable formulations and methods are known to the expert and are disclosed by, for example, the following

10 15 20 文件中·· US 4,272,417 A,US 4,245,432 A,us 4,8〇M30 A, US 5,876,739 A,US 2003/0176428 A卜 WO 2002/080675 A1,WO 2002/028186 A2 〇 根據本發明的活性化合物組成物也適於供增加作物的 產量’此外’它們顯現對植物為減少的毒性及更好的耐受 性。 在某種濃度及施用率下,根據本發明的活性化合物組 成物也具有在植物内強化植物之潛力,它們因此適於供固 定化植物的防禦力,用於對抗不想要的微生物之攻擊。 植物-強化的(抗性_誘發的)物質,可理解的,在本文中 係才曰一種具有能力激發植物的防禦系統的物質,當植物接 著在受到不想要的微生物接種後,經處理 银 實質的對抗這錄生物之能力。 了,、、、員現 本發明的情況下,可理解的,不想要的微生物係指上 述提及的病原真8、細«及病毒,於是,以根據本發明9 化合物處理植物後’可被顧供賴植物以對抗上述的 原菌之攻擊達-段時間,此有效的保護期間通常在以活= 化合物處理植物後可延續1至10天,宜為自丨至7天。 在用於控制植物疾病所需的濃度下,活性化合物可被 -139- 200814928 植物耐受得很好的事實下,允許以其處理空氣中的植物部 分、用於繁殖的樹桿及種子、以及土壤。 在此’根據本發明的活性化合物被使用於供控制下述 的疾病方面有特別好的結果··穀類方面之疾病,例如,用 於對抗銹菌屬(pucciniaspecips)引起之疾病,以及葡萄中的 疾病與果樹及蔬菜的栽培中之疾病,例如,用於對抗灰黴 il 屬(Botrytis species)、黑星菌屬(Venturia species)或鏈格抱 菌屬(Alternaria species)之菌。 根據本發明的活性化合物也適於供增加收穫量,此 外’它們對植物顯現較低程度的毒性且能被植物耐受得很 好。 適當地’根據本發明的活性化合物也可在某種濃度及 施用率下被作為殺草劑使用、用於調節植物生長及用於供 控制動物有害生物,適當地,它們也可作為中間物及前驅 物’用於合成其他的活性化合物。 根據本發明,有可能處理全株的植物及植物的各部 .位,在此可理解的,所稱之植物係指全部的植物與植物族 群,例如,想要的與不想要的野生植物或作物植物(包括天 然出現的作物植物);作物植物為可被種植、得自藉由傳統 的育種及最適化方法或藉由生物科技的與基因工程法,或 併用這些方法取得者,包括轉殖基因的植物愈包括可受植 物育種者的認證保護的與不被保護的植物品種;植物部分 可了解的係指植物在地表上的與在地下部分的全部植物斑 器官’例如’幼芽,葉’花與根’可提及的實例為葉子? -140- 200814928 針葉、莖桿、樹桿、花、果實體、果子以及種子,及根, 球莖與匍匐莖;植物的部分也包括被收穫的材料及生長中 部分及繁殖用材料,例如,種苗、球莖、匍匐莖、插及 種子。 5 根據本發明以活性化合物處理植物與植物部分,係以 傳統的方式直接地處理植物本身或作用其周圍、環境^生 活空間或儲存處,例如藉由滴浸、喷灌、蒸散、霧=、撒 • 佈、刷上、以及,對於繁殖材料,特別是種子,尚可藉由 施用-或多詹塗覆物之方式;在此,活性化合物組合^可 ι〇 在處理前將個別的活性化合物藉由混合被製備,或^處理 方式係以相繼地先施用(1)類之羧醯胺,接著再施用至 類之活性化合物之方式處5里’然而,也有可能以⑺至⑽ 類之活性化合物處理植物或植物的部位,接著以G)類之羧 酿胺處理。 、 15 如前面已提過的,根據本發明,可處理全部植物及 • 各部位,於一較佳的具體實施例中,用於處理野生植物2 種及植物栽培品種,或那些藉由傳統生物育種方法取得^ 植物,例如那些經雜交或原生質融合而得者,以及其各部 位;在另一較佳的具體實施例中,用於處理藉由基因二程 20 &,且適當的併用傳統方法取得之轉殖基因植物與植物栽 培品種(基因改造的有機體),以及其各部位;所謂的“部位”、 ‘‘植物的部位”或“植物部分,,,其含義如前面的解釋。 特別適宜地,根據本發明用於處理之植物為那些可講 得或被使用中之植物栽培品種。 -141 - 200814928 視植物的品種或植物栽培品種,其分佈與生長條件(土 壤,氣候,生長期間,營養狀態),根據本發明的處理也可 導致超加成的(“協乘的,,)效果,於是,例如,減少的施用率 及/或增廣的活性譜及/或增加可根據本發明被使用的物質 5 及組成物的活性,較佳的植物生長,更财高溫或财低溫, 更耐乾旱或耐水或耐土壤鹽分含量,增加的開花期,更容 易的收割,加速的成熟,更高的收穫量,更佳的品質及/或 • 具較咼的營養價值之收穫物,收穫產品的更佳儲存安定性 及/或加工性,均可能超出實際被預期的效果。 10 根據本發明被處理之較佳的轉殖基因的植物或植物栽 培如種(即那些藉由基因工程的方法取得者)包括所有那 些,由基因改造,獲得有利的有用性質(“特色”)之基因材料 之植物,這類特色的實例為:較佳的植物生長、更耐高溫 或耐低溫,更耐乾旱或水或土壤中鹽含量、增加的開花期、 15 ^容易的收割、加速的成熟、更高收量、收穫品之較佳品 • 貝及/或較高的營養價值、收穫品之較佳的儲存安定性及/ 或加工性’值得特別被強調之這類特色的實例為,植物對 抗動物及微生物等有害生物(例如,昆蟲,蟎類,植物病原 真菌、細菌及/或病毒類)之具更佳的防禦性,也增加植物對 2〇 某些具除草活性化合物之耐性,可提及的轉殖基因的植物 為重要的作物植物,例如穀物(小麥、稻米),玉米,大豆, 馬,薯,棉花,油菜以及果樹(蘋果樹,梨樹,柑橘樹與葡 ,藤)’且特別要強調的為玉米,大豆,馬鈐薯,棉花與油 菜’尤其被強調的特色為藉由形成於植物中的毒素使增加 -142- 200814928 植物抵抗力以對抗昆蟲之能力,特別是那些藉由來自於蘇 力菌桿菌(万的基因材料者(例如,藉由 基因 CrylA(a),CrylA(b),CrylA(c),CryllA,CrylllA,10 15 20 In the document ... US 4,272,417 A, US 4,245,432 A,us 4,8〇M30 A, US 5,876,739 A, US 2003/0176428 A, WO 2002/080675 A1, WO 2002/028186 A2 活性Activity according to the invention Compound compositions are also suitable for increasing crop yields 'in addition' they exhibit reduced toxicity and better tolerance to plants. At certain concentrations and application rates, the active compound compositions according to the invention also have the potential to reinforce plants within plants, which are therefore suitable for the defense of fixed plants for attack against unwanted microorganisms. Plant-enhanced (resistance-induced) substance, understandably, in this context, a substance that has the ability to provoke a plant's defense system, when the plant is subsequently inoculated with unwanted microorganisms, the treated silver substance The ability to fight this creature. In the case of the present invention, it is understood that the undesired microorganism refers to the pathogens mentioned above, the fine «and the virus, and thus, after treating the plant with the compound according to the present invention 9 can be The plants are protected against the above-mentioned original bacteria for a period of time, and the effective protection period is usually 1 to 10 days after the treatment of the plants with the live = compound, preferably from 7 to 10 days. The fact that the active compound can be well tolerated by the plant at -139-200814928 at the concentration required to control plant diseases allows for the treatment of plant parts in the air, tree stems and seeds for propagation, and soil. Herein, the active compound according to the present invention is used for controlling diseases which are particularly good. · Diseases in cereals, for example, for diseases caused by the genus Puccinia specips, and in grapes. Diseases and diseases in the cultivation of fruit trees and vegetables, for example, bacteria against Botrytis species, Venturia species, or Alternaria species. The active compounds according to the invention are also suitable for increasing the yield, in addition they exhibit a lower degree of toxicity to plants and are well tolerated by plants. Appropriately, the active compounds according to the invention can also be used as herbicides at certain concentrations and application rates, for regulating plant growth and for controlling animal pests, suitably they can also serve as intermediates and Precursor' is used to synthesize other active compounds. According to the present invention, it is possible to treat plants and plants of the whole plant, and it is understood herein that the term "plant" refers to all plants and plant communities, for example, desired and unwanted wild plants or crops. Plants (including naturally occurring crop plants); crop plants can be grown, obtained by traditional breeding and optimization methods or by biotechnology and genetic engineering, or by using these methods, including transgenic genes The more plants include the unprotected plant species that are certified by the plant breeder; the plant parts are understood to refer to all plant plaques on the surface and in the underground part of the plant, such as 'sprouts, leaves' An example of a flower and root can be mentioned as a leaf? -140- 200814928 Needles, stems, tree stems, flowers, fruit bodies, fruits and seeds, and roots, bulbs and stolons; parts of plants also include harvested materials and growing parts and propagation materials, for example, seedlings , bulbs, stolons, seeds and seeds. 5 According to the invention, the plant and plant parts are treated with the active compound, in a conventional manner, directly treating the plant itself or acting on its surroundings, in the living space or in the storage, for example by dripping, sprinkling, evapotranspiration, fog =, sprinkling • cloth, brush, and, for propagation material, especially seeds, by means of application- or multi-Jan coating; here, the active compound combination can be used to treat individual active compounds before treatment. Prepared by mixing, or treated in such a manner that the carboxamide in the class (1) is applied successively, followed by the application to the active compound of the class 5, however, it is also possible to use the active compound of the class (7) to (10) The site of the plant or plant is treated, followed by treatment with a carboxamide of the G) class. 15, as already mentioned, according to the invention, all plants and parts can be treated, in a preferred embodiment, for the treatment of two species of wild plants and plant cultivars, or those by conventional organisms Breeding methods for obtaining plants, such as those obtained by hybridization or protoplast fusion, and their various parts; in another preferred embodiment, for processing by gene two-way 20 & and appropriate combination of traditions Methods The transgenic plants and plant cultivars (genetically modified organisms) obtained by the method, and various parts thereof; so-called "sites", "plant parts" or "plant parts", whose meanings are as explained above. Particularly suitably, the plants for treatment according to the invention are those which can be mentioned or used in plant cultivars. -141 - 200814928 Depending on the plant variety or plant cultivar, its distribution and growth conditions (soil, climate, growth period, nutritional status), the treatment according to the invention may also lead to super-addition ("co-multiplied,") The effect, therefore, for example, a reduced application rate and/or an augmented activity profile and/or an increase in the activity of the substance 5 and the composition which can be used according to the invention, preferably plant growth, more economical or low temperature, More resistant to drought or water or soil salt, increased flowering, easier harvesting, accelerated ripening, higher yield, better quality and / or • Harvest with more nutritious value, harvest Better storage stability and/or processability of the product may exceed the actual expected effect. 10 Plants or plant cultivation of preferred transgenic genes to be treated according to the invention (ie those by genetic engineering) Method acquirer) includes all those plants genetically engineered to obtain beneficial useful properties ("features") of genetic material, examples of which are: better plant growth, more High temperature or low temperature resistance, more resistant to drought or salt content in water or soil, increased flowering period, 15^ easy harvesting, accelerated ripening, higher yield, better harvested products • shellfish and/or higher nutrition Value, better storage stability and/or processability of harvested products. An example of such a characteristic that deserves special emphasis is that plants are resistant to pests such as animals and microorganisms (eg, insects, mites, phytopathogenic fungi, bacteria). And/or virus) has better defensiveness and also increases plant tolerance to certain herbicidal compounds. Plants that can be mentioned as transgenic genes are important crop plants, such as grains (wheat, rice). ), corn, soybeans, horses, potatoes, cotton, canola and fruit trees (apple, pear, citrus and Portuguese, vine) and especially emphasize corn, soybean, horse yam, cotton and rapeseed The emphasis is on the ability to increase the resistance of plants to - insects by the toxins formed in plants, especially those from the genetic material from S. faecalis (10,000) For example, by gene CrylA (a), CrylA (b), CrylA (c), CryllA, CrylllA,

CryIIIB2,Cry9c,Cry2Ab,Cry3Bb 及 CrylF 以及也包括其 5CryIIIB2, Cry9c, Cry2Ab, Cry3Bb and CrylF and also include 5

10 15 組合物)(後面歸之為“Bt植物”);其他也特別要強調的特色 為,植物對某些具除草地活性化合物(例如,味嗤琳酮類, 石黃酿基脲類,嘉構塞(glyphosate)或膦基三辛 (phosphinotricin)(例如“PAT”基因))之增加的而f性;參與至所 要的特色的基因毫無疑問的也可與他種基因成混合型式出 現於轉殖基因的植物中,可被提及的“Bt植物”之實例為以 下述的貿易名稱(trade name)被販售之玉米品種、棉花品 種、大豆品種及馬鈴薯品種:YIELD GARD⑧(例如玉米, 棉花’大豆),KnockOut⑧(例如玉米),StarLink® (例如玉 米),Bollgard㊣(棉花),Nucotn® (棉花)與 NewLeaf® (馬鈴 薯);可提及的耐-殺草劑的植物類為玉米品種、棉花品種及 大豆品種,其以下列貿易名稱被販售:Roundup Ready⑧(耐 最石粦基’例如玉米,棉花,大豆),Liberty Link⑧(财膦基三 辛’例如油菜),IMI⑧(耐咪唑啉酮)及STS⑧(耐磺醯基脲, 例如玉米),可提及的财-除草劑之植物(以傳統方式育成的 耐除草劑之植物)包括以Clearfielf⑧之名稱販賣者(例如玉 米),當然,這些聲明也適用於具這些基因特色或其在將來 會被發展及/或販售而具有將被發展的基因特色之植物栽培 品種。 視其個別的物理及/或化學性質,此活性化合組合物可 -143- 20 200814928 被轉變成習用的配製劑,例如,溶液、乳液、懸浮液、粉 劑、塵劑、泡沫物、糊劑、可溶性粉末、粒劑,氣溶液、 懸浮-乳液濃縮物、浸潤了活性化合物之天然及合成的材 料、以及包覆於聚合性材料内之微膠囊及供種子使用之塗 覆用組成物,以及ULV冷及溫熱的霧狀配製劑。 這些配製物係以已知的方式產生,例如,將活性化合 物與展延劑混合,展延劑係指液體溶劑類、加壓下的液化 氣體、及/或固體載劑類,選擇地使用界面活性劑類,即, 乳化劑類及/或分散劑類,及/或泡沫形成劑。 如果使用的展延劑為水時,也有可能使用,例如,有 機/谷劑作為輔助溶劑類,主要地,適當的液態溶劑類為: 芳族類,例如二甲苯、甲苯或烷基萘類;氯化的芳族類或 氯化的脂肪族烴類,例如,氯苯類、氯乙烯類或二氯甲烷; 脂肪族烴類,例如環己烷或石蠟類,例如石油分劃物;礦 物及植物油類;醇類,例如,丁醇或甘醇及彼等之醚類與 酯類,酮類,例如丙酮、甲基乙基_、甲基異丁基酮或環 己酮,強極性溶劑類,例如,二甲基甲醯胺及二甲亞碉; 或是水。 液化的氣體展延劑或載劑,可理解的,係指在標準的 溫度及壓力下為氣體之液體,例如,氣溶液喷射劑類,例 如,丁烷,丙烷,氮氣及二氧化碳。 適當的固體載劑類為,例如,錢鹽類與研磨過的天然 礦物類,例如,高嶺土、粘土、滑石、白堊土、石英、美 國活性白土、蒙脫土或矽藻土以及研細的合成材料類,^ -144 - 200814928 510 15 Composition) (hereinafter referred to as "Bt plant"); other features that are particularly emphasized are that plants have certain herbicidal compounds (eg, misoprostone, scutellaria, An increase in glyphosate or phosphinotricin (such as the "PAT" gene); the genes involved in the desired characteristics can be undoubtedly mixed with other genes. Among the plants of the transgenic gene, an example of a "Bt plant" that can be mentioned is a corn variety, a cotton variety, a soybean variety, and a potato variety sold under the trade name: YIELD GARD8 (for example, corn). , cotton 'soybean', KnockOut8 (eg corn), StarLink® (eg corn), Bollgard (cotton), Nucotn® (cotton) and NewLeaf® (potato); the herbicide-tolerant plant species Corn varieties, cotton varieties and soybean varieties are sold under the following trade names: Roundup Ready8 (resistant to the most stone bases such as corn, cotton, soybeans), Liberty Link 8 (Finyl Phosphate Trisin' such as oil Dish), IMI8 (imidazole-resistant ketone) and STS8 (sulfonyl-resistant urea, such as corn), which can be mentioned as a herbicide-weaking plant (a herbicide-tolerant plant bred in a conventional manner) including the name of Clearfielf8 Vendors (such as corn), of course, these statements also apply to plant cultivars that have these genetic characteristics or that will be developed and/or sold in the future with the genetic characteristics to be developed. Depending on its individual physical and/or chemical nature, the active compound composition can be converted into conventional formulations, for example, solutions, emulsions, suspensions, powders, dusts, foams, pastes, Soluble powders, granules, gas solutions, suspension-emulsion concentrates, natural and synthetic materials infiltrated with active compounds, microcapsules coated in polymeric materials, and coating compositions for seed use, and ULV Cold and warm misty formulation. These formulations are produced in a known manner, for example, by mixing the active compound with a spreading agent, which is a liquid solvent, a liquefied gas under pressure, and/or a solid carrier, optionally using an interface. Active agents, ie, emulsifiers and/or dispersants, and/or foam formers. If the extender used is water, it is also possible to use, for example, an organic/treat agent as an auxiliary solvent. Primarily, suitable liquid solvents are: aromatics such as xylene, toluene or alkylnaphthalenes; Chlorinated aromatic or chlorinated aliphatic hydrocarbons, for example, chlorobenzenes, vinyl chlorides or methylene chloride; aliphatic hydrocarbons such as cyclohexane or paraffin, such as petroleum repellents; minerals and Vegetable oils; alcohols, for example, butanol or glycol and their ethers and esters, ketones, such as acetone, methyl ethyl, methyl isobutyl ketone or cyclohexanone, strong polar solvents For example, dimethylformamide and dimethylhydrazine; or water. By liquefied gas extender or carrier, it is understood to mean a liquid which is a gas at standard temperature and pressure, for example, a gaseous solution propellant such as butane, propane, nitrogen and carbon dioxide. Suitable solid carriers are, for example, money salts and ground natural minerals such as kaolin, clay, talc, chalk, quartz, American activated clay, montmorillonite or diatomaceous earth, and fine synthetic Materials, ^ -144 - 200814928 5

10 15 如南度分散的二氧切,氧化缺械細;肖於顆 粒體之適當的固態_為:例如,碾碎並分_的天然岩 石,例如,方解石、大理石、輕石、海泡石與白雲石”戈 是無機與有機碎料之合成的顆粒,及有機材料的顆粒,例 如、,鑛屑、、椰子殼、玉耗軸與料莖;適當的乳化劑及/ 或泡沫形成劑為:例如,非離子與陰離子乳化劑類,例如 聚氧乙烯脂肪酸i旨類,聚氧乙稀脂肪族醇醚類,例如,烧 基芳基聚甘醇醚類、烷基磺酸鹽類、烷基硫酸鹽類、芳基 磺酸鹽類,或是蛋自質水解產物;適當的分散劑為 例如, 木質素亞硫酸廢液及甲基纖維素。 枯著劑類’例如,竣甲基纖維素及呈粉狀、粒狀或乳 膠態之天然與合成的聚合物類,例如,阿拉伯膠、聚乙烯 醇與聚乙烯醋酸酯,以及天然磷脂質類,例如,腦磷脂與 卵麟脂,以及合成的磷脂質類,均可被加於調配物中,其 他可能的添加物為礦物油類及植物油類。 也有可能用及著色劑,例如,無機色素類,例如,氧 化鐵,一氧化欽及晋魯士藍,以及有機染料類,例如,茜 素染料,偶氮類染料與金屬酞花青染料,以及微量營養成 分,例如鐵、锰、蝴、銅、鈷、钥與鋅等的鹽類。 由市售的配製劑調配得的使用型式中之活性化合物含 量可在廣範圍間變化,供控制動物有害生物(例如昆蟲及蜘 蛛蟎類)的使用型式之活性化合物的濃度,可為包含自 〇.〇〇〇〇〇〇1與95%重量計間的活性化合物且較佳地為包含自 0.0001至1%重量計間者,以習用的適用於使用变式的方式 -145- 20 200814928 施用。 用於供控制不想要的病原真菌的調配劑中通常包含介 於0·1與95%重量計的活性化合物,宜為介於0.5與90%間 者。 5 根據本發明的活性化合物組合物可呈現為其市售可得 的配製劑以及由這些配製劑製備得的使用型式被使用,例 如,即用溶液、可乳化的濃縮物、乳液、懸浮液、可濕性 | 粉末、可溶性粉末、塵染劑及粒劑,它們係以習用的方式 被使用,例如,藉由洗水(浸水)、灌派、喷瀵、霧化、撒佈、 10 塵染、泡沫、鋪上、以及以乾粉處理種子、以溶液處理種 子、以可溶於水的粉劑處理種子、以可溶於水的粉漿處理 種子、或藉由形成於外殼的方式等等。 根據本發明的活性化合物組合物可呈現為其市售可得 的配製劑以及由這些配製劑製備得的使用型式,與其他已 15 知的活性化合物類(例如,殺昆蟲劑,引誘劑,不孕劑,殺 I 菌劑,殺蟎劑,殺線蟲劑,殺真菌劑,生長調節劑或殺草 劑)作成混合物被使用。 當使用根據本發明的活性化合物組合物時,施用率可 視施用的種類在實際上相對地廣大的範圍内變化,當用於 20 處理植物部位時,活性化合物組合物之施用率通常為介於 0.1與10 000克/公頃間,宜為介於10與1000克/公頃間, 當用於處理種子時,活性化合物組合物之施用率通常為介 於0·001與50克/公斤種子間,宜為介於0·01與10克/公斤 種子間,當用於處理土壤時,活性化合物之施用率通常為 -146 - 200814928 介於0·1與10 〇〇〇克/公頃間,宜為介於i與5〇〇〇 間〇 活性化合物組合物可呈濃縮物或,通常為被配製成配 製劑使用,例如被配製成粉劑’粒劑,溶液劑,懸浮气_ 乳劑或糊劑。10 15 If the south is dispersed, the oxidizing is not fine; the appropriate solid state of the granule is: for example, natural rock crushed and divided, for example, calcite, marble, pumice, sepiolite And dolomite "go is a synthetic particle of inorganic and organic scrap, and particles of organic material, for example, mineral chips, coconut shell, jade shaft and stem; suitable emulsifier and / or foam forming agent is : for example, nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid i, polyoxyethylene aliphatic alcohol ethers, for example, alkyl aryl polyglycol ethers, alkyl sulfonates, alkanes a base sulfate, an aryl sulfonate, or an egg-derived hydrolysate; suitable dispersants are, for example, lignin sulfurous acid waste liquid and methyl cellulose. Drying agents 'for example, 竣 methyl fiber And natural and synthetic polymers in powder, granule or latex form, for example, gum arabic, polyvinyl alcohol and polyvinyl acetate, and natural phospholipids, for example, cephalin and egg ly, Synthetic phospholipids can be added to the formulation Other possible additives are mineral oils and vegetable oils. It is also possible to use coloring agents, for example, inorganic pigments such as iron oxide, monomethicone and Jinluslan, and organic dyes such as alizarin. Dyes, azo dyes and metal phthalocyanine dyes, and trace nutrients such as salts of iron, manganese, butterfly, copper, cobalt, molybdenum and zinc, etc. used in the formulation of commercially available formulations. The active compound content can vary over a wide range, and the concentration of active compound used to control the use of animal pests (eg, insects and spider mites) can be comprised from 〇.1 and 95% by weight. The active compound in between and preferably comprises from 0.0001 to 1% by weight, administered in a conventional manner suitable for the use of the variant -145-20 200814928. Used in a formulation for controlling unwanted pathogenic fungi The active compound is usually comprised between 0.1 and 95% by weight, preferably between 0.5 and 90%. 5 The active compound composition according to the invention can be present as a commercially available formulation and Formulations prepared using the formulations are used, for example, ready-to-use solutions, emulsifiable concentrates, emulsions, suspensions, wettables|powders, soluble powders, dusting agents, and granules, which are conventionally used. Use, for example, by washing (soaking), irrigating, sneezing, atomizing, spreading, dusting, foaming, laying, and treating the seeds with dry powder, treating the seeds with solution, and being water soluble Powder treatment of seeds, treatment of seeds with water-soluble slips, or by formation in the outer shell, etc. The active compound compositions according to the invention may be presented as commercially available formulations and from these formulations The prepared form and other active compounds (eg, insecticides, attractants, infertile agents, fungicides, acaricides, nematicides, fungicides, growth regulators or The herbicide) is used as a mixture. When the active compound composition according to the invention is used, the application rate can vary within a substantially relatively broad range depending on the type of application, and when used for 20 treatment of plant parts, the application rate of the active compound composition is usually between 0.1. Between 10 000 g / ha, preferably between 10 and 1000 g / ha, when used to treat seeds, the application rate of the active compound composition is usually between 0. 001 and 50 g / kg of seed, preferably Between 0. 01 and 10 g / kg of seed, when used to treat soil, the application rate of active compound is usually -146 - 200814928 between 0 · 1 and 10 gram / hectare, should be The active compound composition may be in the form of a concentrate or, usually, formulated as a formulation, for example, as a powder, a granule, a solution, a suspension gas, an emulsion or a paste.

10 20 上述的調配劑可採用已知的方式配製,例如,將活性 化合物混合與至少一種的溶劑或稀釋劑、乳化劑、分散, 及/或枯結劑或固定劑、潑水劑混合,有需要的話,加入f 燥劑及UV安定劑,且,有需要的話,加入著色劑及色素^ 及其他的加工辅助劑。 根據本發明的活性化合物組合物之良好的殺真菌的作 用,可由下述實例獲得應證,雖然個別的活性化;^物顯現 弱的殺真菌的作用,組合物所呈現的作用遠超過其個別成 分的作用之總和。 當活性化合物組合物在殺真菌的作用上常超過其個別 的活性化合物的作用之總和時,其為具有協乘效果。 對於一種包含所給兩種活性化合物的級合物之被預期 的氣真繭的作用,可根據S.R· Colby的算式,^1(ϊιιΜη§ Synergistic and Antagonistic Responses Herbicide10 20 The above formulation may be formulated in a known manner, for example, by mixing the active compound with at least one solvent or diluent, emulsifier, dispersion, and/or dry or fixative, water repellent, If necessary, add a desiccant and a UV stabilizer, and if necessary, add a coloring agent and a pigment and other processing aids. The good fungicidal action of the active compound compositions according to the invention can be exemplified by the following examples, although the individual activations exhibit a weak fungicidal effect, and the compositions exhibit far more effects than their individual The sum of the effects of the ingredients. When the active compound composition often exceeds the sum of the effects of its individual active compounds in the fungicidal action, it has a synergistic effect. For a desired gas enthalpy effect of a fraction comprising the two active compounds given, according to the formula of S.R. Colby, ^1(ϊιιΜη§ Synergistic and Antagonistic Responses Herbicide

Combinations”,Weeds 1967. U,20-22),被計算如下: 如果 X 代表以迟克/么^#的施用率施用活性化合物A時之致 力、 -147- 200814928 γ 代表以沒;/么1境的施用率施用活性化合物Β時之咬 力、 Ε 代表以m及η克/么ν礞的施用率施用活性化合物人與^ 時之政力, 5 • τ X X γ 貝1J Ε-Χ +Υ--- 100 祕在此,效力以%表示,〇%代表相當於未經處理之對照 組之效力,而100%的效力代表無感染被發現。 如果真正的殺農菌一赴作用超過計算得的數值時,則組 合物的活性係超加成的,即,出現一種協乘效果,此情況 中,真正被觀祭到的效力需超過使用上述公式計算得之被 15 預期的效力(Ε)。 ^ 本發明以下述實例予以說明,但本發明不限於這些實 【實施方式】 5途實例 直例Α ·_Α枯絲核菌(及/^z〇c如試驗(被營中)/名 定板 此微型試驗係於微滴定板上,使用馬鈐薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical_grade) 活性成分’接種入立枯絲核菌(麗⑺⑽〇之菌絲懸 -148 - 200814928 浮液,在暗室及振搖(10 Hz)下接種5天後,以光電比色計 測定微滴定板的各充填的孔腔之透光性。 0%代表相當於對照組中生長的效力,100%效力代表沒 見到真菌的生長。 下面的表A1及A2清楚地顯示,根據本發明的活性化 合物組合物之活性要大於計算得的活性,即,其中呈現有 協乘性效果。 表A1 :立枯絲核菌試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-1) 0.01 83 (1-28) 0.1 28 (1-31) 0.1 53 (1-31) 0.03 36 (1-31) 0.003 63 (1-39) 1 46 (1-39) 03 37 (GBO 827) 0.3 46 表苯菌酮(metrafenone) 1 46 表苯菌酮(metrafenone) 0.1 1 滅康峻(metconazole) 0.003 12 環氧康峻(epoxyconazole) 0.1 25 環氧康 ^(epoxyconazole) 0.03 14 .-149 - 200814928 環氧康嗤(epoxyconazole) 0.01 73 根據本發明: (1-1)+環氧康嗤(1 : 1) 0.01+0.01 實測得 97 計算得 95 (1-28)+環氧康唑(1 : 1) 0.1+0.1 52 46 (1-31)+滅康唑(1 : 1) 0.1+0.1 63 53 (1-31)+表苯菌酮(1 : 1) 0.003 + 0.003 82 67 (1-31)+環氡康唑(1 : 1) 0.03 + 0.03 62 45 (1-39)+表苯菌酮(1 : 1) 1 + 1 92 71 (1-39)+ GBO 827(1 : 1) 03 + 03 98 66 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 表A2:立枯絲核菌試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-39) 0·1 43 環氧康 ^(epoxyconazole) 0.1 42 根據本發明: (1-39)+環氧康唑(1 : 1) 0.1+0.1 實測得 計算得 91 67 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 -150- 200814928 實例衫一:—Φ f摄撒繭(Pg/|/ei7/|·!!所知gy/m⑽/g)試驗(試管 ίι/微滴定板 此微型試驗係於微滴定板上,使用馬鈴薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 5 活性化合物係使用溶解於丙酮内之工業級(technical-grade) 活性成为’接種入小帚樣徽菌Z>reWcanw/e)之抱 子懸浮液,在暗室及振搖(1〇 Hz)下接種4天後,以光電比 _ 色計測定微滴定板的各充填的孔腔之透光性。 〇%代表相當於對照組中生長之效力,而1〇〇。/0效力代表 ίο 沒見到真菌的生長。 下面的表B清楚地顯示,根據本發明的活性化合物組 合物之活性要大於計算得的活性,即,其中呈現有協乘性 效果。 表B:小帚樣黴菌試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%)— (1-39) 03 65 滅康嗤(metconazole) 0.3 3 根據本發明: (1-39)+滅康唑(1 : 1) 0.3+ 0.3 實測得 計算得 73 66 L·'--L- ——— 15 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 -151 - 200814928 宜例C :灰葡葙孢(如的沿試驗(試管中)/微滴定_ 此微型試驗係於微滴定板上,使用馬鈴薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical-grade) 活性成分’接種入灰葡萄抱(万0^;沿之抱子懸浮 液,在暗室及振搖(10 Hz)下接種4天後,以光電比色計測 定微滴定板的各充填的孔腔之透光性。 〇%代表相當於對照組中生長之效力,而1〇〇%效力代表 沒見到真菌的生長。 下面的表C1及C2清楚地顯示,根據本發明的活性化 合物組合物之活性要大於計算得的活性,即,其中呈現有 協乘性效果。 表C1:灰葡萄孢(試管中)/微滴定板 活性化合物 活性化合物施用率 (Ppm) 效力(%) (1-1) 〇·01 18 (1-29) 1 54 (1-39) 〇J 51 百克敏(pyrachlostrobin) 0.1 42 百克敏(pyrachlostrofoin) 1 27 滅康嗤(metconazole) 0.01 5 根據本發明: (1-1)+ 滅康口圭(1 : 1) —---- 0.01+0.01 實測得 31 計算得 22 -152- 200814928 (1-29)+ 百克敏(1 : 1) 1 + 1 93 66 (1-39)+百克敏(1 : 1) 0.1+0.1 94 72 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 表C2:灰葡萄孢(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-1) 03 31 (1-4) 1 29 (1-31) 0·1 39 百克敏(pyrachlostiObm) 0.3 20 百克敏(pyrachlostrobin) 1 16 百克敏(pyradilostrobin) 0.1 42 根據本發明: (1-4)+ 百克敏(1 : 1) 1 + 1 實測得 78 計算得 40 (1_1)+ 百克敏(1 : 1) 0.3 + 0.3 90 45 (1-31)+百克敏(1 : 1) 0.1 +0.1 86 65 實測得=實際發現的效力;計算得二使用Colby公式計算得的效力 •153- 200814928 實例D :稻疲繭(PyriVrt</ar/a orvza)試驗(試營中)/微滴定板 此微型試驗係於微滴定板上,使用馬鈴薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical-grade) 5 活性成分’接種入稻盘菌(jPyr/cw/flr/fl orj;za)之孢子懸浮液, 在暗室及振搖(10 Hz)下接種4天後,以光電比色計測定微 滴定板的各充填的孔腔之透光性。 〇%效力代表相當於對照組的生長情形,100%效力代表 > 沒見到真菌的生長。 ίο 下面的表Dl,D2及D3清楚地顯示,根據本發明的活 性化合物組合物之活性要大於計算得的活性,即,其中呈 現有協乘性效果。 表D1 :稻痙菌試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-29) 3 55 (1-29) 0.03 18 (1-4) 1 9 (1-31) 0.1 16 (M) 0.03 6 GBO 827 0.03 76 GBO 827 0.1 87 GBO 827 3 80 表苯菌酮(metrafenone) 3 60 -154- 200814928 滅康口坐(metconazole) 1 74 滅康 ^(metconazole) 0.03 66 環氧康嗤(epoxyconazole) 3 81 根據本發明: (1-29)+環氧康唑(1 : 1) (1-29)+ 滅康唑(1 : 1) 3 + 3 0.03 + 0.03 實測得 98 85 計算得 91 72 (1-29)+表苯菌酮(1 : 1) 3 + 3 90 82 (1-4)+ 滅康唑(1 : 1) 1 + 1 97 76 (1-31)+ GBO 827(1 : 1) 0.1 +0.1 99 89 (1-1)+ GBO 827(1 : 1) 0.03 + 0.03 87 77 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 表D2 #·稻瘂菌(Pjr/cw^r/fl )試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-4) 3 33 (1-28) 0.03 19 滅康 ^(metconazole) 0.03 10 表苯菌 _(metrafeiKme) 3 80 表苯菌酮(metrafenone) 0.03 45 根據本發明: (1-4)+ GBO 827(1 : 1) 3 + 3 實測得 99 計算得 87 (1-28)+表苯菌酮(1 : 1) 0.03 + 0.03 95 55 -155 - 200814928 (1-28)+ 滅康唑(1 : 1) 0.03 + 〇.〇3 58 27 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 表D3 :稻瘟菌(Pjr/c«/ariVi 試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-4) 3 33 表苯菌酮(metrafenone) 3 55 根據本發明: (1·4)+表苯菌酮(1 : 1) 3 + 3 實測得 計算得 75 70 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 _實_例E :玉蜀黍赤徽⑽g)試驗(試管中v檄滴定柄 此被型试驗係於微滴定板上,使用馬铃箸右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical_grade) 活性成分,接種入玉蜀黍赤黴之孢子懸浮 液,在暗室及振搖(10 Hz)下接種3天後,以光電比色計測 定微滴定板的各充填的孔腔之透光性。 0%效力代表相當於對照組的生長情形,1〇〇0/。效力代表 沒見到真菌的生長。 下面的表E清楚地顯示,根據本發明的活性化合物組 合物之活性要大於計算得的活性,即,其中呈現有協乘性 效果。 -156- 200814928 表E:玉蜀黍赤黴試驗(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(%) (1-4) 1 —---—___ — (1-28) 0·1 (1-29) 0.3 —_ -_ 59 環氧康嗤(epoxyconazole) 1 65 GBO 827 0.1 ] GBO 827 03 --- 24 根據本發明: 0.1+0.1 實測得 計算得, (1-29)+ GBO 827(1 : 1) 78 69 (1-28)+ GBO 827(1 : 1) 0.3 + 0.3 43 37 (1-4)+環氧康唑(1 : 1) 1 + 1 ---- 84 73 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 實例F :蘋果键格孢菌試驗(試管中)/衍;济 5 此微型試驗係於微滴定板上,使用馬鈐薯右旋糖肉汁 (Potato-Dextrose Broth,PDB)作為液體試驗培養基下進行, 活性化合物係使用溶解於丙酮内之工業級(technical_grade) 活性成分’接種入蘋果鏈格孢菌(乂/化⑺狀以W(3//)之抱子懸 10 浮液,在暗室及振搖(10 Hz)下接種3天後,以光電比色計 測疋微滴定板的各充填的孔腔之透光性。 -157- 200814928 〇%效力代表相當於對照組的生長情形,100%效力代表 沒見到真菌的生長。 下面的表F清楚地顯示,根據本發明的活性化合物組 合物之活性要大於計算得的活性,即,其中呈現有協乘性 效果 表F ·蘋果鏈格孢菌(試管中)/微滴定板 活性化合物 活性化合物施用率 (ppm) 效力(°/〇) (1_1) 0.03 66 表苯菌酮(metrafenone) 0.03 14 根據本發明: (1-1)+表苯菌酮(1 : 1) 03 + 03 實測得 計算得*) 72 71 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 复例G :_I核腔菌(Pyrg/i即/Wg化rgs)試驗(大來V徭謹性 讓溶劑: 50份重的ΛΓ,τν-二f差乙鏞屉 乳化劑·· 1份重的烷基芳基聚甘醇醚 為產生適當的活性化合物配製劑,將1份重的活性化 合物或活性化合物組合物,混合所述量的溶劑及乳化劑, 15 再以水將此濃縮物稀釋至所要的濃度。 為測5式保遵的活性,以所述的施用率將活性化合物製 劑喷灑幼年植物,待喷灑層乾燥後,對植物喷灑上圓核腔 菌ieres)之分生抱子的懸浮液,植物被留置在 •158· 200814928 20°C及100%相對濕度之培養箱内經48小時。 再將植物移至約2(TC及約80%相對濕度之溫室中。 接種後10天進行評估,0%代表相當於對照組之效力, 而100%之效力代表沒見到感染。 表G ··圓核腔菌試驗(大麥)/保護性 活性化合物 活性化合物施用率(克/ 公頃) 效力(%) (1-2) 3L25 22 (1-12) 31.25 ---—----- 56 百克司多賓 (pyraclostobin) 31.25 78 表苯菌 _(metrafenone) 31.25 0 環氧康哇(epoxyconazole) 31.25 0 滅康哇(metconazole) 31.25 0 得克力(tebuconazole) 31.25 0 GBO 827 31.25 0 白克力(boscalid) 31.25 22 根據本發明: (1_2)+百克司多賓 31.25 + 31.25 實測得 —94 78 計算得 83 22 (1-2) +表苯菌酮 31.25 + 31.25 (1-2)+環氧康α坐 31.25 + 31.25 89 22 (1-2)+滅康0坐 31.25 + 31.25 89 22 (1-2) + HWG1608 3L25 + 3L25 100 22 -159- 200814928 (1-2) + GB0827 31,25+ 31.25 78 22 (l-2) + RK02273 31.25 + 31.25 100 39 (1-12)+百克司多賓 31.25 + 31.25 100 92 (1-12)+表苯菌_ 31.25 + 31.25 89 56 (1_12) +環氧康唑 31.25+ 31.25 89 56 (1-12) +滅康嗤 31.25 + 31.25 94 56 (1-2) +得克力 31.25 + 31.25 89 56 (1-2) + GB0827 3L25 + 3L25 94 56 (1-2)+白克力 31.25+ 3L25 89 66 實測得=實際發現的效力;計算得=使用Colby公式計算得的效力 實例H: 疫菌(P/IV加/?/|认仍71)試驗(蕃茄V保護性 溶劑:24.5份重的丙酮 5 24.5份重的二甲基乙醯胺 I 乳化劑:1份重的烧基芳基聚甘醇醚 為產生適當的活性化合物配製劑,將1份重的活性化 合物或活性化合物組合物,混合所述量的溶劑及乳化劑, ίο 再以水將此濃縮物稀釋至所要的濃度。 為測試保護的活性,以所述的施用率將活性化合物製 劑喷灑幼年植物,待喷灑層乾燥後,對植物喷灑上致病疫 菌/«/⑵加則)之抱子的水性懸浮液,將植物留 置在2(TC及100%相對濕度之培養箱内。 -160- 200814928 而::二進二:代表相當於對照組之效力Combinations", Weeds 1967. U, 20-22), calculated as follows: If X represents the exertion of active compound A at the application rate of gram/m^^, -147-200814928 γ represents no; The rate of application of the active compound Β, Ε represents the application rate of the active compound at the application rate of m and ηg / νν礞, 5 • τ XX γ 1 1J Ε-Χ +Υ --- 100 Secrets here, the efficacy is expressed in %, 〇% represents the equivalent of the untreated control, and 100% of the efficacy represents no infection was found. If the real bactericidal effect is more than calculated The value of the composition is superadditive, that is, a synergistic effect occurs. In this case, the effectiveness of the actual sacrifice is greater than the expected effect of 15 using the above formula (Ε). The present invention is illustrated by the following examples, but the present invention is not limited to these embodiments. [Examples] 5 examples of straight cases Α · Α 丝 核 ( ( and / ^ z 〇 c such as test (in the camp) / name This micro-test is attached to a microtiter plate using a horse yam dextrose gravy (Potat) o-Dextrose Broth, PDB) was carried out as a liquid test medium, and the active compound was inoculated into Rhizoctonia solani using a technical grade (active material) dissolved in acetone (Li (7) (10) 菌 菌 悬 -148 - 200814928 After floating for 5 days in a dark room and shaking (10 Hz), the light transmittance of each filled cavity of the microtiter plate was measured by a photoelectric colorimeter. 0% represents the efficacy of growth in the control group. The 100% potency represents no growth of the fungus. Tables A1 and A2 below clearly show that the active compound composition according to the invention is more active than the calculated activity, i.e., exhibits a synergistic effect. Table A1 : Rhizoctonia solani test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-1) 0.01 83 (1-28) 0.1 28 (1-31) 0.1 53 ( 1-31) 0.03 36 (1-31) 0.003 63 (1-39) 1 46 (1-39) 03 37 (GBO 827) 0.3 46 meperfenone 1 46 meperfenone 0.1 1 metconazole 0.003 12 epoxyconazole 0.1 25 epoxyconazole 0.03 14 .-149 - 200814928 Epoxyconazole 0.01 73 According to the invention: (1-1) + epoxy conjugate (1: 1) 0.01+0.01 Calculated 97 Calculated 95 (1-28)+ Epoxyconazole (1 : 1) 0.1+0.1 52 46 (1-31) + thiconazole (1 : 1) 0.1+0.1 63 53 (1-31) + benzophenone (1 : 1) 0.003 + 0.003 82 67 (1-31) + Cycloconazole (1 : 1) 0.03 + 0.03 62 45 (1-39) + benzophenone (1 : 1) 1 + 1 92 71 (1-39) + GBO 827(1 : 1) 03 + 03 98 66 measured = actual found efficacy; calculated = effectiveness calculated using the Colby formula Table A2: Rhizoctonia solani test (in vitro) / microtiter active compound active compound Application rate (ppm) Efficacy (%) (1-39) 0·1 43 Epoxyconazole 0.1 42 According to the invention: (1-39) + epoxyconazole (1 : 1) 0.1+0.1 Calculated 91 67 measured = the actual found effectiveness; calculated = the effectiveness calculated using the Colby formula -150- 200814928 Example one: - Φ f photo 茧 (Pg / | / ei7 / | ·!! Gy/m(10)/g) test (test tube ίι/microtiter plate) This micro-test is applied to microtiter plates using potato dextrose gravy (Potato-Dextrose Broth, PDB) was carried out as a liquid test medium, and 5 active compounds were used as the 'technical-grade' dissolved in acetone to become 'inoculated into the sputum-like bacteria Z> reWcanw/e) The sub-suspension was inoculated for 4 days in a dark room and shaking (1 Hz), and the light transmittance of each filled cavity of the microtiter plate was measured by a photoelectric ratio meter. 〇% represents the equivalent of the growth in the control group, while 1〇〇. /0 effectiveness representative ίο did not see the growth of fungi. Table B below clearly shows that the active compound composition according to the present invention is more active than the calculated activity, i.e., exhibits a synergistic effect. Table B: Ophiopogon fungus test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) - (1-39) 03 65 metconazole 0.3 3 according to the invention: 1-39) + diconazole (1: 1) 0.3 + 0.3 The calculated 73 66 L·'--L-———— 15 measured = the actual found effect; calculated = calculated using the Colby formula Efficacy - 151 - 200814928 Example C: Fusarium oxysporum (eg, along the test (in vitro) / microtiter _ This micro-test is on a microtiter plate using Potato-Dextrose Broth (PDB) The reaction is carried out as a liquid test medium, and the active compound is inoculated into a gray grape hug using a technical-grade active ingredient dissolved in acetone (approximately 0 ^; along the stalk suspension, in a dark room and shaken (10) After 4 days of inoculation at Hz), the light transmittance of each filled cavity of the microtiter plate was measured by a photoelectric colorimeter. 〇% represents the efficacy equivalent to growth in the control group, and 1% of the efficacy represents no Growth of fungi. Tables C1 and C2 below clearly show the active compound group according to the invention The activity of the substance is greater than the calculated activity, that is, it exhibits a synergistic effect. Table C1: Botrytis cinerea (in vitro) / microtiter plate Active compound active compound application rate (Ppm) Efficacy (%) (1- 1) 〇·01 18 (1-29) 1 54 (1-39) 〇J 51 pyrachlostrobin 0.1 42 pyrachlostrofoin 1 27 metconazole 0.01 5 According to the invention: (1 1)+ 灭康口圭 (1 : 1) —---- 0.01+0.01 Measured 31 Calculated 22 -152- 200814928 (1-29)+ Bai Kemin (1 : 1) 1 + 1 93 66 (1 -39)+100gmin (1:1) 0.1+0.1 94 72 measured = actual found efficacy; calculated = potency calculated using the Colby formula C2: Botrytis cinerea (in vitro) / microtiter active compound Active compound application rate (ppm) Efficacy (%) (1-1) 03 31 (1-4) 1 29 (1-31) 0·1 39 100 gram (pyrachlostiObm) 0.3 20 pyrachlostrobin 1 16 克克敏(pyradilostrobin) 0.1 42 According to the invention: (1-4) + baikemin (1 : 1) 1 + 1 measured 78 calculated 40 (1_1) + 100 gram (1 : 1) 0.3 + 0.3 90 45 (1- 31) + Bai Kemin (1 : 1) 0.1 +0.1 86 65 measured = actual found efficacy; calculated using the Colby formula calculated 153-200814928 Example D: rice fatigue (PyriVrt </ar/a orvza) test (in trial camp) / micro Titration plate This microtest was performed on a microtiter plate using Potato-Dextrose Broth (PDB) as a liquid test medium, and the active compound was used in a technical-grade 5 dissolved in acetone. The active ingredient was inoculated into a spore suspension of rice blast fungus (jPyr/cw/flr/fl orj; za), and after inoculation for 4 days in a dark room and shaking (10 Hz), the microtiter plate was determined by photoelectric colorimeter. Transparency of each filled cavity. The 〇% potency represents the growth of the control group, and the 100% potency represents > no fungal growth was observed. Ίο The following Tables D1, D2 and D3 clearly show that the activity of the active compound composition according to the present invention is greater than the calculated activity, i.e., it exhibits an existing synergistic effect. Table D1: Rice blast test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-29) 3 55 (1-29) 0.03 18 (1-4) 1 9 ( 1-31) 0.1 16 (M) 0.03 6 GBO 827 0.03 76 GBO 827 0.1 87 GBO 827 3 80 Metrafenone 3 60 -154- 200814928 Metaconazole 1 74 Meconazole ^ (metconazole) 0.03 66 epoxyconazole 3 81 According to the invention: (1-29) + epoxyconazole (1 : 1) (1-29) + diconazole (1 : 1) 3 + 3 0.03 + 0.03 Measured 98 85 Calculated 91 72 (1-29) + benzophenone (1 : 1) 3 + 3 90 82 (1-4) + thiconazole (1 : 1) 1 + 1 97 76 (1 -31)+ GBO 827(1 : 1) 0.1 +0.1 99 89 (1-1)+ GBO 827(1 : 1) 0.03 + 0.03 87 77 Measured = actual found effect; calculated = calculated using Colby formula Table of potency D2 #· rice blast fungus (Pjr/cw^r/fl) test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-4) 3 33 (1- 28) 0.03 19 灭康^(metconazole) 0.03 10 苯苯菌_(metrafeiKme) 3 80 phenoxylinone (metrafenone) 0.03 45 according to this hair : (1-4)+ GBO 827(1 : 1) 3 + 3 Measured 99 Calculated 87 (1-28) + benzophenone (1 : 1) 0.03 + 0.03 95 55 -155 - 200814928 (1- 28) + Deconazole (1 : 1) 0.03 + 〇.〇3 58 27 Measured = actual found efficacy; calculated = potency table D3 calculated using Colby formula: rice blast fungus (Pjr/c«/ariVi Test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-4) 3 33 mettrafenone 3 55 according to the invention: (1·4) + benzene The ketone (1: 1) 3 + 3 was calculated to be 75 70 measured = the actual found efficacy; calculated = the effect calculated using the Colby formula _ real _ case E: maize red emblem (10) g) test (in test tube v檄Trip handle This type test was applied to a microtiter plate using Pot-Dextrose Broth (PDB) as a liquid test medium, and the active compound was used in an industrial grade dissolved in acetone ( Technical_grade) Active ingredient, inoculated into a spore suspension of Gibberella zeae, inoculated in a dark room and shaken (10 Hz) for 3 days, the microtiter plate was determined by photoelectric colorimeter Transparency of each filled cavity. The 0% potency represents the growth of the control group, 1〇〇0/. The efficacy representative did not see the growth of fungi. Table E below clearly shows that the active compound composition according to the present invention is more active than the calculated activity, i.e., exhibits a synergistic effect. -156- 200814928 Table E: Gibberella rubrum test (in test tube) / microtiter plate active compound active compound application rate (ppm) potency (%) (1-4) 1 —---—___ — (1-28) 0·1 (1-29) 0.3 —_ —_ 59 Epoxyconazole 1 65 GBO 827 0.1 ] GBO 827 03 --- 24 According to the invention: 0.1+0.1 Calculated, (1-29 ) + GBO 827 (1 : 1) 78 69 (1-28) + GBO 827 (1 : 1) 0.3 + 0.3 43 37 (1-4) + Epoxyconazole (1 : 1) 1 + 1 --- - 84 73 Measured = actual found efficacy; calculated = effectiveness calculated using the Colby formula Example F: Pseudomonas pallidum test (in test tube) / derivative; ji 5 This micro-test is applied to a microtiter plate Potato-Dextrose Broth (PDB) was carried out as a liquid test medium, and the active compound was inoculated into Alternaria alternata using a technical grade (active) formulated in acetone. (7) The suspension was suspended with W(3//), and after inoculation for 3 days in the dark room and shaking (10 Hz), the light transmittance of each filled cavity of the microtiter plate was measured by photoelectric colorimeter. Sex. -157- 2008 14928 〇% potency represents the growth of the control group, 100% efficacy means no growth of the fungus. Table F below clearly shows that the activity of the active compound composition according to the invention is greater than the calculated activity, ie , which exhibits a synergistic effect table F · Alternaria alternata (in vitro) / microtiter plate active compound active compound application rate (ppm) potency (° / 〇) (1_1) 0.03 66 phenacridone (metrafenone 0.03 14 According to the invention: (1-1) + benzophenone (1 : 1) 03 + 03 Calculated by calculation *) 72 71 Measured = actual found efficacy; calculated = calculated using the Colby formula Efficacy of the case G: _I nuclear cavity (Pyrg / i or / Wgized rgs) test (Daily V 徭 让 让 让 让 溶剂 溶剂 溶剂 : : : : : : : : : : : : τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ τ The heavy alkylaryl polyglycol ether is a suitable active compound formulation, 1 part by weight of the active compound or active compound composition, mixed with the amount of solvent and emulsifier, 15 and this concentrate in water Dilute to the desired concentration. To measure the activity of the formula 5, at the stated application rate. The active compound preparation is sprayed on the young plant, and after the spray layer is dried, the plant is sprayed with a suspension of the genus of the genus of the genus, and the plant is left at 158·200814928 20° C. and 100% relative The humidity in the incubator was carried out for 48 hours. The plants were then transferred to a greenhouse of about 2 (TC and about 80% relative humidity. Evaluation was performed 10 days after inoculation, 0% represents the efficacy equivalent to the control group, and 100% of the efficacy represents no infection. Table G · · Bougainvillea test (barley) / protective active compound active compound application rate (g / ha) potency (%) (1-2) 3L25 22 (1-12) 31.25 --------- 56 Pycrostobin 31.25 78 Epirubicone _ (metrafenone) 31.25 0 Epoxyconazole 31.25 0 metconazole 31.25 0 tebuconazole 31.25 0 GBO 827 31.25 0 white (boscalid) 31.25 22 According to the invention: (1_2) + 100 gram dorbin 31.25 + 31.25 Measured - 94 78 Calculated 83 22 (1-2) + benzophenone 31.25 + 31.25 (1-2) + epoxy Kang α Sit 31.25 + 31.25 89 22 (1-2) + 灭康0 sit 31.25 + 31.25 89 22 (1-2) + HWG1608 3L25 + 3L25 100 22 -159- 200814928 (1-2) + GB0827 31,25+ 31.25 78 22 (l-2) + RK02273 31.25 + 31.25 100 39 (1-12) + 克克司多宾31.25 + 31.25 100 92 (1-12) + Epirubicin _ 31.25 + 31.25 89 56 (1_12) + Epoxy Oxazole 31.25+ 31 .25 89 56 (1-12) + 消康嗤31.25 + 31.25 94 56 (1-2) + 克力力31.25 + 31.25 89 56 (1-2) + GB0827 3L25 + 3L25 94 56 (1-2)+白克力31.25+ 3L25 89 66 Measured = actual found efficacy; calculated = effectiveness calculated using the Colby formula Example H: Phytophthora (P/IV plus /? / | recognized still 71) test (tomato V protective solvent: 24.5 parts by weight of acetone 5 24.5 parts by weight of dimethylacetamide I emulsifier: 1 part by weight of aryl aryl polyglycol ether to give a suitable active compound formulation, 1 part by weight of active compound or active The compound composition is mixed with the amount of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration. In order to test the protective activity, the active compound preparation is sprayed onto the juvenile plant at the stated application rate, and after the spray layer is dried, the plant is sprayed with the aqueous suspension of the disease-causing bacteria/«/(2) plus) Liquid, the plants are placed in 2 (TC and 100% relative humidity incubator. -160- 200814928 and:: two into two: represents the equivalent of the control group

表H·疫菌(P办師/|从_)試驗(蕃霖)/保 活性化合物 活性化合物施用率 (克/公頃) —-—---- 效力(%) (1-2) 20 —-~—---- 8 賽座滅(Cyazofamid), 實例14-1 2 ——-- 24 根據本發明: (1-2)+ 賽座滅(lO^JL 20 + 2 46 計算得^ Λα 實測得==實際發現的效力,δ十异得=使用Colby公式計算得的饮力 -161-Table H· Phytophthora (P-engineer/|from_) test (fanlin)/protective compound active compound application rate (g/ha) —----- effectiveness (%) (1-2) 20 — -~—---- 8 Cyazofamid, Example 14-1 2 ——-- 24 According to the invention: (1-2)+ Saibo (lO^JL 20 + 2 46 calculated ^ Λα Measured == the actual found effectiveness, δ ten different = the use of Colby formula calculated drinking power -161-

Claims (1)

200814928 十、申請專利範圍· /種殺真菌的活性化合物組合物, 式(I)的羧醯胺 係包含第(1)類之具200814928 X. Patent application scope / / fungicidal active compound composition, carboxamide of formula (I) comprising class (1) 其中 R 代表氫或氟, R1代表_素’ Ci-CV烧基’ 基燒基,礼美, 硝基’ CrC3_烷氧基’具有1.至7個氟,氯及/或 >臭原子之CrC3_鹵基-燒氧基或代表 -C(R4)=N-OR5, 又 R2代表鼠’鹵素’ crcv烧基,crcv鹵基烧基,氮 基,硝基,CrCr烷氧基,或代表具有i至7個敦% 氣及/或溴原子之C1-C3-鹵基烧氧基, R4代表氫或曱基, R5代表CVCV烧基,CVCV烯基或crc5_炔基, 以及至少一種挑選自下述第(2)類至第(25)類的活性化 合物: JlilllL_县式(ID之史托比系(Strobihidns) (Π) -162- 200814928 其中 A1 代表下述基之一Wherein R represents hydrogen or fluorine, R1 represents _'s 'Ci-CV alkyl' group, and nitro, 'CrC3_alkoxy' has from 1. to 7 fluorine, chlorine and/or > CrC3_halo-alkoxy or represent -C(R4)=N-OR5, and R2 represents a murine 'halogen' crcv alkyl, crcv haloalkyl, nitrogen, nitro, CrCr alkoxy, or a C1-C3-halo alkoxy group having from i to 7 hydrogen and/or a bromine atom, R4 representing hydrogen or a fluorenyl group, R5 representing a CVCV alkyl group, a CVCV alkenyl group or a crc5-alkynyl group, and at least one selected Active compounds from categories (2) to (25) below: JlilllL_ County (Strobihidns (ID) -162- 200814928 of ID) where A1 represents one of the following groups 10 A2 代表NH或Ο, A3 代表N或CH, L 代表下述基之一10 A2 represents NH or Ο, A3 represents N or CH, and L represents one of the following groups 其中以星號(*)標示的鍵係附接至苯基環, 15The bond marked with an asterisk (*) is attached to the phenyl ring, 15 R11代表苯基,苯亞曱基,苯氧基或吼啶基,各為選 擇地經一或二個相同或相異的,挑選自包括氯, 氰基,曱基及三氟曱基之取代基取代,或代表1-(4-氣苯基)吼唑-3-基或代表1,2-丙二酮-雙(0-曱基 將)_1_基, R12 代表氫或氟; 第(3)類 具式(III)之三唑類(Triazoles)R11 represents phenyl, benzylidene, phenoxy or acridinyl, each of which is optionally substituted by one or two identical or different, selected from the group consisting of chlorine, cyano, decyl and trifluoromethyl Substituted, or represents 1-(4-phenylphenyl)oxazol-3-yl or represents 1,2-propanedione-bis(0-fluorenyl)-1-yl, R12 represents hydrogen or fluorine; 3) Triazoles of formula (III) m -163 - 20 ^00814928 其中 Q代表氫或SH, m代表0或1, ^代表氫,氣,氯,苯基或4、氣苯氧基, 代表氫或氯, A4代表一種直接鍵,七出-,_(CH2)2_4_〇·,代表m -163 - 20 ^00814928 wherein Q represents hydrogen or SH, m represents 0 or 1, ^ represents hydrogen, gas, chlorine, phenyl or 4, gas phenoxy, represents hydrogen or chlorine, A4 represents a direct bond, seven Out -, _(CH2)2_4_〇·, represents 10 -CH2-CHR -或*-CH=CR17-,其巾以*號標示的鍵 係附接至苯環, /、中 R 及 R —起代表·CH2 CH2 CH[CH(CH3)士或 -CH2-CH2-C(CH3)2-, A5代表C或Si(石夕), A也代表-N(R )-及a5也一起與r15及r16代表 ON-R18之基,其中Rn&Ru 一起代表下面之基:10 -CH2-CHR - or *-CH=CR17-, the label of the towel marked with * is attached to the benzene ring, /, where R and R together represent · CH2 CH2 CH[CH(CH3) ± or - CH2-CH2-C(CH3)2-, A5 represents C or Si (Shixi), A also represents -N(R)- and a5 also together with r15 and r16 represent the group of ON-R18, in which Rn&Ru Represents the following base: 其中以*號標示的鍵係附接至R17, R15代表氫,羥基或氰基 R代表卜環丙基乙基,1-氯環丙基,CrC4-烧基, CrC6-羥基烷基,crC4-烷基羰基,CrC2-鹵基烷 氧基-CrC2·烷基,三曱基矽烷基_crC2-烷基,單 氟苯基或苯基, R15 及 R16 尚一起代表-〇-CH2-CH(R18)-〇-, _o-ch2_ch(r丨8)-ch2-,-0-CH(OCH2CF3)_(CH2)2- 或-0-CH-(2-氯笨基)-, -164- 20 200814928 A4,A5 及 rU 尚 鍵_接Μ ί CH=C_,其中以*號標示的 崎:丨尔附接至本基環, Aicrc4戈基或漠; 5 ~ ~" 酿胺類(Sulphenamides) (IV)The bond indicated by the * symbol is attached to R17, R15 represents hydrogen, hydroxy or cyano R represents cyclopropylethyl, 1-chlorocyclopropyl, CrC4-alkyl, CrC6-hydroxyalkyl, crC4- Alkylcarbonyl, CrC2-haloalkoxy-CrC2.alkyl, tridecylsulfanyl-crC2-alkyl, monofluorophenyl or phenyl, R15 and R16 together represent -〇-CH2-CH (R18 )-〇-, _o-ch2_ch(r丨8)-ch2-,-0-CH(OCH2CF3)_(CH2)2- or -0-CH-(2-chlorophenyl)-, -164- 20 200814928 A4, A5 and rU 尚键_接Μ ί CH=C_, where the singularity marked with * is attached to the base ring, Aicrc4 Goki or desert; 5 ~ ~" Sulphenamides ( IV) 1010 其中R代表氫或甲基; 充(5)痛--Ik廷自下填之顯胺酿胳類(Valinamides): (5-1)異丙菌胺(iprovaHcarb) (5-2) Λ^[2-(4-{|>(4-氯苯基)-2_丙炔基]氧}-3-曱氧基 苯基)乙基]-ΛΓ2-(甲基磺醯基>D-纈胺醯胺 (5-3)笨嗟菌胺(benthiavalicarb) 15Wherein R represents hydrogen or methyl; Charge (5) Pain--Iktin is self-priming of Valinamides: (5-1) IprovaHcarb (5-2) Λ^[ 2-(4-{|>(4-chlorophenyl)-2-propynyl]oxy}-3-decyloxyphenyl)ethyl]-indole 2-(methylsulfonyl)>D- Amidoxime (5-3) benthiavalicarb 15 第(6)類具式(V)之幾酿胺類(Carboxamides)Carboxamides of type (6) with formula (V) Η (V) 其中 X 代表孓氯-3』比啶基,代表2,4-二氯冬吼啶基,代 表在3-位置經甲基,二氟甲基或三氟曱基取代且 於5-位置經氫或氯取代之1-甲基吼唑-4-基,代表 4-乙基-2-乙基胺基-1,3-噻唑-5-基,代表2-甲基-4-三氟甲基-1,3-噻唑-5-基,代表1-甲基環己基,代 -165- 20 200814928 5Η (V) wherein X represents chloro-3-indenyl group, representing 2,4-dichloroindazinyl, which represents a methyl, difluoromethyl or trifluoromethyl group at the 3-position and substituted at 5 - 1-methyloxazol-4-yl substituted by hydrogen or chlorine, representing 4-ethyl-2-ethylamino-1,3-thiazol-5-yl, representing 2-methyl-4- Trifluoromethyl-1,3-thiazol-5-yl, representing 1-methylcyclohexyl, substituted-165- 20 200814928 5 10 表2,2-二氯-1-乙基-3 -曱基壞丙基,代表2 -氣-2-丙 基,3,4-二氣異噻唑-5-基,5,6·二氫-2-曱基-1,4-氧硫雜環(〇xathiin)-3-基,4,4-二氧代-5,6-二氫-1,4-氧硫雜壤-3-基’ 4-曱基·1,2,3-σ塞二嗤·5-基’ 4,5_ 二曱基-2-二曱基碎烧基σ塞吩-3-基’ 1 -甲基σ比洛-3-基,其在4-位置經曱基或三氟曱基取代且於5-位 置經氫或氣取代,或代表經一至三個相同或相異 的挑選自包括氯,曱基及三氟甲基之取代基取代 之苯基,或代表2-甲基呋喃-3-基, Υ 代表一種直接鍵,選擇地經氯,氰基或氧代基之 取代基取代之crc6-烷二基(亞烷基),代表c2-cv 烯二基(亞烯基)或硫苯二基, Z 代表氫,crc6-烷基或下面之基:10 Table 2, 2-dichloro-1-ethyl-3-indenyl-propylpropyl, representing 2-air-2-propyl, 3,4-dioxaisothiazol-5-yl, 5,6·2 Hydrogen-2-mercapto-1,4-oxothio (杂环xathiin)-3-yl, 4,4-dioxo-5,6-dihydro-1,4-oxothiazepine-3- '4-indolyl·1,2,3-σ-cetyl-5-yl' 4,5-dimercapto-2-diindenyl ketone-based thiophene-3-yl' 1-methyl σ Pilo-3-yl, which is substituted at the 4-position with a fluorenyl or trifluoromethyl group and substituted at the 5-position with hydrogen or gas, or represents one to three identical or different selected from the group consisting of chloro, fluorenyl And a phenyl group substituted with a substituent of a trifluoromethyl group, or a 2-methylfuran-3-yl group, Υ represents a direct bond, and is optionally substituted with a substituent of a chlorine, a cyano group or an oxo group. Dibasic (alkylene), representing c2-cv enediyl (alkenylene) or thiophenyldiyl, Z represents hydrogen, crc6-alkyl or the group below: A6 代表 CH,CBr 或 N, r2()代表氫,氯,溴,氰基或crc6-烷基,選擇地經 一或二個相同或相異的挑選自包括氣及二(CrCr 烷基)胺基羰基之取代基取代之苯基,或代表可經 甲基取代之環丙基-環丙基, R21代表氫,氣或異丙氧基, R22代表氫,氣,溴,羥基,曱基,三氟曱基,三氟 曱氧基或二(CrC3-烷基)胺基羰基, -166- 20 200814928A6 represents CH, CBr or N, and r2() represents hydrogen, chlorine, bromine, cyano or crc6-alkyl, optionally selected from one or two identical or different selected gases and bis(CrCr alkyl)amines. a phenyl group substituted with a substituent of a carbonyl group, or a cyclopropyl-cyclopropyl group which may be substituted by a methyl group, R21 represents hydrogen, a gas or an isopropoxy group, and R22 represents a hydrogen, a gas, a bromine, a hydroxyl group, a thiol group, Trifluoromethyl, trifluoromethoxy or bis(CrC3-alkyl)aminocarbonyl, -166- 20 200814928 10 1510 15 R2G 及 R21 也一起代表 *-CH(CH3)-CH2-C(CH3)2-或 *-ch(ch3)-o-c(ch3)2-,其中以*號標示的鍵係附 接至R20 ; 挑選自下述之二硫胺基甲酸酯類: 1)鋅 I孟乃浦(mancozeb) 猛乃浦(maneb) 免得爛(metiram) (7-4)甲基鋅乃浦(propineb) (7_5)得恩地(thiram) (7-6)鋅乃浦(zineb) (7、7)福美鋅(ziram) __具式(VD之酿基丙胺酸類(Acylalanines)R2G and R21 also together represent *-CH(CH3)-CH2-C(CH3)2- or *-ch(ch3)-oc(ch3)2-, wherein the bond marked with an * is attached to R20; From the following dithiocarbamates: 1) Zinc Imanoze (mancozeb) Meng Naipu (maneb) to avoid ruin (metiram) (7-4) methyl zinc napo (propineb) (7_5) Dean ( Thiram) (7-6) Zinna (zineb) (7, 7) ziram zirconia __ with formula (VD alkaline (Acylalanines) 其中 代表具R-或S-組態之一種碳原子,較佳地為呈現 s-組態者, 20 f3代表笨甲基,呋喃基或曱氧基甲基; —具式 ί VII)之笨胺基,唆類(Anilinopyrimidines)Wherein it represents a carbon atom having an R- or S-configuration, preferably an s-configurator, 20 f3 represents a stupid methyl group, a furyl group or a decyloxymethyl group; Amine, anilinopyrimidines ch3 -167- 200814928 其中 R24代表甲基,環丙基或1-丙炔基; 第(10)類) 具式(VIID的笨并咪唑類 5Ch3 -167- 200814928 where R24 represents methyl, cyclopropyl or 1-propynyl; group (10) has the formula (VIID of stupid imidazoles 5 其中among them 10 R25及R26各代表氫或一起代表-0-CF2-0-, R27代表氫,CrC4-烷基胺基羰基或代表3,5-二甲基異 σ惡峻-4-基續醯基, R28代表氯,曱氧基羰基胺基,氯苯基,呋喃基或噻 嗤基; 第Π1)類 具式(DO之胺基甲酸酯類 1510 R25 and R26 each represent hydrogen or together represent -0-CF2-0-, R27 represents hydrogen, CrC4-alkylaminocarbonyl or represents 3,5-dimethyliso-sigma-4-yl fluorenyl, R28 represents chloro, decyloxycarbonylamino, chlorophenyl, furyl or thioxyl; Π1) is a formula (DO urethane 15 r2、cA〆。 师 Η 其中 R29代表正-或異丙基, R3G代表二(crc2-烷基)胺基-c2-c4-烷基或二乙氧基苯 基, 也包括這些化合物之鹽類; 第(12) 類挑選自下述之二羧基亞醯胺類(Dicarboximides): (12-1)四氯丹(captafol) (12-2)蓋普丹(captan) …168- 20 200814928 (12-3)福爾培(folpet) (12-4)依普同(iprodione) (12-5)撲滅寧(procymidone) (12-6)免克寧(vinclozolin) 5 第(13)類 挑選自下述之胍類(Guanidines) · (13-1)多寧(dodine) (13-2)克熱淨(guazatine)R2, cA〆. Wherein R29 represents n- or isopropyl, R3G represents bis(crc2-alkyl)amino-c2-c4-alkyl or diethoxyphenyl, and also includes salts of these compounds; (12) The class was selected from the following Dicarboxyboximides: (12-1) tetramdan (captafol) (12-2) captan (168-2) 200814928 (12-3) Folpet (12-4) iprodione (12-5) procymidone (12-6) vinclozolin 5 (13) selected from the following mites ( Guanidines) · (13-1) dodine (13-2) guazatine 10 (13-3)雙胍辛胺三乙酸鹽(iminoctadine triacetate) (13-4)克熱淨(烧苯績酸鹽)[iminoctadine tris (albesilate)] (13-5)多寧(dodine (游離驗)) (13-6)克熱淨(immoctadine)(游離驗) 第(14)類 挑選自下述之味嗤類(Imidazoles) · (14-1)賽座滅(cyazofamid) 15 (14-2)撲克拉(prochioraz) (14-3)三嗤嗪(triazoxide) (14-4)稻瘦 g旨(pefurazoate) 第(13類 < 具式OQ之嗎啉類(或其鹽類)·· 其中10 (13-3) bisinoctylamine triacetate (13-4) gram heat net (burning benzoate) [iminoctadine tris (albesilate)] (13-5) donin (dodine (free test) )) (13-6) Imgoctadine (free test) Item (14) is selected from the following Imidazoles (14-1) Cyazofamid 15 (14-2) ) poker (prochioraz) (14-3) triazoxide (14-4) rice thin g (pefurazoate) (13th class < OQ morpholine (or its salt)·· among them (X) R31及R32彼此獨立地代表氫或曱基, R33代表CrC14-烷基(較佳地為C12-CH-烷基),C5-C〗r -169- 20 200814928 壞院基(較佳地為Ci〇-Ci2_^烧基)’苯基-Ci-Cr烧 基,其可在苯基部位經鹵素或CrC4-烷基取代或 代表丙烯基,其可經氯苯基及二甲氧基苯基取代; 第Π 6)類 具式(XI)之吡咯類(Pyrroles) 5(X) R31 and R32 independently of each other represent hydrogen or a fluorenyl group, R33 represents a CrC14-alkyl group (preferably a C12-CH-alkyl group), and C5-C〗 r-169- 20 200814928 Is a Ci(R)-Ci2-(alkyl)-phenyl-Ci-Cr alkyl group which may be substituted at the phenyl moiety by halogen or CrC4-alkyl or represents a propylene group which may be chlorophenyl and dimethoxy Phenyl substitution; Π 6) Pyrroles of formula (XI) 5 ID 15 其中 R34代表氯或氰基, R35代表氣或硝A基, R36代表氯, R35及R36尚可一起代表-0-CF2-0-; 第Π7)類 挑選自下述之(硫)膦酸酯類: (17-1)福賽得-鋁(fosety 1-A1) (17-2) 膦酸 (17-3)曱基立枯鱗(tolclophos-methyl) 第Π8)類 具式(XII)之笨基乙醢胺類ID 15 wherein R34 represents chlorine or cyano, R35 represents gas or nitrate A, R36 represents chlorine, R35 and R36 together represent -0-CF2-0-; and group 7) is selected from the following (thio)phosphine Acid esters: (17-1) Fossex-aluminum (fosety 1-A1) (17-2) Phosphonic acid (17-3) tolclophos-methyl Π8) genus (XII) Stupid base acetamide 其中 R37代表無取代的或經氟-,氯-,溴-,曱基-或乙基-取代的苯基^ 2-蔡基^ 1,2,3,4-四氮秦基或茚滿基; -170- 20 200814928 第(19)類選自下述之殺真菌劑類 (19-1) 苯并嗟二嗤 1旨(acibenzolar-S-met;hyl) (19-2) 氯塞尼(chlorothalonil) (19-3) 克絕(cymoxanil) 5 (19-4) 護粒松(edifenphos) (19-5) 凡殺同(famoxadone) (19-6) 伏寄南(fluazinam) • (19-7) 氯氧化銅(copper oxychloride) (19-8) 氫氧化銅 10 (19-9) 歐殺斯(oxadixyl) (19-10) 螺環菌胺(spiroxamine) (19-11) 二硫酿(dithianon) (19-12) 表苯菌酮(metrafenone) (19-13) 口米唾菌酮(fenamidone) 15 (19-14) 2,3-二丁基-6-氯噻吩并[2,3-d]嘧啶-4(3H)-酮 (19-15) 撲殺熱(probenazole) (19-16) 稻痕靈(isoprothiolane) (19-17) 嘉賜黴素(kasugamycin) (19-18) 熱必斯(phthalide) 20 (19-19) 富米熱斯(ferimzone) (19-20) 三賽口坐(tricyclazole) (19-21) N-({4-[(環丙基胺基)羰基]苯基}磺醯基)-2-甲 氧基苯甲醯胺 (19-22) 2-(4-氯苯基)-N-{2-[3-曱氧基-4-(丙-2·炔-1-基 -171 - 200814928 乳)苯基]乙基}-2_(丙-2-快-1-基氧)乙酿胺 (19-23)快諾芬(quinoxyfen) 第(20)類選自下述之(硫)脲衍生物 (20-1)賓克隆(pencycuron) (20-2)曱基-多保淨(thiophanate-methyl) (20-3)乙基-多保淨(thiophanate-ethyl) 第(2Π類具式(XIII)之醯胺類Wherein R37 represents unsubstituted or fluoro-, chloro-, bromo-, decyl- or ethyl-substituted phenyl^2-caiyl^ 1,2,3,4-tetrazinyl or indanyl -170- 20 200814928 Class (19) is selected from the group of fungicides described below (19-1) benzoxanthene (acibenzolar-S-met; hyl) (19-2) chloroseni ( Chlorothalonil) (19-3) cymoxanil 5 (19-4) edifenphos (19-5) fascinated (famoxadone) (19-6) volts south (fluazinam) • (19- 7) Copper oxychloride (19-8) Copper hydroxide 10 (19-9) Oxadixyl (19-10) Spiroxamine (19-11) Disulfide ( Dithianon) (19-12) metrafenone (19-13) fenamidone 15 (19-14) 2,3-dibutyl-6-chlorothieno[2,3 -d]pyrimidin-4(3H)-one (19-15) prague fever (19-16) rice saponin (isoprothiolane) (19-17) kasugamycin (19-18) heat Phthalate 20 (19-19) Fermizone (19-20) Tricyclazole (19-21) N-({4-[(cyclopropylamino)carbonyl) Phenyl}sulfonate 2-methoxybenzoguanamine (19-22) 2-(4-chlorophenyl)-N-{2-[3-decyloxy-4-(propan-2-alkyn-1- Base -171 - 200814928 Milk)Phenyl]ethyl}-2_(propan-2-free-1-yloxy)ethinamide (19-23) quinoxyfen (20) is selected from the following (thio)urea derivative (20-1) pencycuron (20-2) thiophanate-methyl (20-3) ethyl-polyphanate-ethyl ( 2 hydrazines of the formula (XIII) (xm) 其中 A7代表一種直接鍵或-0-, A8 代表 _C(=0)NH-或-NHC(=0)-, R38代表氫或CrC4-烷基, R39代表Ci-Cf烧基; 第(22)類具式(XIV)之三嗤并。密咬類(Triazolopyrimidines)(xm) wherein A7 represents a direct bond or -0-, A8 represents _C(=0)NH- or -NHC(=0)-, R38 represents hydrogen or CrC4-alkyl, and R39 represents a Ci-Cf alkyl group; Class (22) has the same formula (XIV). Triazolopyrimidines R4G代表crc6-烷基或c2-c6-烯基, R41代表CrC6-烷基, R40及R41也一起代表C4-C5-烷二基(亞烷基),其為經 -172- 20 200814928 一或二個的crc6-烷基取代, R42代表溴或氯, R43及R44彼此獨立地代表氫,氟,氯或甲基, R44及R46彼此獨立地代表氫或氟, 5 R45代表氫,氟或甲基, 第(23)類具式(XV)之破代色酮類(Iodochromones)R4G represents crc6-alkyl or c2-c6-alkenyl, R41 represents CrC6-alkyl, and R40 and R41 together represent C4-C5-alkanediyl (alkylene), which is -172- 20 200814928 or Two of the crc6-alkyl groups, R42 represents bromine or chlorine, R43 and R44 independently of each other represent hydrogen, fluorine, chlorine or methyl, R44 and R46 independently of each other represent hydrogen or fluorine, and 5 R45 represents hydrogen, fluorine or Base, Idochromones of type (23) with formula (XV) 10 'Xx!jC0S 其中 R48代表CrC6-烷基, R49代表C「C6-烷基,C2-C6-烯基或C2-C6-炔基; 第(24)類具式(XVI)之聯笨基羧醯胺類 (Biphenvlcarboxamides) 1510 'Xx!jC0S wherein R48 represents CrC6-alkyl, R49 represents C"C6-alkyl, C2-C6-alkenyl or C2-C6-alkynyl; and (24) has the formula (XVI) Biphenvlcarboxamides 15 (XVI) 其中 R5()代表氫或氟, R51代表氟,氯,溴,甲基,三氟曱基,三氟曱氧基, -CH=N-OMe 或-C(Me)二N-OMe, R52代表氫,氟,氯,溴,曱基或三氟曱基, -173- 20 200814928 Het代表下述Hetl至Het7基之一:(XVI) wherein R5() represents hydrogen or fluorine, and R51 represents fluorine, chlorine, bromine, methyl, trifluoromethyl, trifluoromethoxy, -CH=N-OMe or -C(Me) di N-OMe , R52 represents hydrogen, fluorine, chlorine, bromine, decyl or trifluoromethyl, -173-20 200814928 Het represents one of the following Hetl to Het7 groups: 5 R53代表碘,曱基,二氟甲基或三氟曱基, | R54代表氫,氟,氯或甲基, R55代表甲基,二氟曱基或三氟曱基, ίο R56代表氯,溴,碘,甲基,二氟甲基或三氟甲基, R57代表甲基或三氟甲基; 第(25)類具式(XVID之烷基羧醯胺類5 R53 represents iodine, fluorenyl, difluoromethyl or trifluoromethyl, | R54 represents hydrogen, fluorine, chlorine or methyl, R55 represents methyl, difluoroindenyl or trifluoromethyl, ίο R56 represents chlorine, Bromine, iodine, methyl, difluoromethyl or trifluoromethyl, R57 represents methyl or trifluoromethyl; (25) has the formula (XVID alkyl carbamide) 1515 其中 Het的定義如前, R58代表氫或氟, R59代表氫,鹵素,CrC3-烷基或具有1至7個的氟, 氯及/或溴原子之CrC3-鹵基烷基。 2· —種殺真菌的活性化合物組合物,係包含第(1)類之具 式⑴的叛醯胺 -174- 20 200814928Wherein Het is as defined above, R58 represents hydrogen or fluorine, and R59 represents hydrogen, halogen, CrC3-alkyl or CrC3-haloalkyl having 1 to 7 fluorine, chlorine and/or bromine atoms. 2. A fungicidal active compound composition comprising the rebel amine of formula (1) of formula (1) -174-20 其中 R 代表氬或氟, R 代表鹵素’ Ci-Cg-烧基’ Ci-Cg-i基烧基^鼠基, 硝基,CrC3-烷氧基,具有1至7個氟,氯及/或 >臭原子之C1-C3-鹵基-烧氧基或代表 -C(R4)二N-OR5, R2代表氫,i素,crc6-烷基,crc6-鹵基烷基,氰 基’頌基’ C1-C3-烧氧基’或代表具有1至7個氟^ ’ 氯及/或溴原子之crc3-鹵基烷氧基, R4代表氫或曱基, R5代表CrC5-烷基,CrC5-烯基或CrC5-炔基, 以及至少一種挑選自下述第(26)類的活性化合物: 第(26)類具式(XVIID之烷基羧醯胺類Wherein R represents argon or fluorine, and R represents halogen 'Ci-Cg-alkyl' Ci-Cg-i-based alkyl group, nitro group, CrC3-alkoxy group, having 1 to 7 fluorine, chlorine and/or > C1-C3-halo-alkoxy of the odor atom or represents -C(R4)di-N-OR5, R2 represents hydrogen, i, crc6-alkyl, crc6-haloalkyl, cyano'颂The base 'C1-C3-alkoxy' or a crc3-haloalkoxy group having 1 to 7 fluorine and/or bromine atoms, R4 represents hydrogen or a fluorenyl group, and R5 represents a CrC5-alkyl group, CrC5 An alkenyl group or a CrC5-alkynyl group, and at least one active compound selected from the following class (26): Group (26) of the formula (XVIID alkyl carboxy guanamine) -175- R代表氫或氟, r61代表氫,鹵素,CrC3·烧基或具有1至7個的氟, 氣及/或漠原子之C1-C3- _基烧基。 A’代表下述A’l至A,8基之一-175- R represents hydrogen or fluorine, and r61 represents hydrogen, halogen, CrC3.alkyl or a C1-C3- yl group having 1 to 7 fluorine, gas and/or a desert atom. A' represents one of the following A'l to A, 8 bases 200814928 R代表Ci_C3~烧基, 63 R代表氫,鹵素,crc3-烷基或具有1至7個的氟, 氯及/或溴原子之crcr鹵基烷基, R64代表氫,鹵素或crcr烷基, R6代表鹵素,CrC3-烧基或具有1至7個的氟,氯及 /或演原子之Ci-CV鹵基烧基, R66代表氫,鹵素或crc3-烧基,胺基,單-或二(cr(V 烷基)胺基, 67 R代表氫’鹵素,CrCV院基或具有1至7個的氟, 氯及/或溴原子之crcr鹵基烷基, R代表鹵素,Ci-Cr烷基或具有1至7個的氟,氯及 /或溴原子之crc3-鹵基烷基, R代表鹵素,Ci-C^烷基或具有1至7個的氟,氯及 /或溴原子之crc3-鹵基烷基, -176- 200814928 3.200814928 R represents Ci_C3~alkyl, 63 R represents hydrogen, halogen, crc3-alkyl or has 1 to 7 fluorine, chlorine and/or bromine atom crcr haloalkyl, R64 represents hydrogen, halogen orcrcr alkyl , R6 represents halogen, CrC3-alkyl or has 1 to 7 fluorine, chlorine and/or a Ci-CV haloalkyl group, R66 represents hydrogen, halogen or crc3-alkyl, amine, mono- or Di(cr(V alkyl)amino group, 67 R represents hydrogen 'halogen, CrCV, or a crcr haloalkyl group having 1 to 7 fluorine, chlorine and/or bromine atoms, R represents halogen, Ci-Cr An alkyl group or a crc3-haloalkyl group having 1 to 7 fluorine, chlorine and/or bromine atoms, R represents a halogen, a Ci-C^alkyl group or a fluorine, chlorine and/or bromine atom having 1 to 7 Crc3-haloalkyl, -176- 200814928 3. 10 15 酉蓋胺’其中 R代表氫或氟 r7〇 >vv . ^ 代表氣,自素,crc3-烷基或具有i 氯及/或漠原子之CrC』基燒基。至7個的既, 圍第1或2項的活性化合物組合物, 酿;ίΓ範圍第1項之具式(1)之第⑴類的繞 R代表氟,氯’溴,碘’曱基’乙基,正-丙基,異 丙基,三氟甲基,三氣曱基,氰基,甲氧基,/乙 氧基,正丙氡基,異丙氧基,三氟甲氧基;i 甲氧基或代表-C(R4)=N-OR5, 、 R代表氫,氟,氯,溴,碘,曱基,乙基,正_丙基, 異丙基,三氟甲基,三氯曱基,氰基,甲氧 乙氧基,正丙氧基,異丙氧基,三氟甲氧基或代 表三氯曱氧基, r4代表氫或甲基, R代表Ci-C5-烧基。 4·根據申請專利範圍第1項的活性化合物組合物,其中 第(2)至(25)類的活性化合物係挑選自下列的化合物: (2-1)亞托敏(azoxystrobin),(2-2)氟喷菌 g旨 (fluoxastrobin),〇3) (2五)-2·(2-{[6-(3-氣甲基苯氧 基)-5·氟-4-嘧啶基]氧}苯基)-2-(甲氧基亞胺基)-#-甲基 乙醯胺,(2-4)三氟敏(trifloxystrobin),(2-5) (2五)-2-(曱 氧基亞胺基曱基_2-(2-{[({(1£>1-[3_(三氟曱基)苯 基]乙二基}胺基)氧]曱基}苯基)乙醯胺,(2·6) -177- 20 (2£>2-(甲氧基亞胺基)U基_2_{2-[(£>({1-[3-(三氟 甲基)苯基]乙氧基}亞胺基)-甲基]苯基}乙醯胺,(2-7) 將醚菌胺(orysastrobin),(2-8) 5-曱氧基-2-甲基 -4-(2-{[({(1五)小[3-(三氟甲基)苯基]乙二基}胺基)氧]_ 甲基}苯基)-2,4-二氮-3//-l,2,4-二嗤-3·嗣,(2-9)克收 辛·甲基(kresoxim-methyl),(2-10)大滅嗤丙 (dimoxystrobin),(2-11)咬氧菌酯(picoxystrobin),(2-12) σ圭菌胺酯(pyraclostrobin) ’ (2-13) 苯氧菌胺 (metominostrobin),(2-14)英司多丙(enestrobin),(3-1) 氮雜康嗤(azaconazole),(3-2)伊他康哇(etaconazole), (3-3)普比康嗤(propiconazole),(3-4)待芬康唾 (difenoconazole),(3-5)溴克利(bromuconazole),(3-6) 西普康嗤(cyproconazole),(3-7)菲克斯(hexaconazole),(3-8) 平康哇(penconazole),(3-9)邁克別尼(myclobutanil), (3-10)四康嗤(tetraconazole),(3-11)福採扶 (flutriafol),(3-12)依普座(epoxiconazole),(3-13)護 石夕唾(flusilazole),(3-14)辛康嗤(simeconazole),(3-15) 普硫康嗤(prothioconazole),(3-16) 芬布康唾 (fenbuconazole),(3-17)得克力(tebuconazole),(3-18) 艾普那嗤(ipconazole),(3-19)滅康嗤(metconazole), (3-20)三替康峻(triticonazole),(3-21)比多農 (bitertanol),(3-22)三泰隆(triadimenol),(3_23)三泰 芬(triadimefon),(3-24)氣啥康唾(fluquinconazole), (3-25)啥康嗤(quinconazole),(3-26)二氯布康嗤 -178- 200814928 (diclobutrazole),(3-27)得尼康唑(diniconazole),(3-28) 得尼康峻-m (diniconazole-m), (3-29)扶康哇 (furconazole),〇30)優尼康唑(uniconazole),(3-M)優 尼康唑 p (uniconazole p),(4-1)二氯氟尼 5 (dichlofluanid) ’(4-2)甲基益發靈(tolylfluanid),(5-1) 異丙菌胺(iprovalicarb) , (5-3) 苯噻菌胺 (benthiavalicarb),(6-1) 2'氣-N-(l,l,3-三甲基茚滿+基) _ 於驗醯胺,(6-2)白克力〇(^&1丨(!),(6-3)福滅比 (furametpyr),(6-4) N-(3-對-甲苯基噻吩-2-基)-1-甲基 10 冬三氟甲基°比哇_4_叛隨胺,(6-5)售峻菌胺 (ethaboxam),(6-6)環醯菌胺(fenhexamid),(6-7)卡普 米(carpropamid),(6-8) 2-氯-4-(2-氟-2-甲基丙醯基胺 基)-N,N-二甲基苯曱醯胺,(6_9)氟啶醯菌胺 (fhiopicolide),(6-10)唑查醯胺(zoxainide),(6-11) 3,4- 15 二氯氰基苯基)異嗟嗤緩醢胺,(6-12)卡保信 瞻 (carboxin),(6-13)噻醯菌胺(tiadinil),(6-14)噻菌胺 (penthiopyrad),(6-15)矽噻菌胺(siithi〇fam),(6-16) 1[2-(1,3-二甲基丁基)苯基]小曱基_4-(三氟甲基)-1仏 0比略-3-羧酿胺’(6-17)福多寧(flut〇ianii),(6-18)芬富 20 南(fenfuram) ’(6-19)嘉保信(OXyCarb〇xin),(6-20)塞 氟醯胺(thifluzamide),(6-21) Ν·{2-[3-氯-5_(三氟曱基) 0比咬基]乙基}-2_(三氟甲基)苯甲醯胺,(6-22) Ν·(2-雙環丙基-2-基苯基)小甲基冬三氟甲基·1Η_吡唑_4_羧 醯胺,(6-23) Ν-(2-雙環丙基·2_基苯基)小甲基二氟 -179 - 200814928 曱基-1H-吡唑-4-羧醯胺,(6-24)Ν-[2-(Γ-甲基雙環丙基 _2_基)苯基]小曱基·3·三氟甲基坐-4-竣醯胺, (6-25) Ν-[2-(Γ-甲基雙環丙基-2-基)苯基]-1-甲基-3-二 氟甲基-1Η-吡唑冰羧醯胺,(6-26)Ν-[1·(5-溴-3-氯吡啶 5 -2-基)乙基]-2,4-二氯菸鹼醯胺,(6-27) Ν-(5-溴各氯吼 啶-2-基)甲基-2,4-二氣菸鹼醯胺,(7-1)辞錳乃浦 (mancozeb),(7-2)錳乃浦(maneb),(7-3)免得爛 _ (metiram),(7-4)甲基鋅乃浦(propineb),(7-5)得恩地 (thiram) ’ (7-6)辞乃浦(zineb),(7-7)福美鋅(ziram), 10 (8-1)本達樂(benalaxyl)’(8-2)福達樂(furalaxyl),(8·3) 滅達樂(11^&1&\>4),(8-4)滅達樂-]\4,(8-5)本達樂-]\4, (9-1)西普地尼(cyprodinil),(9-2)滅盤尼比 (mepanipyrim),(9-3)必滅寧(pyrimethanil),(10-1) 6-氣-5-[(3,5-二甲基異嚼哇-4-基)石黃醯基]-2,2-二氟 is -5H-[1,3]二噁茂并[4,5-f>苯并咪唑,(10-2)免賴得 • (benomyl),(10-3)貝芬替(carbendazim),(10-4)氯芬 那唾(chlorfenazole),( 10-5)麥穗寧(fuberidazole),( 10-6) 腐絕(thiabendazole),(11-1)二硫芬克(diethofencarb), (11-2)普拔克(propamocarb),(11·3)鹽酸普拔克 2〇 (propamocarb-hydrochloride),(11-4)普拔克-福賽得 (propamocarb-fosetyl),(12-1)四氯丹(captafol),(12-2) 蓋普丹(captan),(12-3)福爾培(folpet),(12-4)依普同 (iprodione),(12_5)撲滅寧(procymidone),(12-6)免克 寧(vinclozolin),(13-1)多寧(dodine),(13-2)克熱淨 -180 - 200814928 (guazatine) ’(13-3)雙脈辛胺三乙酸鹽(iminoctadine triacetate) ’(13-4)克熱淨(烧苯石黃酸鹽)[iminoctadine tris(albesilate)],(13·5)多寧(dodine (游離鹼)),(13-6) 克熱淨(immoctadine)(游離鹼),(14·1)賽座滅 5 (cyazofamid),(14-2)撲克拉(prochloraz),(14-3)三唑 嗪(triazoxide),(14_4)稻痕 g旨(pefurazoate),(15,1)阿 得摩福(aldimorph),(15-2)三得芬(tridemorph),(15-3) 敵草隆(dodemorph) , (15-4) 芬普比福 _ (fenpropimorph) ’(15-5)大滅芬(dimethomorph),(16,1) ίο 芬畢克尼(fenpiclonil),(16-2)伏地口惡尼(fludioxonil), (16-3)吼洛尼精(pyrrolnitrin),(17-1)福賽得-鋁 (fosetyl-Al),(17-2)膦酸,(17-3)曱基立枯磷 (tolclophos-methyl),(18-1) 2-(2,3-二氫-1H-茚-5-基)-N_[2-(3,4-二甲氧基苯基)乙基]-2-(甲氧基亞胺基) is 乙醯胺,(18-2) Ν-[2-(3,4-二曱氧基苯基)乙基]-2-(曱氧 基亞胺基)-2-(5,6,7,8-四氮-奈-2-基)乙酿胺,(18-3)2-(4· ® 氣苯基)-Ν·[2-(3,4-二曱氧基苯基)乙基]-2-(甲氧基亞胺 基)-乙醯胺,(18-4)2-(4-溴苯基)-:^[2-(3,4-二曱氧基苯 基)乙基]-2-(甲氧基亞胺基)-乙醯胺,(18-5) 2-(4-甲基苯 2〇 基)-N-[2-(3,4-二曱氧基苯基)乙基]-2-(曱氧基亞胺基)- 乙醯胺,(18-6) 2-(4·乙基苯基)-Ν-[2-(3,4·二曱氧基笨基) 乙基]-2-(曱氧基亞胺基)-乙醯胺,(19-1)苯并噻二唑酯 (acibenzolar-S-methyl),(19-2)氯塞尼(chlorothalonil),( 19-3) 克絕(cymoxanil),(19-4)護粒松(edifenphos),(19-5)凡 -181- 200814928 殺同(famoxadone),(19_6)伏寄南(fluazinam),(19·7) 氣氧化銅(copper oxychloride),(19-9)歐殺斯 (oxadixyl),(19-10)螺環菌胺(spiroxamine),( 19-11)二 硫 i昆(dithianon),(19_12)表苯菌酮(metrafenone), 5 (19-13)咪唆菌酮(fenamidone),(19-14) 2,3-二丁基-6- 氣噻吩并[2,3-d]嘧啶-4(3H)-酮,(19-15)撲殺熱 (probenazole),(19-16)稻痕靈(isoproliiiolane),(19-17) ,嘉賜黴素(kasugamycin),(19-18)熱必斯(phthalide), (19-19)富米熱斯(ferimzone),(19-20)三賽口坐 ίο (tricyclazole) ’(19-21) Ν-({4-[(環丙基胺基)羰基]苯基} 磺醯基)-2-曱氧基苯曱醯胺,(19-22) 2-(4-氯苯 基)-N- {2-[3-曱氧基-4-(丙-2-炔-1-基氧)苯基]乙 基卜2-(丙-2-炔-1-基氧)乙醯胺,(19-23)快諾芬 (quinoxyfen) ’ (20-1)賓克隆(pencycuron),(20-2)甲基 is -多保淨(thiophanate-methyl),(20-3)乙基-多保淨 (thiophanate-ethyl),(21-1)氰菌胺(fenoxanil),(21-2) ® 雙氯氰菌胺(diclocymet),(22-1) 5-氯-ΛΗΓ7Θ·2,2,2-三 氟-1-甲基乙基>6-(2,4,6-三氟苯基)[1,2,4]三唑并[l,5-a] 嘧啶-7-胺,(22-2) 5-氯-尽二甲基丙 2〇 基]-6-(2,4,6-三氟苯基)[1,2,4]三唑并[l,5-a]嘧啶_7_胺, (22-3) 5-氯-6-(2-氯-6·氟苯基)-7-(4-曱基六氮°比〇定-1-基)[1,2,4]三唑并[l,5-a]-嘧啶,(22-4) 5-氯-6-(2,4,6-三氟 苯基)-7-(4-甲基六氫吼啶小基)[1,2,4]三唑并[l,5-a]嘧 °定’(23-1) 2-丁氧基-6-蛾-3 -丙基苯并1^比喃-4-S同,(23-2) -182- 200814928 乙氧基-6-碘-3-丙基苯并吡喃-4-酮,(23_3) 6-碘-2-丙 氧基-3-丙基苯并吡喃-4-酮,(23-4) 2-丁-2-炔基氧-6-碘 -3-丙基苯并吡喃酮,(23-5) 6-碘-2-(1-甲基丁氧 基)-3_丙基苯并吡喃-4-酮,(23-6) 2·丁-3-烯基氧-6-碘笨 并吡喃斗酮,(23-7) 3-丁基-6-碘-2-異丙氧基苯并吼喃 酮,(24_1)%(3’,4’-二氯_5-氟-1,1,-聯苯基|基)各(二 氟甲基)小甲基-lif-11比唾-4-羧酸胺,(24-2) #-(4,-溴 -1,Γ-聯苯基-2-基)-4-(二氟甲基)·2-甲基-1,3-嚷α坐-5-緩 醯胺,(24-3) 4-(二氟^曱基)冬甲基-尽[4,-(三氟甲 基)-1,Γ-聯苯基-2-基]-1,3-嗟哇-5-羧醯胺,(24-4) 二氯聯苯基冬基)-5-氟-1,3-二甲基-lif』比 唑I羧醯胺,(24-5) ΛΚ4,-氯-3,-氟-1,1,-聯苯基-2-基)-2-曱基-4-(三氟甲基)-1,3-噻唑-5-羧醯胺,(24_6)尽(4,-氯 •l,lf-聯苯基-2-基)-4-(二氟甲基)-2-甲基-1,3-σ塞峻-5-缓 醯胺,(25-1) #-[2-(1,3-二甲基丁基)苯基]-1,3_二甲基 -1//-吡唑-4-羧醢胺,(25-2) 7V-{2-(l,3-二曱基丁基)苯 基}-5-氟-1,3-二甲基-1/f-吡唑-4-羧醯胺,(25-3) 1[2-(1,3-二曱基丁基)苯基]-5-氯-1,3-二甲基比唑 -4-叛酿胺 ’(25-4)3-(二氟甲基)-7V~[2-(l,3-二甲基丁基) 苯基]-1_甲基-1乐吡唑-4-羧醯胺,(25-5) 3-(三氟甲 基)-Λ42-(1,3-二甲基丁基)苯基]-5-氟-1-甲基比唑 -4-羧醯胺,(25-6)3-(三氟甲基)-Λ42-(1,3-二甲基丁基) 苯基]-5-氯-1-甲基-1丑比唑冰羧醯胺,(25-7) 1,3-二甲 基-Λ42-(1,3,3-三甲基)苯基]-1仏口比唑-4-羧醯胺,(25-8) -183- 200814928 5-氟-1,3-一曱基-iV-[2(l,3,3-三曱基丁基)苯基]-1凡π比唾 -4-羧醯胺,(25-9) 3-(二氟甲基)小甲基-Λ42·(1,3,3-三 甲基丁基)苯基]-17^比唑-4-羧醯胺,(25-10) 3-(三氟f 基Μ-甲基1-[2-(1,3,3-三甲基丁基)苯基]-1//-,比唑_4_ 5 羧醯胺,(25-11) 3-(三氟曱基)冬氟-1-甲基j-[2-(l,3,3、 三曱基丁基)苯基]吼唑-4-羧醯胺,(25-12)3-(三氟 甲基)-5_氣-1-甲基善[2-(1,3,3-三甲基丁基)苯基>1//_ ,吡唑-4-羧醯胺,(25-13) 7V-[2-(l,3-(二曱基丁基)笨 基)-2-碘苯曱醯胺,(25-14) 2-硤-Λ/42-(1,3,3-三甲基丁 10 基)苯基]苯甲醯胺,(25-15) Ν-{2-(1,3-二甲基丁基)笨 基}-2-(三氟曱基)苯曱醯胺,(25-16) 2-(三氟甲 基)-Λ42-(1,3,3-三曱基丁基)苯基]苯甲醯胺。 5· 根據申請專利範圍第2項的活性化合物組合物,其中 第(26)類的活性化合物係挑選自下列的化合物: 15 (26-1) 5-氟-1,3-二甲基-曱基丁基)苯基]比 唑-4-羧醯胺,(26·2) 3-(二氟甲基)-Λ42-(3,3-二甲基丁 Ρ 基)·4-氟苯基]-1-甲基-ΐπ。比唑-4-羧醯胺,(26-3) 3-(二 氟曱基)-Α42-(3,3-二甲基丁基)苯基]-1-甲基比唑 -4-羧醯胺,(26-4)豕[2-(3>二曱基丁基)苯基]-2-(三氟 2〇 甲基)苯甲醯胺,(26-5) iV-[2-(3,3-二甲基丁基)-4-氟苯 基]-2-甲基-4-(三氟甲基)-1,3-噻唑-5-羧醯胺,(26-6) iV-[2-(3,3-二曱基丁基)-3-曱基嗔吩-2-魏醯胺。 6· 根據申請專利範圍第1至5項中任一項的活性化合物 組合物,其中式(XVI)的聯苯基羧醯胺與式(I)之羧醯胺 -184- 200814928 係不同類的化合物。 «申請專利範圍第i至6項中任—項的活性化合物 ,合物’包含一種式⑴的羧醯胺,其中R2基係位於聯 本基的遠端苯基環的2,-位置。 一種根據申請專利範圍第!至7項令任一項的活性化 口物組合物用於防治不想要的植物病原性真菌之用 途。10 15 guanamine 'wherein R represents hydrogen or fluorine r7 〇 > vv . ^ represents gas, self-priming, crc3-alkyl or CrC" group having i chlorine and/or a desert atom. The composition of the active compound of the first or the second of the seventh or the second of the formula (1) of the formula (1) of the winding R represents fluorine, chlorine 'bromine, iodine 'fluorenyl' Ethyl, n-propyl, isopropyl, trifluoromethyl, trimethyl decyl, cyano, methoxy, /ethoxy, n-propenyl, isopropoxy, trifluoromethoxy; i methoxy or represents -C(R4)=N-OR5, R represents hydrogen, fluorine, chlorine, bromine, iodine, decyl, ethyl, n-propyl, isopropyl, trifluoromethyl, tri Chloromethyl, cyano, methoxyethoxy, n-propoxy, isopropoxy, trifluoromethoxy or trichloromethoxy, r4 represents hydrogen or methyl, R represents Ci-C5-burn base. 4. The active compound composition according to claim 1, wherein the active compounds of the (2) to (25) are selected from the group consisting of: (2-1) azoxystrobin, (2- 2) Fluoxastrobin, 〇3) (2-5)-2·(2-{[6-(3-Vinylmethylphenoxy)-5·fluoro-4-pyrimidinyl]oxy} Phenyl)-2-(methoxyimino)-#-methylacetamide, (2-4) trifloxystrobin, (2-5) (25)-2-(oxygen) Amidino-based fluorenyl 2-(2-{[({(1)>1-[3_(trifluoromethyl)phenyl]ethylenediyl}amino)oxy)indolyl}phenyl) Indoleamine, (2·6) -177- 20 (2£>2-(methoxyimino) U-based_2_{2-[(£>({1-[3-(trifluoromethyl) (phenyl)ethoxy}imido)-methyl]phenyl}acetamidamine, (2-7) willsostazone, (2-8) 5-decyloxy-2- Methyl-4-(2-{[({(1)5)][3-(trifluoromethyl)phenyl]ethylenediyl}amino)oxy]-methyl}phenyl)-2,4- Dinitro-3//-l,2,4-dioxin-3·嗣, (2-9) kesoxim-methyl, (2-10) dimoxystrobin, (2-11) picoxystrobin, (2-12) σ galactosamine (pyraclostrobin) ' (2-13) metominostrobin, (2-14) enestrobin, (3-1) azaconazole, (3-2) itacon (aconaconazole), (3-3) propiconazole, (3-4) difenoconazole, (3-5) bromuconazole, (3-6) Cyproconazole, (3-7) hexaconazole, (3-8) penconazole, (3-9) myclobutanil, (3-10) tetraconne ( Tetraconazole), (3-11) flutriafol, (3-12) epoxiconazole, (3-13) flusilazole, (3-14) simeconazole ), (3-15) prothioconazole, (3-16) fenbuconazole, (3-17) tebuconazole, (3-18) ipuna ( Ipconazole), (3-19) metconazole, (3-20) triticonazole, (3-21) than bitertanol, (3-22) triadimenol (3_23) triadimefon, (3-24) fluquinconazole, (3-25) quinconazole, (3-26) Dichlorobuconazole-178- 200814928 (diclobutrazole), (3-27) Nikonazole (diniconazole), (3-28) Nikon Jun-m (diniconazole-m), (3-29 ) furconazole, 〇30) uniconazole, (3-M) uniconazole p, (4-1) dichlofluanid '(4-2) ) tolylfluanid, (5-1) iprovalicarb, (5-3) benthiavalicarb, (6-1) 2' gas-N-(l,l , 3-trimethylindan+yl) _ in the test of guanamine, (6-2) 克克力〇 (^&1丨(!), (6-3) blessing ratio (furametpyr), (6-4 N-(3-p-tolylthiophen-2-yl)-1-methyl10-winter trifluoromethyl °° wow _4_ rebel amine, (6-5) ethaboxam, (6-6) fenhexamid, (6-7) carpropamid, (6-8) 2-chloro-4-(2-fluoro-2-methylpropanylamino) -N,N-dimethylbenzamide, (6_9) fliopicolide, (6-10) zoxainide, (6-11) 3,4- 15 dichloride Cyanophenyl)isoxime, (6-12) card insurance (carboxin) (6-13) thiadinil, (6-14) penthiopyrad, (6-15) thiathicillin (siithi〇fam), (6-16) 1[2-( 1,3-Dimethylbutyl)phenyl]indenyl_4-(trifluoromethyl)-1仏0 to slightly 3-carboxychiral amine '(6-17) fordone (flut〇ianii) ), (6-18) Fenfu 20 South (fenfuram) '(6-19) OXyCarb〇xin, (6-20) thifluzamide, (6-21) Ν·{2 -[3-chloro-5-(trifluoromethyl) 0-bito]ethyl}-2_(trifluoromethyl)benzamide, (6-22) Ν·(2-bicyclopropyl-2- Phenyl) small methyl winter trifluoromethyl 1 Η pyrazole _4 carboxy carbamide, (6-23) Ν-(2-bicyclopropyl -2-phenylene) small methyl difluoro- 179 - 200814928 Mercapto-1H-pyrazole-4-carboxamide, (6-24) Ν-[2-(Γ-methylbicyclopropyl-2-yl)phenyl]indolyl·3·3 Fluoromethyl -4-meramine, (6-25) Ν-[2-(Γ-methylbicyclopropyl-2-yl)phenyl]-1-methyl-3-difluoromethyl- 1Η-pyrazole carbaryl amide, (6-26) Ν-[1·(5-bromo-3-chloropyridine 5 -2-yl)ethyl]-2,4-dichloronicotinium amide, ( 6-27) Ν-(5-bromochloroacridin-2-yl)methyl-2,4-di-nicotinamide (7-1) Yan Mannapu (mancozeb), (7-2) Manganese (maneb), (7-3) free of _ (metiram), (7-4) methyl zinc ispo (propineb) (7-5) thiram ' (7-6) 乃奈浦 (zineb), (7-7) ziram, 10 (8-1) benalaxyl'8 -2) Fura (furalaxyl), (8·3) Ganda (11^&1&\>4), (8-4) Gendari-]\4, (8-5) Dale-]\4, (9-1) cyprodinil, (9-2) mepanipyrim, (9-3) pyrimethanil, (10-1) 6-Gapent-5-[(3,5-dimethylisoxan-4-yl) sulphate]-2,2-difluorois -5H-[1,3] dioxin and [4,5 -f>benzimidazole, (10-2) free (benomyl), (10-3) carbendazim, (10-4) chlorfenazole, ( 10-5) Fuberidazole, (10-6) thiabendazole, (11-1) dithiofene (diethofencarb), (11-2) propamocarb, (11·3) HCl Propamocarb-hydrochloride, (11-4) propamocarb-fosetyl, (12-1) tetrahydropalm (captafol), (12 -2) Captan, (12-3) Folpet, (12-4) iprodione, (12_5) procymidone, (12-6) Ning (vinclozolin), (13-1) dodine, (13-2) gram heat net-180 - 200814928 (guazatine) '(13-3) bisinoctyl triacetate (iminoctadine triacetate) '( 13-4) gram heat net (burning phenoflavin) [iminoctadine tris (albesilate)], (13·5) linine (dodine (free base)), (13-6) gram heat (immoctadine) ( Free base), (14·1) cyazofamid, (14-2) prochloraz, (14-3) triazoxide, (14_4) rice mark g (pefurazoate) , (15,1) adimorph, (15-2) tridemorph, (15-3) dodemorph, (15-4) fenpropimorph _ (fenpropimorph ) '(15-5) dimethomorph, (16,1) ίο fenpiclonil, (16-2) fludioxonil, (16-3) 吼洛尼精(pyrrolnitrin), (17-1) foss-aluminum (fosetyl-Al), (17-2) phosphonic acid, (17-3) fluorenylphosphorus (tolclophos-m Ethyl),(18-1) 2-(2,3-dihydro-1H-indol-5-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-( Methoxyimino) is acetamide, (18-2) Ν-[2-(3,4-dimethoxyphenyl)ethyl]-2-(decyloxyimido)-2 -(5,6,7,8-tetrazole-n-2-yl)ethinamide, (18-3)2-(4· ® gas phenyl)-Ν·[2-(3,4-di曱oxyphenyl)ethyl]-2-(methoxyimino)-acetamide, (18-4) 2-(4-bromophenyl)-:^[2-(3,4- Dimethoxyphenyl)ethyl]-2-(methoxyimino)-acetamide, (18-5) 2-(4-methylphenyl 2 fluorenyl)-N-[2-( 3,4-Dimethoxyphenyl)ethyl]-2-(decyloxyimino)-acetamide, (18-6) 2-(4·ethylphenyl)-indole-[2 -(3,4·didecyloxy)ethyl]-2-(decyloxyimido)-acetamide, (19-1) benzothiazolidine (acibenzolar-S-methyl) , (19-2) chlorothalonil, (19-3) cymoxanil, (19-4) edifenphos, (19-5) 凡-181- 200814928 杀同 (famoxadone ), (19_6) voltazinam, (19·7) copper oxychloride, (19-9) oxadixyl, (19-10) spirocycline (spirox Amine), (19-11) dithianon, (19_12) metrafenone, 5 (19-13) fenamidone, (19-14) 2,3- Dibutyl-6-oxythieno[2,3-d]pyrimidin-4(3H)-one, (19-15) probenazole, (19-16) isofoliioliane, (19 -17), kasugamycin, (19-18) phthalide, (19-19) ferimzone, (19-20) three races ίο (tricyclazole) '(19-21) Ν-({4-[(cyclopropylamino)carbonyl)phenyl}sulfonyl)-2-decyloxybenzamine, (19-22) 2-(4- Chlorophenyl)-N- {2-[3-decyloxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl 2-(prop-2-yn-1-yloxy) Ethylamine, (19-23) quinoxyfen '(20-1) pencycuron, (20-2) methyl is-thiophanate-methyl, (20-3) Ethyl-polyphanate-ethyl, (21-1) fenoxanil, (21-2) ® diclocymet, (22-1) 5-chloro-ΛΗΓ7Θ· 2,2,2-trifluoro-1-methylethyl>6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[l,5-a]pyrimidine- 7-amine (22-2) 5-Chloro-D-dimethylpropan-2-yl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[l,5-a] Pyrimidine-7-amine, (22-3) 5-chloro-6-(2-chloro-6.fluorophenyl)-7-(4-mercaptohexanitrogen-pyridin-1-yl)[1, 2,4]triazolo[l,5-a]-pyrimidine, (22-4) 5-chloro-6-(2,4,6-trifluorophenyl)-7-(4-methylhexahydro Acridine small group) [1,2,4]triazolo[l,5-a]pyrimidine '(23-1) 2-butoxy-6-moth-3-propylbenzo-1 -4--4-S, (23-2) -182- 200814928 Ethoxy-6-iodo-3-propylbenzopyran-4-one, (23_3) 6-iodo-2-propoxy- 3-propylbenzopyran-4-one, (23-4) 2-but-2-ynyloxy-6-iodo-3-propylbenzopyrone, (23-5) 6-iodine -2-(1-methylbutoxy)-3-propylbenzopyran-4-one, (23-6) 2·but-3-enyloxy-6-iodobenzopyranone ,(23-7) 3-butyl-6-iodo-2-isopropoxybenzopyrone, (24_1)% (3',4'-dichloro_5-fluoro-1,1,- Biphenyl group; each) (difluoromethyl) small methyl-lif-11 than saliva-4-carboxylic acid amine, (24-2) #-(4,-bromo-1, fluorene-biphenyl- 2-yl)-4-(difluoromethyl)-2-methyl-1,3-indolyl-5-sulfanylamine, (24-3) 4-(difluorofluorenyl) Winter methyl-[4,-(trifluoromethyl)-1, fluorenyl-biphenyl-2-yl]-1,3-aluminum-5-carboxamide, (24-4) dichloride Phenylmethylene)-5-fluoro-1,3-dimethyl-lif"pyrazole Icarboxamide, (24-5) ΛΚ4,-chloro-3,-fluoro-1,1,-biphenyl -2-yl)-2-mercapto-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide, (24_6) (4,-chloro•l,lf-biphenyl- 2-yl)-4-(difluoromethyl)-2-methyl-1,3-σ stopper -5-hydrazide, (25-1) #-[2-(1,3-dimethyl Butyl)phenyl]-1,3-dimethyl-1//-pyrazole-4-carboxamide, (25-2) 7V-{2-(l,3-didecylbutyl) Phenyl}-5-fluoro-1,3-dimethyl-1/f-pyrazole-4-carboxamide, (25-3) 1[2-(1,3-didecylbutyl)benzene 5-[Chloro-1,3-dimethylbizozol-4-reactive amine '(25-4)3-(difluoromethyl)-7V~[2-(l,3-dimethyl Butyl) phenyl]-1_methyl-1-leprazole-4-carboxamide, (25-5) 3-(trifluoromethyl)-indole 42-(1,3-dimethylbutyl) Phenyl]-5-fluoro-1-methylpyrazole-4-carboxamide, (25-6)3-(trifluoromethyl)-indole 42-(1,3-dimethylbutyl)phenyl ]-5-chloro-1-methyl-1 ugidazole carbamide, (25-7) 1,3-dimethyl-Λ42-(1,3,3-three Phenyl]-1 仏 比 比 -4- -4- 醯 醯 醯 ,, (25-8) -183- 200814928 5-fluoro-1,3-indolyl-iV-[2 (1,3,3- Trimethyl butyl)phenyl]-1 π pi-salt-4-carboxamide, (25-9) 3-(difluoromethyl)small methyl- Λ42·(1,3,3-trimethyl Butyl)phenyl]-17^bazole-4-carboxamide, (25-10) 3-(trifluorof-decyl-methyl 1-[2-(1,3,3-trimethyl) Butyl)phenyl]-1//-, azole _4_ 5 carboxamide, (25-11) 3-(trifluoromethyl) fluoro-1-methyl j-[2-(l,3 , 3, tridecyl butyl) phenyl] oxazole-4-carboxy decylamine, (25-12) 3-(trifluoromethyl)-5 qi-1-methyl good [2-(1, 3,3-trimethylbutyl)phenyl>1//, pyrazole-4-carboxamide, (25-13) 7V-[2-(l,3-(didecylbutyl)) Stupid)-2-iodobenzamine, (25-14) 2-硖-Λ/42-(1,3,3-trimethylbutanyl)phenyl]benzamide, (25- 15) Ν-{2-(1,3-dimethylbutyl) phenyl}-2-(trifluoromethyl)benzamide, (25-16) 2-(trifluoromethyl)-indole 42 -(1,3,3-tridecylbutyl)phenyl]benzamide. 5. The active compound composition according to claim 2, wherein the active compound of the (26) class is selected from the group consisting of: 15 (26-1) 5-fluoro-1,3-dimethyl-anthracene Butyl)phenyl]pyrazole-4-carboxamide, (26·2) 3-(difluoromethyl)-indole 42-(3,3-dimethylbutanyl)·4-fluorophenyl ]-1-methyl-ΐπ. Biazole-4-carboxyguanamine, (26-3) 3-(difluoroindolyl)-indole 42-(3,3-dimethylbutyl)phenyl]-1-methylpyrazole-4-carboxylate Indoleamine, (26-4) 豕[2-(3> Dimercaptobutyl)phenyl]-2-(trifluoro-2-indenyl)benzamide, (26-5) iV-[2- (3,3-Dimethylbutyl)-4-fluorophenyl]-2-methyl-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide, (26-6) iV-[2-(3,3-Dimercaptobutyl)-3-indolyl porphin-2-propanolamine. The active compound composition according to any one of claims 1 to 5, wherein the biphenylcarboxamide of the formula (XVI) is different from the carboxamide of the formula (I)-184-200814928. Compound. The active compound of the invention in the scope of claims i to 6 includes a carboxamide of the formula (1) wherein the R2 group is located at the 2,-position of the distal phenyl ring of the group. One is based on the scope of the patent application! Use of the activated mouth composition of any of the seven items for controlling unwanted phytopathogenic fungi. 10 10- 11 12· 15 13. 20 14· 一種根射請專利範圍第】i 7項中任—項的活性化 合物組合物用於處理種子之用途。 一種根據申請專利範圍第1 1 7項中任—項的活性化 合物組合物用於處理轉殖基因植物之用途。 請專利_第m項中任—項的活性化 合物組合物用於處理轉殖基因植物的種子之用途。 一種以根據申料㈣㈣丨至7項中任—項的活性 化合物組合物處理過的種子。 :種用於防治不想要的植物病原性真菌的方法,特徵 為,將根據申請專利範圍第1至7項中任-項的活性 ==:不想要的病原性真菌及,或其生 撼Hi製備殺真8的_物的方法’特徵為,將根 ,申5月專利範圍第1至7項令任一項的活性化合物组 ό物與展延劑及/或界面活性劑混人。 、 子以對抗不想要的植物病原性真菌的 彳特徵為,將根據申請專利範圍第1至7項中任 -185- 15. 200814928 一項的活性化合物組合物施加於種子。 4 200814928 七、指定代表圖: (一) 本案指定代表圖為:第(無)圖。 (二) 本代表圖之元件符號簡單說明: 益10 10- 11 12· 15 13. 20 14· The use of the active compound composition of any of the items in item 7 of the above-mentioned item 7 for the treatment of seeds. A use of an active compound composition according to any one of the claims of claim 1 17 for the treatment of a transgenic plant. The use of the active compound composition of any of the patents, item m, for the treatment of seeds of a transgenic plant. A seed treated with an active compound composition according to item (4) (4) to item 7. : A method for controlling unwanted phytopathogenic fungi, characterized by activity according to any one of items 1 to 7 of the patent application scope ==: unwanted pathogenic fungi and or oysters thereof The method for preparing the smear of the smear 8 is characterized in that the root of the active compound group of any one of the first to seventh aspects of the patent of the invention is mixed with a stretching agent and/or a surfactant. The active compound composition according to any one of the claims 185- 15.200814928 is applied to the seed in the form of an active compound against any of the phytopathogenic fungi which is not desired. 4 200814928 VII. Designation of representative representatives: (1) The representative representative of the case is: (No). (2) A brief description of the symbol of the representative figure: 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式:8. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: (I)(I)
TW96110022A 2006-03-24 2007-03-23 Fungicidal active compound combinations TW200814928A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200610013784 DE102006013784A1 (en) 2006-03-24 2006-03-24 Fungicidal active combination used to combat phytopathogenic fungus, comprises carboxamide compound and e.g. strobilurin- or triazole- compound
DE200610014723 DE102006014723A1 (en) 2006-03-30 2006-03-30 Fungicide combinations useful for plant and material protection comprise a pyrazole carboxamide and at least one fungicide selected from 24 groups of compounds

Publications (1)

Publication Number Publication Date
TW200814928A true TW200814928A (en) 2008-04-01

Family

ID=38442052

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96110022A TW200814928A (en) 2006-03-24 2007-03-23 Fungicidal active compound combinations

Country Status (5)

Country Link
EP (1) EP2001299A2 (en)
AR (1) AR060066A1 (en)
CL (1) CL2007000765A1 (en)
TW (1) TW200814928A (en)
WO (1) WO2007110173A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4410099A3 (en) * 2008-02-05 2024-10-09 Basf Se Plant health composition
EP2512244B1 (en) 2009-12-16 2014-06-25 Bayer CropScience AG Active compound combinations comprising proquinazid, bixafen and optionally prothioconazole
EP2443928A1 (en) 2010-10-25 2012-04-25 LANXESS Deutschland GmbH Fungicide penflufen mixtures
WO2012055674A1 (en) 2010-10-25 2012-05-03 Lanxess Deutschland Gmbh Fungicidal penflufen mixtures
EP2443927A1 (en) 2010-10-25 2012-04-25 LANXESS Deutschland GmbH Penflufen as agent for protecting woods against wood-destroying basidiomycetes
PL2632266T3 (en) 2010-10-25 2017-07-31 Lanxess Deutschland Gmbh Penflufen as a wood preservative against xylophagous basidiomycetes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10347090A1 (en) * 2003-10-10 2005-05-04 Bayer Cropscience Ag Synergistic fungicidal drug combinations
US20080108686A1 (en) * 2004-06-18 2008-05-08 Basf Aktiengesellschaft N-(Ortho-Phenyl)-1-Methyl-3-Difluoromethylpyrazole-4-Carboxanilides And Their Use As Fungicides
ATE458722T1 (en) * 2004-06-18 2010-03-15 Basf Se 1-METHYL-3-TRIFLUORMETHYL-PYRAZOLE-4-CARBONIC ACID (ORTHO-PHENYL) ANILIDES AND THEIR USE AS A FUNGICIDE
PE20070409A1 (en) * 2005-06-29 2007-05-07 Basf Ag FUNGICIDE MIXTURES BASED ON PYRAZOLCARBOXYL ACID BIPHENYLAMIDES DISUSTITUTED IN 2.4
WO2007003540A1 (en) * 2005-06-30 2007-01-11 Basf Aktiengesellschaft Fungicidal mixtures based on 2,5-disubstituted pyrazol carboxylic acid biphenylamides
WO2007003564A1 (en) * 2005-07-01 2007-01-11 Basf Aktiengesellschaft Fungicide mixtures based on 3,5-disubstituted pyrazol-carboxylic acid biphenylamides
WO2007003603A2 (en) * 2005-07-05 2007-01-11 Basf Aktiengesellschaft Fungicide mixtures based on 3-monosubstituted pyrazole carboxylic acid biphenyl amides
WO2007003643A1 (en) * 2005-07-06 2007-01-11 Basf Aktiengesellschaft Fungicidal mixtures based on 3,4-disubstituted pyrazolecarboxylic acid biphenylamides
JP2009500375A (en) * 2005-07-06 2009-01-08 ビーエーエスエフ ソシエタス・ヨーロピア Disinfectant mixture prepared from 1-methylpyrazol-4-ylcarboxyanilides
BRPI0613007A2 (en) * 2005-07-14 2016-11-29 Basf Ag fungicidal mixtures to combat phytopathogenic harmful fungi, agent, process to combat phytopathogenic harmful fungi, seed, and, use of compounds
AU2007224576A1 (en) * 2006-03-14 2007-09-20 Basf Se Method of inducing tolerance of plants against bacterioses

Also Published As

Publication number Publication date
AR060066A1 (en) 2008-05-21
EP2001299A2 (en) 2008-12-17
WO2007110173A2 (en) 2007-10-04
WO2007110173A3 (en) 2009-03-19
CL2007000765A1 (en) 2008-02-01

Similar Documents

Publication Publication Date Title
KR102037333B1 (en) Fungicidal pyrazoles and their mixtures
JP5101491B2 (en) Bactericidal active substance combination showing synergistic action
CN105492432B (en) Tetrazolinone compounds and their uses
JP5816871B2 (en) Plant disease control agent and control method containing D-tagatose as active ingredient
JP5101496B2 (en) Active substance combinations
KR102185569B1 (en) Binary fungicidal and bactericidal combinations
US9888688B2 (en) Tetrazolinone compounds and applications thereof
CN105408322B (en) Tetrazolinone compounds and their uses
JP2018070635A (en) Fungicidal composition
TW200810691A (en) Synergistic active compound combinations
KR101302266B1 (en) Fungicidal mixtures of thiophene derivative
TW200528023A (en) Synergistic fungicidal active compound combinations
BR122020019349B1 (en) composition, its preparation process, method for controlling one or more harmful microorganisms, seed resistant to harmful microorganisms and its method of treatment
BR112016002063B1 (en) tetrazolinone compound, its use, agent and method of pest control
CN107108661A (en) Kill the benzoxaborole heterocyclic pentene of microorganism
KR20200041892A (en) How to control rice pests from rice
TW200814928A (en) Fungicidal active compound combinations
MX2008014416A (en) Synergistic active ingredient combinations.
BR112016008406B1 (en) tetrazolinone compound and its application
JP5000636B2 (en) Synergistic fungicidal active substance combinations
TW200812484A (en) Fungicidal active compound combinations
KR20090096430A (en) Fungicidal mixtures
CN106132952B (en) Tetrazolinone compounds and their applications
CN109843065A (en) Active agent combinations comprising the 5- imdazole derivatives replaced
CN105557702B (en) A kind of active ingredient compositions